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Abstract 
Dietary nitrate is a natural component of vegetables that can have profound effects 
on physiological functions in the body. One vegetable in particular, beetroot (Beta 
Vulgaris), has received attention in the last decade as a source of nitrate and more 
importantly, nitric oxide (NO). NO is a potent vasodilator that is produced 
endogenously from L-arginine but can also be produced from the sequential 
reduction of dietary nitrate to nitrite in the oral cavity and further to NO in the acidic 
environment of the stomach. The production of NO is essential in maintaining a 
healthy vascular system and low availability of NO is implicated in vascular 
dysfunction and thus the onset of cardiovascular and cerebrovascular diseases. Low 
endogenous NO production is closely associated with the ageing process and could 
contribute to the increase in high blood pressure and impairment of endothelial and 
cognitive function seen in older adults. Moreover, it is postulated that age attenuates 
the production of NO from exogenous nitrate, further contributing to the symptoms of 
low NO availability. Thus, ways to increase NO availability in an ageing population 
are imperative. 
 
Although highly concentrated beetroot juice has been used as an effective vehicle of 
dietary nitrate in several studies, there is a significant gap in the research regarding 
longer-term intervention, for which whole beetroot may be more applicable. 
Processed forms of beetroot are more costly, contain more sugar and lack the dietary 
fibre present in the whole vegetable. Fibre, alongside the range of phenolic 
compounds, antioxidants and vitamins present in beetroot, may have further health 
benefits. Therefore, the overarching aim of this thesis was to investigate the effects 
of whole beetroot consumption in both acute and prolonged studies, particularly in an 
older population. A number of noteworthy findings emerged from the studies 
conducted during this research. Firstly, although whole beetroot, providing between 
272mg and 816mg nitrate, was found to effectively raise plasma nitrate and nitrite 
levels in older participants, this did not translate to beneficial physiological outcomes 
such as blood pressure reduction and improved blood flow, which were evident in a 
younger population. Larger nitrate doses (1000mg) in the form of potassium nitrate 
did, however, lower blood pressure in an older population, reducing the disparity 
between the age groups. Secondly, more prolonged and consistent consumption of 
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whole beetroot over an eight-week period was found to reduce blood pressure in an 
older population and led to improvements in gut bacterial diversity, short-chain fatty 
acid (SCFA) production, cognitive reaction time and memory retrieval speed. This 
suggests additive effects of dietary nitrate beyond those seen in an acute setting and 
highlights the benefits of the whole vegetable as a supplement to the diet. In 
summary, whole beetroot was found to be an acceptable dietary source of nitrate and 
one that had acute physiological benefits in a young population. Ageing, however, 
reduced the activity of dietary nitrate in this acute setting. Despite this, the prolonged 
consumption of whole beetroot has the potential to lower blood pressure, improve 
cognitive function and potentially impact on gut health in an ageing population.  
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Chapter 1. Introduction 
The aim of this introduction and literature review is to explore and critically discuss 
the research into two important questions that relate beetroot to healthy ageing. 
Firstly, is whole beetroot an effective means to elicit the beneficial effects of dietary 
nitrate? Secondly, does ageing stand in the way of these effects? The review will 
begin with the negative consequences of ageing and highlight the main causes of 
these detriments, specifically the production, or lack of, nitric oxide (NO). It will 
describe the processes of NO production, how these are influenced by age and ways 
in which NO production can be manipulated. This will be followed by a review of the 
research on beetroot and the physiological responses to its consumption. This is with 
a view to highlighting the potential benefit of utilising beetroot in its whole and 
unprocessed form in a population most at risk of the consequences of a low 
availability of NO. 
1.1 Ageing 
The UK ageing population is growing, from 10.3 million adults over the age of 65 
years in 2013 to 11.8 million in 2016, which equates to around 18% of the total 
population (Howdon & Rice, 2018; ONS, 2017; Rutherford, 2012). This proportion is 
expected to rise to 25% in 2050 due to increased longevity and the knock-on effect of 
the current age structure of the population, as illustrated in Figure 1.1. 
  
 
Figure 1.1: Office of National Statistics (ONS) report on principal projections for 
the population of the UK.  
Population age restructuring towards an older population is associated with an 
increased demand in medical services and thus greater healthcare costs. Ironically, it 
is these healthcare services, specifically the improvements in recent decades that 
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have been a driving force in the increased longevity in the present day and allow 
adults to remain healthier and more independent into old age. The term “successful 
ageing” is described as remaining free of major chronic disease and maintaining 
normal physical and cognitive functioning (Newman et al., 2003). Those who age 
successfully have low numbers of risk factors for prevalent chronic diseases, 
particularly for cardiovascular disease (CVD) (Newman et al., 2003). Therefore, 
successful ageing can significantly reduce the medical services cost associated with 
the current UK population. 
1.2 Theories of ageing 
Ageing is characterised by the progressive deterioration in physiological function of 
organ systems and weakening of cell structure and function (Scott-Warren & 
Maguire, 2017). Two theories of ageing exist: 1) the programmed biological timetable 
of deterioration and 2) accrued cellular or molecular damage as a result of a build-up 
of noxious by-products of metabolism or environmental assaults (Scott-Warren & 
Maguire, 2017). One sub-category of the programmed theory is the immunological 
theory, which suggests that programmed decline of the immune system leads to an 
increased susceptibility to infection and thus ageing (Jin, 2010). This dysregulation of 
the immune system has been linked to CVD, Alzheimer’s disease (AD), inflammation, 
and cancer (Jin, 2010). Theories of ageing interconnect and have not yet been 
brought to a consensus. Understanding more about the ageing process and the 
factors that influence it may help promote healthy ageing, thereby reducing the 
burden of an ageing population on the healthcare system. 
1.3 Features of ageing and age-related disease  
Ageing affects the mechanical and contractile efficiency of the cardiovascular 
system. This presents itself through thickening of the arterial walls and increases in 
smooth muscle tone, inflammatory markers and total peripheral resistance. 
Additionally, there are reductions in arterial dilation, endothelial NO release and 
superoxide dismutase (SOD) activity (Egashira et al., 1993; Ferrari et al., 2003). 
Consequently, systolic arterial pressure and systemic vascular resistance are 
elevated (Navaratnarajah & Jackson, 2017). The same detrimental effects of ageing 
present themselves in vessels in the brain, contributing to neurovascular dysfunction 
and the onset of cerebrovascular disease. The risk of gastrointestinal (GI) and 
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oesophageal disorders is heightened with ageing, due to physiological changes in 
the stomach and oesophagus (Salles, 2007). Alongside this, alterations to the 
microbiome, both in the oral cavity and the gut, lead to changes in the breakdown 
and utilisation of nutrients from food and make the body more susceptible to 
pathogenic bacteria (Woodmansey, 2007). These features of ageing combined or in 
isolation increase the risk of multiple diseases such as CVD and cancer of the bowel, 
making older adults an important population in preventative nutritional intervention 
studies. Some common targets of diet and nutrition research will now be discussed in 
more detail. 
1.3.1 Vascular dysfunction 
Vascular endothelial cells line every capillary to artery in the circulatory system where 
they play a vital role in vascular biology (Rajendran et al., 2013). These cells are 
paramount in regulating blood flow, blood vessel tone, haemostasis, and neutrophil 
recruitment. Vascular endothelial dysfunction is a hallmark of disease, with 
endothelial cells being directly implicated in stroke, heart disease, diabetes, insulin 
resistance, and tumour growth, amongst others (Rajendran et al., 2013). Dysfunction 
in the vascular system develops with age and causes changes such as 
vasoconstriction, inflammation and pro-coagulation (Raubenheimer et al., 2017; 
Sepúlveda et al., 2015). Vascular dysfunction therefore negatively affects blood flow 
and has been implicated in the pathogenesis of AD (Dede et al., 2007). 
 
One key feature of vascular endothelial dysfunction is the reduced production of NO 
by endothelial NO synthase (eNOS) (Kunz, 2000). The release of NO from vascular 
endothelial cells maintains a background vasodilatory tone and this NO is continually 
synthesised by eNOS from the precursor L-arginine (Lyons et al., 1997; Palmer et al., 
1988). eNOS converts L-arginine to citrulline and then NO, which, when released, 
disperses to the underlying smooth muscle (Sessa, 2004). Here it stimulates the 
production of cyclic guanosine monophosphate (cGMP), which results in relaxation of 
the vessel wall via changes in intracellular calcium concentration (Sessa, 2004). 
Disruption of the vasodilatory action in the vascular system by NO can lead to 
hypertension and atherosclerosis. NO production, from L-arginine and a more 
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recently discovered pathway involving dietary nitrate, will be discussed in more detail 
in Chapter 1.5, as dietary intervention may enable an increase in NO production. 
 
Animal studies initially linked a reduction in NO-dependent vasodilation to ageing but 
Lyons et al. (1997) also demonstrated that NO-mediated vasodilation in the forearm 
vascular bed of humans is reduced in old age. The overall availability of L-arginine 
and the NOS cofactor tetrahydrobiopterin is lower in older adults (Delp et al., 2008), 
which could explain the reduction in NO production from the process outlined 
previously. Reactive oxygen species (ROS) can inactivate NO (Schulz et al., 2004), 
implicating oxidative stress in vascular dysfunction. 
1.3.2 Oxidative stress 
Harman (1956) first proposed that damage by ROS, or free radicals, might be a key 
player in the mechanism of ageing. This theory of free radical damage may explain 
some of the structural changes that occur with ageing, such as DNA damage, decline 
in mitochondrial function, and lipid peroxidation of membranes (Bar-Shai et al., 
2008). ROS are generally unstable molecules that induce the non-enzymatic 
oxidation of proteins, carbohydrates, lipids and nucleic acids (Canizzo et al., 2011), 
and in ageing the antioxidant balance shifts towards increased production of these 
molecules. The excessive production of ROS is evident in many conditions such as 
hypertension, hypercholesterolaemia and diabetes. Furthermore, vascular oxidative 
stress has been implicated in alterations to cerebrovascular regulation and an 
increase in ROS generation has been demonstrated in cerebral ischaemia (Girouard 
& Iadecola, 2006). Oxidative stress has therefore been associated with the 
progression of AD. 
 
Oxidative stress is caused by an imbalance in ROS and antioxidant systems, which 
allows free radicals to pass freely through plasma membranes and cause damage to 
the cells (Li et al., 2013). The main cellular defence against ROS damage is activity 
by catalase, SOD, and glutathione peroxidase (Gupta et al., 2001; Wang et al., 
2018), and levels of these free radical-scavenging enzymes are all reduced in ageing 
cells (de la Fuente et al., 2004). SOD, for example, catalyses the dismutation of the 
radical superoxide into oxygen or hydrogen peroxide, thus reducing the levels of 
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superoxide, which, when not regulated, can combine with NO to form a potent 
oxidant peroxynitrite (Pacher et al., 2007). The body also utilises antioxidants such 
as ascorbic acid, α-tocopherol and flavonoids (Li et al., 2013) to combat ROS. 
Dietary antioxidants can help to limit the damage of oxidative stress by acting directly 
on ROS or by stimulating the cells’ defence systems (Scalbert et al., 2005). The 
phenolics in polyphenols, for example, can accept an electron and thereby form 
stable phenoxyl radicals, disrupting oxidation reactions in cells (Scalbert et al., 2005). 
Flavonoids donate hydrogen atoms to radicals, terminating free radical chain 
reactions and stopping the oxidation of lipids and other molecules (Li et al., 2013). 
Ascorbic acid works either through its direct interaction with superoxide radicals or 
indirectly by recycling tocopherol (Som et al., 1983). 
  
The central nervous system (CNS) is particularly vulnerable to oxidative stress, 
especially during ageing (Joseph et al., 1998). This is due to a high content of 
polyunsaturated fatty acids that are easily oxidised, weaker antioxidative enzymes, 
and high oxygen consumption in the CNS (Garaschuk et al., 2018; Li et al., 2013 for 
review). Oxidative stress contributes to motor and cognitive behavioural deficits in the 
ageing brain (Shukitt-Hale, 1999), which may stem from a deficiency in glucose and 
oxygen consumption caused by the high levels of ROS (Mosconi, 2013). In a rodent 
study, supplementation with strawberry or spinach extract for eight months halted 
decrements in cognitive performance and neuronal function in senescent animals 
(Shukitt-Hale et al., 2015), demonstrating the potential potency of nutritional 
compounds when confronting oxidative stress. 
 
Oxidative stress can also contribute significantly to the structural remodelling in blood 
vessel walls that contribute to arterial stiffness (Patel et al., 2011), which is described 
in more detail in Chapter 1.4. Polyphenols can attenuate this remodelling and 
improve endothelial dysfunction before the onset of the formation of plaque (Pandey 
& Rizvi, 2009), something that is associated with several risk factors for 
atherosclerosis. Ultimately, the accumulation of oxidative stress is a highly 
detrimental yet inevitable consequence of ageing but the body has a powerful 
defence mechanism in the form of antioxidant compounds. Many of these can be 
supplied or at least enhanced by dietary intake, which may help the body challenge 
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oxidants and delay or diminish the detrimental effects of oxidative stress on a number 
of systems. Oxidative stress, when able to infiltrate, has been implicated in the 
maintenance of the low-grade inflammatory state associated with ageing. 
1.3.3 Inflammation 
Adaptive immunity declines with age in a phenomenon known as 
immunosenescence, making individuals more vulnerable to infection and delaying 
recovery following bouts (Canizzo et al., 2011). Conversely, innate immunity is more 
active in ageing, inducing a pro-inflammatory state known as “inflamm-ageing” 
(Franceschi et al., 2007).  
 
The chronic systemic inflammation associated with ageing has been attributed to 
heightened binding of nuclear factor κΒ (NFκΒ) to DNA in tissues and organs 
(Hinojosa et al., 2009). The NFκΒ signalling system is the regulator of innate 
immunity, organising cellular defence in response to pathogens or cellular danger 
signals (Salminen et al., 2008). The cytokines interleukin-1 (IL-1), interIeukin-6 (IL-6) 
and tumour necrosis factor-α (TNF-α) are key mediators in the innate inflammatory 
response. In older adults, higher levels of these pro-inflammatory cytokines are often 
observed in the circulation and in tissue resident macrophages (Salminen et al., 
2008) and elevated tissue expression of these pro-inflammatory cytokines indicates 
chronic low-grade inflammation. Heightened levels of these cytokines are also 
associated with motor dysfunction and disability in older adults, in addition to reduced 
cognitive performance (Ferrucci et al., 1999; Szelenyl, 2001). 
 
The innate immune response is associated with an oxidative burst, which up-
regulates the formation of ROS and the oxidative stress response. Consequently, 
cellular antioxidant capacity is reduced. This interplay between reduced antioxidant 
capacity and chronic inflammation with ageing increases the risk of a variety of 
diseases including CVD and may accelerate cognitive decline. 
1.3.4 Cognitive decline and dementia 
Increased longevity in society today brings with it challenges, especially from age-
related diseases such as CVD and dementia. Cognitive decline is one of the key 
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reasons why long-term care is required in old age (Celidoni et al., 2017), with 40% of 
admissions to care institutions in the UK being due to cognitive failure (Deary et al., 
2009). 
 
Age-associated cognitive decline is described as normal or non-pathological 
cognitive ageing and can affect mental domains such as memory, executive function 
and processing speed (Deary et al., 2009). There is a slower decline in cognitive 
function from the age of 50 to 70 years compared to the more pronounced and faster 
decline from the age of 70 years (Buckner, 2004). Brain ageing is accompanied by 
low-grade immune activation (Garaschuk et al., 2018), which is characterised by 
increased levels of the pro-inflammatory cytokines TNF-α and IL-6, for example. The 
term “inflamm-ageing” thus applies in the brain as well as other tissues. Cognitive 
decline is a feared aspect of growing old (Corner & Bond, 2004) and a public health 
goal is to help maintain or enhance cognitive health into older age (Deary et al., 
2009). Dementia is not inevitable and there is a clear distinction between normal 
cognitive ageing and mild cognitive impairment (MCI), the latter of which may convert 
to Alzheimer’s disease (AD).  
By the age of 80, there is estimated to be a 30% loss of brain mass, primarily in grey 
matter (Scahill et al., 2003). Due to a reduction in neural density, production of 
central neurotransmitters such as serotonin and catecholamines is reduced and there 
is a deficiency in dopamine uptake sites and transporters (Peters, 2006). 
Consequently, ‘fluid’ cognitive abilities such as working memory, speed of processing 
and executive functioning decline with age, and these may be viable targets for 
preventative interventions such as nutritional supplementation or dietary changes 
(Scholey, 2018). For example, brain atrophy has been related to high levels of 
circulating homocysteine, which can be reduced by compounds such as folic acid 
and betaine (McRae, 2013).  
Reduced blood flow to the brain has been implicated in cognitive impairment and 
decline, and this diminished cerebral perfusion has been found to precede and likely 
contribute to the onset of dementia (Ruitenberg et al., 2005). Normal blood flow to 
the brain is maintained around 50ml per 100g of brain tissue per minute (Cipolla, 
2009) and cognitive impairment is evident when cerebral blood flow drops to around 
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37ml per 100g per minute and below (Marshall et al., 2001). AD shows a stable, 
progressive decline in cerebral blood flow and cognition. Neurocognitive research 
points towards white matter hyperintensity (WMH), or leukoaraiosis, occurring with 
ageing and this appears to lead directly from chronic ischaemia (Holland et al., 
2008). The ageing process leads to abnormal arterioles, capillaries and venules, 
causing or contributing to a chronic ischaemic state in an ageing brain. Age-related 
white matter degeneration has been linked specifically to reduced executive 
functioning capacity, which is measured by tests such as task switching and working 
memory (O’Sullivan et al., 2001; Oosterman et al., 2008). Disrupted neurovascular 
coupling occurs when cerebrovascular blood flow is not matched to regional 
metabolic demand (Justice et al., 2015). This destabilises neurons, synapses and 
neurotransmission and has been linked to a reduction in NO bioavailability (Girouard 
& Iadecola, 2006).  
1.3.5 Hypertension 
When blood pressure levels are consistently high (equal to or above 140/90mmHg) 
an individual is classed as hypertensive (NICE, 2011). Hypertension is currently one 
of the leading causes of death and disability in the world, and age, obesity, sodium 
intake and physical inactivity are amongst the main risk factors for high blood 
pressure (Kannel, 1996). High blood pressure itself is a major risk factor for CVD 
(Yusuf et al., 2001) and stroke (Robinson et al., 1998). Gee and Ahluwalia (2016) 
describe blood pressure as a continuum, with increasing pressures leading to 
increased risk of CVD. Hypertension is more prevalent in the older population and 
there is a direct relationship between increasing age and higher blood pressure 
(Chobanian et al., 2003). According to the latest (2015) Health Survey for England 
statistics, the percentage of those with hypertension aged 55-64, 65-74 and 75+ 
years are 45.0%, 58.5% and 66.5%, respectively, clearly illustrating the increasing 
age and blood pressure relationship and the extent of the problem in the population. 
 
Anti-hypertensive medications, such as beta-blockers and diuretics, are prescribed in 
an attempt to lower blood pressure to normal levels. With every 20mmHg systolic 
and 10mmHg diastolic increase in blood pressure, mortality from both stroke and 
ischaemic heart disease doubles (Chobanian et al., 2003). A reduction in diastolic 
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blood pressure (DBP) by 5mmHg is said to reduce the risk of stroke by one third and 
coronary heart disease (CHD) by one fifth (Collins et al., 1990) and every 10mmHg 
reduction in systolic blood pressure (SBP) significantly reduces the risk of major CVD 
events with a 13% reduction in all-cause mortality (Ettehad et al., 2016).  
 
There are a number of causes of high blood pressure but in relation to ageing it can 
be caused by structural changes to the cardiovascular system such as stiffening and 
plaque formation. The role of NO in the structural integrity of the vascular system 
again puts NO production central to this age-related problem. 
1.3.6 Digestion and microbiotal changes 
A preponderance in medication use into old age can cause hyposalivation (dry 
mouth) and changes to the gut microenvironment with antibiotics, each leading to an 
increased risk of pathogenic bacterial growth (Tiihonen et al., 2010). Modification of 
the oral microenvironment may influence non-enzymatic, or bacterial, conversion of 
nitrate into nitrite (Percival et al., 1991); this nitrate conversion process is key in NO 
production and is described in more detail in Chapter 1.5. Reduced secretion of 
hydrochloric acid, known as hypochlorhydia (Britton & McLaughlin, 2013) and pepsin 
in the stomach are also associated with ageing, leading to a rise in gastric pH. 
Furthermore, the ageing process is associated with alterations in colonic functioning, 
such as increases in the colonic transit time due to a decline in the peristaltic activity 
in the colon. This is postulated to be due to a reduction in expression of neural 
transmitters, such as NO or acetylcholine (Salles, 2007). 
 
In addition to changes that occur as a result of medication use, the ageing process 
itself can modify the body’s microenvironment, affecting the gut microbiome as well 
as the population of oral bacteria. The gut microbiome plays a pivotal role in the 
absorption of nutrients, as well as maintaining a natural barrier to pathogens (Britton 
& McLaughlin, 2013). Age-related alterations in this barrier could lead to a systemic 
and luminal inflammatory response. Indeed, the elderly show an increased 
susceptibility to gut infections relative to younger adults (Ogra, 2010). Changes in the 
bacterial content of the gut have been linked with both inflammatory and metabolic 
disorders, including inflammatory bowel disease, diabetes, CVD and colorectal 
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cancer (Frank et al., 2007; Jeffery et al., 2012). Furthermore, it has been proposed 
that the gut microbiota can influence brain chemistry and function, affecting motor 
control (Heijtz et al., 2011).  
 
Colonic bacteria are predominantly anaerobes with wide-ranging metabolic activities. 
Many of these anaerobes can ferment dietary carbohydrates to form short chain fatty 
acids (SCFAs), for example acetate, propionate and butyrate, which all have a role in 
gut health (Duncan & Flint, 2013). There are a number of dominant bacterial species 
in a healthy colon, including Faecalibacterium prausnitzii, which possesses anti-
inflammatory activities (Duncan & Flint, 2013). The dominant phyla of the gut 
microenvironment include Firmicutes, Bacteroidetes and Actinobacteria, as well as 
Proteobacteria and Verrucomicrobia in lower numbers (Duncan et al., 2008; Karlsson 
et al., 2013). A decline in bacterial diversity occurs with ageing and in the elderly 
there seems to be a reduction in Bifidobacteria and an increase in 
Enterobacteriaceae and certain Proteobacteria (O’Toole & Claesson, 2010). The 
balance shifts towards higher numbers of Bacteroidetes and lower numbers of 
Firmicutes in elderly compared to younger adults (Tiihonen et al., 2010). Additionally, 
butyrate levels tend to be lower in the elderly compared to younger adults due to a 
reduction in bacterial species that produce it (Biagi et al., 2010). It is clear that there 
are changes to the gut microbiota during ageing and disruption to the normal balance 
of bacteria can lead to both local and systemic inflammation (Saffrey, 2014).  
 
The gut microbiota clearly play a crucial role in the health and functioning of the 
digestive system specifically and have now also been linked to functioning of other 
systems in the body such as the gut-brain axis. The digestive and bacterial changes 
that occur with age are likely to have repercussions on a number of functions in the 
body, placing dietary aspects such as fibre, prebiotics and antioxidant nutrients in a 
prominent and influential position. Both short- and long-term dietary changes have 
been found to have an impact on the gut microenvironment (Thomas et al., 2011), as 
the microbial community adapts to release the most energy from the available 
substrates. The diet of an ageing population may therefore be of particular 
importance not only to the microbiome but also to the overall health status of the 
population. 
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1.3.7 Changes in physiological function 
The capacity of skeletal muscle to maintain an efficient regenerative pathway is 
compromised in ageing (Carosio et al., 2011). Muscle tissue diminishes, causing a 
reduction in mass and strength; this condition is known as sarcopenia (Marcell, 
2003). Sarcopenia contributes to a reduction in functional capacity in older adults, 
contributing to frailty and a loss of independence. Cognitive decline also contributes 
to this reduction in capacity.  
 
Maintaining independent functioning is key in healthy ageing. A high quality of life is 
dependent on being able to perform activities of daily living (ADL) into old age and 
these functions are also related to hospitalisation, surgical outcome and mortality 
(Gault & Willems, 2013; Penninx et al., 2000). The inability to perform daily tasks is 
linked to weaker muscles and a reduced capacity to generate force (Close et al., 
2005). The cytokines IL-6, TNF-α and C-reactive protein (CRP) have been implicated 
in this weakness, resulting in poor physical performance in older adults (Legrand et 
al., 2013).  
 
Changes in vascular function, blood pressure levels and gut microbial diversity, 
amongst the other features of ageing mentioned, may be subject to intervention 
studies aimed at slowing the rate of decline into older age. It is therefore important to 
assess the functioning of these systems to better understand how the ageing process 
may attenuate their capacity.  
1.4 Assessment of vascular function, functional capacity and cognition 
In monitoring the integrity and functioning of the vascular system into older age, 
researchers are afforded the opportunity to carry out an assessment of the potential 
for beneficial interventions in this area. Both the macrovascular and microvascular 
system can be examined, allowing comprehension of the overall vascular system’s 
efficiency. At a whole-body level, functional capacity and cognitive functioning 
measures can reflect an individual’s ability to carry out basic daily tasks, thereby 
helping them to maintain independence into older age.  
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1.4.1 Macrovascular assessment 
The vascular endothelium helps to maintain blood flow and alterations to this can 
cause the build-up of plaque inside the blood vessels (atherosclerosis) or augment 
the vasodilatory response. Arterial distensibility, or its opposite arterial stiffness, is an 
indicator of endothelial function and thus atherosclerosis. Aortic pulse wave velocity 
(PWV), for example, has an inverse relationship with arterial distensibility and has 
been found to be a predictor of cardiovascular risk in patients with hypertension 
(Blacher et al., 1999). PWV is the assessment of the length of time in which pressure 
pulse waves travel from the carotid to the femoral arteries and measurement of this is 
considered the gold standard for assessment of arterial stiffness (Ecobici & 
Stoicescu, 2017). PWV assessment requires accurate measurement of the distance 
between the two arterial sites and the femoral artery can be an intimate 
measurement site, which can hinder reliable assessment. Nevertheless, PWV is the 
most reported marker of arterial stiffness in studies with older adults (Table 1.2). 
Ageing results in an increase in PWV and this has been found to be associated with 
CV mortality, stroke and CHD even in healthy older adults (Sutton-Tyrrell et al., 
2005). Augmentation index (AIx) is also inversely related to arterial distensibility and 
it increases with age. AIx is an indirect measure of arterial stiffness derived from 
central arterial pressure waves (Ecobici & Stoicescu, 2017). 
 
Brachial flow-mediated dilation (FMD) is another non-invasive measure of endothelial 
function and is considered the gold standard for measurement in this area (Raitakari 
& Celermajer, 2000). FMD is said to represent arterial functioning following NO 
release from the endothelium and thus act as a marker for vascular function 
(Thijssen et al., 2011). It is a non-invasive ultrasound measurement of blood flow 
following occlusion and is compared to the response following the administration of 
sublingual nitroglycerin, which is an endothelium-independent dilator. Although FMD 
benefits from being a non-invasive measurement, it is difficult to perform and requires 
extensive training and skill (Raitakari & Celermajer, 2000), making it a less 
appropriate tool in a research setting. There is impairment in brachial FMD with age, 
which may be due in part to a reduction in NO synthesis by NO synthase (Gates et 
al., 2007; Yeboah et al., 2007). Similar to PWV and AIx, FMD is a predictor of 
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cardiovascular events. For every 1% increase in FMD, the risk of experiencing a 
cardiovascular event is reduced by 13% (Inaba et al., 2010) 
1.4.2 Microvascular assessment 
The microcirculatory system is made up of the smallest blood vessels such as 
capillaries and arterioles. It is responsible for adjustments in vascular tone that match 
tissue perfusion with oxygen demand (Gutterman et al., 2016). The microvasculature 
has a crucial role in modulating vascular tone by the release of NO, other ROS, and 
arachidonic acid metabolites from the endothelium (Gutterman et al., 2016). 
Dysfunction in the microvasculature, similar to the macrovascular system, is a 
predictor of CV events (Lanza & Crea, 2010).  
 
Reactive hyperaemia (RH) is a phenomenon that occurs following arterial occlusion, 
in which there is a sudden rise in skin and muscle blood flow above resting levels. 
Blood flow is initially high but returns to the pre-occlusive level within a few minutes 
(Imms et al., 1988). Measurement and assessment of this non-invasive yet sensitive 
post-occlusive reactive hyperaemia (PORH) is used as an indicator of macro- and 
micro-vascular dysfunction (Yamamoto-Suganuma & Aso, 2009).  
 
Assessment of PORH may be a reflection of microvascular endothelial function, 
which is dependent on NO production in endothelial cells (Yamamoto-Suganuma & 
Aso, 2009). These same authors identify two phases of RH: 1) a peak response that 
occurs within a few seconds post-occlusion and 2) a prolonged total hyperaemia 
period that reflects the blood flow debt repayment. Results from a study by Tagawa 
et al. (1994) suggest that NO plays a small but significant role in maintaining 
vasodilation subsequent to the peak or maximal reactive hyperaemia response but a 
minimal role at the peak or early phase, as characterised by Yamamoto-Suganuma 
and Aso (2009). The maximal peak blood flow (MPF) and the time to MPF after 
ischaemia are generally used as indices of microvascular endothelial function 
(Yamamoto-Suganuma & Aso, 2009). 
 
PORH has been found to be associated with several risk factors for CVD, for 
example high blood pressure (Carberry et al., 1992). Carberry, Shepherd and 
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Johnson (1992) outline that the vasodilatory capacity of forearm skin is reduced in 
individuals with hypertension and that an increased resistance to blood flow is key in 
the maintenance of this high blood pressure. A more recent study identified a 
significant correlation between impairment of PORH and cardiovascular risk factors 
in a healthy female population (Vuilleumier et al., 2002).  
 
Measurement of PORH and other RH markers by laser Doppler is considered a 
valuable, non-invasive tool to monitor and assess the functioning of the 
microvascular system. PORH is therefore a sensitive marker of vascular function in 
both healthy (Vuilleumier et al., 2002) and diseased populations (Yamamoto-
Suganuma & Aso, 2009). A major advantage of using laser Doppler is its sensitivity 
at detecting changes in skin blood flow in response to given stimuli (Cracowski et al., 
2006). Cracowski et al. (2006) describe a number of ways to minimise the variability 
of laser Doppler measurement of microvascular function but this variability can be a 
significant limitation of microvascular assessment.  
1.4.3 Assessing functional capacity  
A well-used assessment tool into old age is the measurement of ADL performance 
and capacity. For example, the 6-minute walk test (6MWT) tests exercise tolerance, 
aerobic capacity and endurance, most often in participants with CVD or pulmonary 
disease (Steffen et al., 2002). Other tests include hand-grip strength, sit-to-stands 
and timed-up-and-go (TUG). TUG, for example, is a basic assessment of balance 
during a simple task that has good reliability within and between investigators 
(Steffen et al., 2002). Each of these tasks, as well as measures of agility, muscle 
strength, and lung capacity, may highlight the risk of falls or a lack of independent 
movement. These are important in tasks that require quick movement, such as 
getting off the bus in time and answering the phone and are highly relevant in an 
ageing population. More attention is rightly turning to outcomes relevant to daily 
living, as opposed to clinical values and measurements. For example, basic ADLs 
consist of feeding, bathing and using the toilet, whilst instrumental ADLs refer to 
shopping, cooking and housework (Kingston et al., 2012). These are essential 
measures of disability in older adults, particularly the very old (Kingston et al., 2012).  
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Lung function can also be used as a measure of functional capacity and tests such 
as spirometry are widely used to determine the presence of respiratory disease. 
Spirometry measures lung volume against time and is quick and easy to use (Ranu 
et al., 2011). It has been shown that compounds that inhibit the breakdown of cGMP, 
such as sildenafil, have positive effects on pulmonary vascular resistance (Beghetti 
et al., 2014). Sildenafil preserves levels of cGMP, which is a downstream target of 
NO, thus enhancing NO-mediated vasodilation in the pulmonary blood vessels 
(Chapman et al., 2009).   
 
The presence of NO in the lung specifically is measured by fractional exhaled nitric 
oxide (FeNO). NO production in the lung has been implicated in the pathophysiology 
of asthma and other lung diseases due to its key role in lung biology (Dweik et al., 
2011). These roles include, but are not limited to, vasodilation, neurotransmission, 
bronchodilation, and mediation of inflammatory responses (Nathan & Xie, 1994; 
Ricciardolo, 2004 for review). Guo et al. (2000) described the role of NO in asthma, 
suggesting higher concentrations in asthmatic individuals, as well as an increase in 
L-arginine, which is the precursor to NO production. Ricciardolo (2004) also 
describes abnormal concentrations of NO in activated states of inflammatory airway 
disease. As discussed previously, NOS catalyses the oxidation of L-arginine to 
generate NO and this occurs in various cell types in the respiratory tract, as with 
other parts of the body (Ricciardolo, 2004). Exhaled NO is derived primarily from the 
lower respiratory tract, in particular from the airways of the lung (Kharitonov et al., 
1996), and the correlation between it and some measures of airway inflammation 
implicate FeNO as a measure of NO production (Travers et al., 2007). Both 
spirometry and FeNO are straightforward and quick tests of lung function and the 
latter can be influenced by external stimuli such as dietary nitrate. 
1.4.4 Assessing cognitive function 
Age-associated cognitive decline or memory impairment (AAMI) describes benign 
and non-clinical cognitive deficits associated with ageing (Werner & Korczyn, 2008). 
MCI, however, involves cognitive decline to an extent beyond what is expected with 
age or educational background (Werner & Korczyn, 2008). This is most often 
diagnosed through the use of a Mini Mental State Exam (MMSE) or equivalent. 
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Cognitive function, on the other hand, can be assessed by a plethora of cognitive 
tasks, both computer- and paper-based. Collerton et al. (2007) described that 
computer- and paper-based tests were equally effective for assessing cognitive 
function in older adults but computerised tests were more acceptable to both 
participants and investigators. Computer-based batteries are frequently used in 
cognitive assessment and resources such as the Cambridge Neuropsychological 
Testing Automated Battery (CANTAB) and CogTrackTM allow the allocation of tests to 
key areas of interest, such as a healthy cohort or a population at risk of cognitive 
impairment. A number of computer-based assessment tools have been reviewed by 
Wild et al. (2008). Computerised batteries are more sensitive and precise and can be 
highly standardised (Luciana, 2003; Wild et al., 2008), and also reduce the time 
required of the investigator. Paper-based tasks, however, such as the Trail Making 
Task (TMT) are often utilised in research (LaRoche et al., 2014; Justice et al., 2015), 
which involves connecting numbered circles with a line or connecting numbered and 
lettered circles in sequence. Combinations of cognitive tasks can be used to inform 
functioning in certain domains or areas of the brain, for example in global cognition, 
executive functioning, attention, or psychomotor speed.  
 
The fact that both computer- and paper-based cognitive assessments are employed, 
spanning a large variety of tasks, makes it difficult for applicable conclusions to be 
drawn. Furthermore, confounders such as practice effects have been identified in 
serial cognitive assessment, which can affect clinical outcomes (Goldberg et al., 
2015). Using alternative forms or pre-baseline testing, however, are appropriate 
solutions to this problem (Goldberg et al., 2015).  
1.4.5 The role of NO in age-related diseases 
A common theme throughout the preceding sections is the reduction in NO 
production in the endothelial cells or availability with age, which can manifest itself in 
vascular dysfunction and dementia. Given the role of endothelial and vascular 
dysfunction in disease it is beneficial to research NO production and ways to 
maintain it into older age. NO plays such a large role in maintaining a healthy 
vasculature and this itself is associated with quality of life into older age (Miller et al., 
2012). There is a substantial body of research on the pathways involved in NO 
 17 
production and a brief summary will be presented here. There is then opportunity to 
explore ways to manipulate these pathways to ensure the maintenance of NO 
production with ageing. 
1.5 NO production 
It wasn’t until the discovery of NO as an endothelial-reducing factor that research into 
the effects of NO and consequently dietary nitrate began. Louis Ignarro, who won the 
Nobel Prize for demonstrating the properties of NO, elegantly described the 
signalling roles of NO in a review (Ignarro, 2002); the vasodilatory pathway was also 
described in brief in Chapter 1.3.1. NO has wide diffusibility in the body and is crucial 
for endothelial integrity, vascular smooth muscle cell proliferation and the regulation 
of vascular tone and blood pressure (Ignarro, 2002). 
 
The classical pathway for the generation of NO is via NO synthases, producing NO 
from the precursor amino acid, L-arginine. Until the 1990s, this was thought the only 
pathway for the production of NO and the breakdown products, nitrate and nitrite, 
were thought inert waste products (Moncada & Higgs, 1993). However, two research 
groups discovered that the pathway could in fact be reversed, with NO being 
produced from the breakdown of nitrate and nitrite in a stepwise manner (Benjamin et 
al., 1994; Lundberg et al., 1994). This process does not require NO synthases and 
has been found to be even more efficient at times of hypoxia in tissues. The non-
enzymatic system therefore acts as a back-up system to the enzymatic pathway 
during periods of low oxygen. It is the non-enzymatic production of NO from nitrate 
that will be focussed on here, as this system can be manipulated through dietary 
components. 
 
The conversion of inert nitrate to the bioactive NO spurred research into dietary 
nitrate and a study by Larsen et al. (2006) was the first to discover a positive effect, 
akin to that exerted by NO, on the cardiovascular system from dietary nitrate intake. 
The breakthrough by Larsen et al. in 2006 led to scientists studying dietary nitrate 
intake manipulation to induce positive effects on vascular function and blood 
pressure in the human body. 
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1.5.1 Nitrate and nitrite 
Inorganic nitrate has been long-used as a method of acutely lowering blood pressure, 
first used by the Chinese to treat coronary artery disease as far back as 700 AD 
(Butler & Feelisch, 2008). The bioconversion of nitrate to nitrite and further to NO and 
other secondary reaction products is thought to underlie any protective effects on the 
cardiovascular system (Lundberg et al., 2006). Nitrate itself serves as the primary 
plant form of the nutrient and must undergo metabolic activation to an active form i.e. 
nitrite (Bryan & Ivy, 2015). Nitrite, however, is an active secondary breakdown 
product of nitrate and although nitrite was long considered to be equally inert, more 
recent research established that nitrite forms a stable reservoir for the bioactive NO 
during hypoxia when the oxygen-dependent pathway involving NO synthases is 
limited (Shiva, 2013). 
 
Nitrate and nitrite have been used for centuries in cheese production and for the 
curing and preservation of meat and fish. The addition of nitrite in the curing of meats 
contributes to the flavour by inhibiting rancidity, forms an attractive pink colour 
through interaction with myoglobin and inhibits the growth of bacteria, specifically 
Clostridium botulinum (Bryan & Ivy, 2015). High nitrate levels accumulate in the 
leaves of green leafy vegetables and in roots such as beetroot. Vegetables contribute 
the largest proportion of dietary nitrate to the diet and will be discussed in more detail 
in Chapter 1.6. Common sources of nitrate and nitrite are shown in Table 1.1. A small 
amount of dietary nitrate comes from drinking water but the nitrate content does vary 
across regions. WHO recommendations limited the concentration of nitrate in 
drinking water to 50mg/L in Europe, due to historical cases of “blue baby syndrome” 
that were linked to contaminated well water high in nitrate. Blue baby syndrome is 
caused by methemoglobineamia, which is anaemia resulting from the oxidation of the 
ferrous iron in haemoglobin, forming methemoglobin (Manassaram et al., 2010). This 
acute toxicity and its link to nitrate and nitrite is being contested due to the high levels 
of bacteria present in the well water (Powlson et al., 2008). However, high nitrate and 
nitrite intake in infants and young children should be cautioned.  
 
Another concern with nitrate and nitrite intake is the potential formation of N-
nitrosamines, of which some are carcinogenic. A number of epidemiological studies 
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have tested the link between nitrate and stomach cancer but have found no 
conclusive link between the incidence and mortality of the cancer and nitrate intake 
(Powlson et al., 2008). Processing of nitrite in the acidic stomach produces nitrous 
acid (HNO2) and dinitrogen trioxide (N2O3), which produce N-nitrosamines when they 
react with dietary secondary amines (Schoental, 1963). There is equivocal research 
surrounding the roles, if any, of nitrite and N-nitrosamines in human cancer and a 
review of these is beyond the scope of this thesis. Studies in this area have been 
reviewed by a number of authors (Bryan & Ivy, 2015; Omar et al., 2012) and a finding 
relevant to this thesis has been highlighted: antioxidant compounds, such as those 
found in fruit and vegetables, inhibit nitrosation pathways that produce N-
nitrosamines (Bartsch et al., 1988; Tannenbaum et al., 1991). Furthermore, a diet 
rich in fruit and vegetables, some of which are known to be high in nitrate, has been 
found to be reduce the risk of some cancers (Benetou et al., 2008; González et al., 
2006).  
 
The accurate analysis of nitrate and nitrite in vegetables and biological tissues is 
undoubtedly important and a number of methods are available, differing in sensitivity. 
Nitrate and nitrite can be analysed using high-performance liquid chromatography 
(HPLC), gas chromatography-mass spectrometry (GC-MS), colorimetry, or 
chemiluminescence (Jobgen et al., 2007; Moorcroft et al., 2001). Nitrate and nitrite 
content of vegetables is often analysed using GC-MS, which involves the reduction of 
nitrate to nitrite followed by derivatization with, for example, sulphanilamide 
(Campanella et al., 2017). This method is often limited by interference between 
compounds. HPLC allows for simultaneous assessment of nitrate and nitrite but lacks 
sensitivity and is, similar to GC-MS, vulnerable to interference from chloride in 
biological samples. Nitrate in, for example, cured meats and cheeses can be 
assessed by colorimetry using the Griess Method, which involves again reduction to 
nitrite and a coupling reaction that provides a red azo chromophore, from which 
nitrite concentration can be assessed (Moorcroft et al., 2001). This method can be 
limited by the reduction of nitrate to nitrite and interference with reagents. 
Chemiluminescence is unaffected by chloride and is deemed the gold standard in 
analysis of nitrate and nitrite. This method will be discussed in more detail in Chapter 
2, as it was the analysis method used in the present study. 
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Table 1.1: Common sources of dietary nitrate. 
 
Classification Source Nitrate (mg/100g) 
Very high (>250mg/100g) Rocket 260 
High (100-250mg/100g) Spinach 214 
Lettuce 189 
Radish 187 
Beetroot 146 
Chinese cabbage 139 
Medium (50-100mg/100g) Turnip 62 
Low (20-50mg/100g) Broccoli 40 
 Carrot 22 
 Processed sausages 9 
 Bacon 6 
 Banana 5 
 Water 2.6 (mg/100ml) 
Data from Hord, Tang and Bryan (2009) and Lidder and Webb (2013). 
 
It is clear that nitrate and nitrite are available both through the diet and through 
endogenous production from the oxidation of NO via the L-arginine/NOS pathway, as 
shown in Figure 1.2. Manipulation of these pathways to increase NO production is a 
focus of current research, specifically regarding the ageing process during which NO 
has been shown to be less available. There is an extensive body of literature 
surrounding the production of NO from nitrate but it will be discussed in brief here, 
paying attention to age-related changes that may affect the efficiency of the pathway. 
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Figure 1.2: Schematic of the nitrate-nitrite-NO pathway. Abbreviations – NO: nitric 
oxide, NOS: nitric oxide synthase, deoxy-Hb: deoxyhaemoglobin, deoxy-Mb: 
deoxymyoglobin. Created using information from Weitzberg and Lundberg (2013), 
Kobayashi et al. (2015) and Shannon et al. (2017). 
 
1.5.2 Salivary pathway 
When consumed and once in the bloodstream, dietary nitrate mixes with 
endogenously produced nitrate (McKnight et al., 1997), reaching a peak plasma 
concentration within 60 minutes following ingestion; it is then distributed throughout 
the body via the circulatory system. 75% of the nitrate is excreted in urine by the 
kidneys, unprocessed (Spiegelhalder et al., 1976). It is also thought that some nitrate 
is excreted in sweat and faeces (Saul et al., 1981; Weller et al., 1996). The remaining 
25% of the absorbed nitrate is extracted from the blood, transported to the salivary 
glands and into the oral cavity through the saliva (Duncan et al., 1995; Spiegelhalder 
et al., 1976). This can be seen in Figure 1.3. 
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Figure 1.3: Schematic of the enterosalivary nitrate pathway. Adapted from 
Bondonno et al., 2015.   
The process of nitrate breakdown in the mouth has been widely studied and has 
been found to occur due to a symbiosis between mammals and bacteria designed to 
convert nitrate to nitrite (Duncan et al., 1995). Microbial reduction of nitrate in the 
mouth was suggested as early as 1976, with experiments showing that saliva from 
the salivary glands contained nitrate but not nitrite (Spiegelhalder et al., 1976). 
Dietary nitrate is broken down in the mouth by commensal bacteria with nitrate 
reductase activity, for example Staphylococcus species. Bacteria are necessary in 
this process because humans lack the functional enzyme, nitrate reductase, to 
reduce nitrate to nitrite (Bryan, 2015). The oral bacteria are located in the deep 
interpapillary clefts of the posterior surface of the tongue, which allow for a greater 
density of bacteria (Duncan et al., 1997). When these bacteria use nitrate as an 
alternative electron acceptor in their energy production, nitrite is produced as a by-
product (Spiegelhalder et al., 1976). 
 
Without the oral microflora, nitrate would be excreted from the body in an unmodified 
state, as demonstrated by many studies using antibacterial mouthwash. For 
example, Govoni et al. (2008) demonstrated that rinsing the mouth with antibacterial 
mouthwash prior to a nitrate load abolished the conversion of nitrate to nitrite in the 
saliva. This study found that the mouthwash had no effect on the accumulation of 
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nitrate in the saliva or plasma, indicating that commensal bacteria in the mouth are 
necessary for the conversion of nitrate to nitrite; antibacterial mouthwash thus stops 
the nitrate reductase activity of oral bacteria. In addition, avoidance of swallowing 
following a nitrate load was shown to stop the rise in plasma nitrite (Lundberg & 
Govoni, 2004). In this study, participants avoided swallowing for one hour after the 
nitrate load and when swallowing resumed, plasma nitrite levels increased. These 
studies not only elegantly demonstrate the importance of saliva in the production of 
plasma nitrite but also indicate that the contribution of other reductase enzymes, 
such as mammalian xanthine oxidoreductase (Zhang et al., 1998), is very small in 
the breakdown of nitrate to nitrite. 
1.5.3 Nitrite to NO 
Upon swallowing, the nitrite produced from nitrate in the saliva enters the circulation 
(Larsen et al., 2006; Webb et al., 2008). When nitrite comes into contact with the 
acidic environment in the stomach, some is further converted to NO and the 
remainder is absorbed back into the bloodstream, raising circulating plasma nitrite 
levels (Webb et al., 2008). In the stomach, NO has been found to increase the gastric 
mucosal blood flow and the thickness of mucus in rodents, thereby help to protect 
against pathogens (Björne et al., 2004). Nitrite has a half-life of around 40-50 minutes 
(Dejam et al., 2007) and is therefore considered a somewhat stable reserve of NO. 
Plasma nitrite levels have been found to reflect acute changes in eNOS and act as a 
reliable marker of NO availability (Lauer et al., 2001). The reduction of nitrite to NO is 
particularly prevalent in hypoxic tissues, such as contracting skeletal muscle. Nitrite 
is reduced to NO by members of enzyme families that possess nitrite-reductase 
activity, for example deoxymyoglobin and NO synthases (Cosby et al., 2003; Vanin et 
al., 2007).  
 
NO has a short half-life of less than one second (Kelm & Schrader, 1990) but has a 
number of actions in the body including, but not restricted to, glucose and calcium 
homeostasis (Stamler & Meissner, 2001), immune function (Bogdan, 2001), 
vasodilation (Moncada & Higgs, 1993) and neurotransmission (Bult et al., 1990). 
Remaining nitrate, nitrite and NO from the processes detailed above diffuse to the 
general circulation and contribute to the NO pool (Lundberg et al., 2006). Therefore, 
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the ingestion of dietary nitrate, most prominently through vegetable sources, can be 
viewed as a key modulator of the beneficial activities of NO.  
1.5.4 NO formation and ageing 
A number of symptoms known to be associated with the ageing process may 
attenuate the efficiency of the nitrate-nitrite-NO cycle. For example, older adults may 
suffer from a reduction in or absence of hydrochloric acid secretion (achlorhydia) in 
the stomach and this may influence the reduction of nitrite to NO in the gastric 
environment (Lundberg et al., 1994). Furthermore, salivary breakdown of nitrate to 
nitrite may be influenced by other features of ageing such as a dry mouth, intestinal 
health and changes to the populations of oral bacteria. Percival, Challacombe and 
Marsh (1991) found that Lactobacilli, opportunist pathogens and Staphylococci in 
saliva increase with age and the prevalence of Actinomyces species shifted. 
Staphylococci species are nitrate-reducers, so preponderance in these bacteria in 
the mouth may work to increase salivary nitrate to nitrite breakdown. However, the 
work by Percival, Challacombe and Marsh (1991) shows an increase in both 
pathogenic and pathogenic-protective bacteria in the mouth such as Lactobacilli, 
making it difficult to draw conclusions as to the beneficial or negative effects of 
bacterial changes with age. Little work has been carried out on salivary bacterial 
changes with age since but this is an important avenue of research in the context of 
the nitrate-nitrite-NO pathway. Overall, changes in the environment that support NO 
production suggest that overall NO production from dietary nitrate will be reduced in 
older adults compared to a younger population. 
 
Ageing may also be associated with reduced sensitivity to the effects of NO, 
specifically its dilatory properties. Early rodent studies found an impaired vasodilatory 
response of vascular smooth muscle in older animals and a reduced responsiveness 
to endothelium-dependent vasodilators, such as NO (Kung & Luscher, 1995; 
Winquist et al., 1984). Additionally, as mentioned previously, levels of L-arginine and 
tetrahydrobiopterin, which is a co-factor for NO production, are reduced in older age, 
which will have a deleterious effect on overall endogenous NO production. Lyons et 
al. (1997) for example, directly compared 12 young and 12 older participants and 
postulated that the basal release of NO from the endothelium of resistance vessels in 
 25 
the older group was lower than the younger group, which explains the blunted 
response to infusion of NG-monomethyl-L-arginine (L-NMMA), a NO synthase 
inhibitor.  
 
A meta-analysis by Lara et al. (2016) reported that the effect of dietary nitrate on 
endothelial function was reduced with age. The authors found that improvements in 
endothelial function following nitrate supplementation were greater in those below the 
age of 60 years than those above 60 years. A study by Gilchrist et al. (2013) for 
example, demonstrated that, in adults aged 67±5 years, plasma nitrate and nitrite 
levels increased in response to dietary nitrate supplementation but there was no 
effect on blood pressure or endothelial function. This suggests that although the 
nitrate-nitrite-NO salivary pathway may be functioning, basal NO is already low or the 
resistance vessels are not responding to an increase in NO from dietary nitrate 
breakdown. However, this study was carried out in patients with Type 2 diabetes and 
factors associated with the chronic disease may attenuate responses to nitrate loads. 
Due to a lack of research in more prolonged dietary nitrate supplementation, Lara et 
al. (2016) recommend that longer-term studies are carried out assessing dietary 
nitrate and endothelial function, especially in older adults and those with higher risk 
of CVD. 
 
To this point, it is clear that the biology of ageing impacts on resistance vessels, 
contributing to hypertension and vascular dysfunction. Dietary nitrate has been 
repeatedly shown to be an effective means of increasing circulating NO levels in the 
body but it is unclear as to the mechanisms surrounding age-related differences in 
responses to or production of NO. It is possible that higher doses of dietary nitrate 
may elicit more favourable responses in an older population but nitrite toxicity 
demonstrates the need for caution, particularly with nitrate and nitrite use out with the 
natural context of vegetables i.e. in salt form. Dietary nitrate intake through vegetable 
consumption remains a safe and effective way to increase NO production in the 
body, at least in a younger population. What is less clear is the additive effect, if any, 
of prolonged intake of nitrate-rich vegetables, especially in older adults with a 
dampened response to an acute dose. Active nutrients in vegetables can have 
synergistic effects when consumed in the whole form and the increased fibre 
recommendations in the UK can be achieved more easily through the intake of whole 
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vegetables. Studies on extended intake of high-nitrate vegetables, consumed in their 
whole form, will be a valuable addition to the NO research, as they encompass not 
only the specific role of dietary nitrate but also the benefits of increasing vegetable 
consumption overall. 
1.6 Lifestyle modification and disease 
Lifestyle modification is often the first line of prevention of or treatment for many 
conditions. For example, Public Health England introduced salt reduction targets for 
convenience foods to reduce the salt content of the diet (PHE, 2017), in an effort to 
reduce the risk of high blood pressure and consequently stroke and CVD. Another 
lifestyle factor that can play a role in diseases such as these is a diet rich in fruit and 
vegetables. This dietary modification, along with a reduction in saturated fat, can 
substantially lower blood pressure (Appel et al., 2006) and forms the basis of the 
“Dietary Approaches to Stop Hypertension” or DASH. A high fruit and vegetable diet 
is also associated with a reduced risk of CHD and ischaemic stroke (Bazzano et al., 
2002; Joshipura et al., 1999). More specifically, Joshipura et al. (1999) concluded 
that cruciferous and green leafy vegetables, as well as citrus fruits and juice, were 
particularly beneficial in this context. Fruit and vegetables can also provide folate, of 
which low serum levels have been associated with hypertension (Robinson et al., 
1998; Forman et al., 2005). Despite this, increasing habitual fruit and vegetable 
intake in the population has been an ongoing challenge and the five-a-day 
recommendations, which would supply beneficial nutrients, are not yet being met 
(Brown et al., 2016). 
 
The WHO recommends that each individual consume 400g of fruit and vegetables 
per day, which corresponds to five portions of 80g. Those aged 65-74 years eat the 
most fruit and vegetables but only 24% of men and 27% of women across the age 
groups consume the recommended five-a-day (Brown et al., 2016). Consequently, 
the recommended 400g intake of fruit and vegetables is not being achieved and thus 
micronutrient intake is likely below an adequate level. Rink et al. (2013) suggest 
reduced levels of oxidative stress biomarkers and an increased antioxidant defence 
in those who meet the five-a-day recommendation, at least in some populations such 
as pre-menopausal women. 
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Fruit and vegetables contain an abundance of different vitamins, minerals and other 
nutrients, which can often work synergistically to have a greater effect together than 
on their own. Vitamin C, for example, which is found in large quantities in many fruit 
and vegetables, has been found to greatly enhance the generation of NO from nitrite 
(Modin et al., 2001) and the absorption of iron from foods (Hallberg et al., 1989). 
Furthermore, vitamin C is a potent antioxidant that can scavenge radicals by 
donating electrons (Padayatty et al., 2003). Polyphenols, again through their 
antioxidant properties, also reduce the scavenging of NO and enhance nitrite 
reduction to NO (Weitzberg & Lundberg, 2013), thereby increasing the bioavailability 
of NO. Therefore, the combination of vitamin C, polyphenols and nitrate in food, for 
example, may contribute to a more potent effect that the nutrients in isolation.  
With a reluctance in the general population to consume more fruit and vegetables 
overall, highlighting the benefits of a smaller number of select products may help 
consumers initiate the behavioural change towards increasing consumption. There 
has been a recent turn towards so-called ‘functional foods’ for their specific effects on 
health and disease. Functional foods are foods that deliver additional or enhanced 
benefits beyond the provision of essential nutrients (Hasler, 2002). Functional foods 
will have an active ingredient or various active components that can positively impact 
on health. There is good evidence for the application of functional foods in areas 
such as cardiovascular risk and cognitive function, where researchers have 
investigated pomegranate, berries and nuts, for example, and shown positive effects 
(Pribis and Shukitt-Hale, 2014; Asgary, Rastqar and Keshvari, 2018). 
The benefits of nitrate have been discussed previously, in addition to the foods that 
are rich in this nutrient. High-nitrate foods such as beetroot, which is the focus of this 
thesis, may therefore be classed as functional foods because of their specific effect 
on vascular function. It has been suggested that a major benefit of a high vegetable 
intake to CVD comes from the nitrate content of these foods (Lundberg et al., 2006). 
The Japanese diet, for example, delivers around 18.8mg/kg/day of nitrate, which is 
significantly higher than a Western diet and this population has one of the lowest 
incidences of hypertension and CVD in the world (Sobko et al., 2010). A study by 
Ashworth et al. (2015) on healthy female volunteers compared the effects of one 
week of consumption of high nitrate vegetables to a control group where they were 
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avoided and found a reduction in blood pressure only in the high nitrate group. This 
study had a small sample size and is short in duration but highlights that it is not 
necessarily all vegetables per se that provide benefit to the cardiovascular system. It 
has been proposed that potassium plays a large role in the blood pressure-lowering 
effects of fruit and vegetables (Adrogue and Madias, 2007), however further research 
has moved away from this theory (Webb et al., 2008).  
1.7 Nitrate intake from vegetables 
Daily dietary nitrate intake is around 81-106mg (Coles & Clifton, 2012) with up to 
80% of this coming from vegetables in a typical Western diet (Lundberg et al., 2004). 
The rest, 35-44mg/day, comes from cured meats and water, as mentioned 
previously. The acceptable daily intake (ADI) for nitrate is set at 3.7mg/kg body 
weight/day, amounting to around 296mg for an average 80kg male. The ADI is an 
estimate of the maximum amount of a substance that can be ingested daily over a 
lifetime without presenting an appreciable health risk (EFSA, 2018). However, 
adherence to the DASH can lead to daily consumption of around 1222mg nitrate 
(Hord et al., 2009). Furthermore, if consuming a Japanese diet, this would amount to 
1504mg/day in an 80kg male, around five times higher than the ADI. A Japanese diet 
is rich in vegetables that have a high nitrate content and rank highly on the nitrate 
veg-table created by Lidder and Webb (2013), typically containing both spinach and 
Chinese cabbage. Vegetables with large green leaves, such as spinach, extract more 
nitrate from the soil than other vegetables in order to facilitate growth. The six 
highest-ranking vegetables are as follows in order of content: rocket, spinach, lettuce, 
radish, beetroot, and Chinese cabbage. The average nitrate content of these 
vegetables is around 124mg per UK portion of 80g. Of these high-nitrate vegetables, 
beetroot has become a focus of research because of its availability, low cost, and 
acceptability as a supplement.  
1.8 Beetroot as a functional food  
Beetroot is a member of the Chenopodiaceae family, which also includes spinach 
and chard. It is a widely consumed vegetable in traditional Western cooking 
(Morgado et al., 2016). Red beetroot (Beta vulgaris rubra) has been used as food 
since 1000 B.C. with the Romans using the leaves for food and the roots for 
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medicinal purposes (Ninfali & Angelino, 2013). From here on, red beetroot will be 
referred to as beetroot.  
1.8.1 Nitrate levels  
Beetroot and other bulbous vegetables store nitrate in their roots in high 
concentrations. As mentioned previously, beetroot sits within the highest-ranking 
vegetables for nitrate content; per 100g of fresh weight, beetroot contains more than 
250mg of nitrate (Hord et al., 2009) (Table 1.1). However, the nitrate level in beetroot 
varies greatly during the season, with vegetables harvested in the summer containing 
substantially lower levels of nitrate; this is due to light reducing the nitrate 
accumulation (Umar & Iqbal, 2007). The nitrate content of the vegetable is also very 
dependent on the nitrate concentration of the soil in which it is grown and the 
presence or lack of nitrogen-based fertilisers (Gee & Ahluwalia, 2016). Although the 
nitrate content of beetroot can vary, average levels are still high and nitrate remains 
the most bioactive component of this vegetable. The nutritional profile of beetroot can 
be seen in Table 4.1.  
 
In addition to nitrate however, beetroot does contain many other active compounds 
that may prove beneficial to health including phenolic acids, flavonoids, carotenoids, 
ascorbic acid, and betalains (Georgiev et al., 2010; Wootton-Beard & Ryan, 2011). 
Phenolic acids and flavonoids are compounds found in many other vegetables but 
beetroot is quite unique in its betalain content, with only a few other plants containing 
this compound. Wootton-Beard et al. (2014) found that, excluding nitrate, the 
yellow/orange pigment neobetanin was the predominant secondary metabolite in 
beetroot juice.  
1.8.2 Betalains 
Betalains are water-soluble derivatives of betalamic acid (Esatbeyoglu et al., 2015) 
and there are two subclasses: betacyanins and betaxanthines, which give beetroot 
its red or yellow colour respectively. Beetroot contains an average of 120mg of 
betalains per 100g of fresh weight (Lee et al., 2014). Betalains are characteristic of 
species in the order Caryophyllales, with beetroot and prickly pear being the only 
edible food products containing these pigments (Kujala et al., 2002). They 
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accumulate in the cell vacuoles of flowers, fruits and leaves, mainly in epidermal or 
sub-epidermal tissues and act as pollinator attractants or protective compounds. 
Betanin is a betacyanin, giving red beetroot its distinctive rich colour and it is 
therefore widely used as a food colourant (E162) in many dairy products such as 
milk, ice cream and yoghurt, juices, and sweets. 
 
Betalains are similar to anthocyanins, which give foods such as red cabbage and 
blackberries their bright red/purple colouration. However, beetroot is one of the few 
edible and accessible plants to contain the potent betalains. Anthocyanins and 
betalains play exactly the same role in plants and every species of plant will contain 
one or the other of these compounds (Wootton-Beard et al., 2014). The antioxidant 
effects of anthocyanins have been well described in the literature (Basu et al., 2010; 
Fang, 2014) and it is not unjust to assume a similar effect of betalains if applied in the 
same conditions. The antioxidant activity of fruits and vegetables is measured on an 
ORAC scale and beetroot is ranked among the top 10 most potent vegetables with 
regards to antioxidant activity (Lee et al., 2014). In beetroot, the content of flavonoids 
and phenolic acids is thought to be too low to account fully for the observed 
antioxidative effects. Therefore, it is proposed that the betalain, betanin, and its 
degradation product neobetanin has comparable effects to phenolic compounds 
(Wootton-Beard et al., 2014). Betanin is a betanidin 5-O-beta-glucoside containing a 
phenolic and a cyclic amine group, both of which act as antioxidants by donating 
electrons (Kanner et al., 2001). Both betaxanthins and betacyanins have a radical-
scavenging capacity three to four times that of ascorbic acid, catechin and rutin in the 
DPPH assay (Cai et al., 2003). Sawicki, Bączek and Wiczkowski (2016) 
demonstrated that the antioxidant capacity of beetroot was positively and significantly 
associated with betalain content. Oxidative damage to cells, proteins, lipids and DNA 
accumulates with age and contributes to the pathogenesis of age-related 
degenerative diseases such as CVD, cancer and osteoporosis (Scalbert et al., 2005). 
Antioxidants found in foods are therefore widely studied, as they have the potential to 
limit oxidative damage by acting directly on ROS or by stimulating endogenous 
defence systems (Scalbert et al., 2005).  
Betalains have also been found to have anti-radical and anti-cancer activities 
(Zielińska-Przyjemska et al., 2012; Esatbeyoglu et al., 2015). They have been found 
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to protect LDLs from oxidation, even at low concentrations (Kanner et al., 2001). 
Tesoriere et al. (2004) demonstrated that biomarkers of lipid oxidation, for example 
lipid hydroperoxide, were reduced by betalains. Betalains reach the plasma in 
relatively high concentrations but have a short half-life in the plasma and erythrocytes 
of around five hours (Wootton-Beard et al., 2014). These researchers demonstrated 
a maximum plasma betanin concentration of 0.2µmol/L around three hours after a 
16mg dose of betanin. Betalains can also be incorporated into red blood cells, 
protecting them from oxidative haemolysis (Sawicki et al., 2016). Research suggests 
that phenolic compounds could be beneficial to endothelial function by stimulating the 
synthesis of NO (Heiss et al., 2003; Schini-Kerth et al., 2010). However, none of the 
nitrogen-containing glycosylated and phenolic compounds in beetroot, such as 
betacyanins, betaxanthins, and ferulic acid, have been found to increase NO 
synthesis (Kujala et al., 2002).  
It may be, despite the known specific actions of compounds such as betalains and 
nitrate that the whole complex of active components in beetroot work synergistically 
to protect cells and have other beneficial effects on the body. Indeed, Cao et al. 
(1998), for example, suggests that the perceived benefits of a high intake of fruit and 
vegetables on the risk of disease is not exclusively due to the action of single 
antioxidants, rather from the combination of various antioxidants present in foods. 
However, before conclusions can be drawn on the beneficial activities of compounds, 
their bioavailability within the human body must first be demonstrated. 
1.8.3 Bioavailability of the active components in beetroot 
The bioavailability of a compound is the proportion that is digested, absorbed and 
metabolised through normal pathways in the body (Pandey & Rizvi, 2009) and 
reaches the circulation unchanged. The efficacy of dietary compounds cannot be fully 
elucidated unless their bioavailability in the body has been determined. Ingested 
nitrate is quickly and effectively absorbed in the upper GI tract or small intestine with 
a bioavailability of almost 100% (Bescús et al., 2011). This demonstrates that the 
nitrate content of beetroot can still be considered functional following ingestion. There 
is no effect of cooking on the bioavailability of nitrate from vegetables, as evident 
from comparable values following consumption of raw lettuce and cooked beetroot 
and spinach (van Velzen et al., 2008). 
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The bioavailability of nitrate from beetroot is certainly high in young, healthy 
individuals, on whom bioavailability studies are most often carried out, but Siervo et 
al. (2015) found age differences in plasma nitrite concentrations following 
consumption of beetroot juice. Variability in plasma nitrite concentrations, as 
discussed in Chapter 1.5, can allude to either a reduction in dietary nitrate initially 
reaching the blood or an impaired breakdown of nitrate to nitrite in the saliva, despite 
high availability of nitrate in the circulation. These authors postulate that age 
differences could be reflected in, for example, oral microbiota, gastric redox 
environment and oxygen tension, and that higher doses of nitrate may be necessary 
in older individuals to make up for the differences in bioavailability. Conversely, 
Presley et al. (2011), in a study on cerebrovascular blood flow (CBF) following a high 
or low nitrate diet, found rises in plasma nitrite in older adults comparable to those 
found in younger adults.  
 
It might be the case, however, that normal baseline levels of NO, produced 
endogenously from L-arginine, are reduced in older adults, regardless of a dietary 
nitrate load; this was discussed in Chapter 1.5. Indeed, Lyons et al. (1997) and Ashor 
et al. (2016) demonstrated a significantly lower baseline NO concentration in older 
adults compared to younger adults. These are the only two studies that directly 
compare the availability of and response to dietary nitrate in young and older 
participants in the same study. The pharmacokinetics of nitrate have not been 
specifically compared in younger and older adults, taking into account the many 
processes involved, such as salivary breakdown, urinary output and plasma 
concentrations. A full picture of this pharmacokinetic profile would aid research, 
especially surrounding age-related alterations in the pathways involved.    
 
Betalains can be absorbed into the circulation in their unaltered form, allowing them 
to preserve their molecular structure and biological activity (Ting et al., 2014). In 
2001, Kanner, Harel and Granit identified the betacyanins betanin and isobetanin in 
the urine of healthy volunteers following the consumption of 300ml beetroot juice at 
levels of 0.5-0.9% of the ingested total, which signifies successful absorption of 
betalains in humans. A later study by Frank et al. (2005) also identified small 
amounts of betanin and isobetanin, around 0.3% of the total ingested, in the urine of 
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young, healthy volunteers following consumption of beetroot juice. These authors 
suggested that a reason for the small traces of betalains detected is that they have 
low availability or other major pathways of elimination may exist, such as metabolism. 
Both these studies investigated bioavailability solely through urinary output, which 
does not take into account the distribution of molecules to other tissues and may 
underestimate overall bioavailability (Rein et al., 2013). 
 
In a bioavailability study, Clifford et al. (2017) were unable to detect betanin in 
plasma following consumption of whole beetroot or beetroot juice in young, healthy 
males. Tesoriere et al. (2013) investigated absorption rates of betanin from both 
cactus pear and beetroot and found that epithelial transport in a model of the 
intestinal wall was slower with beetroot-derived betanin. This could explain the 
varying bioavailability results from different sources of betanin and suggests that 
betanin availability from beetroot is lower than from other sources. However, there 
also lies a difficulty in the lack of available standards for analysis of betanin, thus the 
true bioavailability of this compound is yet to be quantified. 
 
The bioavailability of the total phenolic compounds within beetroot has been 
described by Netzel et al. (2005) but individual compounds have not been tested to 
date. Following consumption of 500ml of beetroot juice, Netzel et al. (2005) observed 
~685mg of phenolic compounds in the urine of healthy females aged 23-24 years, 
97% more than following water consumption. This demonstrates that beetroot is a 
bioavailable source of nitrate and phenolic compounds, at least in a young 
population. Further work is warranted on the bioavailability in an older population and 
with other forms of beetroot such as the whole vegetable.  
1.9 Forms of beetroot and their use in research 
Beetroot is currently widely used in nutrition and health research as a means to 
provide a source of dietary nitrate. It has been provided in a number of forms 
including juice, bread, gel and, most recently, powder. These processed products 
provide a concentrated source of bioactive compounds, some of which can be 
manipulated to form a nitrate-free “placebo” if nitrate is the primary compound under 
investigation. Nitrate has been found to be highly bioavailable following consumption 
in young participants but the pharmacokinetic profiles of nitrate following different 
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sources may vary, which can be important for the timing or frequency of consumption 
of certain beetroot products. van Velzen et al. (2008), for example, discovered 
varying plasma nitrate peaks and times to maximum following sodium nitrate, lettuce, 
spinach, and whole beetroot. Results do, however, appear to point towards a dose 
response rather than differences between sources, as different nitrate doses were 
provided with each source. 
1.9.1 Beetroot juice 
Beetroot juice is the most widely used source of dietary nitrate in research today. It is 
transportable, practical and has a nitrate-free alternative that can be used as a 
placebo drink. 70ml concentrated “shots” (Kelly et al., 2013; Jajja et al., 2014; 
Bondonno et al., 2015) or 250-500ml of regular beetroot juice (Casey et al., 2015; 
Kapil et al., 2015; Kenjale et al., 2011) are used as doses. Beetroot juice varies in its 
content from ~310 to 521mg nitrate per 100g (Morgado et al., 2016) due to varying 
seasons of harvest and processing techniques, as mentioned previously. 
Furthermore, Jajja et al. (2014) found a discrepancy in reported levels on the bottle of 
beetroot juice shots, with their analysis showing the bottles to contain 165±2mg of 
nitrate compared to the 300-400mg written on the bottles. This is a common limitation 
of research on nutrients within vegetables and it is important that the concentrations 
of the nutrients of interest are tested regularly. 
One major benefit of beetroot juice is that a nitrate-free placebo has recently been 
developed, allowing a true test of benefits specific to nitrate contained in the juice. 
These placebo drinks have been developed by manufacturers for research and are 
not available to the public. However, the effect of betalains, for example, cannot be 
tested in these placebos and instead requires other varieties of beetroot such as 
yellow beetroot to determine the role of specific red or yellow pigments. When 
considering the health benefits of fruit and vegetables, some of these come from their 
fibre content, which is lacking in juice. Whole food leads to higher satiety ratings due 
to the fibre content, volume of food, and increased chewing compared to a juice 
(Haber et al., 1977). For applicability to more prolonged interventions, therefore, 
whole foods may improve compliance. Furthermore, the sugar content of fruit and 
vegetable juices is considered high and beetroot is often sweetened or combined 
with apple juice to improve palatability. This could have consequences on dental 
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caries and overall sugar consumption in populations if they were to consume 
sweetened beetroot juice regularly over the long-term.  
1.9.2 Whole beetroot 
As with the juice, a variety of nitrate contents have been reported in whole beetroot, 
such as 110-3670mg/kg (Siervo et al., 2013) and 125mg/100g, ranging from 35 to 
258mg (van de Avoort et al., 2018). In its whole form, beetroot provides dietary fibre 
in addition to the bioactive components nitrate and betalains found in the vegetable. 
One research group examined the components of beetroot grown in organic vs. 
conventional conditions, demonstrating good levels of sugars, vitamin C, flavonoids, 
phenolic acids, and betanin in the whole vegetable (Kazimierczak et al., 2014).  
 
A bioavailability study by Clifford et al. (2017) demonstrated that both beetroot juice 
and whole beetroot raised markers of plasma NO concentrations in young, healthy 
participants, reaching a peak at two hours post-ingestion for both food products. NO 
levels remained elevated above baseline at eight hours post-ingestion with beetroot 
juice and five hours post-ingestion with whole beetroot. The reason for the disparity 
in pharmacokinetics is unclear but as the nitrate content of the whole beetroot was 
not tested, it could have been due to a smaller nitrate load provided in the whole food 
compared to the juice. Furthermore, van Velzen et al. (2008) demonstrated a 106% 
bioavailability of nitrate from 300g cooked beetroot that provided 636mg nitrate. 
Similar to the study by Clifford et al. (2017), participants were healthy and aged 
between 21 and 28 years. Both of these studies provided 300g whole beetroot in a 
sitting and compared it to a variety of other nitrate sources. Large doses such as this 
are commonplace in bioavailability studies but limit the applicability of the vegetable 
to everyday consumption. With an average vegetable portion of 80g, research into 
smaller and more practical doses are important in the area of public health and 
nutrition. The population-wide concern surrounding the lack of fruit and vegetable 
intake demonstrates the importance of research that focuses on whole fruit and 
vegetables in a real-world situation, even to simply highlight barriers to consumption 
of these whole foods in a community setting in order for appropriate 
recommendations to be made.  
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1.9.3 Other forms of beetroot – gel and enriched bread 
Morgado et al. (2016) describe the benefits of beetroot gel as being a bio-accessible 
and convenient source of compounds, with positive acceptance; their beetroot gel 
contained 620mg of nitrate per 100g. Previously, James et al. (2015) found that a 
high-nitrate gel, made from chard or beetroot, exhibited an earlier plasma nitrate 
peak compared to beetroot juice suggesting that, although eliciting the same effects, 
different nitrate sources may affect the overall plasma pharmacokinetics of nitrate. 
These types of studies need to be replicated, especially with the creation of new 
beetroot products, and sources of nitrate must be matched for nitrate content to 
establish a real comparison. The longer-term acceptance of a beetroot gel is unclear 
and, similar to beetroot juice, concentrated gel contains a higher sugar content than 
less processed products. This makes the long-term applicability of beetroot gel 
limited.  
 
A novel beetroot-enriched bread was developed and tested by Hobbs et al. in  2012, 
containing around 68mg nitrate per 100g. Both red and white beetroot have been 
incorporated into bread for research and red beetroot-enriched bread has been found 
to significantly increase total urinary nitrate and nitrite following ingestion (Hobbs et 
al., 2012). This group also found that the beetroot bread reduced DBP and improved 
endothelium-independent vasodilation over six hours. This acute study was carried 
out on young males with a mean age of 25 years, so repeat studies are warranted in 
an older population and also over a more prolonged period if this beetroot bread is to 
be deemed a cardio-protective food product. Although this is a novel approach to 
incorporating more vegetables into the diet, it is important to take notice of the 
additional calories that will be consumed alongside the vegetable; calorie surplus can 
lead to obesity and increase the risk of a number of non-communicable diseases.  
 
It is clear that beetroot has many beneficial effects on the human body and this is the 
case when it is used in a variety of forms. There is little research surrounding the 
benefits of betalains compared to the plethora of studies on the effects of nitrate, or 
specifically NO, but their poor availability hinders progress in this area. The beneficial 
effects of beetroot on markers of cardiovascular risk, such as blood pressure and 
vascular function, stem from the nitrate content of the vegetable. Because of the 
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effects of ageing on these markers, it is important that research focuses more on the 
ageing population than young and healthy cohorts, although this has not been the 
case to date. The following sections explore the application of beetroot in research 
on blood pressure, vascular function and cognition, and aim to highlight the benefits 
of targeting populations such as older adults in this area. 
1.10 The effects of beetroot on blood pressure  
NO concentration in the body is an important factor in the regulation and 
maintenance of blood pressure and blood pressure has been the focus of research 
on dietary nitrate to date. Following the discovery of the nitrate-nitrite-NO pathway, 
Larsen et al. (2006) first demonstrated the blood pressure-lowering effect of sodium 
nitrate, showing an acute reduction of DBP by 3.2mmHg after 6.2mg nitrate/kg body 
weight. This seminal research directed investigations into other sources of nitrate i.e. 
beetroot and led researchers to postulate that the blood pressure-lowering effects of 
the DASH, which can lead to a reduction in SBP by 2.3mmHg, are due to the nitrate 
content.  
1.10.1 Blood pressure in young participants 
Webb et al. (2008) demonstrated that the blood pressure-lowering effect of beetroot 
juice comes from the conversion of nitrate to nitrite, evident through the lack of blood 
pressure reduction associated with spitting after consumption of the nitrate load. This 
acute study was carried out in healthy volunteers aged between 18 and 45 years and 
supplemented with 500ml beetroot juice providing ~1395mg nitrate. Jonvik et al. 
(2016) later compared the effects of different sources of 800mg of nitrate, using 
sodium nitrate, beetroot juice, rocket salad juice and a spinach beverage. All 
beverages caused an acute rise in plasma nitrate and nitrite but sodium nitrate was 
the only intervention not to reduce SBP. DBP, however, was reduced following all 
interventions. The rise in plasma nitrate and nitrite and reduction in DBP following all 
interventions prompted the researchers to conclude, similar to Webb et al. (2008), 
that nitrate-rich vegetables could be used as dietary supplements and that they have 
the ability to lower blood pressure. Studies have repeatedly found a correlation 
between increased plasma nitrite levels and reduced blood pressure (Webb et al., 
2008; Siervo et al., 2013 for review; Kapil et al., 2015), which implicates nitrate-rich 
beetroot in this blood pressure-lowering effect.  
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Vanhatalo et al. (2010) found a reduction in blood pressure following beetroot juice 
compared to a nitrate-depleted placebo both acutely (2.5 hours) and over a more 
prolonged period (15 days) when participants consumed 322mg nitrate per day. The 
amount of nitrate in this study is small compared to the dose provided by Webb et al. 
(2008) and Jonvik et al. (2016) but the longer duration of the study necessitates this, 
as well as demonstrates that blood pressure-lowering effects can be maintained over 
a longer time period. Hobbs et al. (2012) also assessed the effects of smaller doses 
of beetroot juice on blood pressure and found a trend for blood pressure reduction 
with increasing beetroot juice doses from 100g to 250g and 500g, providing 143mg, 
353mg and 707mg nitrate, respectively. 100g of beetroot juice did result in a 
significant reduction in blood pressure, indicating that smaller doses of nitrate can 
have positive effects on young and healthy participants. Hobbs et al. (2012) also 
utilised a novel method of dietary nitrate consumption with the incorporation of 
beetroot into bread, containing ~112mg nitrate. The maintenance of the blood 
pressure-lowering effect of beetroot after the processing into bread illustrates that 
nitrate’s biological effects are preserved and again suggests that there is a dose 
response rather than an effect of source on the activity of nitrate.  
 
Cheng, Cheng and George (2015) investigated whether the varying betalains in 
yellow and red beetroot had any influence on the blood pressure-lowering effect of 
beetroot using 24-hour ambulatory blood pressure measurement. There was no 
significant difference between colour variants on SBP and DBP but both reduced 
blood pressure overall. This suggests that the different betalains in beetroot make no 
difference to the blood-pressure lowering effect of the vegetable. Hobbs et al. (2012) 
reiterate this finding by comparing red and white beetroot in their bread products and 
finding that both lowered blood pressure to a similar extent in young, healthy males. 
 
It is clear that beetroot, due to its nitrate content, has a positive effect on blood 
pressure in young and healthy participants. The effect of dietary nitrate on plasma 
nitrite levels is well known in these young participants and the pharmacokinetics of 
the nitrate has been sufficiently described. In 2013, Siervo et al. conducted a 
systematic review on nitrate and blood pressure and concluded that there was a 
greater effect of nitrate on SBP but an over-representation of young, healthy men in 
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the studies. It is important, therefore, to direct research into populations who would 
benefit most from a reduction in blood pressure i.e. older adults and those with 
cardiovascular risk factors and chronic disease. 
1.10.2 Beetroot on blood pressure in older or diseased populations 
From the previous sections in this Chapter it is evident that the ageing process and 
low-grade inflammation, which is a characteristic of disease, may affect the 
breakdown of dietary nitrate and the production and response to NO. Despite this, it 
has been repeatedly demonstrated that dietary nitrate can increase plasma nitrite 
levels in older adults and those with chronic disease (Table 1.2). Compared to young, 
healthy adults however, plasma nitrite levels do not always translate to a reduction in 
blood pressure in older or diseased participants following supplementation with 
beetroot juice (Miller et al., 2012; Bondonno et al., 2015; Shepherd et al., 2015; de 
Oliveira et al., 2016). Results on blood pressure in these populations are equivocal, 
with some research demonstrating a reduction in solely DBP (Kenjale et al., 2011), 
solely SBP (Eggebeen et al., 2016; Jajja et al., 2014) or both (Kelly et al., 2013). 
Although there are some positive results following the consumption of dietary nitrate, 
there is no consensus on the effects, dose or target population. 
 
Kapil et al. (2015) found a reduction in both clinic and home blood pressure after four 
weeks of 250ml of beetroot juice daily in hypertensive adults aged 18-85 years; the 
dose provided was approximately 397mg daily. Ashworth et al. (2015) also found that 
both raw beetroot juice (250ml) and cooked beetroot (250g) consumed daily for two 
weeks reduced SBP and DBP in hypertensive participants aged between 25 and 68 
years. Nitrate and nitrite levels were not measured in the beetroot or the plasma, so 
the dose and association with increased NO levels is not clear in this study. A recent 
study by Blekkenhorst et al. (2018) however, found no blood pressure-lowering 
effects of a four-week high nitrate (~150mg/day) diet in hypertensive adults between 
the ages of 21 and 75 years. Given that the daily intake of nitrate if people reached 
the WHO recommended fruit and vegetable intake would be 157mg, 150mg may not 
be classed as a high nitrate dose in this context, although it is higher than the 
average intake of 108mg/day (Babateen et al., 2018). Each of these studies had a 
cohort with a wide range of ages from young adults to elderly. It is therefore unclear 
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whether there were different effects on those classed as younger or older and if this 
may explain the presence or lack of a blood pressure-lowering effect.  
 
Table 1.2 also illustrates that beetroot juice is the primary source of dietary nitrate 
used in research on older adults. The dose varies considerably from 165mg to 
1159mg nitrate given acutely or daily up to six weeks and on one occasion the dose 
provided was lower than described on the product (Jajja et al., 2014). Only four 
studies to date have supplemented with beetroot juice for longer than seven days, 
which warrants more focus on a prolonged intervention period, especially on older 
adults and those at more risk of cardiovascular events. It is unclear whether the 
acute effects of dietary nitrate, such as blood pressure reduction, are maintained 
longer term. The effects of oxidative stress and low-grade inflammation on the 
vascular system into older age open up research into more prolonged intervention 
with dietary nitrate in an attempt to ameliorate the effects and promote NO 
production. 
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Table 1.2: Summary of RCTs assessing the effect of dietary nitrate on a range of biological outcomes in older adults. 
  
Authors Cohort Dosage Duration Measurements Study design Conclusions 
Kenjale et al., 
(2011) 
8 adults aged 67±13 with 
PAD 
500ml beetroot juice 
providing 1116mg 
nitrate 
Single bolus Plasma nitrate and 
nitrite, BP, endothelial 
function 
Randomised, 
open-label, 
crossover trial 
Increase in plasma 
nitrate and nitrite 
levels. Reduction in 
DBP. No effect on 
endothelial function. 
Presley et al., 
(2011) 
5 adults aged 74.7+6.9  High (242mg) and low 
nitrate diet. High 
supplemented with 
500ml beetroot juice 
containing 527mg 
nitrate 
4-day diet. 3 
hour 
intervention 
period 
Plasma nitrate and 
nitrite  
2-arm, 
randomised, 
crossover trial 
Significant increases 
in plasma nitrate and 
nitrite levels  
Presley et al., 
(2011) 
14 adults aged 74.7+6.9  High (242mg) and low 
nitrate diet. High 
supplemented with 
500ml beetroot juice 
containing 527mg 
nitrate 
2-day diet. 3 
hour 
intervention 
period 
Cerebral blood 
perfusion 
2-arm, 
randomised, 
crossover trial 
Increased CBF within 
subcortical and deep 
white matter of the 
front lobe, but no 
global increase in 
CBF 
Miller et al., 
(2012) 
8 adults aged 72.5±4.7 500ml (527mg nitrate) 
beetroot juice. 43mg 
nitrate in control diet 
and 155mg in HN diet. 
HN, HN + juice, control 
diet and control diet + 
juice 
3-day control 
diet vs. HN. 3 
hour 
intervention 
period 
Likert scale for 
acceptance to 
beetroot, blood 
pressure, plasma 
nitrate and nitrite 
Randomized 
four period 
cross-over 
controlled 
design 
High nitrate 
supplement elevated 
plasma nitrate and 
nitrite levels 
throughout day, but 
high nitrate diet did 
not. No effect on BP. 
Kelly et al., 
(2013) 
12 healthy adults aged 
64±2.7 
2 x 70ml/day of 
beetroot juice (595mg 
of nitrate per day) 
3 days  Resting BP and 
plasma nitrite 
concentration. 6-
minute walk test, brain 
metabolite 
concentrations, 
cognitive tests 
Double-blind, 
randomized, 
crossover study 
Increase in plasma 
nitrite. SBP and DBP 
reduced, no 
improvement in 
6MWT, brain 
metabolite 
concentrations or 
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cognitive performance 
Gilchrist et al., 
(2014) 
27 adults aged 67.2 with 
Type 2 DM, mean BMI of 
30.8 
250ml beetroot juice 
(465mg nitrate) or 
placebo drink  
14 days, 250ml 
drink per day 
Plasma nitrate and 
nitrite levels. Cognitive 
function  
Double-blind, 
randomised, 
placebo-
controlled 
crossover trial 
Increase in plasma 
nitrate and nitrite. 
Reduction in simple 
reaction time 
Jajja et al., 
(2014) 
21 adults aged 62±1.4, 
mean BMI of 30.1 
70ml beetroot juice 
per day (165mg 
nitrate) or blackcurrant 
placebo 
21 days with 7 
day interruption 
and then 
continuation 
Blood pressure – clinic, 
daily and 24-hour 
ABPM. Salivary and 
urinary nitrate. 
2-arm, parallel, 
randomized 
Increase in salivary 
and urinary nitrate. 
No changes in resting 
clinic BP or 24-hr 
ABPM. Reduced daily 
SBP after 3 weeks 
but effect not 
maintained after 
interruption 
Rammos et 
al., (2014) 
21 adults aged 63±5 with 
moderate CV risk  
Sodium 
nitrate,150µmol/kg 
BW (equivalent to 
300g spinach) 
4 weeks Endothelial function – 
FMD, vascular stiffness 
– PWV and AIx. 
Plasma nitrate and 
nitrite 
Randomised, 
placebo-
controlled, 
double-blind, 
parallel trial 
Improved PWV and 
AIx compared to 
control. Lowered SBP 
but not DBP. 
Increased plasma 
nitrate and nitrite 
levels. 
Bondonno et 
al., (2015) 
27 adults aged 63.3+4.4 
on anti-hypertensive 
medication 
2 x 70ml beetroot 
juice per day 
containing 434mg 
nitrate 
7 days Blood pressure, 
plasma, salivary and 
urinary nitrate 
Randomized, 
placebo-
controlled, 
double-blind, 
crossover trial 
Increase in plasma, 
salivary and urinary 
nitrate. No difference 
in BP  
Casey et al., 
(2015) 
12 healthy adults aged 
64±2  
500ml beetroot juice 
providing 1159mg 
nitrate 
Single bolus 3 
hours prior to 
exercise 
Rhythmic forearm 
exercise in normoxia 
and hypoxia. BP and 
forearm blood flow 
Placebo-
controlled, 
crossover trial 
Increased 
compensatory 
vasodilator response 
to hypoxic exercise  
Justice et al., 
(2015) 
22 old mice Sodium nitrite 
supplemented water 
(50mg/l) 
8 weeks Motor behaviour, 
forelimb grip strength, 
open field locomotor 
activity, accelerating 
and endurance run 
Randomised, 
parallel, rodent 
trial 
Improved grip 
strength and open 
field distance. 
Reduced low-grade 
inflammation in 
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ability muscle 
Justice et al., 
(2015) 
30 healthy adults aged 
62+7  
Sodium nitrite, either 
80mg or 160mg 
capsules/day 
10 weeks Motor function. 
Cognitive function 
(speed and executive 
function), plasma 
nitrate and nitrite. 
Randomised, 
placebo-
controlled, 
double-blind 
Small chronic 
increase in plasma 
nitrite. Improved 
maximal exercise 
capacity with 80mg. 
Reduced balance 
errors step test. 
Improved cognitive 
performance 
Kapil et al., 
(2015) 
64 hypertensive adults 
aged 57.3±13.9 
250ml beetroot juice 
daily providing 397mg 
nitrate 
4 weeks BP, vascular function, 
plasma, salivary and 
urinary nitrate 
Double-blind, 
randomised, 
placebo-
controlled trial 
Increased nitrate. 
Reduction in SBP, 
DBP, AIx and PWV. 
No change in PORH 
Shepherd et 
al., (2015) 
14 adults aged 64.7±7.7 
with mild-moderate COPD 
2 x 70ml beetroot 
juice (420mg nitrate) 
or nitrate-depleted 
beetroot juice  
2 days before 
testing and 
once on day of 
testing 
Brachial artery BP, 6-
minute walk test 
Double-blind, 
placebo-
controlled, 
cross-over 
design 
Rise in plasma nitrate 
concentration. No 
improvement in BP or 
6MWT 
de Oliveira et 
al., (2016) 
20 adults aged 70.5+5.6 
with cardiovascular risk 
factors 
100g beetroot gel 
providing 756mg 
nitrate 
Single bolus Endothelial function, 
arterial stiffness and 
BP. Urinary nitrate. 
Randomised, 
double-blind, 
crossover and 
placebo-
controlled 
Increase in FMD and 
blood flow velocity. 
Increased in urinary 
nitrite and nitrate. RH 
increased. No effect 
on BP. 
DeVan et al., 
(2016) 
32 healthy adults aged 
62+1 
Sodium nitrite 
capsules (80mg or 
160mg) daily  
10 weeks PWV, arterial stiffness, 
plasma concentration, 
FMD 
Double-blind, 
placebo-
controlled, 
randomized 
parallel-design 
Plasma nitrite 
increased acutely and 
chronically. 
Endothelial function 
increased, arterial 
elasticity improved. 
Particularly with 
smaller dose 
Eggebeen et 
al., (2016) 
20 adults aged 69±7 with 
heart failure with 
preserved ejection fraction 
70ml beetroot juice, 
providing 378mg 
nitrate 
Single bolus or 
daily intake for 
7 days 
Plasma nitrate and 
nitrite, BP 
Randomised, 
placebo-
controlled, 
Increased plasma 
nitrate and nitrite and 
reduced SBP both 
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crossover trial acutely and following 
7-day 
supplementation.  
Hughes et al., 
(2016) 
12 healthy adults aged 
64±5 
500ml beetroot juice 
providing 583mg 
nitrate  
Single bolus Plasma nitrate and 
nitrite, aortic BP and 
Aix 
Randomised, 
parallel design 
comparing 
young and old 
participants 
Increased plasma 
nitrite. Reduction in 
aortic BP in both 
young and old but AIx 
reduced only in young 
Velmurugan et 
al., (2016) 
67 adults aged 53.3±10.1 
with hypercholesterolemia  
250ml beetroot juice 
daily, providing 372mg  
6 weeks Vascular and platelet 
function by FMD. 
Plasma, urine and 
saliva sampling. Oral 
microbiome profile. 
Randomised, 
double-blind, 
placebo-
controlled 
parallel study 
Improvement in 
vascular function. 
Associated with 
alterations in oral 
microbiome and 
nitrate-reducing 
genera 
Raubenheimer 
et al., (2017) 
12 adults aged 64 140ml beetroot juice 
providing 800mg 
nitrate 
Single bolus BP, plasma nitrate and 
nitrite, vascular 
inflammation 
Randomised, 
placebo-
controlled, 
crossover trial 
Increase in plasma 
nitrate and nitrite. 
Reduction in BP, and 
granulocyte and 
platelet activation 
Oggioni et al., 
(2018) 
19 healthy adults aged 
64.7±3.0 
2x70ml beetroot 
juice/day, providing 
744mg 
7 days BP, vascular function, 
inflammatory markers 
Double-blind, 
randomised, 
crossover 
placebo-
controlled trial 
No difference in BP or 
AIx. No changes in 
inflammatory 
markers.  
 
Abbreviations: RCTs = randomised controlled trials, PAD = peripheral arterial disease, BP = blood pressure, DBP = diastolic 
blood pressure, SBP = systolic blood pressure, CBF = cerebral blood flow, HN = high nitrate, VO2 = maximum rate of oxygen 
consumption, 6MWT = 6-minute walking test, DM = diabetes mellitus, BMI = body mass index, ABPM = ambulatory blood 
pressure monitoring, CV = cardiovascular, BW = body weight, FMD = flow-mediated dilatation, PWV = pulse wave velocity, AIx 
= augmentation index, PORH = post-occlusive reactive hyperaemia, O2 = oxygen, RH = reactive hyperaemia. 
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1.11 The effects of beetroot on vascular function 
Enhanced NO production from the consumption of beetroot i.e. dietary nitrate to 
offset the reduction in endogenous production seen with vascular dysfunction could 
have a profound effect on vascular function. However, other components of beetroot, 
namely flavonoids, may also contribute to this benefit. Indeed, flavonoids have been 
associated with a reduction in vascular oxidative stress due to their interaction with 
ROS (Torel et al., 1986) and supplementation has been found to have positive 
effects on vascular tone, NO-mediated endothelium-dependent dilation, and NO 
formation (review by Schini-Kerth et al., 2010). Overall, enhanced NO bioavailability 
and reduced oxidative stress in the vascular system may work to reverse macro- and 
micro-vascular endothelial dysfunction. 
 
Four weeks of supplementation with sodium nitrate has been found to reduce PWV 
and AIx and improve FMD (Rammos et al., 2014) but importantly FMD is also 
improved after supplementation with beetroot gel and beetroot juice (Asgary et al., 
2016; Kapil et al., 2015; de Oliveira et al., 2016; Velmurugan et al., 2016). These five 
studies were all carried out in adults with hypertension or other cardiovascular risk 
factors, which may explain the consistent beneficial results. In contrast to these 
studies, Gilchrist et al. (2013) found no improvements in FMD or microvascular 
endothelial function after two weeks of 250ml beetroot juice daily (465mg nitrate) in 
older adults with Type 2 diabetes. Plasma nitrate and nitrite concentrations did 
increase after the two weeks in the beetroot group compared to the placebo but this 
did not correlate with endothelial function. This could be attributed to a reduced 
responsiveness to NO and thus a diminished vascular reactivity with age and Type 2 
diabetes. 
 
de Oliveira et al. (2016) describe that high nitrate doses i.e. ~744mg are required to 
obtain positive effects in endothelial function in the elderly; however smaller doses 
between 350 and 400mg have been found to elicit improvements in older adults 
(Kapil et al., 2015; Velmurugan et al., 2016).  Similar to findings in blood pressure, 
there is no consensus on the dose of dietary nitrate required to elicit a response, 
although there appears to be a more positive effect of a range of doses on vascular 
function overall. FMD, PWV, AIx, and RH can assess functioning of the vascular 
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function and dietary nitrate has varying effects on these markers, making it difficult to 
draw conclusions on the effectiveness of beetroot overall.  
1.12 The effects of beetroot on cognitive function 
Researchers have demonstrated improvements in cognitive performance after a 
dose of dietary nitrate in young participants (Wightman et al., 2015). In this study, 
participants received 450ml beetroot juice containing ~341mg nitrate before 
completing cognitive tasks and CBF analysis. There was an increase in plasma nitrite 
and an initial rise in CBF following nitrate consumption, which were accompanied by 
an improvement in performance on the serial 3s subtraction task. In a study on older 
diabetic participants, 14 days of daily supplementation with 250ml beetroot juice 
providing 465mg was found to increase plasma nitrate and nitrite concentrations and 
improve simple reaction time (Gilchrist et al., 2014). Conversely, Kelly et al. (2013) 
found no improvement in cognitive function following three days of supplementation 
with 140ml concentrated beetroot juice (~595mg nitrate) in older adults, despite rises 
in plasma nitrite concentrations and the provision of a larger dose compared to 
Wightman et al. (2015) and Gilchrist et al. (2014). Diffusion coefficients in the frontal 
lobes, markers of CBF, were also unchanged. This work contrasts with the study by 
Presley et al. (2011), who found that two days of a high nitrate diet (containing 500ml 
beetroot juice) increased CBF within the frontal lobe of older adults. The nitrate 
content of this diet was found to be 527mg, similar to that supplied by Kelly et al. 
(2013), so it is unclear whether ageing or baseline cognitive functioning may play a 
role here. 
 
Thus far, only one study has investigated more prolonged effects of supplementation 
on cognitive function. Justice et al. (2015) demonstrated that 10 weeks of 
supplementation with sodium nitrite improved cognitive performance in middle-aged 
and older adults, as indicated by reductions in time to complete TMT. These authors 
investigated two doses of sodium nitrite: low (80mg/day) and high (160mg/day). 
There was a 14% and 18% improvement in task performance following the low and 
high nitrate dose, respectively. As mentioned previously, more prolonged studies 
may warrant a more accessible form of nitrate i.e. beetroot in order to ensure 
compliance. A recent systematic review and meta-analysis on nitrate and cognitive 
function outlined a lack of overall effect but stipulate that there is insufficient evidence 
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to make firm conclusions on this (Clifford et al., 2018). These authors postulate that 
larger sample sizes and longer duration trials are warranted in this area.  
 
Although much of the beetroot research focuses on nitrate, other compounds such as 
the potent antioxidants betalains and phenolics may elicit benefits. Betalains are very 
similar to anthocyanins in their structure and function but anthocyanins are much 
more widely researched due to their preponderance in fruits and vegetables. 
Anthocyanin-rich cherry juice, for example, has been found to improve verbal fluency 
and short- and long-term memory in older adults with mild-to-moderate dementia 
when supplemented for 12 weeks (Kent et al., 2017). Previous short-term 
supplementation with cherry juice was found to have no effect on cognitive 
performance in young, old or older adults with dementia (Caldwell et al., 2016). 
Prolonged supplementation (12 weeks) with anthocyanin-rich blueberry juice was 
also found to improve memory in older adults with early memory decline, tested by 
word recall and paired associate learning (Krikorian et al., 2010). The focus on 
prolonged intervention in these studies suggests that the nutritional compounds may 
be having their effect through a reduction in oxidative stress, which is not achieved 
through acute dosing. The combination of nitrate, which can have an acute effect on 
vascular function, and antioxidant compounds such as betalains that may work over 
a more prolonged period suggest that beetroot may improve blood flow to the brain 
and attenuate cognitive decline.   
1.13 The effects of beetroot on functional capacity 
Executive functioning, such as task switching and working memory, is directly related 
to motor function and performance-based ADLs. For example, in healthy older adults, 
lower levels of executive function are associated with a reduction in gait performance 
(LaRoche et al., 2014). With nitrate supplementation improving blood perfusion to 
parts of the brain involved in executive functioning i.e. the frontal lobes, it is possible 
that nitrate supplementation could impact on functional capacity.  
 
Shepherd et al. (2015), while assessing the effect of nitrate supplementation on 
blood pressure and walking performance, measured functional capacity in COPD 
patients before and after supplementation using the 6MWT. 70ml of concentrated 
beetroot juice did not improve performance in the 6MWT after 2.5 days of 
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supplementation and this is postulated to be due to the increased oxidative stress 
leading to uncoupling of NO synthase and consequently reducing NO availability. 
Similarly, 140ml concentrated beetroot juice supplementation over three days did not 
improve 6MWT performance in healthy older adults (Kelly et al., 2013). A study by 
Siervo et al. (2016) found modest but non-significant improvements in measures of 
physical capability including hand-grip strength, timed up-and-go, repeated chair 
standing and 10-minute walking test following seven days of beetroot juice 
supplementation in older adults.  
 
If a lack of effect of beetroot juice on functional capacity in older adults is due to 
heightened oxidative stress then the short intervention periods in these trials are 
likely to be a contributing factor. As mentioned previously, Justice et al. (2015) 
investigated the effects of 80mg and 160mg sodium nitrite in middle-aged and older 
adults and found a reduction in the number of balance errors in the rapid step test. 
TUG was not affected but there was a trend for improvements in grip strength 
following the smaller dose of sodium nitrite. This research follows on from a rodent 
study by the same authors, who found that eight-week supplementation with sodium 
nitrite in old and young mice improved grip strength and endurance run distance in 
old mice. This is attributed in part to anti-inflammatory effects on aged skeletal 
muscle with chronic low-grade inflammation (Justice et al., 2015). It is evident, 
therefore, that more prolonged intervention studies with beetroot are justified in order 
to elicit benefits to functional capacity through a reduction in oxidative stress and 
inflammation. This is particularly relevant to older adults and it is likely that this 
population will benefit most from improvements in functional capacity. 
1.14 The effects of beetroot on gut health 
Dietary fibre plays a large role in the digestive system, helping the body to remove fat 
and creating an environment for healthy gut bacteria to thrive and digest food 
efficiently, contributing to the overall health of the gut microbiota. Any vegetable with 
3g of fibre per 100g is classed as a source of fibre, according to the European 
Commission, and beetroot falls close to this at 2.8g fibre/100g. The addition of 
fibrous foods to the diet over a prolonged period may benefit the functioning of the 
gut and the microbiota that populate it. 
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Research has illustrated an association between microbiota and cognition in ageing 
(Leung & Thuret, 2015), being termed the “microbiota-gut-brain” axis. In particular, 
the production of SCFAs is of interest due to their influence on the blood-brain barrier 
and the health of the colon (Fava et al., 2018; Natarajan & Pluznick, 2014). In the 
brain, SCFAs have a neuroprotective effect and butyrate specifically has anti-
inflammatory actions in the brain and the gut (Noble et al., 2017). As mentioned 
previously, SCFAs are produced from fermentation of dietary carbohydrate by 
anaerobes and the levels of various SCFAs are affected by ageing. It has also been 
shown that different polyphenols affect the viability of different gut bacterial species, 
indicating the potential for modulation of the gut microbiota balance through bioactive 
compounds present in fruit and vegetables (Parkar et al., 2013).  
 
Furthermore, nitrite has been posed as a protective compound against gut pathogens 
in humans, as it can eradicate Helicobacter pylori and other pathogenic bacteria 
(Duncan et al., 1997), indicating a positive impact on gut microbiota. The nitrite in 
saliva, which is present due to the bacterial breakdown of nitrate in the oral cavity, 
has been found to increase gastric mucosal blood flow and mucus thickness in rats, 
through an increase in NO (Björne et al., 2004). This is then thought to have gastro-
protective effects. More recently, Velmurugan et al. (2016) showed that persistent 
dietary nitrate ingestion over six weeks raised numbers of oral bacteria possessing 
nitrate reduction capacity. Further studies in this area are warranted to establish 
whether changes in oral bacteria following nitrate ingestion may improve nitrate 
breakdown long term.  
 
Thus, an increase in nitrite formation from ingested dietary nitrate may have 
beneficial effects on gut health, helping to control pathogenic bacteria. Furthermore, 
dietary carbohydrates found in beetroot may help to stimulate SCFA production, 
leading to anti-inflammatory effects. This may also relate to increased consumption 
of the potent antioxidants betalains present in beetroot. Changes to the gut 
microbiota and increases in fibre intake from vegetables may also influence gut 
motility changes that occur with ageing. No studies, however, have directly 
investigated the effects of whole beetroot on gut health and the microbiota but this 
may be an interesting avenue of research. 
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From the literature, it is clear that there is a large body of research surrounding NO, 
its effects on the body, and methods in which its production can be manipulated 
through the diet or with supplementation. There is no clear consensus on the dose of 
dietary nitrate required to elicit a response or the duration of intervention required, 
especially regarding vascular function. Age effects are seen in the production of NO 
and/or the body’s sensitivity to it in some but not all studies, leaving age-related 
differences inconclusive. Where evidence is lacking is in longer-duration trials, 
particularly on cognitive function, functional capacity and gut health. It is unknown 
whether dietary nitrate effects are seen only acutely, or whether there is an additional 
benefit with a more prolonged intervention period. Furthermore, few studies are 
applicable to real life situations, in which people consume a variety of foods, with little 
restriction. The diet of an ageing population is becoming increasingly important and 
there should be more focus on compounds, nutrients and whole food groups that can 
make a real difference in this area.   
1.15 Research questions 
Hypotheses, aims and objectives 
 
The hypotheses for this project were: 
1. The bioavailability of nitrate from whole beetroot will be less in older adults 
than in younger adults. There will be a trend towards a dose-response to 
incremental portions, with higher amounts of beetroot leading to an increased 
bioavailability of nitrate in both populations. 
2. The positive effect on vascular function associated with nitrate will be reduced 
in the older population. The response to the potassium nitrate will be higher 
than that of beetroot, eliciting greater reductions in blood pressure and 
improved blood flow. The vascular response to the beetroot will be greater 
with higher quantities in both populations. 
3. More prolonged supplementation with beetroot will affect cognitive function in 
a group more at risk of cognitive impairment i.e. an ageing population. 
Prolonged supplementation may also affect functional capacity in an older 
population. 
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4. Prolonged beetroot supplementation will cause changes to the gut microbiota 
and have a positive effect on SCFA production and bacterial diversity. 
 
The aims of this thesis were to test the above hypotheses by investigating the 
bioavailability of nitrate and its physiological effects following incremental whole 
beetroot doses in young and old adults. Furthermore, this thesis aimed to investigate 
the longer-term effects of whole beetroot consumption on cognitive function, 
functional capacity and gut health in older population. 
 
The objectives of the study were: 
1. To carry out a crossover trial using incremental portions of whole beetroot in 
addition to a positive control involving both young and old participants. This 
trial will investigate the pharmacokinetics of nitrate in both groups and the 
vascular effects of the doses. 
2. To evaluate the acceptability and tolerance of beetroot portions to be used in a 
prolonged intervention study. 
3. To carry out a prolonged free-living intervention trial using whole beetroot in 
older adults to test whether beetroot supplementation improves cognitive 
performance and functional capacity and affects the gut microbiome. 
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Chapter 2. The pharmacokinetics of nitrate and nitrite following 
incremental beetroot doses in young and old participants 
2.1 Introduction 
Fruit and vegetable intake is linked to protection against cardiovascular disease 
(CVD) and some cancers, and has been found to effectively lower blood pressure 
(Appel et al., 2006). It has been postulated that dietary nitrate, found primarily in 
green leafy vegetables and beetroot, underpins this blood pressure-reducing effect 
(Larsen et al., 2006). In light of this, research is focussing on nitrate-rich vegetables 
such as beetroot and the dietary nitrate pathway as a natural anti-hypertensive. 
Dietary nitrate, when sequentially broken down to nitrite and further to nitric oxide 
(NO) positively impacts the vascular system through the maintenance of blood 
pressure, vascular tone and endothelial integrity (Ignarro, 2002). Following ingestion, 
dietary nitrate mixes with endogenously produced nitrate and levels in plasma peak 
after around 60 minutes (McKnight et al., 1997). Much of this nitrate is excreted 
through the urine but 25% of the absorbed nitrate is transported to the salivary 
glands where commensal bacteria begin the conversion of nitrate to nitrite. Nitrite is 
then reduced to NO by enzymes such as NO synthase and deoxymyoglobin (Shiva, 
2013).  
 
Nitrate has been found to be almost 100% bioavailable following the consumption of 
beetroot juice (Bescús et al., 2011) and whole beetroot (van Velzen et al., 2008) in 
young, healthy individuals. Bioavailability studies are required to accurately map the 
pharmacokinetic profile of nutrients following consumption to identify excretory 
pathways, bioconversion and the time course of physiological effects, and these 
studies are frequently carried out in young populations (Clifford et al., 2017; van 
Velzen et al., 2008). The ageing process has been found to have an impact on NO 
availability through lower levels of the precursor and co-factors involved in 
endogenous NO production (Delp et al., 2008). The pharmacokinetic profile of dietary 
nitrate and the bioconversion to nitrite by bacterial species may therefore be altered 
in an older population, affecting ultimately the availability of NO and its downstream 
vasodilatory properties. There is a lack of pharmacokinetic data in older adults, 
particularly when directly compared to a younger population following a dose of 
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dietary nitrate. Furthermore, large, often impractical doses of beetroot are provided in 
such bioavailability studies, which make the applicability of the vegetable in a real 
world setting problematic. Data on the pharmacokinetic profile of smaller doses of 
beetroot, especially in older adults, would aid research into achievable and practical 
vegetable intakes and their impact on health parameters such as blood pressure.  
 
Therefore, the aim of this study is assess if whole beetroot effectively raises NO 
levels in both young and old participants through the stepwise breakdown of nitrate to 
nitrite and finally to NO. To better understand the pharmacokinetic profile of nitrate 
and nitrite, this study will measure changes in plasma and salivary nitrate and nitrite 
levels over five hours, as well as urinary excretion in both the young and the old 
participants following incremental doses of whole cooked beetroot. It is hypothesised 
that the bioavailability of nitrate from whole beetroot would be less in older adults 
than in younger adults and that there would be a trend towards a dose-response to 
incremental portions i.e. higher amounts of beetroot would show an increased 
bioavailability of nitrate in both populations. 
2.2 Methods  
2.2.1 Participants 
This study involved two age groups: 18-35 years and 60-75 years. Participants were 
recruited through the Newcastle university email system, poster dispersion and NHS 
intranet from November 2016 to October 2017 and provided informed written consent 
before beginning the study. Recruited participants had a body mass index (BMI) 
between 20.0 and 29.9kg/m2 and were non-smoking, healthy and both male and 
female. The young group comprised six males and six females and the old group 
comprised of three males and nine females. The study was registered with the 
ISRCTN registry (ISRCTN86706442) and was approved by the Cambridge Research 
Ethical Committee (Appendix A). The sample size calculation was based on 
preliminary data from a previous, similar trial testing the acute effects of inorganic 
nitrate supplementation compared to placebo in young and older healthy individuals. 
The calculation can be seen in Appendix C.  
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2.2.2 Exclusion criteria 
Healthy participants i.e. those without chronic illness and disease were recruited to 
take part in this study. Excluded medications included: corticosteroids, sildenafil, 
aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), anti-hypertensives (Ca2+ 
channel blockers, ACE inhibitors), diuretics, beta-blockers, antacids, anticoagulants, 
nitrate-derived agents, and anti-cholinergics. Each of these medications can have an 
effect on NO production. Participants were excluded if they were vegetarian, as they 
are likely to have a higher habitual nitrate intake, or self-reported to consume 
excessive volumes of alcohol (>30 units per week). Other exclusion criteria included 
a high blood pressure (>140/90mmHg), smoker, history of repetitive gastric reflux 
and an intolerance or allergy to beetroot. 
2.2.3 Study design and randomisation 
This study was a four-arm, randomised, crossover clinical trial. Randomisation was 
generated online using Research Randomizer, where 30 sets of numbers from one to 
four that represented the interventions were generated; participants were assigned to 
a set following screening. Participants were given 100g, 200g, and 300g of whole 
cooked beetroot and a 1000mg potassium nitrate (PN) solution in a random order as 
per their allocated set. A sample of the beetroot was analysed using ozone-based 
chemiluminescence and found to contain 272mg nitrate per 100g cooked weight. 
This is around the average content defined in the literature (Hord et al., 2009), so this 
value was used to describe the dose provided in this study. 
2.2.4 Study protocol 
Participants who registered an interest in the study were contacted and sent the 
participant information sheet (Appendix B). Potential participants were given time to 
deliberate and ask questions and were then screened over the phone via a short 
questionnaire. During this telephone call, participants were asked questions about 
their medications, medical conditions, current height and weight and availability for 
the study. Eligible participants were invited to attend the Newcastle NIHR Clinical 
Research Facility (CRF) at the Royal Victoria Infirmary (RVI) for a full screening visit, 
where height, weight and blood pressure were measured to confirm eligibility. Four 
further visits were booked in, separated by seven to ten days to allow for the 
 55 
complete return of nitrate and nitrite to pre-supplementation levels between trials. For 
24 hours before the first visit, participants were asked to collect their total urine 
volume in a 2.5L urine container prepped with 5ml sodium hydroxide (1M NaOH) to 
preserve the nitrate in the sample. 
 
Each of the four visits followed the same protocol, differing only in the intervention 
provided (Figure 2.1). Participants were asked to fast on the morning of the visit and 
arrived between 8:15am and 9:00am for testing. Body composition and weight were 
measured at the beginning of each visit using bioelectrical impedance (TANITA Body 
Composition Analyser). Participants removed their shoes before standing on the 
scales and 0.5kg was added to account for clothing weight. Waist circumference was 
measured with a tape measure at the narrowest part of the trunk. Baseline blood 
pressure was measured three times with the participant seated, with a one-minute 
rest in between each measurement. Blood flow was measured by laser Doppler at 
baseline using a standardised protocol; participants were lying supine and in a 
temperature-controlled room (22-24°C). A cannula was fitted in the antecubital fossa 
or other appropriate area and baseline blood samples were taken. A saliva sample 
was collected, as detailed in section 2.2.8. The final baseline measure was fractional 
exhaled nitric oxide (FeNO), measured using a handheld device (NIOX), which 
involved participants exhaling into a mouthpiece for around 10 seconds to provide a 
reading. Participants were then given a 15-minute window in which to consume the 
beetroot or PN that had been provided. Once the relevant dose had been taken, the 
five-hour intervention period began, and participants were fed a standardised 
breakfast of cereal with milk and natural yoghurt. This meal contained around 
450kcal with 62% carbohydrate, 16% protein and 22% fat. Breakfast items were 
chosen from the list of low-nitrate foods described by Wang et al. (1997) and the 
nitrate content of the meal was around 2.8mg. Following breakfast, participants 
rested in the research facility and further measurements of blood flow were taken at 
150 and 300 minutes. Blood pressure was measured every 30 minutes after the 
consumption of the intervention, with the final measurement at 300 minutes. Saliva 
and blood samples and FeNO were measured at 30, 60, 120, 180, 240 and 300 
minutes. Urine samples were collected at 0-3 hours, 3-6 hours, 6-12 hours, and 12-
24 hours to gain a full 24hr sampling period. Participants were given disposable jugs 
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to measure the total volume of each urine sample, which was noted, and 50ml was 
collected from the larger volume and stored for later analysis. 
 
During their first visit, participants completed the international physical activity 
questionnaire (IPAQ) (Craig et al., 2003), which estimated their activity levels in the 
previous seven days. Participants also completed a nitrate intake questionnaire for 
the previous seven days to estimate their habitual nitrate intake before study visits 
and a visual analogue scale (VAS) to assess their opinion of the beetroot 
intervention. Participants completed the IPAQ, nitrate intake questionnaire and VAS 
on each subsequent visit. On the final visit, participants were asked to complete a 
feedback questionnaire that included questions on their opinion of the beetroot dose 
and positive and negative aspects of the study. The nitrate intake questionnaire and 
VAS can be found in Appendices D and E. At the end of the five-hour intervention 
period and following the final blood sample, the cannula was removed and 
participants were provided with a standardised low-nitrate lunch of a chicken or tuna 
sandwich and a packet of ready salted crisps, which they consumed in the research 
facility. Participants were provided with sample pots to continue the urine collection 
for the remainder of the day, as described above, and a low-nitrate ready meal to 
consume at home. They were then free to leave the research facility.  
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Figure 2.1: Study day protocol followed for each intervention. Low-nitrate meals 
provided at times shown and beetroot or potassium nitrate consumed within 15 
minutes following baseline measurements and cannula insertion. Participants 
collected urine and saliva samples after leaving the research facility, which were 
frozen and returned to the research facility. 30-300 represents time points where 
blood and saliva samples were collected and exhaled nitric oxide (FeNO) was 
measured. Blood flow using laser Doppler measured at 0, 150 and 300 minutes. 
 
2.2.5 Interventions 
Participants were randomised to receive either 1) 100g of whole cooked beetroot 
(~272mg nitrate), 2) 200g beetroot (~544mg nitrate), 3) 300g beetroot (~816mg 
nitrate), 4) 200ml solution of potassium nitrate (1000mg nitrate). The cooked beetroot 
was grown and processed by G’s Fresh Ltd in Cambridgeshire and purchased from 
Tesco. Beetroot was purchased on a per participant basis to adhere to the use by 
dates and was refrigerated until used. The beetroot was steamed and dipped in 
vinegar and represented what members of the public would buy as a ready-to-eat 
product. The potassium nitrate was produced by Newcastle Specials Pharmacy 
Production Unit in the Royal Victoria Infirmary with codes assigned to them at the 
time of preparation e.g. Y01 or OL01 for young and old participants, respectively. The 
intervention was given at the same time each visit, depending on cannulation, and 
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consumed within 15 minutes, with exception of three participants who took between 
15 and 30 minutes to consume the beetroot due to an aversion to the larger 
amounts. 
2.2.6 Dietary control 
Participants were required to follow a low nitrate and phenolic diet in the two days 
before each trial, as well as the entirety of the testing day. This included avoidance of 
most vegetables, fruits, cured meats, strong cheese, chocolate, wholegrain breads 
and grains, tea, coffee and alcohol; a list of foods to avoid was provided alongside a 
food diary. Participants were also instructed to consume the same or similar meals in 
the days before each of the trials. To reduce the burden of the dietary restrictions, 
participants were provided with ready meals to consume on the night before and day 
of testing. Meals were chosen based on the content of low nitrate and phenolic 
compound products and included fish pie, mushroom risotto and macaroni cheese. 
The aim of these restrictions was to eliminate the potential influence that the 
consumption of nitrate- or phenolic-rich foods other than the intervention under 
investigation may have on study outcomes, particularly surrounding bioavailability. 
These restrictions have been implemented in other studies to more accurately 
establish the bioavailability of functional foods (Clifford et al., 2017; Frank et al., 
2005; Keane et al., 2016). Participants were given three-day food diaries (Appendix 
F) to record their dietary intake before and during the study days in order for 
compliance to the dietary restrictions to be assessed. All participants were also 
asked to refrain from using anti-bacterial mouthwash and gum throughout the study 
due to its potential influence on the conversion of nitrate to nitrite (Webb et al., 2008).  
2.2.7 Urinary output 
The day before their first visit, participants collected a 24-hour urine sample in 2.5L 
urine containers prepped with 5ml of a 1M NaOH solution, prepared in the laboratory. 
This was stored out of direct sunlight, either in the fridge or in a provided cooler bag, 
and returned to the researcher on the morning of their first visit. During the study 
visit, total urinary output was measured over two time periods: 0-3 hours and 3-6 
hours post-intervention. Total volume was measured using disposable measuring 
jugs and a small sample pot was filled. The sample pot was prepped with 100µl of 
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NaOH solution. Participants were given labelled sample pots and measuring jugs to 
repeat the collections at home between 6-12 hours and 12-24 hours post-
intervention. The sample pots were refrigerated or frozen and returned to the 
researcher. The total volume of each time point was recorded and the urine was 
aliquoted and frozen at -20°C until analysis. Before analysis, samples were defrosted 
and diluted to 1:100 with deionized water.  
2.2.8 Saliva sampling 
Salivary nitrate was measured in the saliva following stimulation by chewing. 
Participants chewed a small cotton wool ball for approximately two minutes or until 
wet and this was deposited into a syringe. The cotton wool ball was then squeezed 
into a 1ml Eppendorf tube prepped with 3.7µL NaOH solution. Tubes were then 
frozen at -20°C until analysis. Before nitrate analysis, samples were defrosted and 
diluted to 1:100 with deionized water.  
2.2.9 Blood sampling and processing 
17ml of blood was collected at each time point in three vacutainers: two lithium 
heparin and one serum gel. One lithium heparin tube was spun immediately at 
5000rpm for three minutes, aliquoted into dark-coloured Eppendorf tubes and frozen 
at -80°C to preserve the nitrite. Each Eppendorf tube was pre-treated with a stop 
solution of 10µl of diethylenetriaminepentaacetic acid (DTPA) and 6.5µl of N-
ethylmaleimide (NEM), to prevent transition between compounds, as described by 
Nagababu and Rifkind (2007). To prepare the solutions, firstly a 1M NaOH solution 
was prepared by dissolving 40g NaOH pellets in 1L water. To make the DTPA 
solution, 39.3mg DTPA was suspended in 5ml distilled water. With the contents 
being constantly stirred, 1M NaOH was added drop wise until the DTPA was 
completely dissolved. The final volume was made up to 10ml with distilled water. This 
solution was stable at room temperature and was prepared twice over the course of 
the study. Before each visit the NEM solution was prepared by dissolving 12.5mg 
NEM in 10ml of distilled water. This was kept at 4°C and fresh reagent was prepared 
for each study visit. DTPA and NEM prevent the destruction of plasma S-nitrosothiols 
to nitrite (Nagababu & Rifkind, 2007) and samples were spun and frozen as quickly 
as possible in order to maintain stability in the samples. The remaining vacutainers 
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were kept cool and processed within 30 minutes, or after clotting had occurred in the 
serum tubes. They were spun at 3000rpm for 10 minutes at 4°C then aliquoted and 
frozen at -80°C. The plasma samples were used to measure nitrate and nitrite 
concentrations. Due to time constraints, not every time point was able to be 
analysed, so the most appropriate samples were chosen: baseline, 60 minutes, 180 
minutes and 300 minutes.  
2.2.10 Fractional exhaled nitric oxide (FeNO) 
A handheld device called the NIOX VERO was developed as a tool for non-invasive 
measurement of FeNO as a marker of airway inflammation (Travers et al., 2007; 
Ricciardolo, 2004), aiding the diagnosis and management of asthma. The NIOX 
VERO device (Circassia, USA) was used to collect data on FeNO in this study. This 
portable, non-invasive device provides a simple and quick method of data collection; 
set up takes around two minutes per trial. Each participant receives a new 
mouthpiece per trial and is trained on its use at the first visit. The participant is 
required to breathe steadily and consistently into the handheld sensor until a suitable 
measurement has been taken, as signalled by the device. The sensor then takes 
around one minute to produce a reading of FeNO in parts per billion (ppb). Exhaling 
too vigorously or too gently renders the measurement unusable and it must then be 
restarted. Measurements were taken at baseline and at 30, 60, 120, 180, 240 and 
300 minutes following the intervention. Readings were recorded in ppb in a data 
sheet throughout the visit and inputted into a spreadsheet after completion. Each 
sensor supplied by the manufacturers takes 500 readings and the sensor was 
replaced and calibrated mid-way through the study. The breathing handle was also 
replaced, as guided by the software. 
2.2.11 Sample analysis 
Plasma samples were first deproteinised before analysis using cold ethanol 
precipitation. The required ethanol was first chilled to 0°C. 0.5ml of each sample was 
placed in a 1.5ml microcentrifuge tube and 1ml of cold ethanol was added. The tubes 
were then vortexed for 10 seconds and placed at 0°C for 30 minutes. Samples were 
centrifuged at 14,000rpm for five minutes. The supernatant was removed for the 
determination of nitrate and nitrite. The whole beetroot was juiced and diluted to 
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1:1000 in deionized water prior to analysis for nitrate content. The researcher 
conducted the deproteinisation and dilution, however ozone-based 
chemiluminescence was carried out by a trainer laboratory assistant who worked 
closely with a principal investigator in the research group. 
 
The ozone-based chemiluminescence method was used to measure plasma and 
salivary nitrate and nitrite and urinary nitrate concentrations using the Sievers gas-
phase chemiluminescence nitric oxide analyser (NOA 280i, Analytix, UK). Briefly, 
prior to analysis a standard curve was created for both nitrate and nitrite and an 
equation was derived to calculate nitrate and nitrite concentrations by fitting a linear 
regression line to the standard concentrations. R2 was greater than 0.99. Diluted 
samples were injected into the purge vessel using a glass Hamilton (Fisher) syringe 
with an injection volume ranging from 10µl to 100µl. The injection volume was 
adjusted to maximise the sensitivity of the measurements and taken into account 
when calculating the final concentrations. The area under the curve of the peaks was 
calculated automatically by the Analytix software, which minimises the risk of 
between-operator differences in the calculation of results, and was used to calculate 
the concentrations of the samples using the standard regression equations. Samples 
were analysed in singlicate and quality of the peaks was checked visually based on 
height, fronting and tailing. Analyses were repeated for samples with low quality 
peaks. Calibration of the device is ensured by a maintenance contract with Analytix 
and a service is provided twice per year. The internal calibration of the analysis is 
performed by using serial dilutions of nitrate and nitrite standards with known 
concentrations. In addition, each run of the samples is preceded by the injection of a 
standard with known concentration to ensure the accuracy of the results. The assay 
performance of the nitrate and nitrite analysis is high, with a within-operator 
coefficient of variation of 91% for nitrate and 89% for nitrite after a series of ten 
consecutive manual injections of a standard solution with known concentration.  
2.2.12 Statistical analysis 
All statistical analyses were completed using IBM SPSS (version 24.0). Summary 
data are presented as means ± SD with 95% confidence intervals (CI). Intraclass 
coefficient values (ICC) were used to calculate the reliability of the measurements 
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over the multiple baseline values (time 0) obtained at the beginning of each 
supplementation visit. FeNO values were amalgamated into baseline (0min), early 
(30-90min), mid (120-210min) and late (240-300min) measurement points to better 
capture changes in FeNO after supplementation and improve graphical presentation 
of the results across the time points. Independent t-tests were used to assess 
differences in baseline measures between the two age groups. Changes over time 
were analysed using a two-factor repeated measures analysis of variance (ANOVA) 
with time and intervention as within-subjects factors. Area under the curve (AUC) 
over the five-hour period was calculated using the trapezoid method to assess age-
related differences, which were analysed using a mixed model repeated measures 
ANOVA with intervention as the within-subjects factor and age as the between-
subjects factor. Data was assessed for normality using the Shapiro-Wilks test. 
Models were checked for sphericity using Mauchly’s test and multivariate models 
were applied if these assumptions were violated. Where significances were found 
and to assess intervention or age specific outputs, post hoc tests with Bonferroni 
adjustment to control for multiple comparisons were run. Associations between 
changes in plasma nitrate and nitrite and changes in FeNO were analysed using 
Pearson product-moment correlation coefficient. Statistical significance was set at 
P<0.05.  
2.3 Results 
2.3.1 Baseline characteristics 
A total of 24 participants were randomised to the interventions, 12 young (27.3±3.8 
years) and 12 old (64.3±4.6 years) participants (Figure 2.2). The interventions were 
well tolerated and no adverse events were reported, although participants did 
describe beeturia and faecal discolouration following ingestion of the beetroot. 
Baseline characteristics (Table 2.1) illustrates that the young and old group were 
matched for BMI, height and weight but the old group had a significantly higher waist 
circumference (P=0.04) and body fat percentage (P=0.04) than the young group. 
Baseline systolic and diastolic blood pressures and FeNO were similar across the 
groups. Physical activity levels, measured in metabolic equivalent in minutes per 
week (MET-min/wk), were significantly lower in the old group than the young group 
(P=0.02) with values of 3546 MET-min/wk and 4260 MET-min/wk, respectively.  
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2.3.2 Dietary intake 
Inspection of the food diaries revealed that participants adhered to the dietary 
restrictions and their food intake prior to each visit did not significantly differ between 
trials. Habitual daily nitrate intakes over the four-week period were similar for both 
groups but the mean for all participants was approximately 238mg/day, which is 
higher than the average daily intake of 108mg/day (Babateen et al., 2018).  
 
 
Figure 2.2: Recruitment flowchart, study 1. 
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Table 2.1: Mean (±SD) baseline characteristics for participants in study 1. 
 
 All Young Old P value 
Number 24 12 12  
Gender (male/female) 9/15 6/6 3/9  
Age (years) 45.8±19.4 27.3±3.8 64.3±4.6 <0.001 
Height (cm) 169.0±8.5 172.1±7.5 166.0±8.5 0.07 
Weight (kg) 68.2±8.8 70.0±9.3 66.4±8.2 0.33 
Body mass index (kg/m2) 23.9±2.5 23.6±2.1 24.2±2.9 0.59 
Waist circumference (cm) 82.9±6.3 80.3±4.9 85.5±6.7 0.04 
Body fat (%) 26.7±10.1 22.6±9.2 30.8±9.5 0.04 
SBP (mmHg) 117.7±10.5 115.3±8.4 120.2±12.1 0.27 
DBP (mmHg) 74.6±2.3 72.6±4.2 76.54±7.0 0.11 
FeNO (ppb) 26.5±18.4 30.9±22.2 22.2±13.2 0.25 
Nitrate intake (mg/day) 238.4±126.7 223.8±124.6 252.9±132.6 0.59 
Physical activity (MET-
min/wk) 
3839.5±517.2 4260.4±2088.2 3456.7±2650.8 0.02 
 
Statistical analysis using independent t-tests. SBP = systolic blood pressure, 
DBP = diastolic blood pressure. 
2.3.3 Plasma nitrate 
Young 
There was a significant effect of time (P<0.001) and intervention (P<0.001) on 
plasma nitrate levels in the young and a significant interaction between the two 
factors (P<0.001), as illustrated in Figure 2.3. Pairwise comparisons show that 
plasma nitrate levels following PN were significantly higher than following 100g 
beetroot (+157.5µmol/L; P=0.001; 95%CI: 66.74, 248.22), 200g beetroot 
(+121.1µmol/L; P=0.001; 95%CI: 52.15, 190.04) and 300g beetroot (+85.6µmol/L; 
P=0.04; 95%CI: 3.87, 167.40). Levels following 300g beetroot were also higher than 
following 100g beetroot (+71.8µmol/L; P=0.01; 95%CI: 14.72, 128.96), which 
demonstrates a stepwise dose response to increasing nitrate intakes. Plasma nitrate 
was significantly higher at one, three and five hours than at baseline (P<0.001). 
Analyses show that plasma nitrate levels were significantly raised from baseline at 
one, three, and five hours post-ingestion of all nitrate doses but there was a stepwise 
increase alongside higher doses compared to 100g beetroot after one hour with 
+50.4µmol/L, +89.3µmol/L and +254.1µmol/L higher following 200g, 300g and PN, 
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respectively. Over the 300-minute period, plasma nitrate increased from baseline by 
257%, 358%, 538% and 1027% on average following 100g, 200g, 300g beetroot and 
PN, respectively.  
 
Figure 2.3: Mean (±SEM) plasma nitrate levels over five hours following 
incremental doses of nitrate in the young group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. * denotes significant increase from baseline 
across nitrate doses. 
Old 
There was a significant effect of time (P<0.001) and intervention (P<0.001) on 
plasma nitrate levels in the old and a significant interaction between the two factors 
(P<0.001), as illustrated in Figure 2.4. Pairwise comparisons show that plasma 
nitrate levels following PN were significantly higher than following 100g beetroot 
(+217.9µmol/L; P<0.001; 95%CI: 121.43, 314.46), 200g beetroot (+169.9µmol/L; 
P=0.02; CI: 27.02, 312.80) and 300g beetroot (+164.5µmol/L, P=0.001; 95%CI: 
65.42, 263.61), demonstrating a stepwise dose response to increasing nitrate 
intakes. Post hoc analyses show that plasma nitrate levels were significantly raised 
from baseline at one, three, and five hours post-ingestion of all nitrate doses 
  * 
   * 
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(P<0.001), although after one hour there was a larger increase following PN than 
100g beetroot (+302.9µmol/L; P<0.001; 95%CI: 165.2, 440.8), 200g beetroot 
(+248.8µmol/L; P=0.002; 95%CI: 90.8, 406.7) and 300g beetroot (+249.3µmol/L; 
P=0.002; 95%CI: 93.9, 404.7). This stepwise increase is evident in Figure 2.4. Over 
the 300-minute period, plasma nitrate levels were higher than baseline by 373%, 
749%, 1015% and 1442% on average following 100g, 200g, 300g beetroot and PN, 
respectively.  
 
 
Figure 2.4: Mean (±SEM) plasma nitrate levels over five hours following 
incremental doses of nitrate in the old group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. * denotes significant increase from baseline 
across nitrate doses. 
AUC 
The AUC over the five-hour period for the young and the old groups demonstrates no 
age effect (P=0.23) but a significant effect of intervention (P<0.001) (Figure 2.5). 
There was no interaction between age and intervention (P=0.24). Pairwise 
comparisons indicate that there was no difference between responses to 100g and 
 * 
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200g beetroot but consumption of 300g beetroot produced a larger AUC than the 
consumption of 100g (+23424.3; P=0.004; 95%CI: 6300.5, 40548.2), as did PN 
(+67894.6; P<0.001; 95%CI: 46672.4, 89116.8). Analyses show that this occurs in 
both the young and the old group (P<0.05). There is also a notable trend towards a 
smaller AUC following PN in the young group than the old group (-30821.2; P=0.08; 
95%CI: -66095.1, 4452.8). 
 
 
Figure 2.5: Mean (±SEM) area under the curve (AUC) for plasma nitrate levels in 
the young and the old groups; n = 24 (12 young and 12 old). Data analysed using 
mixed model repeated measures ANOVA (intervention as within-subjects factor 
and age as between-subjects factor). BR = beetroot, PN = potassium nitrate 
positive control. * denotes significant difference between interventions for both 
age groups. 
2.3.4 Plasma nitrite 
Young 
There was a significant effect of time (P<0.001) and intervention (P<0.001) on 
plasma nitrite levels in the young group and a significant interaction between the two 
factors (P<0.001), as illustrated in Figure 2.6. Pairwise comparisons show that 100g 
 * 
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beetroot caused the lowest rise in nitrite levels, with larger values following 200g 
(+39.3nmol/L; P=0.009; 95%CI: 9.1, 69.5), 300g beetroot (+137.7nmol/L; P<0.001; 
95%CI: 87.0, 188.3), and PN (+473.0nmol/L; P<0.001; 95%CI: 384.8, 561.2). As with 
plasma nitrate, this demonstrates a stepwise dose response in plasma nitrite to 
higher doses of nitrate. Analyses show that all doses of beetroot significantly 
increased plasma nitrite levels from baseline at all subsequent time points (P<0.001) 
but at five hours plasma nitrite levels were higher than 100g beetroot following 300g 
beetroot (+230.1nmol/L; P<0.001; 95%CI: 128.3, 331.8) and PN (+837.0nmol/L; 
P<0.001; 95%CI: 664.1, 1009.9). Over the 300-minute period, plasma nitrite 
increased from baseline by 93%, 144%, 179% and 495% on average following 100g, 
200g, 300g beetroot and PN, respectively. 
 
Figure 2.6: Mean (±SEM) plasma nitrite levels over five hours following 
incremental doses of nitrate in the young group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. * denotes significant increase from baseline 
across nitrate doses.  
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Old 
As with the young group, there was a significant effect of time (P<0.001) and 
intervention (P<0.001) on plasma nitrite levels in the old group and a significant 
interaction between the two factors (P<0.001), as shown in Figure 2.7. Higher nitrate 
consumption raised plasma nitrite levels in an incremental fashion, with higher levels 
following 200g beetroot (+33.1nmol/L; P=0.04; 95%CI: 10.3, 55.8), 300g beetroot 
(+106.8nmol/L; P<0.001; 95%CI: 51.6, 161.9), and PN (+398.3nmol/L; P<0.001; 
95%CI: 268.2, 527.9) compared to 100g beetroot ingestion. 100g beetroot itself did 
significantly raise plasma nitrite levels from baseline by 167.3nmol/L (P<0.001; 
95%CI: 117.1, 217.6). Plasma nitrite levels were significantly higher than baseline at 
one, three and five hours following all doses of nitrate (P<0.05). Over the 300-minute 
period, plasma nitrite levels were higher than baseline by 121%, 141%, 239% and 
528% on average following 100g, 200g, 300g beetroot and PN, respectively. 
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Figure 2.7: Mean (±SEM) plasma nitrite levels over five hours following 
incremental doses of nitrate in the old group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. * denotes significant increase from baseline 
across nitrate doses. 
AUC 
The AUC over the five-hour period for plasma nitrite in the young and the old groups 
shows a significant effect of age (P=0.008), as illustrated in Figure 2.8. There was 
also a significant effect of intervention (P<0.001) but no interaction between 
intervention and age (P=0.17). Pairwise comparisons show that there was a dose 
response to nitrate intake, with each incremental dose producing a larger AUC than 
the smaller doses (all P<0.001). Pairwise comparisons also demonstrate that the 
young had a significantly larger AUC than the old group (+16096.3; P=0.008; 95%CI: 
4717.3, 27475.2) across the interventions. Post hoc analyses show that the young 
group had a significantly larger AUC than the old group following 200g beetroot 
(+9180; P=0.03; 95%CI: 1182.0, 17177.9) and 300g beetroot (+16147.5; P=0.04; 
95%CI: 1264.8, 31030.2). There was also a notable trend towards a larger AUC 
following PN in the young group compared to the old (+33587; P=0.07; 95%CI: -
 * 
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2436.3, 69611.3). The AUC following 100g beetroot was not significantly different in 
the young and the old groups (P=0.29). 
 
Figure 2.8: Mean (±SEM) area under the curve (AUC) for plasma nitrite levels in 
the young and the old groups; n = 24 (12 young and 12 old). Data analysed using 
mixed model repeated measures ANOVA (intervention as within-subjects factor 
and age as between-subjects factor). BR = beetroot, PN = potassium nitrate 
positive control. * denotes significant difference between age groups. 
2.3.5 Salivary nitrate 
Young 
Analysis shows a significant effect of time (P<0.001) and intervention (P<0.001) on 
salivary nitrate in the young and an interaction between the two factors (P=0.01). 
This is illustrated in Figure 2.9. Pairwise comparisons show that there was no 
difference in nitrate levels between 100g and 200g beetroot (P=0.51) or 200g and 
300g beetroot (P=0.16) but nitrate levels following 100g were significantly lower than 
following 300g (-1.7mmol/L; P=0.02; 95%CI: -3.2, -0.2) and following PN (-
4.4mmol/L; P=0.004; 95%CI: -7.4, -1.4). Nitrate levels following the consumption of 
PN were also higher than following 300g beetroot (+2.7mmol/L; P=0.02; 95%CI: 0.5, 
 * 
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5.0), demonstrating a dose response to higher amounts of nitrate. Salivary nitrate 
levels were higher than baseline at one and two hours following consumption of all 
nitrate doses but levels following 300g beetroot and PN remained elevated over the 
five-hour period; nitrate levels following 100g and 200g beetroot were not maintained 
at a significantly higher level. Nitrate levels at the 12-hour period were not different 
from baseline (P=1.00), demonstrating that salivary nitrate levels had returned to 
normal. Over the 300-minute period, salivary nitrate levels rose by on average 466%, 
669%, 510% and 1089% from baseline following 100g, 200g, 300g beetroot and PN, 
respectively. 
 
Figure 2.9: Mean (±SEM) salivary nitrate levels over 12 hours following 
incremental doses of nitrate in the young group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate. * denotes significant increase from baseline across nitrate 
doses. 
Old  
There was a significant effect of time (P<0.001) and intervention (P<0.001), as well 
as an interaction between the two factors (P<0.001), on salivary nitrate levels in the 
old group (Figure 2.10). Nitrate levels were incrementally higher compared to 100g 
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beetroot following 200g (+0.8mmol/L; P=0.005; 95%CI: 0.3, 1.3), 300g (+1.8mmol/L; 
P=0.003; 95%CI: 0.6, 2.9), and PN (+5.1mmol/L; P<0.001; 95%CI: 3.7, 6.3). Nitrate 
levels were elevated from baseline at all time points across the five-hour period 
following all nitrate doses (all P<0.05). Similar to the young group, nitrate levels at 
baseline and at 12 hours were not significantly different in any of the interventions 
(P=1.00). Over the 300-minute period, salivary nitrate levels rose by 649%, 1035%, 
437% and 1129% from baseline following 100g, 200g, 300g beetroot and PN, 
respectively. 
 
Figure 2.10: Mean (±SEM) salivary nitrate levels over 12 hours following 
incremental doses of nitrate in the old group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate. * denotes significant increase from baseline across nitrate 
doses. 
AUC 
There was no effect of age (P=0.28) but a significant effect of intervention (P<0.001) 
on AUC for salivary nitrate (Figure 2.11). There was no interaction between 
intervention and age (P=0.86). Pairwise comparisons show that the AUC was 
significantly larger following PN than all other interventions (all P<0.001) and AUC 
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rose incrementally, with higher values after 200g beetroot than 100g beetroot 
(+289.7; P=0.009; 95%CI: 59.3, 520.1) and higher values after 300g than 200g 
(+675.3; P=0.001; 95%CI: 232.9, 1117.8). Analyses show that there was no 
difference in AUC between the young and old groups following any of the 
interventions (all P>0.05) but there was a trend towards a higher AUC in the old than 
the young following 200g beetroot (+416.2; P=0.09; 95%CI: -70.9, 903.3).  
 
Figure 2.11: Mean (±SEM) area under the curve (AUC) for salivary nitrate levels in 
the young and the old groups; n = 24. Data analysed using mixed model repeated 
measures ANOVA (intervention as within-subjects factor and age as between-
subjects factor). BR = beetroot, PN = potassium nitrate positive control. * denotes 
significant difference between interventions for both age groups. 
2.3.6 Salivary nitrite 
Young 
There was a significant effect of time (P<0.001) and intervention (P<0.001) on 
salivary nitrite levels in the young and an interaction between the two factors 
(P=0.04), as shown in Figure 2.12. Pairwise comparisons identify higher levels 
following PN compared to 100g beetroot (+460.4µmol/L; P=0.03; 95%CI: 41.1, 879.7) 
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and compared to 200g beetroot (+425.1µmol/L; P=0.005; 95%CI: 122.2, 727.9). 
Nitrite levels were significantly higher at all time points over the five-hour period than 
baseline across interventions. As with salivary nitrate, there was no difference 
between salivary nitrite levels at baseline and at 12 hours. 100g beetroot did not 
significantly raise nitrite levels over time but 200g (+422.9µmol/L; P=0.008; 95%CI: 
92.3, 753.5) and 300g beetroot (+617.3µmol/L; P=0.01; 95%CI: 116.4, 1118.1) did. 
Over the 300-minute period, salivary nitrite levels rose by 381%, 308%, 564%, and 
573% from baseline following 100g, 200g, 300g beetroot and PN, respectively.  
 
Figure 2.12: Mean (±SEM) salivary nitrite levels over 12 hours following 
incremental doses of nitrate in the young group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. 
 
Old 
There was a significant effect of time (P<0.001) and intervention (P=0.004) on 
salivary nitrite levels in the old group and an interaction between the two factors 
(P=0.01) (Figure 2.13). There was no difference between 100g and 200g beetroot but 
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levels following 100g were significantly lower than following 300g (-215.4µmol/L; 
P=0.05; 95%CI: -433.6, 2.8) and following PN (-426.3µmol/L; P=0.008; 95%CI: -
747.2, -105.5). Contrary to what was seen in the young group, salivary nitrite levels 
did not return to baseline after 12 hours; levels were 289.5µmol/L higher than 
baseline (P=0.003; 95%CI: 93.1, 485.9) for all interventions combined. 100g beetroot 
did not significantly raise nitrite levels over the five-hour period but there was a 
noteworthy trend towards an increase in nitrite following 200g beetroot 
(+446.9µmol/L; P=0.06; 95%CI: -11.4, 905.3). Levels were raised at multiple time 
points following 300g beetroot and at all time points following PN. Over the 300-
minute period, salivary nitrite levels were 206%, 466%, 544%, and 860% higher than 
baseline following 100g, 200g, 300g beetroot and PN, respectively.  
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Figure 2.13: Mean (±SEM) salivary nitrite levels over 12 hours following 
incremental doses of nitrate in the old group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. 
 
AUC 
There was no effect of age (P=0.74) but a significant effect of intervention on AUC 
over the 300-minute period for salivary nitrite (P<0.001), as shown in Figure 2.14. 
There was no interaction between intervention and age (P=0.74). The AUC over the 
300-minute period was significantly larger following PN than 100g beetroot 
(+293492.5; P<0.001; 95%CI: 137490.6, 449494.4), 200g beetroot (+229182.5; 
P<0.001; 95%CI: 92273.5, 366091.5) and 300g beetroot (+152418.8; P=0.03; 
95%CI: 13240.5, 291596.9). The AUC following 300g was also significantly larger 
than following 100g beetroot (+141073.8; P=0.01; 95%CI: 22463.6, 259683.9).  
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Figure 2.14: Mean (±SEM) area under the curve (AUC) for salivary nitrite levels in 
the young and the old groups; n = 24 (12 young and 12 old). Data analysed using 
mixed model repeated measures ANOVA (intervention as within-subjects factor 
and age as between-subjects factor). BR = beetroot, PN = potassium nitrate 
positive control. * denotes significant difference between interventions across 
both age groups.  
2.3.7 Urinary nitrate 
Presented here are the urinary nitrate concentrations and total nitrate excretion for 
both age groups. Nitrate excretion for both age groups following each intervention 
can be seen in Appendix H.  
Concentrations - young 
There was a significant effect of time (P<0.001) and intervention (P<0.001) on urinary 
nitrate concentrations in the young (Figure 2.15). There was also an interaction 
between the two factors (P=0.003). Pairwise comparisons indicate that there were 
lower concentrations compared to PN after 100g beetroot (-1.8mmol/L; P=0.002; 
95%CI: -2.9, -0.6) and after 200g beetroot (-1.3mmol/L; P=0.01; 95%CI: -2.4, -0.3), 
demonstrating a dose response to larger amounts of nitrate. Urinary nitrate 
concentration was higher than baseline at each other time point measured, but there 
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was no difference between concentrations at 3-6, 6-12 or 12-24 hours. 0-3 hours 
post-nitrate ingestion, urinary nitrate concentrations were significantly higher 
following PN than following 100g beetroot (+1.3mmol/L; P=0.003; 95%CI: 0.5, 2.2) 
and following 200g beetroot (+1.0mmol/L; P=0.02; 95%CI: 0.1, 1.9). At 3-6 hours and 
12-24 hours there were no differences between the interventions, but levels following 
PN were significantly higher than 100g beetroot at 6-12 hours post-ingestion 
(+3.3mmol/L; P=0.008; 95%CI: 0.8, 5.8).  
 
Figure 2.15: Mean (±SEM) urinary nitrate concentrations over 24 hours following 
incremental doses of nitrate in the young group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. * denotes significant difference from baseline 
across nitrate doses.  
Old 
There was a significant effect of time (P<0.001) and intervention (P<0.001) on urinary 
nitrate concentrations in the old group and a significant interaction between the two 
factors (P<0.001) (Figure 2.16). Similar to the young group, urinary nitrate 
concentrations in the old group were lower for 100g (-3.1mmol/L; P<0.001; 95%CI: -
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4.5, -1.7) and 200g beetroot (-2.6mmol/L; P=0.001; 95%CI: -4.0, -1.1) than for PN. 
Nitrate levels were significantly higher than baseline for all other time points 
measured (all P<0.05).  
 
Figure 2.16: Mean (±SEM) urinary nitrate concentrations over 24 hours following 
incremental doses of nitrate in the old group; n = 12. Statistical analysis using 
two-factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. * denotes significant difference from baseline 
across nitrate doses.  
Total nitrate excretion and nitrate recovery 
There was no effect of age (P=0.74) but a significant effect of intervention on total 
urinary nitrate excretion (P<0.001), as shown in Figure 2.17A. There was no 
interaction between age and intervention (P=0.44). Pairwise comparisons show that 
total nitrate excretion was significantly higher following PN than following 100g 
beetroot (+302.3mg; P<0.001; 95%CI: 203.9, 400.8), 200g beetroot (+256.6mg; 
P<0.001; 95%CI: 144.7, 368.5) and 300g beetroot (+162.2mg; P=0.03; 95%CI: 11.9, 
312.4), demonstrating a dose response across both groups. Excretion was also 
higher following 300g beetroot than 100g (+140.2mg; P=0.01; 95%CI: 27.3, 253.1).  
* 
* 
* 
   * 
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Urinary nitrate recovery was calculated as a percentage of the ingested nitrate 
excreted in 24 hours for each intervention. There was no effect of age (P=0.35) but a 
significant effect of intervention (P=0.009) on urinary nitrate recovery. There was no 
interaction between intervention and age (P=0.21) (Figure 2.17B). Pairwise 
comparisons show that recovery was significantly greater following 100g beetroot 
than 200g beetroot (+17.7%; P=0.04; 95%CI: 0.6, 34.7) but there were no other 
significant differences between interventions. Recovery after 100g beetroot was 
significantly greater than 200g beetroot in the young group (+22.9%; P=0.05; 95%CI: 
-0.1, 45.9) but there were no significant differences in the old group.  
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Figure 2.17: Mean (±SEM) total urinary nitrate excretion (A) and urinary nitrate recovery (B) over 24 hours following 
incremental doses of nitrate in the young and old groups; n = 24 (12 young and 12 old). Statistical analysis using mixed model 
repeated measures ANOVA (intervention as within-subjects factor and age as between-subjects factor). BR = beetroot, PN = 
potassium nitrate positive control. * denotes significant difference between interventions. 
 
 * 
B A 
  * * 
 * 
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2.3.8 FeNO 
Young and old participants had statistically similar FeNO values at baseline of 
30.92ppb and 22.17ppb, respectively (P=0.25). The ICC values of 0.96 and 0.92 
demonstrate that, for the young and the old respectively, there was consistency 
across baseline values for each intervention. 
Young 
There was a significant time effect (P<0.001) on FeNO levels but no difference 
between interventions (P=0.51), as shown in Figure 2.18. There was no interaction 
between time and intervention (P=0.23). Pairwise comparisons show that levels rose 
significantly from baseline levels at the early (+8.9ppb; P=0.01; 95%CI: 2.0, 15.8), 
mid (+9.6ppb; P=0.001; 95%CI: 3.9, 15.3), and late (+10.1ppb; P<0.001; 95%CI: 4.9, 
15.1) time points, demonstrating increasing FeNO levels over time. Over the 300-
minute period, FeNO levels rose by 32%, 58%, 54%, and 70% following 100g, 200g, 
300g beetroot and PN, respectively. 
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Figure 2.18: Mean (±SEM) exhaled nitric oxide (FeNO) levels over 300 minutes in 
young group given incremental doses of nitrate; n = 12. Data analysed with a two-
factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. * denotes significant difference to baseline 
across nitrate doses. 
 
Old 
There was a significant time effect in the old group (P<0.001) but no significant effect 
of intervention (P=0.11) (Figure 2.19). Pairwise comparisons show that FeNO levels 
significantly rose from baseline at all time points (all P<0.05). There was no 
significant interaction between time and intervention (P=0.18). Over the 300-minute 
period FeNO levels rose by 36%, 46%, 77%, and 61% following 100g, 200g, 300g 
beetroot and PN, respectively.  
 
   * 
  *   * 
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Figure 2.19: Mean (±SEM) exhaled nitric oxide (FeNO) levels over 300 minutes in 
old group given incremental doses of nitrate; n = 12. Data analysed with a two-
factor repeated measures ANOVA (intervention x time). BR = beetroot, PN = 
potassium nitrate positive control. * denotes significant difference to baseline 
across nitrate doses. 
 
AUC 
The AUC over the 300-minute period shows a noteworthy trend for an effect of 
intervention (P=0.07) but no difference between age groups (P=0.28) (Figure 2.20). 
There was no interaction between intervention and age (P=0.60). Post hoc analyses 
identify only a trend towards a lower AUC following 100g beetroot than PN (+2426.3; 
P=0.09; 95%CI: -260.6, 5113.1) but no other differences between interventions. 
* 
  *   * 
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Figure 2.20: Mean (±SEM) area under the curve (AUC) over 300 minutes for 
exhaled nitric oxide (FeNO) in the young and old groups; n = 24 (12 young and 12 
old). Data analysed using mixed model repeated measures ANOVA (intervention 
as within-subjects factor and age as between-subjects factor). BR = beetroot, PN 
= potassium nitrate positive control. 
2.3.9 Correlation between plasma nitrate and nitrite and FeNO 
A Pearson product-moment correlation coefficient was calculated to assess the 
relationship between changes in plasma nitrate and nitrite levels and changes in 
FeNO. Across both age groups, there was no correlation between changes in plasma 
nitrate and changes in FeNO (r=0.17; n=288; P=0.005) or between changes in 
plasma nitrite and changes in FeNO (r=0.11; n=288; P=0.07).  
 
In the young group, there was no correlation between changes in plasma nitrate and 
changes in FeNO (r=0.13; n=144; P=0.13) or between plasma nitrite and FeNO 
(r=0.08; n=144; P=0.33), as demonstrated in Figure 2.21A. In the old group, there 
was a small, positive correlation between plasma nitrate levels and FeNO (r=0.22; 
n=144; P=0.007). There was no correlation between plasma nitrite and FeNO 
(r=0.15; n=144; P=0.08). This is shown in Figure 2.21B. 
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Figure 2.21: Scatterplot showing correlation between change in plasma nitrate 
levels and change in exhaled nitric oxide (FeNO) in the young group (A); n =144 
and old group (B); n = 144. Statistical analysis using Pearson’s coefficient.  
 
2.4 Discussion 
2.4.1 Summary of the findings 
This is the first study to investigate the pharmacokinetics of nitrate and nitrite 
following incremental doses of whole beetroot in both younger and older healthy 
participants. The main findings were: 1) whole beetroot can raise plasma nitrate and 
nitrite levels in both the young and the old; 2) despite comparable if not higher 
plasma nitrate levels to the young group, older adults had lower levels of plasma 
nitrite following nitrate loads; and 3) FeNO was raised following beetroot 
consumption and to comparable levels in the young and old participants. These 
results together suggest that a small dose of whole beetroot, just above what is 
considered a normal vegetable portion of 80g, is effective at raising plasma nitrite 
levels, implying that NO production can also be raised by this food. This response is 
more pronounced in a young population. What is unclear is whether these plasma 
nitrite levels are high enough to elicit physiological benefits such as a reduction in 
blood pressure and this is discussed in Chapter 3. 
A B 
   P=0.13 P=0.007 
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2.4.2 The pharmacokinetics of nitrate and nitrite from whole beetroot 
Plasma 
Baseline values for both nitrate and nitrite demonstrate adherence to the dietary 
restrictions in place in the two days before each visit. 100g of the whole beetroot 
used in this study was found to contain approximately 272mg of nitrate, which is 
close to the average 250mg described by Hord, Tang and Bryan in 2009 and the 
range described by van der Avoort et al. (2018) as 35 to 258mg/100g. As mentioned 
previously, the nitrate content of beetroot can vary during the growing season due to 
a number of environmental factors, however the above average values were used for 
analysis purposes in this study. Results show that the smallest dose of beetroot, 
100g, significantly raised plasma nitrate levels in both the young and the old 
participants, from 28 to 86µmol/L and from 25 to 128µmol/L, respectively, 
demonstrating the efficient absorption of nitrate from the whole vegetable.  
 
The pharmacokinetics of dietary nitrate through the nitrate-nitrite-NO process are well 
known in young adults but the age-related factors mentioned in Chapter 1, such as 
changes to the oral microbiome, are likely to alter the process in older adults. One of 
the first groups to assess the pharmacokinetics of dietary nitrate in older adults was 
Miller et al. (2012), who found that a high-nitrate diet providing a maximum of 77mg 
nitrate in a single bolus was not sufficient to increase plasma nitrate and nitrite levels. 
Their high nitrate diet included foods such as bacon, spinach, beetroot and green 
vegetables, totalling a daily nitrate intake of ~155mg spread throughout the day. 
Previously, Presley et al. (2011) demonstrated that a high-nitrate diet significantly 
increased plasma nitrate and nitrite levels in older adults. The diet itself contained 
242mg nitrate but this was supplemented by 500ml beetroot juice containing 527mg 
nitrate, taking the overall nitrate content of the diet to 769mg. Results from the 
present study show that 300g beetroot elicited the highest rise in plasma nitrate 
levels compared to 100g by 2.3- and 1.7-fold in the young and the old, respectively. 
Furthermore, plasma nitrite levels following 200g and 300g beetroot were around 1.4- 
and 1.8-fold higher than following 100g. These data together suggest a dose-
dependent response to increasing nitrate intakes on plasma nitrate and nitrite levels 
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It has previously been described that nitrate in the form of a potassium nitrate 
capsule, equivalent to 248mg, can significantly raise plasma nitrate and nitrite levels 
and this was deemed the minimum dose required to exert beneficial effects on blood 
pressure (Kapil et al., 2010). The results of the plasma nitrate analysis in the present 
study demonstrate that levels were raised following a single bolus of 272mg whole 
beetroot in both a young and an old population. Plasma pharmacokinetic data for 
nitrate and nitrite following 300g beetroot in the present study mirror those of other 
studies supplementing with potassium nitrate capsules or beetroot juice (Kapil et al., 
2010; Shepherd et al., 2015). Plasma nitrate levels peaked between two and three 
hours post-ingestion of all doses of beetroot, while PN ingestion caused an earlier 
peak around one hour. Although not all time points were analysed, these peaks are 
thought to accurately reflect the pharmacokinetic profile of nitrate based on previous 
studies using beetroot (Clifford et al., 2017; van Velzen et al., 2008). The difference 
in time to peak for PN most likely reflects the body’s ability to process a nitrate 
solution faster than nitrate from a whole vegetable. Plasma nitrite peaked later at 
around five hours, demonstrating the utilization of the salivary pathway in the 
breakdown of nitrate to nitrite after first reaching the blood. There was no difference 
in peak time between beetroot and PN for plasma nitrite. This comparable 
pharmacokinetic profile reveals that beetroot in its whole form, and at amounts 
equivalent to a standard vegetable dose, is a rich source of available dietary nitrate. 
Furthermore, it is clear that the food matrix, including dietary fibre for example, is not 
a limiting factor in the availability of dietary nitrate from whole beetroot. The 
pharmacokinetic profile of nitrate and nitrite following beetroot consumption, including 
time to peak, is a useful tool in identifying the timing of physiological effects 
associated with the ingestion of these compounds.  
Saliva 
25% of the nitrate that reaches the blood from dietary nitrate ingestion is transported 
to the salivary glands, while 75% is excreted in the urine. Lundberg and Govoni 
(2004) describe that saliva is necessary for a rise in plasma nitrite, elegantly 
demonstrated through the interruption in swallowing saliva following nitrate ingestion. 
Salivary nitrate levels rose quickly in both age groups following 100g beetroot in the 
present study, peaking around one to two hours at 2.6mmol/L and 4.1mmol/L in the 
young and old, respectively. Levels peaked at 5.3mmol/L and 6.0mmol/L following 
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300g beetroot in the young and the old, respectively, again demonstrating the dose 
response to larger amounts of nitrate evident in plasma. Salivary nitrate levels 
appear higher in the older group than the younger group, although it was not found to 
be statistically different. Nitrate levels in the older group also remained significantly 
elevated following all beetroot doses, whereas levels in the young group fell below 
significance. This correlates with the higher plasma nitrate levels seen in the old 
compared to the young, although again this was not found to be a significant 
difference. This suggests heightened utilisation of dietary nitrate in older participants, 
potentially as a protective mechanism against the reduced ability to convert nitrate to 
nitrite. 
 
It is evident from the results of nitrite analysis that 100g of beetroot i.e. a dose of 
272mg nitrate is not sufficient to raise salivary nitrite levels in the young or the old, 
despite significantly raising salivary nitrate. This suggests that the small dose of 
nitrate does not sufficiently stimulate the nitrate-reducing bacteria located in the 
salivary glands to reduce salivary nitrate to nitrite. As early as 1976, it was 
determined that salivary nitrite levels were highly dependent on nitrate ingestion and 
there was a limit below 54mg in which salivary nitrate and nitrite levels did not 
change (Spiegelhalder et al., 1976). Bacteria use nitrate and nitrite as final electron 
acceptors in respiration when it is available in the oral cavity (Spiegelhalder et al., 
1976), therefore a low availability from small nitrate doses may affect respiration 
pathways in the bacteria. It is estimated that 4-8% of the ingested nitrate is converted 
to nitrite in the oral cavity (van Velzen et al., 2008). Higher doses of nitrate i.e. 200g 
beetroot and above were shown to increase salivary nitrite levels in both age groups, 
which suggests that these nitrate doses are able to stimulate nitrate to nitrite 
reduction in the saliva. 
 
It has been shown that there is a continuous uptake of nitrate from the blood to the 
salivary glands and although the exact mechanism behind it is not known, the protein 
sialin may have a role (Qu et al., 2016). Sialin has been found to be a nitrate 
transporter, mediating nitrate influx into the salivary glands where it can be 
processed by nitrate-reducing bacteria (Qu et al., 2016). Although the analysis is 
beyond the scope of this thesis, saliva samples collected are being used for further 
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research into sialin and age-related differences in the uptake of nitrate to the salivary 
glands. 
Urine 
Nitrate from whole beetroot is absorbed from the gut into the systemic circulation and 
75% of the consumed nitrate is excreted in the urine, unprocessed. Nitrate was found 
in the urine within three hours following consumption of beetroot in the present study 
and tended to peak between six and 12 hours, which correlates with evidence in the 
literature (Pannala et al., 2003). Pannala et al. (2003) found that urinary nitrate levels 
peaked at four to six hours following the ingestion of ~222mg nitrate, which is similar 
to the dose provided by 100g beetroot in the present study. Nitrate concentrations 
remained elevated at 12-24 hours post-ingestion in the present study, demonstrating 
that dietary nitrate had not been cleared within 24 hours. Dietary nitrate has a half-life 
of around eight hours and 60% of ingested nitrate has been found to be excreted in 
the urine within 48 hours (Jajja et al., 2014); a longer sampling period in the present 
study may therefore have identified the time when levels returned to baseline. The 
greater excretion and lower retention of nitrate following the consumption of larger 
doses of nitrate suggest a tightly regulated negative feedback loop to maintain nitrate 
levels within a specific range. It may be that nitrate reserves become saturated and 
the body excretes excess amounts through urine. This is the first study to investigate 
incremental doses of nitrate on nitrate excretion in urine and future studies are 
warranted in this area. 
2.4.3 Bioavailability 
The pharmacokinetic profile of nitrate following beetroot consumption demonstrates 
bioavailability of nitrate from this source. van Velzen et al. (2008) demonstrated a 
bioavailability of 106±15% from cooked beetroot in young adults, which provided 
643mg nitrate. Another study to include whole beetroot in its measurements was that 
by Clifford et al. (2017), who found that NO levels, measured through nitrate and 
nitrite concentrations, were raised following the consumption of 300g whole beetroot 
in young, healthy males. The present study shows that dietary nitrate from whole 
beetroot is available to the body in older adults using a direct comparison to a 
younger population. 
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Dietary nitrate exerts its beneficial effects on the body through its breakdown to nitrite 
and further to NO, which has a vasodilatory effect on the vascular system. The 
significant increase in plasma nitrite levels following doses of beetroot demonstrates 
that commensal bacteria in the saliva are converting nitrate to nitrite and raising 
plasma nitrite concentrations on swallowing. As nitrite levels are a marker for NO 
production in the body, this demonstrates that whole beetroot, even in small 
amounts, can increase NO production and therefore have a positive effect on the 
vascular system.  
 
Clifford et al. (2017) found that NO concentration peaked at two hours post-ingestion 
of beetroot and returned to baseline within five hours. The present study found a later 
peak time of around five hours post-beetroot ingestion for nitrite levels. Furthermore, 
plasma nitrite levels remained elevated above baseline at the five-hour period 
following all doses of beetroot, which suggests that NO levels would also remain 
elevated for a longer period. The differences seen here may be due to the analysis 
techniques used, as Clifford et al. (2017) did not use a stop solution to preserve 
plasma nitrite, which may have underestimated the peak nitrite levels.  
 
Although bioavailable to the body, dietary nitrate from smaller doses of beetroot may 
not have physiological effects. For example, Dejam et al. (2007) found that plasma 
nitrite levels of 350nm and above increased forearm blood flow and this level was not 
reached by beetroot amounts below 300g in the old group and below 200g in the 
young group. However, 300g beetroot was found to raise plasma nitrite to 
physiologically beneficial levels in both the young and the old group, at least for 
forearm blood flow. A blood pressure-lowering effect was seen with a nitrate intake of 
~248mg in a study by Kapil et al. (2010b). This nitrate intake can be achieved 
through the consumption of 300g beetroot but not by smaller doses than this. The 
physiological responses to dietary nitrate from beetroot are described in Chapter 3. 
2.4.4 Fractional exhaled nitric oxide (FeNO) 
NO can be formed from nitrite in the oral cavity and stomach (Olin et al., 2001) and 
elevated FeNO levels following a nitrate load demonstrate this pathway. There is 
large variation in normal baseline FeNO, with values described between 3 and 88ppb 
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(Dweik, 2011) and an average of 18ppb (Dressel et al., 2008; Travers et al., 2007). 
FeNO values in the present study can be described as normal, although there is not 
a reliable reference range for older adults. A number of studies have identified 
gender differences in FeNO (Taylor et al., 2007; Travers et al., 2007) but it is out with 
the scope of this thesis to assess FeNO at this level. Other factors that influence 
FeNO, such as smoking status, were controlled for during the screening process.  
 
Each of the beetroot doses in the present study raised FeNO levels within one hour 
of consumption and these levels remained elevated over the five-hour intervention 
period. There was no difference between the interventions, showing that a small 
amount of beetroot, providing 272mg nitrate, has the ability to increase NO levels in 
exhaled air. Vints et al. (2005) tracked exhaled NO over 20 hours following a meal 
providing 230mg nitrate and demonstrated a 60% rise in exhaled NO after two hours 
in participants aged between 24 and 61 years. The percentage increase in FeNO 
between 32% and 36% following the consumption of 272mg nitrate in the present 
study was smaller than that seen by Vints et al. (2005) but levels were still above 
baseline five hours post-ingestion, so it is unclear how long levels remained elevated 
for and if they continued to rise. A longer intervention period is therefore required to 
show the full extent of the effects. Larger doses of beetroot and the PN led to larger 
percentage changes in FeNO in both the young and the old group, reaching a 
maximum of 70% following PN in the young and 77% following 300g beetroot in the 
old. Changes in FeNO following PN in both age groups are larger than those 
demonstrated by Olin et al. (2001) following a meal containing 1g nitrate; a 47% 
increase was seen. This is likely to be due to the different sources of nitrate i.e. 
potassium nitrate solution compared to a nitrate-rich vegetable meal. 
 
Results from the present study demonstrate a small correlation between changes in 
plasma nitrate and FeNO levels in the old group. The trend towards higher plasma 
nitrate levels in the old group than the young group may explain this correlation and 
demonstrates an efficient breakdown of dietary nitrate to NO in the oral cavity. 
Furthermore, although there was no significant difference between young and old 
values for FeNO, there appears to be correlation between higher nitrate doses and 
smaller differences between the groups. The graph for 100g beetroot shows a large 
difference between the young and the old, whereas the PN graph shows the lines for 
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each group converging. The mean difference between FeNO values for the young 
and the old groups following 100g of beetroot is 12ppb, while the mean difference 
following PN is 6ppb. This suggests that larger doses of nitrate bring the FeNO of 
younger and older adults to a more comparable value, which may be more evident 
with a larger sample size.  
2.4.5 The effect of age on nitrate and nitrite levels 
There was a trend towards higher plasma nitrate levels in the old group than the 
young group following PN consumption but not following beetroot consumption. It 
could be that reduced functioning of the nitrate-nitrite-NO breakdown pathway 
stimulates a rise in plasma nitrate levels in a compensatory manner in older adults. 
Despite comparable plasma nitrate levels across the interventions, particularly 
following beetroot consumption, plasma nitrite levels were significantly lower in the 
older group than the younger group. The conversion of nitrate to nitrite occurs in the 
mouth and therefore plasma levels of nitrite are only increased following swallowing; 
this suggests that age differences lie in the oral conversion of nitrate to nitrite. 
However, salivary nitrate and nitrite levels are similar in the young and the old groups 
following the ingestion of nitrate, which contradicts the hypothesis of impaired nitrate-
nitrite breakdown in the older group. 100g beetroot was not sufficient to raise salivary 
nitrite levels in the young or the old but the young responded to 200g beetroot more 
favourably than the old group. This implies that larger nitrate doses are required to 
elicit responses in an older group compared to a younger group. The majority of 
nitrite, ~70%, is produced in the body from endogenous NO synthase-derived NO 
and the lower plasma nitrite levels seen in the old group could be due to a reduced 
background nitrite production and storage pool. The oxidation of NO to nitrite is 
catalysed by ceruloplasmin in the plasma or cytochrome c oxidase in tissues (Shiva, 
2013) but lower levels of NO, which is evident in older age, may result in lower 
circulating nitrite. An independent t-test demonstrates that baseline plasma nitrite 
levels were on average 24nmol/L lower in the old group than the young group 
(P=0.08), suggesting impairment in endogenous nitrite production. Although the 
pharmacokinetic profile shows that the time of peak plasma nitrite levels were the 
same in the young and the old, the lower baseline nitrite and lower amounts 
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produced from dietary nitrate in the old group in this study allude to an overall 
mechanistic impairment compared to younger adults.  
 
Ultimately, plasma nitrite provides a marker for NO production and therefore lower 
levels of plasma nitrite in the old group suggests that NO production following 
ingestion of dietary nitrate is lower in the older group compared to the younger group. 
Although age-related differences in plasma nitrite levels have been demonstrated, 
there was no difference in FeNO between the age groups. Baseline levels were 
comparable, although the older group had an ~8ppb lower value than the young 
group; the sample size here may have been too small to identify significant effects. 
All doses of nitrate significantly raised FeNO levels over time in both age groups, 
demonstrating that dietary nitrate from whole beetroot is bioavailable and it can 
impact on NO levels in both the young and the old. More research is warranted into 
the production of nitrite from both dietary nitrate and endogenous NO into older age, 
as it is evident that there is a reduced efficiency in one or other of these pathways. 
2.4.6 Strengths and limitations 
This study investigated, for the first time, supplementation with practical amounts of 
whole beetroot and the bioavailability of dietary nitrate from this food source in both 
young and old adults. The dietary restrictions and seven-day washout period 
between trials ensured no carry-on effect of nitrate-rich foods consumed before 
testing or of previous trials. It has been demonstrated that concentrations of plasma 
nitrate and nitrite return to baseline levels around 24 hours following consumption of 
dietary nitrate (James et al., 2015). Furthermore, the stringent screening process 
ensured that disease states or medications that may have confounded the effects of 
the interventions on the nitrate-nitrite-NO cycle were screened out. Kidney function 
was not assessed in relation to urinary excretion but exclusion criteria also ensured 
that participants had no history of kidney disorders. 
 
The addition of salivary nitrate and nitrite and urinary nitrate measurement to 
measurement of plasma concentrations of these compounds benefits the body of 
research on the pharmacokinetics of dietary nitrate from whole beetroot in an older 
population. Furthermore, nitrite is unstable in whole blood, so rapid processing and 
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the addition of a stop-solution ensured that analysis was reliable for the 
measurement of nitrite. Previous studies have highlighted omission of this step as a 
limitation in their analysis (Ashor et al., 2016; McIlvenna et al., 2017). This study also 
utilised ozone-based chemiluminescence, which is acknowledged as the gold 
standard method and the most sensitive technique available for the measurement of 
NO and its metabolites (Pinder et al., 2008). 
 
The small sample size limits the application of this study and the conclusions that can 
be drawn from it. However, the crossover design and inclusion of both a young and 
an older participant group of equal size allowed for direct comparison and 
assessment of the impact of age on dietary nitrate processing. The nitrate content of 
commercially available beetroot varies and it was not possible to ensure that all 
beetroot given to participants was from one batch. Purchasing beetroot on a per-
participant basis therefore meant that the nitrate content of the beetroot could have 
varied across participants. However, the beetroot purchased came from the same 
supplier and all trials were conducted within a small a timeframe as possible to 
reduce the impact of nitrate variability. Presenting the participants with beetroot 
meant that the trials were not blinded and measurements may have been 
unconsciously influenced by the allocation to the interventions. The crossover 
randomisation ensured a strict within-volunteer control of factors that may impact on 
outcomes, such as body composition and healthy status. Steps were taken to ensure 
that trials were replicated closely, bar the dose of nitrate provided, in an attempt to 
standardise the study visits. It is acknowledged that instructing participants to follow a 
restrictive diet throughout the study could have influenced the results. Therefore, 
future studies are needed to establish whether results can be replicated alongside 
the maintenance of habitual dietary intakes.  
2.4.7 Conclusions 
This study highlights age differences in utilisation of dietary nitrate from whole 
beetroot, evident from the lower levels of plasma nitrite observed in old participants 
compared to young. As plasma nitrite is a reliable marker for NO levels in the body, 
this suggests that NO production is lower in an older population following the 
consumption of beetroot when compared to a younger population. Despite this, 
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whole beetroot was found to be a source of bioavailable nitrate for both young and 
old participants but larger amounts, up to 300g, are required by older individuals to 
stimulate an increase in plasma nitrite. More research is warranted into the 
production of nitrite from both dietary nitrate and endogenous NO into older age, as it 
is evident that there is a reduced efficiency in one or other of these pathways. 
Subsequent research should now focus on whether whole beetroot, in practical 
amounts, has physiological effects on the body in both young and old participants.  
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Chapter 3. Physiological effects of acute beetroot supplementation 
in young and old participants 
3.1 Introduction 
Nitric oxide (NO) has a very short half-life but has a profound relaxant effect on 
vascular smooth muscle and has been found to inhibit platelet aggregation (Mellion 
et al., 1981). Through its dilatory properties, NO regulates vascular tone and blood 
pressure (Ignarro, 2002) and this prompted investigation into NO availability and 
consequent impacts on blood pressure and blood flow. NO levels can be raised by 
the consumption of dietary nitrate, which is broken down to nitrite and further to NO 
in a stepwise process involving nitrate-reducing bacteria. The richest sources of 
dietary nitrate include beetroot, rocket and lettuce, and beetroot has received a lot of 
attention as an active intervention food. In 2008, Webb et al. first demonstrated blood 
pressure-lowering effects of beetroot ingestion in young, healthy volunteers, which 
led to further exploration into the manipulation of NO levels through the intake of 
nitrate-rich foods.  
 
Beetroot juice, as a potent source of dietary nitrate, has been repeatedly found to 
reduce blood pressure and improve blood flow (Lara et al., 2016; Siervo et al., 2013). 
There has been, however, a wide variety of nitrate doses provided and a 
preponderance of research on young, healthy volunteers. The use of beetroot juice is 
widespread in dietary nitrate research, propelled by the recent development of a 
nitrate-free placebo juice. Young, healthy adults are at a low risk of cardiovascular 
disease (CVD) but are efficient in the breakdown of dietary nitrate to NO and have a 
greater endogenous production of NO than older adults (Ashor et al., 2016). This 
population is therefore able to provide an elegant portrayal of the physiological 
effects of NO following dietary nitrate intake but their low risk of CVD make the 
practical application of supplementation less relevant. Older adults who are more at 
risk of CVD because of the ageing process provide a more suitable cohort in which to 
investigate the positive effects of dietary nitrate intake.  
 
Although the majority of work on beetroot has focussed on juice form, there are many 
other ways to utilise the vegetable, such as in gel form (Morgado et al., 2016), 
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incorporated into bread (Hobbs et al., 2012), or as a whole vegetable. Beetroot in its 
whole form is underused and although nitrate levels vary depending on factors such 
as time of harvest, it provides a bioavailable source of nitrate, as well as dietary fibre. 
What is unclear to date is whether whole beetroot is an acceptable and practical form 
of dietary nitrate that can be consumed in an attempt to reduce blood pressure and 
improve blood flow in both young and older adults. This study explores the effects of 
incremental doses of whole beetroot on blood pressure and vascular function in 
young and old participants and investigates whether or not these are correlated with 
plasma biomarkers of NO production i.e. nitrate and nitrite. The acceptability of the 
beetroot doses is assessed in both groups in an effort to gain an understanding of 
compliance and applicability of whole beetroot consumption. It was hypothesised that 
the positive effect on blood pressure and microvascular function associated with 
nitrate would be reduced in the older population and that the response to the beetroot 
would be greater with higher quantities in both populations. To investigate these 
hypotheses a four-arm, crossover trial was set up, directly comparing the 
physiological responses to incremental doses of whole beetroot and a positive 
control in a young and an old group.  
3.2 Methods 
The participants, interventions, and study design and protocol for this chapter are the 
same as those described in Chapter 2.2. The study day protocol is illustrated in 
Figure 2.1 and involved the consumption of 100g, 200g, and 300g whole beetroot 
and a positive control in the form of potassium nitrate (PN). Two age groups were 
recruited for the direct comparison of physiological effects in a young and an old 
group; participants were aged 18-35 or 60-75 years. Participants followed a two-day 
low-nitrate diet before attending the research facility and were instructed to refrain 
from caffeine intake in these two days also. Participants were asked to avoid the use 
of anti-bacterial mouthwash and gum for the entirety of the study.  
3.2.1 Blood pressure 
Blood pressure and heart rate were measured using an automated pressure cuff 
(Spot Vital Sign Device, Welch Allyn). A cuff was placed on the opposite upper arm 
to the cannula used for blood sampling with the participant in a seated and 
comfortable position. Baseline measurements were taken three times with a one-
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minute interval between each measurement, and one measurement was taken at 
each time point after that i.e. 30, 60, 90, 120, 180, 210, 240, 270, and 300 minutes. 
Measurements were concealed from the participants to ensure that their knowledge 
of their blood pressure readings did not influence later measurements. Time points 
were amalgamated into baseline (0min), early (30-90min), mid (120-210min) and late 
(240-300min) points to better capture changes in blood pressure after 
supplementation and improve graphical presentation of the results across the time 
points. 
3.2.2 Post-occlusive reactive hyperaemia 
A laser Doppler (Moor LDF, Moor Instruments, Axminster, UK) was used to assess 
cutaneous microvascular reactivity, which is based on the ability of the endothelium 
to release NO as a response to proximal arterial occlusion.  After the end of 
occlusion, when the peripheral perfusion is restored, the immediate reduction of 
vascular resistance results in an increase in the blood flow i.e. post-occlusive 
reactive hyperaemia (PORH). This is closely linked to NO release and integrity of 
endothelial function (Carasca et al., 2017). Reactive hyperaemia was chosen for its 
sensitivity to external stimuli and the gold standard, PWV, was deemed unsuitable 
due to the acute nature of the study; FMD was not available to the research team. 
Previous work has shown within-subjects coefficients of variation from 6-11% for 
reactive hyperaemia (Minson and Wong, 2004). The measurement lasted 12 minutes 
and took place with participants lying supine in a 22-24°C temperature-controlled 
room. A pressure cuff was placed on the participants’ upper arm, on the opposite arm 
to the cannula when possible, and a laser Doppler probe was placed on the inner 
forearm of the same arm. A resting measurement lasting five minutes was taken, 
after which the cuff was inflated to 200mmHg to obstruct the blood flow in the 
brachial artery, and remained pressurized for three minutes. The pressure in the cuff 
was then released and the hyperaemic response, measured in perfusion units (PU), 
was recorded using MoorVMS V3.1 software. The measurement continued for a 
further four minutes to allow the blood flow to return to baseline. Participants were 
instructed to keep their arm still during the measurement and tape was used to 
reduce movement of the probe cable. PORH measurements were saved in 
participant folders on a PC and later analysed using the Moor VMS software. The 
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values used for analysis were: resting level (RL), maximum level (ML), time to 
recovery (TR), time to maximum (TM), and PORH index, as outlined in Table 3.1. 
Figure 3.1 illustrates a representation of PORH analysis by the MoorVMS software. 
The laser Doppler was recalibrated twice during the study, as instructed by the 
manufacturer. Researchers have defined a PORH index as the ratio of the post-area 
under the curve (AUC) one minute after the release of the pressure cuff, relative to 
the AUC of a one-minute period of pressure cuff inflation (Yamamoto-Suganuma & 
Aso, 2009). 
 
Table 3.1: Cutaneous microvascular reactivity variables measured at baseline, 
150 minutes and 300 minutes for each intervention.  
Variable Definition 
Resting flux (RL; PU) First three minutes of the procedure 
Maximum flux (ML; PU) Maximum level of the graph of the blood flow 
after the release of the cuff at 200mmHg 
Time to recovery (TR; s) First few seconds following release of the cuff 
Time to maximum flux (TM; s) Time taken to reach the peak of the graph of 
hyperaemia 
PORH index (PU) Area under the curve one minute after the 
deflation of the cuff and area under the curve 
one minute before inflation 
 
PU = perfusion units; s = seconds; PORH = post-occlusive reactive hyperaemia.  
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Figure 3.1: Graphical representation of PORH analysis. Taken from MoorVMS 
recording and analysis software, Vascular Monitoring System Software Manual. 
3.2.3 Questionnaires 
Habitual nitrate intake in the days between each visit was monitored using a nitrate 
intake questionnaire, which asked questions on the frequency and volume of 
common high-, medium-, and low-nitrate foods. Answers were put into a prepared 
spreadsheet, which provided an estimate of the total daily nitrate intake. The short 
version of the international physical activity questionnaire (IPAQ) was used to 
monitor physical activity over the seven days prior to each visit and consistency 
throughout the study (Craig et al., 2003). A VAS was created to assess the 
palatability and acceptability of the beetroot given as an intervention, which 
participants completed immediately after the consumption of the beetroot. 
Participants answered questions on taste, texture, volume, aftertaste, smell, and 
visual appeal, giving their answer on a scale of 0 to 10. The scores were totalled for 
each intervention, giving a VAS score out of 60 for acceptability of the beetroot 
doses. These questionnaires can be seen in Appendices D and E. 
3.2.4 Statistical analysis 
All statistical analyses were completed using IBM SPSS (version 24.0). Summary 
data are presented as means ± SD with 95% confidence intervals (CI). Intraclass 
coefficient values (ICC) were used to calculate the reliability of the measurements 
using the multiple baseline values (time 0) obtained at the beginning of each 
supplementation visit. Baseline differences were analysed using independent t tests 
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and changes were analysed using repeated measures analysis of variance (ANOVA) 
with time and intervention as within-subject factors and age as a between-subject 
factor. Where age groups were compared directly, the area under the curve (AUC) 
across the 300-minute period was calculated for each intervention using the 
trapezoid method. Models were checked for sphericity using Mauchly’s test and 
multivariate models were applied if these assumptions were violated. Where 
significances were found and to assess intervention and age specific outputs, post 
hoc tests with Bonferroni adjustment to control for multiples comparisons were run. 
Associations between changes in plasma nitrite and changes in blood pressure were 
analysed using Pearson product-moment correlation coefficient. Statistical 
significance was set at P<0.05.   
3.3 Results 
3.3.1 Baseline characteristics 
24 participants in total completed the crossover trial, with 12 younger adults aged 
27.3±3.8 years and 12 older adults aged 64.3±4.6 years. No adverse events were 
reported and review of the food diaries revealed that participants adhered to the 
dietary restrictions stipulated. Average baseline systolic blood pressure (SBP) was 
115.3±8.4 mmHg and 120.2±12.1 mmHg for the young and old group, respectively. 
These were not significantly different (P=0.27). Average baseline diastolic blood 
pressure (DBP) was 72.6±4.2 mmHg and 76.5±7.0 mmHg for the young and old 
group, respectively (P=0.11). Groups were matched for weight, with an average of 
68.2±8.8kg across the young and old participants. Both groups also had a healthy 
BMI, averaging 23.9±2.5kg/m2 across groups (Table 2.1). 
3.3.2 Systolic blood pressure 
Baseline values were taken at the beginning of each of the four trials, but the ICC 
shows strong, significant correlation (all P<0.001), with values of 0.91 for SBP and 
0.90 for DBP in the young and 0.92 for SBP and 0.90 for DBP in the old. This 
indicates a comparable basal level for all trials for both age groups. At baseline, SBP 
and DBP did not differ between age groups (P>0.05).  
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Changes in systolic blood pressure in the young 
There was a significant effect of time (P<0.001) but no significant difference between 
interventions for SBP (P=0.55), as shown in Figure 3.2. There was no interaction 
between time and intervention (P=0.81). Pairwise comparisons show that SBP at the 
mid and late time points was significantly lower than at baseline (-5.1mmHg; 
P=0.004; 95%CI: -8.6, -1.7 and -5.2mmHg; P=0.008; 95%CI: -9.2, -1.3, respectively) 
across interventions. Peak reduction occurred between four and five hours for all 
interventions combined. Post hoc analyses show that 100g beetroot reduced SBP at 
the mid time point (-6.4mmHg; P=0.05; 95%CI: -12.8, -0.6) compared to baseline and 
PN reduced SBP at the mid (-6.1mmHg, P=0.004; 95%CI: -10.2, -1.9) and late (-
7.3mmHg, P=0.004; 95%CI: -12.4, -2.3) time points compared to baseline. SBP at 
the late time point was also significantly lower than SBP at the early time point 
following PN (-2.5mmHg; P=0.02; 95%CI: -4.6, -0.4). There were no significant 
effects of 200g or 300g beetroot on SBP in the young group. 
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Figure 3.2: Mean (±SEM) baseline, early, mid and late systolic blood pressure 
(SBP) absolute values in the young group following incremental doses of nitrate; 
n = 12. Statistical analysis using a two-factor repeated measures ANOVA 
(intervention x time). BR = whole beetroot, PN = potassium nitrate positive 
control. * denotes significant difference from baseline across nitrate doses. 
 
Changes in systolic blood pressure in the old 
There was no effect of time (P=0.50) or intervention (P=0.31) on SBP in the old 
group (Figure 3.3) but there was an interaction between time and intervention 
(P=0.04). However, further analyses did not reveal any significant differences 
between interventions at baseline, mid, late or end time points. Figure 3.3 illustrates 
that PN was the only trial to cause a reduction in SBP but statistical analysis does not 
identify this as a significant reduction from baseline or compared to the beetroot 
doses.  
 
 * * 
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Figure 3.3: Mean (±SEM) baseline, early, mid and late systolic blood pressure 
(SBP) absolute values in the old group following incremental doses of nitrate; n = 
12. Statistical analysis using a two-factor repeated measures ANOVA 
(intervention x time). BR = whole beetroot, PN = potassium nitrate positive 
control.  
 
AUC for systolic blood pressure in both age groups 
The AUC of SBP is not statistically different between age groups but shows a trend 
(P=0.08). Similarly, there is no statistically significant difference between 
interventions but a noteworthy trend (P=0.07) (Figure 3.4). There is no interaction 
between age and intervention (P=0.43). There was no difference between 
interventions for the young group but AUC was significantly smaller following PN than 
100g beetroot in the old group (-1403, P=0.05; 95%CI: -2810, 3). The young group 
had a significantly smaller AUC than the old only following 100g beetroot (-3111; 
P=0.04; 95%CI: -6138, -83).  
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Figure 3.4: Mean (±SEM) area under the curve (AUC) of systolic blood pressure 
(SBP) values over 300 minutes in both the young and old groups; n = 24 (12 
young and 12 old). Data analysed by mixed model repeated measures ANOVA 
(intervention as within subjects factor and age as between subjects factor). BR = 
whole beetroot, PN = potassium nitrate positive control. * denotes difference 
between age groups following 100g beetroot (P=0.04); † denotes difference 
between interventions in old group (P=0.05).  
3.3.3 Diastolic blood pressure 
Changes in diastolic blood pressure in the young 
There was a significant effect of time (P<0.001) but no effect of intervention (P=0.77) 
on DBP in the young (Figure 3.5). There was no interaction between time and 
intervention (P=0.35). Pairwise comparisons show that DBP was significantly lower at 
the early (-3.9mmHg; P=0.01; 95%CI: -7.2, -0.6), mid (-4.7mmHg; P<0.001; 95%CI: -
7.2, -2.3) and late time points (-4.1mmHg; P=0.004; 95%CI: -6.9, -1.3) than at 
baseline, demonstrating a blood pressure-lowering effect for all interventions 
combined. Peak reduction occurred between two and 3.5 hours post-nitrate ingestion 
across the interventions. Analyses shows that 100g beetroot reduced DBP between 
baseline and mid (-5.0mmHg; P=0.05; 95%CI: -10.0, -0.0) and late (-4.3mmHg; 
P=0.03; 95%CI: -8.1, -0.4). 200g beetroot had no effect on DBP. The consumption of 
* 
 † 
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300g beetroot reduced DBP between baseline and early (-5.1mmHg; P=0.01; 95%CI: 
-9.4, -0.7), mid (-4.3mmHg; P=0.01; 95%CI: -7.9, -0.6) and end (-5.1mmHg; P=0.005; 
95%CI: -8.7, -1.5). PN reduced DBP between the baseline and mid (-6.4mmHg; 
P=0.007; 95%CI: -11.1, -1.7) time points. 
 
 
 
Figure 3.5: Mean (±SEM) baseline, early, mid and late diastolic blood pressure 
(DBP) absolute values in the young group following incremental doses of nitrate; 
n = 12. Statistical analysis using a two-factor repeated measures ANOVA 
(intervention x time). BR = whole beetroot, PN = potassium nitrate positive 
control. * denotes significant difference compared to baseline. 
 
Changes in diastolic blood pressure in the old  
There was an observable trend towards an effect of time (P=0.07) and intervention 
(P=0.07) on DBP in the old group, as shown in Figure 3.6. There was no interaction 
between time and intervention (P=0.18). Pairwise comparisons indicate that PN 
caused a greater reduction in DBP than 100g beetroot (-2.8mmHg; P=0.05; 95%CI: -
5.79, -0.79) but neither the whole beetroot nor PN significantly reduced DBP overall. 
At the mid time point, blood pressure was significantly lower after PN than 100g 
  *  * 
 * 
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beetroot (-4.9mmHg; P=0.007; 95%CI: -8.6, -1.3), demonstrating a dose response in 
the blood pressure-lowering effect. 
  
 
Figure 3.6: Mean (±SEM) baseline, early, mid and late diastolic blood pressure 
(DBP) absolute values in the old group following incremental doses of nitrate; n = 
12. Statistical analysis using two-factor repeated measures ANOVA (intervention 
x time). BR = whole beetroot, PN = potassium nitrate positive control.  
 
AUC for diastolic blood pressure in both age groups 
There was a significant effect of age (P=0.01) but no effect of intervention on DBP 
(P=0.16) (Figure 3.7). There was no interaction between age and intervention 
(P=0.12). Analyses show that there was no significant difference between 
interventions for the young group but the AUC for PN beetroot was significantly 
smaller than for 100g beetroot in the old group (-1130; P=0.002; 95%CI: -1881.39, -
378.62,). The AUC for the young group is significantly smaller than the old group 
following 100g (-2325; P=0.005; 95%CI: -3866, -783) and 200g (-1766; P=0.02; 
95%CI: -3310, -222) and 300g (-1490; P=0.05; 95%CI: -2986, -6), demonstrating a 
greater blood pressure-lowering response following each of the interventions. There 
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is no difference between age groups following PN. This suggests that high dose of 
nitrate is required in the old to elicit the responses to nitrate seen in younger 
participants.  
 
 
Figure 3.7: Mean (±SEM) area under the curve (AUC) over 300 minutes for 
diastolic blood pressure (DBP) in the young and old groups; n = 24 (12 young and 
12 old). Data analysed by mixed model repeated measures ANOVA (intervention 
as within subjects factor and age as between subjects factor).  BR = whole 
beetroot, PN = potassium nitrate positive control. * denotes significant difference 
between age groups. 
3.3.4 Cutaneous microvascular activity 
Resting flux (RL) 
The ICC for baseline RL across trials shows that they were modestly correlated, with 
a value of 0.33 and 0.54 for the young and the old group, respectively. This shows 
that the repeatability of the measurements was overall moderate. There was no 
effect of intervention (P=0.35) or time (P=0.24) on RL in the young group, or an 
interaction effect (P=0.87). Similarly, there was no effect of intervention (P=0.46), 
time (P=0.28) or an interaction effect (P=0.31) on RL in the old group.  
    *    * * 
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Time to maximum flux (TM)  
There was no effect of intervention (P=0.37) or time (P=0.56) on TM in the young 
group, or an interaction effect (P=0.23). Similarly, there was no effect of intervention 
(P=0.58) or time (P=0.85), or an interaction effect (P=0.36) in the old group. 
Time to resting flux (TR) 
There was no effect of intervention (P=0.76) or time (P=0.72) or an interaction effect 
(P=0.19) on TR in the young group. There was also no effect of intervention 
(P=0.15), time (P=0.74) or an interaction effect (P=0.45) in the old group. 
Maximum flux (ML) 
There was no effect of intervention on ML in the young (P=0.55) but a significant 
effect of time (P=0.05). There was no interaction effect of intervention and time 
(P=0.55). Pairwise comparisons reveal that MF at 300 minutes was significantly 
higher than at 150 minutes (+19.1PU; P=0.02, 95%CI: 3.55, 34.59) for all 
interventions combined. This can be seen in Figure 3.8. There was no effect of 
intervention (P=0.17) or time (P=0.16) on MF in the old group, or an interaction 
between intervention and time (P=0.54) (Figure 3.9). 
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Figure 3.8: Mean (±SEM) maximum flux measured by cutaneous microvascular 
activity in the young group; n = 12. Statistical analysis using two-factor repeated 
measures ANOVA (intervention x time). BR = whole beetroot, PN = potassium 
nitrate positive control. * denotes significant difference compared to baseline.  
  * 
 113 
 
Figure 3.9: Mean (±SEM) maximum flux measured by cutaneous microvascular 
activity in the old group; n = 12. Statistical analysis using two-factor repeated 
measures ANOVA (intervention x time). BR = whole beetroot, PN = potassium 
nitrate positive control.  
 
Post-occlusive reactive hyperaemia (PORH)  
PORH was significantly lower in the older group than the younger group across each 
intervention and time period (P=0.02). Values were 3.53PU and 3.04PU for young 
and old, respectively. There was no effect of intervention (P=0.53) or time (P=0.93) 
on PORH in the young group, or an interaction between intervention and time 
(P=0.67). There was a noteworthy trend towards an effect of intervention on PORH in 
the old group (P=0.06) but no effect of time (P=0.32). There was no interaction 
between intervention and time (P=0.32). Pairwise comparisons show that PORH was 
significantly higher following 200g beetroot than 300g beetroot (+1.4PU; P=0.04, 
95%CI: 0.07, 2.73) but values fluctuated over the time period (Table 3.2). 
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Table 3.2A: Vascular function variables in the young group; n = 12. 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2B: Vascular function variables in the old group; n = 12.           
 
BR = whole beetroot, PN = potassium nitrate positive control, RF = resting flux, MF = maximal flux, PORH = post-occlusive 
reactive hyperaemia, TR = time to resting, TM = time to maximum. P values denote changes over the 300-minute period for all 
intervention combined. 
 
Variable 100g BR 200g BR 300g BR 1000mg PN  
Minutes 0 150 300 0 150 300 0 150 300 0 150 300 P  
RF 12.44 12.75 13.58 14.18 14.07 13.48 14.84 14.06 15.50 12.87 13.81 15.83 0.24 
MF 104.20 100.97 114.55 105.19 108.01 107.56 103.34 101.48 119.28 102.79 104.93 109.29 0.05 
PORH 3.72 3.78 3.65 3.50 3.63 3.59 3.10 3.05 3.61 3.84 3.78 3.06 0.93 
TR 0.65 0.94 1.14 0.78 0.90 0.87 1.24 0.79 0.98 0.67 2.01 2.28 0.72 
TM 10.44 10.58 10.75 9.55 12.02 10.19 11.70 9.94 11.44 12.17 11.61 14.57 0.56 
Variable 100g BR 200g BR 300g BR 1000mg PN  
Minutes 0 150 300 0 150 300 0 150 300 0 150 300 P 
RF 18.17 14.77 11.94 17.28 14.43 13.35 17.22 16.55 13.39 19.63 16.03 12.47 0.28 
MF 124.88 75.58 83.57 119.31 114.45 118.78 108.79 104.80 92.09 132.15 100.57 96.81 0.16 
PORH 3.52 2.19 2.86 3.54 3.47 3.62 2.90 2.64 2.95 2.92 3.00 2.86 0.32 
TR 0.78 0.65 0.45 0.65 0.80 0.73 0.90 0.61 1.56 0.87 0.76 0.79 0.74 
TM 9.74 13.08 12.99 8.90 16.00 12.13 10.24 10.05 10.60 9.53 16.92 11.14 0.85 
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3.3.5 Correlation between plasma biomarkers and blood pressure 
A Pearson product-moment correlation coefficient was calculated to assess the 
relationship between changes in plasma nitrate and nitrite levels reported in Chapter 
2 and changes in blood pressure. Across both age groups, there was no correlation 
between change in plasma nitrate levels and change in SBP over the 300-minute 
period (r=-0.17; n=288; P=0.003). There was no correlation between changes in 
plasma nitrate levels and changes in DBP over time (r=-0.11; n=288; P=0.06). In the 
young group, changes in plasma nitrate were not correlated with changes in SBP 
(r=0.06; n=144; P=0.45) or changes in DBP (r=0.02; n=144; P=0.79). In the old 
group, however, there was a small negative correlation between changes in plasma 
nitrate levels and SBP (r=-0.35; n=144; P<0.001). There was also a small negative 
correlation between changes in plasma nitrate levels and changes in DBP (r=-0.21; 
n=144; P=0.01).  
 
Across both age groups, there was a small negative correlation between change in 
plasma nitrite levels and change in SBP over the 300-minute period (r=-0.28; n=288; 
P<0.001). There was also a small correlation between change in DBP and changes 
in plasma nitrite levels over 300 minutes (r=-0.26; n=288; P<0.001). These are 
summarised in Figures 3.10A and B. 
Figure 3.10: Changes in plasma nitrite levels compared to changes in systolic 
blood pressure (A) and diastolic blood pressure (B) across both age groups. 
Statistical analysis by Pearson’s correlation coefficient.  
 A   B 
  P<0.001   P<0.001 
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Taking each age group separately, the Pearson correlation coefficient shown that 
there was a small negative relationship between changes in plasma nitrite and 
changes in SBP (r=-0.27; n=144; P=0.001) and DBP (r=-0.27; n=144; P=0.001) in the 
young group (Figures 3.11A and B). 
 
Figure 3.11: Changes in plasma nitrite levels compared to changes in systolic 
blood pressure (A) and diastolic blood pressure (B) in the young group. 
Statistical analysis by Pearson’s correlation coefficient. 
 
In the old group, there was also a small negative correlation between changes in 
plasma nitrite and changes in SBP (r=-0.30; n=144; P<0.001) and DBP (r=-0.25; 
n=144; P=0.002) (Figures 3.12A and B)  
 
Figure 3.12: Changes in plasma nitrite levels compared to changes in systolic 
blood pressure (A) and diastolic blood pressure (B) in the old group. Statistical 
analysis by Pearson’s correlation coefficient. 
3.3.6 Questionnaires 
Results from the seven-day nitrate intake questionnaire indicate that participants, on 
average, consumed 223mg/day in the young group and 252mg/day in the old group 
 B  A 
 B  A 
  P=0.001   P=0.001 
  P<0.001 = 2
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(P=0.59 between age groups). Across both groups, the average intake relative to 
body weight (BW) was 3.6±2.0mg nitrate/kg BW/day. This value is very close to the 
ADI of 3.7mg/kg BW/day, demonstrating that participants maintained the 
recommended nitrate intake across the four-week study period. 
 
The IPAQ results show that participants were very active and maintained activity 
levels for the duration of the study. Average activity levels were 3839 MET-min/week, 
which is significantly higher than the recommended 500 MET-min/week (Kaminsky & 
Montoye, 2014). This may have been skewed by a number of highly active 
individuals who took part in the study. Average IPAQ values across the four trials 
ranged from 1545 to 8405MET-min/week in the young group and from 682 to 
7911MET-min/week in the old group. Activity levels were significantly higher in the 
younger group than the older group (+804MET-min/week; P=0.02).  
3.3.7 Acceptability of interventions 
Visual analogue scale (VAS) scores reflect participants’ preference to the dose of 
beetroot given and therefore the acceptability of the supplementation. There was a 
significant effect of intervention on VAS scores (P<0.001) and a significant effect of 
age group (P=0.05), but no interaction between intervention and age (P=0.30) 
(Figure 3.13). Pairwise comparisons show that the old group scored the interventions 
higher than the young group (+8.9; P=0.04; 95%CI: 0.2, 17.6). 300g scored 
significantly lower than 100g beetroot (-7.3; P<0.001; 95%CI: 4.1, 10.4) and 200g 
beetroot (-4.6; P<0.001; 95%CI: 2.1, 7.1), and although not statistically significant 
there was a trend towards higher scores for 200g than 300g beetroot (+2.7; P=0.08; -
0.3, 5.6). 
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Figure 3.13: Mean (±SEM) visual analogue scale (VAS) scores out of 60 for each 
beetroot dose in the young and old groups; n = 24. Data analysed using a mixed 
model repeated measures ANOVA (intervention as within-subjects factor and age 
as between-subjects factor). BR = beetroot. * denotes significant difference 
between interventions across both age groups.  
3.4 Discussion 
3.4.1 Summary of findings 
Results from this study reaffirm the suggestion of age-related differences in the 
effects of dietary nitrate. The main findings were: 1) a small dose of beetroot reduced 
SBP by 6.4mmHg during the five-hour period in young adults; 2) despite receiving 
the same doses over the time period, there was no effect of whole beetroot on blood 
pressure in the old group; 3) higher doses of nitrate in the form of PN had a blood-
pressure lowering effect on the old group; 4) older adults are more tolerant of larger 
doses of beetroot and up to 200g beetroot is a suitable amount for supplementation 
in an acute dosage setting. Together these data suggest that whole beetroot can 
have positive acute effects on the vascular system but larger doses of nitrate are 
required to elicit beneficial effects in older adults. However, larger doses of nitrate in 
 * 
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the form of whole beetroot are well tolerated by older adults, which may result in 
good compliance rates with the application of this vegetable in future research. 
3.4.2 The effect of beetroot on blood pressure 
A recent systematic review reiterated the positive effect of acute nitrate intake on 
blood pressure, highlighting a reduction in SBP by 4.8mmHg and DBP by 1.7mmHg 
(Jackson et al., 2018). To date, 248mg nitrate has been deemed the lowest amount 
found to have beneficial effects on a healthy blood pressure (Kapil et al., 2010). In 
this study, SBP and DBP both fell by 2mmHg in participants ~25 years of age, 
following the consumption of potassium nitrate capsules. Kapil et al. (2010) also 
describe a dose-response to increasing amounts of nitrate and found that 341mg 
nitrate provided in the form of beetroot juice reduced SBP by 5mmHg, with no effect 
on DBP. Similarly, Webb et al. (2008) found that 1395mg nitrate in the form of 
beetroot juice reduced SBP by 10mmHg in participants aged 25 years and DBP was 
reduced by 8mmHg. Peak blood pressure reduction was seen between one and 
three hours post-nitrate ingestion in both studies. In the present study, 100g beetroot, 
providing ~272mg nitrate, reduced SBP by 6.4mmHg and DBP by 5.0mmHg between 
two and three and a half hours in the young group, which is a larger reduction than 
seen by Kapil et al. (2010) with a similar dose of nitrate. This also corresponds to the 
peak plasma nitrate levels seen between two and three hours post-ingestion of 
beetroot. The larger dose of nitrate provided by 300g of beetroot reduced DBP to the 
same extent as the smaller dose but 1000mg of nitrate elicited the largest reduction 
in DBP by 6.4mmHg between two and 3.5 hours post-ingestion. 1000mg also 
reduced SBP by 7.3mmHg between four and five hours, which corresponds with the 
peak plasma nitrite level. It is evident from this that there is a dose response and that 
whole beetroot is effective at reducing blood pressure in young, healthy adults. In an 
older population, however, beetroot or PN supplementation did not result in a 
significant reduction in either SBP or DBP. There was a trend towards an effect of 
nitrate on DBP in the old group and, although not significant, PN was found to cause 
a reduction in DBP by 4.9mmHg between two and 3.5 hours. It may be the case that 
the sample size here was too small to detect significant differences in the old group 
due to individual variations. 
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This is consistent with results seen in the literature, in which the effects of dietary 
nitrate, predominantly from beetroot juice, are irregular in an older population (Table 
1.2). In a healthy cohort, 595mg nitrate from beetroot juice was enough to reduce 
both SBP and DBP in adults aged on average 64 years (Kelly et al., 2013) but there 
was no effect on blood pressure in adults aged on average 73 years following a 
similar dose of nitrate (Miller et al., 2012). Gilchrist et al. (2014) found no effect of 
beetroot juice on blood pressure in participants with Type 2 diabetes and Bondonno 
et al. (2015) similarly found no effect of the juice on blood pressure in older adults 
with high blood pressure and taking anti-hypertensive medication. Conversely, 
Kenjale et al. (2011) described a reduction in DBP following beetroot juice in 
participants with peripheral arterial disease (PAD). The difference in results may 
simply be due to the dose, as Kenjale et al. (2011) provided 1116mg nitrate, which is 
more than double that given by Gilchrist and Bondonno. However, patients with Type 
2 diabetes have been found to generate less NO from L-arginine than healthy 
individuals, which may result in a reduced response to a nitrate load (Avogaro et al., 
2003). Work by Shepherd et al. (2015) found no effect of beetroot juice on blood 
pressure in patients with COPD despite rises in plasma nitrate following consumption 
of the nitrate load. It can be speculated that beneficial effects of beetroot juice on 
blood pressure are blunted in volunteers with chronic conditions such a COPD and 
diabetes, potentially due to elevated oxidative stress increasing the scavenging of 
NO (Shepherd et al., 2015). A high concentration of free radicals such as superoxide 
can increase the breakdown of NO and thus reduce its effectiveness (Taddei et al., 
2001). 
 
Furthermore, the study by Kelly et al. (2013) was the only one with a cohort with a 
healthy BMI, while the other cohorts were overweight or obese. The negative effects 
of a high BMI, such as low-grade inflammation, may therefore be blunting the positive 
effects of dietary nitrate, especially in an older population in which low-grade 
inflammation may already be extant. Participants in the present study were both a 
normal weight and overweight, with BMIs below 29.9kg/m2. This could have 
produced in inconsistent result in blood pressure lowering. 
 
Three weeks of supplementation with beetroot juice led to a progressive decline in 
daily SBP in older obese adults (Jajja et al., 2014), who were given ~165mg 
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nitrate/day in concentrated beetroot juice for 21 days. The more prolonged 
intervention period here may account for the positive effects of the beetroot juice 
despite participants receiving a smaller dose than that provided by other researchers. 
The longer-term supplementation with nitrate- and antioxidant-rich beetroot here may 
have reduced the negative effects of oxidative stress and inflammation associated 
with ageing and obesity and allowed the bioactive nitrate to induce blood pressure 
reduction through NO. Additive effects of nitrate and/or nitrite may have also 
heightened this over the more prolonged time period but little is known about the 
relevance of this. 
 
The present study contributes to the data on sources of dietary nitrate and their 
effects on blood pressure and demonstrates that the consumption of whole beetroot, 
in doses akin to a vegetable portion of 80g, can acutely reduce blood pressure in 
young individuals. It demonstrates that beetroot in forms other than juice can be used 
as effective supplements or additions to the diet. These same benefits do not 
translate to an older population, although large quantities of nitrate reduce the 
difference in blood pressure seen between young and old participants. Longer-term 
studies are required to further examine whether the effect of dietary nitrate on blood 
pressure is solely due to the immediate dose or whether there are benefits that 
accumulate over a more prolonged period. This is particularly relevant for an ageing 
population in which the acute blood pressure-lowering effects appear to be 
dampened. 
3.4.3 Correlations between plasma nitrate and nitrite and blood pressure 
In 2010 and 2018, Kapil et al. described a correlation between plasma nitrite but not 
nitrate and blood pressure following supplementation with 1488mg and 496mg 
potassium nitrate. Peak blood pressure reductions have also been associated with 
higher plasma cGMP levels around three hours following nitrate ingestion (Kapil et 
al., 2015). This demonstrates increased NO availability following the nitrate load, 
which works to increase cGMP levels and subsequently dilate blood vessels (Snyder, 
1992). Baseline plasma nitrite levels are also thought to be an accurate reflection of 
endogenous NO generation via L-arginine (Lauer et al., 2001). In the present study, 
there was no correlation between plasma nitrate levels and blood pressure in the 
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young group but both SBP and DBP reductions were modestly correlated with higher 
plasma nitrate levels in the old group. Although not found to be statistically 
significant, plasma nitrate levels were observed to be higher in the old group than 
young group, which might explain the correlation with blood pressure and these 
higher levels. However, peak plasma nitrate levels were found between two and 
three hours in the old group but blood pressure was not significantly lower than 
baseline at this time. There was large inter-individual variation in blood pressure due 
to the small sample size, which may have influenced the correlation between NO 
metabolites and blood pressure. As discussed in Chapter 2, the association between 
nitrite and blood pressure has been elegantly demonstrated through the blocking of 
the nitrate-nitrite conversion by anti-bacterial mouthwash or spitting (Webb et al., 
2008), therefore more research is warranted in this area. It has been proposed that 
nitrite is involved in “setting” basal blood pressure (Kapil et al., 2018), thus larger 
studies on older adults may further elucidate the correlation between plasma nitrite 
levels following beetroot consumption and consequent effects on blood pressure.  
3.4.4 The effects of beetroot on vascular function 
The expected observation of a lower baseline PORH value for the old compared to 
the young reiterates the deterioration in vascular function into older age. PORH is a 
sensitive marker of vascular function and lower values are associated with higher risk 
of CVD. Nitrate ingestion in the present study was found to have no notable influence 
on PORH in the young or the old groups but the variability in measurements between 
and within participants may have negated any positive effects. Kapil et al. (2015) saw 
no change in PORH following four weeks of daily consumption of beetroot juice 
containing 397mg in hypertensive older adults but demonstrated improvements in AIx 
and PWV over this time. However, de Oliveira et al. (2016) found reactive 
hyperaemia (RH) to be increased following a single bolus of 756mg from beetroot gel 
in older adults with cardiovascular risk factors. A recent systematic review identified 
that inorganic nitrate significantly reduced arterial stiffness, evident through a 
reduction in AIx and PWV (Jackson et al., 2018). It may be that these markers are 
more sensitive to the effects of nitrate consumption and can provide a more accurate 
measure of vascular function. Indeed, Kapil et al. (2015) and Rammos et al. (2014) 
demonstrated a reduction in both AIx and PWV following four weeks intervention with 
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nitrate in the form of beetroot juice or sodium nitrate. These interventions may be of 
most benefit to those with CVD risk factors or elicit benefits due to their prolonged 
supplementation period, as Hughes et al. (2016) and Oggioni et al. (2018) found no 
effect of shorter-term consumption of dietary nitrate on AIx in healthy older adults.  
 
Maximum flux was the only marker of microvascular function to be positively 
influenced by nitrate ingestion and this occurred in the young but not the old group. 
Ingestion of nitrate had no impact on resting flux, time to maximum or time to resting. 
No studies around nitrate ingestion have described the impact on these markers, so 
comparisons cannot be drawn at this time. The effect of nitrate intake on maximum 
flux in the young but not the old group may be reflected in the higher levels of plasma 
nitrite shown in the younger group, which provide evidence for increased NO 
production in this young group. The plasma nitrite levels seen in the old group may 
not have been elevated to the point in which to elicit physiological benefits to the 
vascular system. This has been also been shown to be true for blood pressure, with 
nitrate ingestion having a reduced impact on blood pressure in the old group 
compared to the young.  
3.4.5 The acceptability of whole beetroot as a supplement to the diet 
The VAS results on the acceptability of the beetroot intervention provide information 
about participants’ preferences and attitudes towards the consumption of whole 
beetroot. Overall, the old group rated the beetroot higher than the young group, 
scoring it ~9 points higher out of 60 on the VAS. This could be due to familiarity and 
increased exposure to beetroot in older adults. 300g beetroot, which was used to 
provide a high dose of dietary nitrate, received the lowest VAS score, and this was 
also reflected in three participants’ aversion to the consumption of the large dose. 
100g and 200g beetroot received comparable scores; therefore these doses are 
deemed acceptable in an acute intervention study and elicited high compliance. 
There is no data on the compliance and tolerability of beetroot consumption over a 
more prolonged period of time but these results provide an insight into the 
acceptance of beetroot as an intervention food. 
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3.4.6 Strengths and limitations 
This study investigated, for the first time, the effects of whole beetroot consumption 
on blood pressure and vascular function, making a direct comparison between young 
and old participants provided with the same dose. As with Chapter 2, the dietary 
restrictions and seven-day washout period between trials ensured no carry-on effect 
of nitrate-rich foods consumed before testing. The screening process also identified 
and excluded those on blood-pressure medication and with a high blood pressure, 
which may have confounded the effects of the interventions.  
  
Blood pressure was assessed in clinic, which is the most commonly used method but 
may introduce measurement bias due to white-coat syndrome (Bloomfield & Park, 
2017), operator bias and protocol variations. These were minimised by a single 
operator conducting the blood pressure measurement according to the written 
protocol, using standardised clinical equipment and concealing blood pressure 
readings from participants. Raubenheimer et al. (2017) note that circadian rhythms 
can affect blood pressure, which was minimised in the present study by participants 
attending the research facility at least one hour after waking and with all trials 
beginning around the same time, between 8am and 9am. 
 
This study did not employ PWV or FMD to measure vascular function, which are 
considered the gold standards for measurement. However, RH is considered a 
sensitive marker of vascular function in healthy participants and responds to a given 
stimulus, making this a valuable tool in assessing microvascular activity. There was 
large variation in baseline measurements of RH markers, so it is likely that a larger 
sample size is required to reduce the noise associated with the readings and to 
detect a significant effect size.  
3.5 Conclusions 
Small, practical amounts of beetroot have a positive effect on blood pressure in 
young participants but larger doses are required to elicit comparable effects in an 
older population. This suggests mechanistic differences in the production of NO from 
dietary nitrate in young and old participants. Furthermore, whole beetroot, in amounts 
up to 200g, is a suitable supplement for dietary intervention and is well accepted in 
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acute settings. This data may be used to inform dietary nitrate dosages for longer-
term intervention studies on beetroot, during which the complex of nutrients in the 
whole vegetable may elicit synergistic and additive effects not evident in acute trials.  
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Chapter 4. Physiological effects of prolonged beetroot ingestion in 
older adults 
4.1 Introduction 
Beetroot consumption, most often in juice form, has been found to elicit a range of 
positive effects on the human body, including blood pressure reduction (Siervo et al., 
2013), increased blood flow (Lara et al., 2016) and improvements in cognitive 
performance (Wightman et al., 2015). These effects have been attributed to the 
ingestion of dietary nitrate and the subsequent increase in nitric oxide (NO) 
production throughout the body following the stepwise breakdown of this nitrate. 
Increased NO levels have also been found to acutely improve muscle strength and 
endurance in young adults (Bailey et al., 2010; Lansley et al., 2011) but there is little 
known about the impact of prolonged consumption of dietary nitrate on NO levels and 
on physiological outcomes in other demographics such as older adults. Remaining 
healthy and active into older age is important for maintaining muscle mass, functional 
capacity and cognitive performance (Everard et al., 2000; Hairi et al., 2010), 
therefore supplementing or increasing the consumption of foods rich in nitrate may 
potentially improve activities of daily living (ADL) and quality of life in older adults 
(Gault & Willems, 2013).    
 
Pre-clinical data has demonstrated that consuming sodium nitrite for eight weeks 
improves functional capacity, including grip strength and open-field distance covered 
(Justice et al., 2015). Human data has also supported the use of longer-term sodium 
nitrate supplementation as a potential therapy for risk factors of CVD e.g. arterial 
stiffness and for improving cognitive function (DeVan et al., 2016; Justice et al., 
2015). These studies highlight the potential longer-term benefits of nitrite, which can 
be produced in the oral cavity following the consumption of dietary nitrate. There are 
concerns, however, over the consumption of nitrite and the conversion to 
carcinogenic compounds in the body, so more natural sources of nitrate and nitrite, 
such as beetroot, may be more acceptable in long-term intervention studies. 
 
Beetroot juice has been shown to lower systolic (SBP) and diastolic (DBP) blood 
pressure in hypertensive older adults (Kapil et al., 2015) and improve vascular 
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function (Velmurugan et al., 2016). The improvements in vascular function were 
closely correlated with the oral microbiome, with increases in nitrate-reducing 
bacteria, Rothia Mucilaginosa and Neisseria Flavescens. Research suggests 
similarities between the oral and gut microbiome (Kodukula et al., 2017), which 
together form the majority of the human microbiome. The oral microbiome is 
generally considered stable in healthy adults (Hall et al., 2017) but gut microbiota are 
heavily influenced by dietary intake.  
 
Research into the gut microbiome has demonstrated the symbiotic relationship 
between the host and the microbes that reside within the GI tract, where they have 
been shown to be involved in immunity, inflammation and digestion (van der Beek et 
al., 2017; Belkaid & Hand, 2014). The gut microbiome is therefore a significant 
contributor to health and has been implicated in obesity, diabetes and CVD (Korpela 
et al., 2014; Tilg & Moschen, 2014; Tuohy et al., 2014). Some of the main drivers of 
changes to the gut microbiome are age, genetics and dietary intake (Wu et al., 2011). 
For example, older age is associated with a reduction in bacterial diversity, which can 
contribute to co-morbidities and poor quality of life (O’Toole & Claesson, 2010). In 
addition, the production of key metabolites such as short-chain fatty acids (SCFAs), 
which have been shown to have beneficial effects on the gut and in cardiovascular 
health (Marques, 2016), has been found to be reduced in older populations (Biagi et 
al., 2017). The effect of dietary fibre has been studied in dietary interventions and gut 
microbiome studies, and has been found to be beneficial in the risk of CVD and some 
cancers (Dahl et al., 2017). However, supplementation with whole beetroot, which 
may also offer benefits such as anti-inflammatory action (Noble et al., 2017), 
increased mucosal blood flow and mucus thickness (Björne et al., 2004), and 
increased species richness and diversity (Vandeputte et al., 2016), is not well 
understood in human trials, specifically in older adults.  
 
Therefore, this study investigates longer-term beetroot consumption and its effects 
on functional capacity, blood pressure and gut health in older adults. It was 
hypothesised that regular consumption of whole beetroot over an eight-week period 
would have a positive impact on functional capacity, blood pressure, SCFA 
production and gut microbiotal composition. To this end, participants consumed 
whole cooked beetroot and/or a control food consistently over an eight-week period 
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and attended the research facility on three occasions to assess physiological 
changes over this period. 
4.2 Methods 
4.2.1 Participants 
Participants were recruited through Voice, a research participant database, the 
Newcastle Upon Tyne Hospitals intranet, poster dispersion and adverts in the local 
papers from January 2018 to April 2018. Each volunteer was given a participant 
information sheet and screened over the phone prior to attending the research 
facility. Participants provided informed written consent before beginning the study. 
The study was approved by the Newcastle university ethical committee (Appendix 
G). Recruited participants had a BMI below 30kg/m2, were both male and female and 
were aged between 60 and 80 years. The total participant group consisted 14 males 
and 22 females. 
4.2.2 Exclusion criteria 
This study was based on healthy participants i.e. those with a BMI below 30kg/m2 
and free of chronic illness. Excluded medications included: beta-blockers, antacids, 
anticoagulants, nitrate-derived agents, anti-cholinergics, anti-hypertensives (Ca2+ 
channel blockers, ACE inhibitors), aspirin and diuretics. Each of these medications 
can have an effect on NO production via various mechanisms. The use of antibiotics 
in the past month was excluded due to the negative effect on the gut bacteria. 
Participants were excluded if they were vegetarian, as research points towards a 
higher habitual nitrate intake (Mitek et al., 2013), or consumed excessive volumes of 
alcohol (classed as above 30 units/week). Other exclusion criteria included smoking, 
history of repetitive gastric reflux and an intolerance or allergy to the intervention 
foods.  
4.2.3 Study design and randomisation 
This study was a two-arm, parallel, open-label intervention trial that took place at the 
research facility NU-Food, Newcastle University. Randomisation was generated 
online using www.randomization.com, where the two treatments, beetroot and 
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control, were allocated treatment codes by an independent third party. Participants 
were then assigned a code following screening. 
4.2.4 Study protocol 
Eligible volunteers were invited to attend NU-Food for a training visit, where height, 
weight and blood pressure were measured. Informed written consent was received at 
this visit and participants were then booked in for their baseline visit four to seven 
days following training. Participants were asked to fast for two hours prior to their 
baseline and subsequent visits and to refrain from caffeine intake in this period. 
Those opting to provide stool samples for the assessment of gut health were given a 
collection kit and instructions to take home and asked to collect a sample in the three 
days prior to their visit. 
 
Participants attended a baseline, mid-way, and end of study testing visit, each lasting 
up to one hour and 15 minutes. The visit started with the completion of a caffeine 
intake tool for the 24-hour period before their visit. Following this, blood pressure, 
body composition, grip strength, lung function and timed up and go were measured 
using standard protocols. A blood sample was taken from the antecubital fossa by a 
trained phlebotomist and a urine sample was deposited into a sample pot. 
Participants then completed a 24-hour recall with the researcher and a physical 
activity questionnaire as instructed. Each participant was provided with his or her 
intervention foods at the end of the visit and sample collection kits as required. An 
intervention foods calendar was created for ease with contact details should there be 
any problems. Midway and end of study visits were conducted during weeks five and 
nine, respectively. This can be seen in Figure 4.1. 
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Figure 4.1: Study 2 protocol. Variables measured during study visits: blood 
pressure, functional capacity and cognitive function.  
4.2.5 Interventions 
Participants were randomised to consume either 150g of whole cooked beetroot plus 
one medium-sized banana every second day, or one medium-sized banana every 
second day. Beetroot was provided for the entirety of the study in pre-cooked 
vacuum packed portions of 250g provided by G’s Fresh Ltd, Cambridgeshire. 
Bananas were provided on a per-participant basis and purchased at home in 
between study visits. Participants consumed the intervention foods at home during 
the eight-week period and were given instructions on the consumption and storage of 
the beetroot. As the beetroot was already cooked, participants were instructed not to 
cook the beetroot further or combine into meals that would be consumed by other 
people. Examples and recipes were provided to aid in appropriate consumption of 
the beetroot. Participants were instructed to maintain their normal diet, consuming 
the foods on top as “supplements”; the beetroot could be consumed at any time of 
the day. This has been utilised before to maximise the external validity of the 
outcomes (Coles & Clifton, 2012; Shannon et al., 2016). The beetroot provided was 
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found to contain 390mg nitrate per 100g cooked weight. Therefore, participants 
consumed ~585mg nitrate every second day for eight weeks. Due to the difficulty in 
providing a control diet, it was deemed appropriate for both the intervention group 
and the control group to consume the control food. This resulted in a comparable 
background diet with beetroot consumption as an addition. Bananas were chosen as 
the control food because of their low nitrate content, similar fibre content and 
standardisation due to the lack of varieties available to purchase (Table 4.1). 
According to Public Health England’s Composition of Foods, dietary fibre “is present 
in significant quantities but there is no reliable information on the amount” in beetroot; 
packet information from the beetroot suppliers was therefore used. Compliance to the 
interventions was self-reported and participants provided receipts for the purchase of 
the control food in order to claim expenses.  
 
Table 4.1: Nutrient composition of intervention foods.  
 
 Beetroot/100g Banana/100g 
Energy (kcal) 46 81 
Carbohydrate (g) 9.5 20.3 
Protein (g) 2.3 1.2 
Fat (g) 0.1 0.1 
Sugar (g) 8.8 14.4 
Fibre (g) 2.3 1.4 
Nitrate (mg) 390 5 
 
Data from the McCance and Widdowson’s Composition of Foods Integrated 
Dataset (Public Health England, 2015).  
 
4.2.6 Blood pressure 
Blood pressure was measured in triplicate at each visit using an automated device 
(OMRON M2). Participants were seated and the pressure cuff was placed on the 
upper arm. The arm was then placed in a comfortable and relaxed position and one-
minute rest was given between measurements. Measurements were hidden from the 
participants so that their knowledge of their blood pressure reading did not influence 
future measurements. 
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4.2.7 Hand-grip strength 
Hand-grip strength is used as an indicator of frailty in older adults, as it predicts 
increased risk of disability and functional limitations (Norman et al., 2011; Syddall et 
al., 2003). It is used as a simple and non-invasive marker of muscle strength in the 
upper extremities. Grip strength was measured using a handheld digital 
dynamometer (Takei 5401). Participants began with their dominant hand and grip 
strength in each hand was measured in duplicate. Participants remained standing 
and with their hands by their side for the assessment. Values for each hand were 
averaged and measured in kilograms (kg). Coldham, Lewis and Lee (2006) noted 
that one maximal trial is as reliable as, and less painful than, either the best of or 
mean of three. With an older population suffering from arthritis and other conditions, 
measurement of two maximal trials per hand was chosen. The most important aspect 
is that the same design and instrument is employed for each measurement 
(Mathiowetz, 1984).  
4.2.8 Spirometry 
Lung function was assessed using a portable, handheld spirometer at each visit 
(Vitalograph Micro Handheld Spirometer, UK). Spirometry is a quick and simple way 
to measure lung volume against time (Ranu et al., 2011). Participants were sitting 
upright and in a comfortable position, with both feet on the floor and legs uncrossed. 
Participants were guided through the technique and a disposable, single-use 
mouthpiece was used for each participant. Tidal (normal) breaths were taken first, 
and then participants took a deep breath in before breathing out as hard and as fast 
as possible, until they had emptied their lungs. Forced expiratory volume in one 
second (FEV1) and forced vital capacity (FVC) were measured in triplicate. The 
protocol used was that devised by Moore (2012). The ratio of the two volumes was 
then calculated using the equation:  
FEV1/FVC 
4.2.9 Timed-up-and-go 
The timed up-and-go (TUG) test assesses agility and dynamic balance, and this test 
was performed at each visit using a standardised protocol described by Barry et al. 
(2014). Participants were instructed to rise from a chair, walk three metres to a 
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marker at a comfortable pace, turn around, walk back to the chair and sit down. Each 
participant walked through the test once without being timed to become familiar with 
the task. A stopwatch was used to time the second trial, stopping when the 
participant sat back down on the chair. TUG test times have been found to increase 
with increasing age (Bohannon, 2006), and normative reference values for the test 
are 8.1s for those aged 60-69 years and 9.2s for those aged 70-79 years (Bohannon, 
2006). 
4.2.10 Questionnaires 
Participants were asked to complete a stool frequency questionnaire in the three 
days prior to each of their visits. This questionnaire involved the use of the Bristol 
Stool Chart to identify the type of stool and the frequency of bowel movements during 
those days. During each of the visits, participants completed a 24-hour dietary recall 
with the researcher, to report their nitrate and dietary fibre intake the day before 
testing. Nitrate intake was then analysed using a nitrate specific database developed 
by researchers at the University of Queensland, Australia. Fibre intake was analysed 
using the McCance and Widdowson Composition of Foods Integrated Dataset. The 
short version of the IPAQ was using to monitor physical activity over the seven days 
prior to each visit and consistency throughout the study. 
4.2.11 Blood sampling, processing and analysis 
15ml of blood was collected at baseline and at the end of study visit, in three 
vacutainers: one lithium heparin, one serum gel and one EDTA. The lithium heparin 
and EDTA samples were processed within 30 minutes, while the serum gel was 
given at least 30 minutes to clot before processing. The samples were spun at 
3000rpm for 10 minutes, aliquoted and frozen at -80°C for future analysis. Samples 
were prepared for analysis in the same way as in Chapter 2, using cold ethanol 
precipitation. Plasma nitrate was then analysed by ozone-based chemiluminescence, 
as described in Chapter 2. In order to measure the prolonged effects of beetroot 
ingestion rather than the acute effects, blood samples were taken at least 12 hours 
after the last beetroot dose was consumed.  
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4.2.12 Urine sampling 
Spot urine samples were taken at each visit for the analysis of nitrate. Participants 
deposited a urine sample in a designated bottle and aliquots were drawn and frozen 
immediately at -20°C. Before analysis, urine samples were defrosted and diluted to 
1:100 in deionized water (DH2O). As described in Chapter 2, urinary nitrate was 
analysed using ozone-based chemiluminescence by the Sievers gas-phase 
chemiluminescence nitric oxide analyser (NOA). Human Tissues Act (HTA) training 
was completed by the researcher and samples were stored in an HTA licenced 
freezer and laboratory. 
4.2.13 Stool sample, processing and analysis 
17 participants collected stool samples throughout the study; eight from the 
intervention group and nine from the control group. One stool sample was collected 
prior to each visit on the day before or the morning of the visit day. Participants were 
instructed to freeze the sample immediately and bring it with them in a provided 
cooler bag with ice packs. The stool sample was then transferred to a -80°C freezer 
until analysis. Samples were stored in an HTA licenced freezer and laboratory. A 
Research Associate within the Mitochondrial Research Group at Newcastle 
University carried out the short chain fatty acid (SCFA) analysis. Bacterial analysis 
was conducted at Northumbria University. 
SCFA 
Short chain fatty acid (SCFA) content was determined by gas chromatography (GC). 
Firstly, a deproteinising solution (DPS) was prepared by dissolving metaphosphoric 
acid and 3-methyl valeric acid (3MV) in distilled water, giving a 50mM 3-MV solution, 
which was then stored at 4°C. Stock solutions of 0.2M were prepared for acetic acid, 
propionic acid, isobutyric acid, butyric acid, isovaleric acid and valeric acid. This was 
achieved by adding the appropriate amount of each acid to DH2O as follows (Table 
4.2):  
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Table 4.2: Stock solutions of short chain fatty acids made using deionised water. 
 
 Acid (µl) Water (ml) 
Acetic acid 286 24.71 
Propionic acid 375 24.63 
Isobutyric acid 469 24.53 
Butyric acid 461 24.54 
Isovaleric acid 558 24.44 
Valeric acid 545 24.45 
 
Each of these SCFA standards was run individually on the GC (Shimadzu GC-2014 
with AutoInjector AOC-20i, Japan) in duplicate to identify peaks and retention times. 
A SCFA “master mix” was then prepared using 10ml acetic acid, 5ml propionic acid, 
1ml isobutyric acid, 2ml butyric acid, 1ml isovaleric acid and 1ml valeric acid. 
Standard SCFAs were prepared by combining 2ml of the master mix with 2ml 
distilled water and 1ml DPS, giving a final concentration of 40mM acetate, 20mM 
propionate, 4mM isobuytrate, 8mM butyrate, 4mM isovalerate, and 4mM valerate. 
The standard SCFA mix was then run on the GC to confirm peaks and retention 
times; this graph can be seen in Appendix I. To calculate the response factor (RF) 
the following formula was used (example for acetate): 
 
peak AUC 3MV x [acetate] / peak AUC acetate x [3MV] 
 
To calculate SCFA in the stool samples, 250mg of each stool sample was combined 
with DPS at half weight by volume (125µl) and mixed. 200µl DH2O was then added, 
briefly mixed and then centrifuged at 15,000rpm for 20 minutes. 50µl of the 
supernatant was transferred to glass GC vials and sealed. The concentration of 
SCFAs in each sample was analysed by GC using a 2mm diameter column packed 
with a 10% SP-1200-1% phosphoric acid on 80/100 chromosorb in a PU 4550 gas 
liquid chromatograph. 1µL of sample was injected into the GC instrument using a 
glass-barrelled needle. Concentrations of SCFAs in samples were calculated relative 
to the standard master mixed of SCFA and internal standard (3MV), which is present 
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in the DPS. The following calculation was then used to calculate the concentration of 
each SCFA in the sample, using acetate as an example: 
  
(RF for acetate x [3MV] x peak area for acetate) / peak area for 3MV 
 
DNA extraction and bacterial analysis 
The methods used follow the same protocol as that described by Houghton et al. 
(2018). Briefly, DNA was extracted from 300mg of stool sample from each time point 
(baseline, midway and end of study) using the Powerlyzer Powersoil DNA isolation 
kit (MoBio, UK), following manufacturer’s instructions. The 16s rDNA V4 region was 
amplified using PCR and then sequenced in the MiSeq platform (Illumina); the V4 
region is one of the most well characterised regions of interest. 16s rRNA gene 
sequences were then clustered into operational taxonomic units (OTUs) based on 
sequence similarity, which categorise groups of bacteria that are closely related to a 
value of 97% similarity. OTUs were mapped to the SILVA database, which is an 
online alignment tool used to map the OTUs to up to date 16S sequence data for 
bacteria (Quast et al., 2013). Abundances were reported by mapping demultiplexed 
reads to the OTUs. A custom script constructed a rarefied output table ensuring all 
samples had the same number of OTUs for downstream analysis of alpha- and beta-
diversity, as well as phylogenetic trends.  
4.2.14 Statistical analysis 
All statistical analyses were completed using IBM SPSS (version 24.0). Summary 
data are presented as means ± SD with 95% confidence intervals (CI). Independent 
t-tests were used to assess differences in baseline measures between the two 
intervention groups. Changes over time were analysed using a mixed model 
repeated measures ANOVA with time as the within-subjects factor and intervention 
as the between-subjects factor. Models were tested for sphericity using Mauchly’s 
test and multivariate models were applied if these assumptions were violated. Where 
significances were found, post hoc tests with Bonferroni adjustment to control for 
multiple comparisons were run. R was used to analyse and visualise microbial 
communities using the phyloseq package, allowing alpha- and beta-diversity metrics 
to be calculated. Each sample was rarefied to 15,721 reads. The non-parametric test 
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Kruskal-Wallis was used to determine significance between categorical variables. 
Correlations between two continuous variables were determined with linear 
regression models with P values indicating the probability that the regression line is 
zero. Principal coordinate plots employed the Monte Carlo permutation test to 
estimate P values, and the principal component analysis (PCA) was used to highlight 
patterns and variation in the data. FDR algorithms were used to adjust P values 
when multiple comparisons were conducted. Statistical significance was set at 
P<0.05.   
4.3 Results 
4.3.1 Baseline characteristics  
A total of 36 participants were randomised to the interventions, with an age range of 
60 to 79 years (Figure 4.2). The interventions were well tolerated and no adverse 
events were reported. Participants did not report beeturia (red-coloured urine) with 
the beetroot intervention. Baseline characteristics can be seen in Table 4.3. 17 
participants were allocated into the control group and 19 into the intervention group. 
Participants in each intervention group were matched for height, weight, BMI, waist 
circumference and body fat (P>0.05) but average age in the control group was 
70.1±5.6 years, compared to the intervention group of 65.1±4.4 years (P=0.009). 
Both groups had similar baseline systolic and diastolic blood pressure, and physical 
activity levels (P>0.05). Nitrate intake on the day before baseline testing was similar 
for both groups, with values of 124.9±66.1mg and 103.4±57.1mg for the beetroot and 
control group, respectively (P=0.23). Dietary fibre intakes were also similar across 
groups, with approximately 20.4±3.1g in the beetroot group and 17.8±7.5g in the 
control group (P=0.38). The average across both groups of 19.1±5.7g matches the 
average population intake reported in the National Diet and Nutrition Survey (NDNS) 
of 19g (Public Health England, 2018). Participants consisted of 14 males and 22 
females overall, with a ratio of 6:13 and 8:9 male to female in the beetroot and 
control groups, respectively. One participant was withdrawn from the study due to 
beginning medication that may interfere with study outcomes during the intervention 
period. 
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Figure 4.2: Recruitment flow diagram, study 2 
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Table 4.3: Mean (±SD) baseline characteristics, study 2; n=36.   
 All Intervention Control P value 
Number 36 19 17  
Gender (M/F) 14/22 6/13 8/9  
Age (years) 67.4±5.6 65.1±4.4 70.1±5.6 0.005 
Height (cm) 166.7±8.7 167.3±6.9 166.1±10.5 0.70 
Weight (kg) 70.0±9.4 69.3±10.2 70.9±8.7 0.63 
BMI (kg/m2) 25.1±2.4 24.6±2.7 25.6±1.9 0.23 
Waist (cm) 85.9±9.9 83.9±10.2 88.3±9.3 0.19 
Body fat (%) 27.9±8.6 28.8±8.7 26.8±8.6 0.52 
SBP (mmHg) 137.9±16.7 135.5.±19.6 140.3±13.8 0.40 
DBP (mmHg) 81.6±10.5 86.0±12.8 86.4±6.8 0.89 
Heart rate (BPM) 70.8±8.5 71.1±9.8 70.5±6.9 0.84 
Physical activity 3376.0±2734.3 3866.0±3098.2 2828.4±2225.2 0.26  
Statistical analysis using independent t-tests. SBP = systolic blood pressure, 
DBP = diastolic blood pressure. 
4.3.2 Body composition, physical activity and dietary intake 
Weight, waist circumference and body fat percentage did not change from baseline 
to end of study in either the beetroot group or control (P>0.05). Nitrate intakes on the 
day before testing were significantly higher at the midway and end of study visits than 
at baseline for the beetroot group, rising to 242.8±147.1mg at midway (P=0.02) and 
to 270.2±155.8mg at end of study (P=0.002). Nitrate intake the day before testing 
also rose in the control group to 203.3±162.8mg at midway and 154.7±105.5mg but 
these were not significantly different to baseline (P>0.05). Nitrate intakes the day 
before end of study testing were significantly higher in the beetroot group than the 
control group (+115.5mg; P=0.02; 95%CI: 19.7, 211.3), demonstrating compliance to 
the intervention and success at increasing nitrate intake. Dietary fibre intake on the 
day before testing across both groups rose to 23.5±5.4g, which is above the average 
daily intake in the UK. Fibre intake was significantly higher than baseline at the end 
of the study in the control group (+5.5g; P=0.02; CI: 0.8, 10.2) but there was no 
significant change in the beetroot group (P=0.26). There was, however, a large range 
of fibre intakes at baseline in the control group (8g – 32g) and a smaller range at end 
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of study (15g-32g), so results may have been skewed by individuals with particularly 
low or high intakes.  
4.3.1 Plasma nitrate 
There was no effect of time on plasma nitrate levels (P=0.10) but a noteworthy trend 
towards an effect of intervention (P=0.06) (Figure 4.3). There was no interaction 
between time and intervention (P=0.16). Plasma nitrate levels were found to be 
7.05µmol/L lower in the control compared to the intervention group. Post hoc 
analyses show plasma nitrate levels were significantly higher at the end of study 
compared to baseline in the intervention group (+11.9µmol/L; P=0.04; 95%CI: 0.9, 
22.9) but there was no significant difference in the control group (P=0.86). The 
beetroot given was found to contain 390mg nitrate per 100g cooked weight, meaning 
that if participants consumed their allocated amounts they would have consumed 
~585mg nitrate every second day through the consumption of 150g beetroot. Based 
on the results from Chapter 2, this amount should have been enough to raise both 
plasma nitrate and nitrite levels in the participants. Although there was potentially a 
small additive effect evident through the higher plasma nitrate levels following only 
the beetroot intervention, nitrate levels were not raised from baseline to an extent 
deemed physiological. Levels remained similar to the baseline values observed in 
Chapter 2.  
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Figure 4.3: Mean (±SEM) plasma nitrate levels at baseline and after eight weeks of 
supplementation with beetroot or control; n = 30. Statistical analysis using mixed 
model repeated measures ANOVA (time as within-subjects factor and intervention 
as between-groups factor). * denotes a significant difference when compared to 
baseline in the  beetroot group (P<0.05).   
4.3.2 Urinary nitrate 
There was a significant effect of time on urinary nitrate levels (P=0.005) but no effect 
of intervention (P=0.75) (Figure 4.4). There was no interaction between time and 
intervention (P=0.47). Pairwise comparisons show that urinary nitrate levels were 
higher than baseline at the mid point (+0.39mmol/L; P=0.006; 95%CI: 0.09, 0.69) and 
end of study (+0.33mmol/L; P=0.003; 95%CI: 0.09, 0.56) for both interventions 
combined.  
  * 
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Figure 4.4: Mean (±SEM) urinary nitrate concentration at baseline (0), midway (5) 
and end of study (9) after beetroot supplementation and control; n = 36. 
Statistical analysis using mixed model repeated measures ANOVA (time as 
within-subjects factor and intervention as between-groups factor). * denotes a 
significant difference when compared to baseline across both groups (P<0.05).   
4.3.3 Functional capacity 
Baseline, midway and end of study values for functional capacity are shown in Table 
4.4. There were no significant changes to functional capacity measures over the 
eight weeks following beetroot or the control food (P>0.05).
  * 
 * 
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Table 4.4: Mean (±SD) functional capacity measurements; n = 36.  
 Intervention  Control  
 Baseline Midway End P Baseline Midway End P 
Left grip (kg) 26.4±5.8 24.6±7.8 25.7±7.1 1.00 25.1±8.7 24.5±8.2 24.6±9.0 1.00 
Right grip (kg) 26.5±6.6 24.9±8.5 25.4±8.8 1.00 27.2±8.6 26.1±10.4 26.5±9.3 1.00 
TUG (sec) 6.2±0.9 6.1±1.0 6.2±1.1 1.00 6.7±1.5 6.5±1.4 6.8±1.3 1.00 
FVC 3.4±0.8 3.3±0.8 3.2±0.7 0.29 3.3±1.2 3.3±1.0 3.2±1.0 1.00 
FEV1 2.8±0.6 2.6±0.6 2.7±0.5 0.45 2.6±0.9 2.7±0.7 2.6±0.8 1.00 
FEV1% 83.1±12.5 82.3±8.5 84.4±9.2 1.00 82.4±9.3 82.2±16.1 83.3±9.9 1.00 
 
TUG = timed up-and-go; FVC = forced vital capacity; FEV1 = forced expiratory volume in one second. FEV1% = FVC/FEV1 
ratio. P values represent change from baseline to end to study. 
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4.3.4 Blood pressure 
Baseline SBP was similar between groups, with values of 140mmHg and 136mmHg 
for the control and intervention group, respectively. DBP was also matched across 
groups, with a mean of 86mmHg for both groups. 
 
There was a significant effect of time on SBP (P=0.003) but no effect of intervention 
(P=0.29) (Figure 4.5). There was no interaction between time and intervention 
(P=0.94). Pairwise comparisons show that SBP at the end of study was significantly 
lower than at the mid point (-7.7mmHg; P=0.003; 95%CI: -13.1, -2.2) for both 
interventions combined.  
 
 
 
Figure 4.5: Mean (±SEM) systolic blood pressure (SBP) at baseline (0), midway (5) 
and end of study (9) in the beetroot and control groups; n = 36 (17 beetroot, 19 
control). Statistical analysis using mixed model repeated measures ANOVA with 
time as the within-subjects factor and intervention group as the between-subjects 
factor. * denotes significant difference to midway across interventions. 
 
 * 
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Similarly, there was a significant effect of time (P=0.04) but no effect of intervention 
(P=0.99) on DBP and no interaction between time and intervention (P=0.85). 
Pairwise comparisons and post hoc analyses however do not identify any significant 
changes in DBP over time. 
4.3.5 Gut microbiotal changes 
Results from 16srRNA gene analysis of the 17 stool samples are described below, 
including bacterial abundance, alpha diversity and beta diversity. Alpha diversity 
describes the species richness, measured by both a count of the number of 
distinguishable OTUs in each sample (Goodrich et al., 2014), and by species 
diversity, which measures evenness of distribution. Species diversity is measured by 
the Shannon Index, which examines how evenly bacterial species are distributed in a 
sample and if some species are more dominant than others. Beta diversity is a 
measure of microbial composition in one environment compared to another i.e. over 
time or between interventions. A Bray-Curtis dissimilarity profile, which was used in 
the present study, assesses abundance profiles from different samples and the 
overlap between them (Morgan & Huttenhower, 2012).  
Bacterial abundance 
Firmicutes and Bacteroidetes were the most dominant phyla in all samples, which is 
commonly reported in human studies (Duncan et al., 2008; Karlsson et al., 2013). 
Firmicutes was the most dominant phylum across intervention groups with 
51.4±15.5% relative abundance at baseline and 49.8±10.2% at end of study. 
Bacteroidetes was also abundant across both groups showing 38.6±16.7% and 
39.3±12.0% relative abundance at baseline and end of study, respectively. For the 
beetroot group, baseline abundance of Firmicutes was 52.7±17.2%, increasing to 
54.1±8.0% at end of study. In the control group, abundance of Firmicutes was 
50.2±14.8% and 46.2±10.8% at baseline and end of study, respectively. A full list of 
the bacterial species analysed at phylum level for the beetroot and the control group 
is shown in Figure 4.6. 
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Figure 4.6: Stacked bar plots showing the relative abundance distribution of taxa at phylum level in the beetroot group (A) and 
control group (B) at baseline (T1), midway (T2) and end of study (T3); n = 17 (8 beetroot, 9 control). Each bar represents one 
sample. 
A 
B 
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At genus level, the most abundant bacteria across both groups was Bacteroides, 
which is commonly reported as the predominant genus within the lower intestinal 
tract in humans (Gibson, 1999). Bacteroides had 16.4±9.0% relative abundance at 
baseline in the beetroot group, dropping to 14.2±7.0% at end of study. In the control 
group, Bacteroides abundance was 19.4±13.0% at baseline and 19.4±14.7% at end 
of study. Alistipes abundance was similar across groups at baseline with 5.1±3.7% 
and 5.3±2.6% in the beetroot and control groups, respectively. Relative abundance of 
Alistipes rose to 9.5±4.3% at end of study in the beetroot group and remained similar 
at 4.8±2.7% in the control group. The most abundant bacteria at genus level in each 
intervention group are illustrated in Figure 4.7. 
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Figure 4.7: Stacked bar plots showing the distribution of taxa at genus level in the beetroot group (A) and control group (B) at 
baseline (T1), midway (T2) and end of study (T3); n = 17 (8 beetroot, 9 control). 
A 
B 
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Figures 4.8 and 4.9 below illustrate changes in bacteria at phylum and genus level 
over time in both intervention groups. Abundance of Verrucomicrobia and 
Tenericutes appears to rise in the beetroot group but not the control group, although 
these were not found to be significant (P>0.05). Figure 4.9 illustrates a rise in 
Alistipes and Akkermansia in the beetroot group but not the control group, but again 
these were not found to be significant changes (P>0.05). Alistipes abundance was 
found to rise by 88% in the beetroot group and fall by 8% in the control group 
between baseline and end of study. An increased abundance of Alistipes is indicative 
of the consumption of more plant-based foods. Akkermansia is a mucin-degrading 
bacterium that has been found to increase following the consumption of cranberry 
extract in mice, potentially due to the high content of polyphenols present (Anhê et 
al., 2016). It has also been shown to be important for maintaining gut integrity 
through increased mucus thickness (Cani, 2018).  
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Figure 4.8: Boxplots showing relative abundance of bacteria at phylum level in the beetroot group (A) and the control group 
(B) at baseline (T1), midway (T2) and end of study (T3). Data presented as mean plus upper and lower quartile range. 
Statistical analysis using Kruskal-Wallis.   
A 
 B 
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Figure 4.9: Boxplot showing relative abundance of bacteria at genus level in the beetroot group (A) and the 
control group (B) at baseline (T1), midway (T2) and end of study (T3). Data presented as mean plus upper 
and lower quartile range. Statistical analysis using Kruskal-Wallis.  
A 
B 
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Alpha diversity 
Results from analysis of alpha diversity by OTU count and the Shannon Index is 
shown in Figure 4.10. There was no difference in observed OTU count over time in 
either intervention group (P>0.05). The Shannon Index was seen to rise over time in 
the beetroot group but not the control group, which signifies an increase in bacterial 
diversity following beetroot consumption over eight weeks. This was not found to be 
significant (P>0.05) but this is likely due to the small sample size in the present study.  
 
 
Figure 4.10: Alpha diversity regression analysis of the microbiome for observed 
operational taxonomic units (OTUs) and Shannon Index at baseline (time point 1), 
midway (time point 2) and end of study (time point 3). Group 1 = beetroot, group 2 
= control. n=17 (8 beetroot, 9 control). The grey shading represents the 95% 
confidence interval of the mean. Statistical analysis conducted using Kruskal-
Wallis one-way ANOVA.  
 
Beta diversity 
Principal component analysis across all time points shows a significant difference 
between the beetroot group and the control group (P=0.03). This is shown in Figure 
4.11. 
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Figure 4.11: Principal component (PC) analysis using Bray Curtis dissimilarity 
across all time points (baseline, midway and end of study) in group 1 (beetroot) 
and group 2 (control).  
 
Within the beetroot group, there were no significant changes in beta diversity over 
the eight-week period (P=0.99), however there is a shift at T2 and T3 when 
compared to T1 (baseline), indicating an alteration in bacterial composition. The PC 
analysis can be seen in Figure 4.12. Similarly, in the control group, there were also 
no changes in beta diversity over time (P=1.0) (Figure 4.12). 
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Figure 4.12: Bray Curtis beta diversity at baseline (T1), midway (T2) and end of 
study (T3) in the beetroot group (A); n = 8 and the control group (B); n = 9. 
 
SCFA concentrations 
The concentrations of the SCFAs acetate, propionate, isobutyrate, butyrate, 
isovalerate and valerate were assessed over time and across interventions in eight 
participants from the intervention group and nine from the control group. There were 
no significant differences between groups at baseline for total or individual 
concentrations of SCFA (P>0.05). Total SCFA concentration in the beetroot group 
rose from 22.7±0.4mM to 27.7±0.6mM after the eight-week intervention, which is a 
22% increase from baseline to end of study. In the control group, SCFA 
A 
B 
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concentration rose from 27.9±1.1mM to 31.32±1.6mM over the eight weeks, which is 
an increase of 12% from baseline.  
 
There was a significant effect of time (P=0.01) on total SCFA concentration but no 
effect of intervention (P=0.16) (Figure 4.13). There was no interaction between time 
and intervention (P=0.58). Pairwise comparisons show that total SCFA concentration 
was higher at the end of study than at baseline (+5.1mM; P=0.009; 95%CI: 1.2, 8.9).  
 
Figure 4.13: Mean (+SEM) total SCFA concentration at baseline, midway and end 
of study; n=17. Statistical analysis using mixed model repeated measures ANOVA 
with time as within-subjects factor and intervention as between-subjects factor. * 
denotes significant difference between time points across both groups.  
 
Figure 4.14 illustrates the changes in individual SCFAs over time in both intervention 
groups. There is a significant effect of time (P=0.03) on acetate concentrations but no 
effect of intervention (P=0.18). There was no interaction between time and 
intervention (P=0.36). Pairwise comparisons show that acetate concentrations were 
higher at end of study compared to baseline across both groups (+2.8mM; P=0.01; 
95%CI: 0.6, 5.0).  
 
* 
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There was a significant effect of time (P=0.01) but no effect of intervention (P=0.13) 
on propionate concentration. There was no interaction between time and intervention 
(P=0.51). Pairwise comparisons show that the concentration of propionate was 
higher at the end of study than at midway (+1.0mM; P=0.03; 95%CI: 0.1, 1.9) and at 
baseline (+0.9mM; P=0.04; 95%CI: 0.03, 1.9) for both groups combined. 
 
There was a trend towards an effect of time (P=0.08) but no effect of intervention 
(P=0.34) on concentrations of isobutyrate. There was no interaction between time 
and intervention (P=0.49).  
 
There was a significant effect of time (P<0.001) but no effect of intervention (P=0.16) 
on concentrations of butyrate. There was no interaction between time and 
intervention (P=0.58). Pairwise comparisons show that concentrations are 
significantly higher at end of study compared to baseline (+1.6mM; P<0.001; 95%CI: 
0.8, 2.4) across both groups combined. Butyrate concentrations increased by 99% in 
the beetroot group and 41% in the control group over the eight-week period. 
 
There was no effect of time (P=0.11) or intervention (P=0.49) on concentrations of 
isovalerate. There was no interaction between time and intervention (P=0.43). There 
was also no effect of time (P=0.51) or intervention (P=0.24) on valerate 
concentrations, or an interaction between time and intervention (P=0.71).  
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Figure 4.14: Mean (±SEM) concentration of SCFAs at baseline, midway 
and end of study in the beetroot group (A) and control group (B); n = 
17.  
 
A 
B 
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4.4 Discussion 
4.4.1 Summary of key findings 
This is the first study to investigate the effects of prolonged dietary nitrate intake from 
whole beetroot on healthy older adults. The key findings are that eight weeks of 
dietary supplementation with beetroot: 1) significantly alters plasma nitrate levels; 2) 
significantly increased urinary nitrate; 3) had no negative GI tract symptoms; 4) was 
able to modulate the composition of the gut microbiome and 5) significantly increased 
SCFA concentrations. These data combined indicate that prolonged increased 
beetroot intake was well tolerated and may offer health benefits to those at increased 
risk of co-morbidities such as older adults. 
4.4.2 Prolonged beetroot supplementation and functional capacity 
Studies to date utilising beetroot supplementation have primarily focussed on acute 
interventions (≤ one week) in young adults. Bailey et al. (2010) and Lansley et al. 
(2011) have reported improvements in peak muscle contractile efficiency in knee-
extensor exercise and time-to-exhaustion in high-intensity running following beetroot 
juice consumption in males under the age of 30. These authors attributed these 
improvements to an increase in NO availability and a reduction in energy and oxygen 
cost of muscle force production, but these may only be present at peak exercise. 
Although these studies do offer an insight into the benefits of beetroot 
supplementation, maximal functional capacity measures are generally not used in 
older populations. Instead, studies in older adults tend to focus on functional capacity 
measures such as walking distance, grip strength, balance and standing, which 
become more important to daily living in an ageing population.  
 
In the present study there were no improvements in functional tests including grip 
strength and TUG, which were less challenging than the muscle contraction and 
exercise tests mentioned previously. Similarly, Kelly et al. (2013) and Shepherd et al. 
(2015) reported no significant differences in the six-minute walk test (6MWT) 
following two and 2.5 days of beetroot juice consumption in adults over the age of 60 
years. Siervo et al. (2016) supplemented adults between 60 and 75 years with 
beetroot juice for seven days and utilised a more comprehensive battery of functional 
tests similar to the present study including handgrip strength, TUG, sit-to-stand and 
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10m walking speed in an attempt to detect improvements in functional capacity. 
However, despite additional functional measures, Siervo et al. (2016) did not report 
any significant improvements. The present study addresses the short duration 
intervention periods previously used but the lack of improvement in functional 
capacity suggests that the duration of beetroot supplementation is not the only factor 
to consider. It is more likely that the measures of functional capacity used here and in 
previous studies (Kelly et al., 2013; Shepherd et al., 2015; Siervo et al., 2016) lack 
the sensitivity to detect small improvements or are not sufficient to stress the 
participant sufficiently to display physiological improvements. This may be further 
attenuated by the physically active cohorts used in the present study and in those by 
Kelly et al. (2013). However, longer-term intervention with sodium nitrite has been 
found to have positive effects on functional capacity measures, so it may be the case 
that seven days, which is the longest intervention period described in the literature, is 
not long enough to stimulate physiological benefits.  
 
Other studies in this area employing a longer-term design were those by Justice et al. 
in 2015. Eight weeks of supplementation with sodium nitrite-enriched water improved 
forelimb grip strength and distance run in old mice, as well as reduced low-grade 
inflammation in muscle (Justice et al., 2015). In human participants, 10 weeks of 
sodium nitrite supplementation in the form of daily capsules increased plasma nitrite 
levels, reduced balance errors in a step test and improved muscle strength measured 
by knee flexor and extensor rate of torque development, but did not affect TUG 
(Justice et al., 2015). This was the first study to examine the longer-term effects of 
supplementation with nitrite and shows promise as a beneficial intervention on 
functional capacity in older adults. The improvements demonstrated may be due to 
the intake of nitrite, bypassing the requirement for the breakdown of nitrate in the 
body. As discussed in Chapter 1, this can be a limiting factor in the benefits of dietary 
nitrate to an older population, as changes to the oral microbiome or acidity of the 
stomach may reduce the conversion of nitrate to nitrite and further to NO. 
Furthermore, the reduction in low-grade inflammation in old mice shown by Justice et 
al. (2015) suggests that a more prolonged intake of nitrate or nitrite may be required 
to elicit improvements in functional capacity through the reduction of inflammation in 
the muscles. It is not clear whether nitrite intake has the same effect in humans as it 
does mice, and a review by Calder et al. (2011) suggests that the intake of a single 
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vegetable or fruit is not enough to elicit a reduction in the low-grade inflammation 
associated with ageing in humans. Instead, a high overall intake of vegetables and 
fruit has a beneficial effect on an inflammatory state. Beetroot alone, therefore, 
regardless of the duration of intervention, may not have a positive effect on 
inflammation status in older adults. A high intake of a combination of nitrate-rich 
vegetables, that contain both dietary nitrate and antioxidant compounds, may be 
more beneficial in this context.  
4.4.3 The effects of beetroot intake on blood pressure 
Dietary nitrate acutely lowers blood pressure due to the increased production of the 
vasodilator NO and consequent widening of the blood vessels (Webb et al., 2008). 
However, little is known about the effects of prolonged dietary nitrate intake on blood 
pressure. The half-life of nitrate of around six hours suggests that the blood pressure-
lowering effects will be acute and repeated intake is required to maintain the benefits. 
What is unclear is whether there are additive effects of prolonged dietary nitrate 
intake that may lead to a larger reduction in blood pressure over time. Conversely, it 
may be the case that familiarisation to a dietary nitrate load may reduce the blood 
pressure-lowering effects over time through desensitisation. The present study 
demonstrated a SBP reduction from 136mmHg to 128mmHg between baseline and 
end of study at week nine following repeated beetroot consumption. This reduction is 
consistent with a study by Rammos et al. (2014), who reported an 8mmHg reduction 
in SBP one day after the last intake of sodium nitrate, which was supplemented daily 
for four weeks. Similar to the study by Rammos et al. (2014), blood pressure was 
measured more than 12 hours after the nitrate dose in the present study, suggesting 
a chronic blood pressure-lowering effect of the prolonged beetroot consumption. 
Kapil et al. (2015) demonstrated a reduction in clinic blood pressure by 7.7mmHg 
following four weeks of supplementation with beetroot juice. Together these data 
suggest that the body is not becoming desensitised to the effects of dietary nitrate 
over a prolonged time period. In contrast, Jajja et al. (2014) demonstrated that a 
reduction in daily SBP found following 21 days of supplementation with beetroot was 
not maintained when the intervention was interrupted for seven days. If beetroot is 
able to offer physiological benefits such as reductions in blood pressure, patients at 
risk of CVD may be advised to increase beetroot intake on a regular basis.   
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Interestingly, there was no reduction in SBP at the midway point, which suggests that 
a longer intervention period is more beneficial when considering additive effects. 
However, a trend towards a reduction in SBP was also seen in the control group over 
the eight-week period. Although there was not a statistically significant difference 
between baseline SBP in the beetroot and the control group, the control group had a 
higher baseline SBP of 140mmHg, which is classed as hypertensive. It is 
conceivable that simply taking part in health-related research influenced lifestyle 
choices of participants over the study period, positively affecting their blood pressure. 
There were no changes in physical activity levels over the eight-week period but 
restrictions to caffeine and alcohol intake before study visits may have influenced the 
participants and were not picked up by the 24-hour dietary recall.  
 
Reductions in blood pressure were not accompanied by increases in plasma nitrate 
levels at the time of testing, which represent the plasma levels of the more bioactive 
nitrite. Results from Chapter 3 suggest that higher levels of plasma nitrite are 
correlated with reductions in blood pressure. The plasma nitrate levels in the present 
study were not at a concentration that would stimulate an increase in plasma nitrite 
and subsequent NO production but the time of testing, which occurred at least 12 
hours after the consumption of beetroot, may have missed the peak in plasma nitrate 
and nitrite levels. Chapter 2 demonstrates that plasma nitrite levels reach a peak 
after around three hours following the consumption of whole beetroot and levels rose 
following 100g and 200g beetroot by around 121% and 141%, respectively, in older 
adults. The dose of nitrate provided in the present study was larger than that 
provided in Chapter 2, so it is likely that plasma nitrite levels rose acutely to a greater 
extent. However, beetroot is also rich in other active compounds such as ascorbic 
acid and phenolic compounds, which have been shown to enhance NO synthase 
activity (Bondonno et al., 2015). The blood pressure-lowering effect may therefore be 
due to an increase in NO production and subsequent vasodilatory action through the 
L-arginine pathway. Phenolic compounds such as anthocyanins, which closely 
resemble the betalains found in beetroot, are also considered to have prebiotic 
effects, as their consumption affects the composition of gut bacterial species (Faria et 
al., 2014). The prolonged consumption of the phenolic compounds found in beetroot 
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may therefore have beneficial effects on bacterial species and the health and 
functioning of the gut. 
4.4.4 The effects of beetroot supplementation on gut health 
Bacterial colonisation of the human body is highly host-specific and recent 
developments have enhanced understanding of the relationship between host and 
microbiome and how the gut microbiome contributes towards metabolism, immune 
response, intestinal architecture and GI health (Fava et al., 2018). Imbalance 
between the host and the gut microbiome could potentially contribute to a higher risk 
of co-morbidities and poor health, as previously identified with increased inter-
individual variability and reduced diversity with age (Claesson et al., 2012). 
Therefore, treatments aimed at modulating the gut microbiome by increasing 
diversity and re-balancing the symbiotic relationship between the host and gut 
microbiota could offer a beneficial therapeutic approach to healthy ageing. 
 
One such potential therapy would be to modulate the gut microbiome through dietary 
supplementation, as the diet has been shown to play a significant role in shaping the 
composition of gut bacterial species (David et al., 2014). In the present study, 
beetroot consumption resulted in an increase in abundance of Alistipes and 
Akkermansia over time, which are associated with increased plant-based foods 
(Jiang et al., 2015) and improved gut integrity (Everard et al., 2013). Although these 
changes were not significant, both of these bacteria are associated with a healthy gut 
and improved metabolic control (Zhou, 2017). In addition to individual alterations in 
specific changes at the genus level, diversity also has a crucial role in gut health 
(Claesson et al., 2012). Species richness is associated with colonic transit time, 
which is assessed non-invasively using the Bristol Stool Chart (BSC) (Vandeputte et 
al., 2016). The Western diet has led to more than 50% of stools passed belonging to 
categories 3 and 4 of the BSC, which lie in the medium to firmer end of the chart. 
Species richness has been found to significantly decline with increasing stool 
firmness (Vandeputte et al., 2016). Samples in the present study were found to lie 
between three and four on the BSC, suggesting no effect of beetroot consumption on 
transit time. However, there was a significant difference in the Bray Curtis similarity 
when comparing the beetroot to the control group across time, demonstrating a shift 
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in bacterial composition. Furthermore, there was a slight increase in the number of 
OTUs and Shannon diversity index over time in the beetroot group, which was not 
observed in the control group. The lack of significance reported in these measures is 
likely to be due to the small sample size, especially given the variability commonly 
reported in microbiome studies. These data suggest that beetroot supplementation 
may offer a therapeutic approach to the ageing population.  
 
Modulation of the gut microbiome will inevitably affect the metabolites produced. One 
of the main metabolites that has received considerable attention are the SCFAs, the 
most abundant and commonly reported of which are acetate, propionate and butyrate 
in a ratio of around 3:2:2 (Fava et al., 2018). The present study demonstrated a 
significant increase in total SCFA, which was driven by increases in propionate, 
acetate and butyrate over the eight-week period. SCFAs have been shown to 
contribute to gut health through mechanisms such as maintaining integrity of the gut 
wall and regulating the inflammatory output of adipose tissue (Fava et al., 2018; 
Natarajan & Pluznick, 2014). An increase in SCFA production, therefore, is a marker 
of gut health. The SCFA butyrate is thought to be one of the most important due to its 
ability to initiate apoptosis in colon cancer cells (Heerdt et al., 1997). An increase in 
dietary fibre is known to stimulate the growth and/or activity of beneficial bacterial 
species such as Faecalbacterium prausnitzil, a known butyrate-producing species. 
Butyrate-producing bacteria are found within the Firmicutes and also include 
Eubacterium rectale and Roseburia (Scott et al., 2008). In the present study the 
genus Faecalbacterium increased from baseline to end of study in the beetroot 
group. Although this was not a significant increase, which may be in part due to the 
small sample size here, these data suggest that the increases in SCFAs following 
beetroot consumption may be due to an increase in SCFA-producing bacteria.  
 
Some dietary fibres, such as resistant starches (Schwiertz et al., 2002)  stimulate the 
growth and/or activity of beneficial bacterial species such as Roseburia and are 
termed “prebiotic” (Fava et al., 2018). The increase in butyrate production observed 
following the eight-week intervention in both groups might be due to the resistant 
starch present in the banana control food, as there was no greater affect following 
beetroot consumption in addition to the banana. The increase in total SCFAs 
following beetroot consumption, however, suggests that the dietary fibre, or other 
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compounds, present in whole beetroot, have a beneficial effect more generally on the 
gut. There is limited data available on the effects of the inclusion of foods on SCFA 
production and results are inconclusive. For example, the consumption of pinto 
beans, which are a source of resistant starch, was found to have no effect on the 
production of SCFAs in the colon of ten middle-aged men and women (Finley et al., 
2007). An in vitro study showed that gourds, which are a rich source of soluble and 
insoluble fibre, increased SCFA production in the colon and have significant prebiotic 
effects (Sergis et al., 2013). The large variation in bacterial composition between 
individuals may be a significant limitation to human intervention studies on SCFA 
production and prebiotic abilities of vegetables. It is however, an important area of 
research given the low total dietary fibre intake in the UK population and the impact 
on diseases of the gastrointestinal tract.  
 
4.4.2 Strengths and weaknesses 
The present study is not without limitation. This feasibility study was the first to 
investigate the effects of more prolonged dietary nitrate intake from a fresh vegetable 
source on markers of functional capacity and gut health in an older population. The 
positive effects of beetroot consumption reported here provide a foundation for 
further research in this area and demonstrates that the addition of whole beetroot to 
the diet is feasible with excellent compliance rates.  
 
The free-living design i.e. a two-hour fast prior to testing and no other dietary 
restrictions makes the study applicable to a real-world setting with an unregulated 
diet. However, the timing of blood collection and the consumption of beetroot every 
second day makes it difficult to accurately assess plasma nitrate and the peaks 
following consumption. Although this data does provide information relating to a 
prolonged effect of beetroot, a future study may combine the methods here with 
those used to ascertain the acute effects of dietary nitrate in conjunction.  
 
The parallel design of this study enabled a smaller sample size but giving participants 
the option of providing a stool sample resulted in a very small sample size for the 
analysis of gut microbiota. However, including stool sample collection as a 
mandatory aspect of the study may have reduced compliance in participants, leading 
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to dropout or lower rates of recruitment. There were no dropouts in this study, which 
demonstrates that, at least over the eight-week period, the amounts of beetroot 
consumed were not a significant burden to the participants. Furthermore, the 
vacuum-packed cooked beetroot provided came from the same batch, ensuring 
consistency in nitrate levels across the eight-week intervention. This product is also 
available to the public and represents a widely-used form of beetroot, which 
increases the applicability of this study.  
 
Participants were not matched for age at baseline due to the randomisation effect, 
which would potentially have been controlled for in a larger sample size. There was 
no placebo control in this study but the impacts of this were reduced by the inclusion 
of the control food in both the intervention arms. Any additional effects of beetroot 
consumption on top of the control food could then be identified.  
4.4.3 Conclusions 
The repeated consumption of whole beetroot for eight weeks did not have a positive 
impact on functional capacity in older adults, potentially due to a lack of stimulus to 
initiate a response in plasma nitrate levels at time of testing. There was, however, a 
reduction in blood pressure despite low plasma nitrate levels, which suggests an 
additive effect of nitrite on the vascular system. Beetroot consumption led to 
improvements in gut bacterial diversity and the production of SCFAs in the colon but 
the sample size was too small to identify significant changes in a number of markers 
of gut health. These data suggest that the addition of whole beetroot to the diet, over 
periods more than eight weeks, may improve overall gut health in an older population 
and promote a blood pressure-lowering effect. More research is warranted into the 
effects of beetroot on markers of inflammation, oxidative stress and gut health, and 
the effects of these on functional capacity measures that contribute to activities of 
daily living in the ageing population.  
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Chapter 5. Cognitive function in older adults following an eight-
week intervention with whole beetroot 
5.1 Introduction 
The UK’s population is ageing and it is estimated that there will be an additional 8.6 
million people over the age of 65 in 50 years time (Storey, 2018). An ageing 
population puts more strain on the National Health Service due to age-related 
diseases such as CVD and dementia. Deary et al. (2009) describe that, in the UK, 
40% of admissions to care institutions are due to cognitive failure. Cognitive decline 
has been linked to a reduced blood flow to the brain and this can contribute to the 
development of dementia (Rabbitt et al., 2006). Normal cognitive ageing results in 
abnormal blood vessels, which can lead to chronic ischaemia in the brain. This 
ischaemic state can cause degeneration in the white matter of the brain, which is 
linked to executive functioning, for example working memory and task switching. 
Although dementia is not preventable, delaying brain ischaemia or modulating the 
low-grade inflammation that is associated with brain ageing is a viable target of 
nutritional intervention. Furthermore, a reduction in nitric oxide (NO) availability is 
once again implicated in vascular ageing in the brain, as disrupted neurovascular 
coupling occurs when blood flow is not matched to the demand in a specific brain 
region (Girouard & Iadecola, 2006).  
 
NO is a potent vasodilator with wide diffusibility in the human body. It has a half-life of 
less than one second but the intake of dietary nitrate and the subsequent reduction to 
nitrite enables a more stable reservoir for the production of NO. NO is synthesised 
continually by endothelial NO synthase (eNOS), which converts the precursor L-
arginine to citrilline and then to NO (Palmer et al., 1988). NO then diffuses into the 
smooth muscle and stimulates the production of cyclic guanosine monophosphate 
(cGMP), leading to relaxation of the vessel wall (Lyons et al., 1997). To date, much of 
the research around nitrate and vascular function focuses on vessels of the 
cardiovascular system and shows positive effects on blood flow, especially in a 
young, healthy population. Although effects on blood flow in older adults is equivocal, 
there appears to be a greater and more consistent benefit following a more 
prolonged intervention period with dietary nitrate i.e. over weeks rather than days or 
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hours. It is also emerging that dietary nitrate, in part through the vasodilatory effects 
of NO, can have a positive impact on cerebrovascular blood flow and consequently 
on cognitive function. Indeed, beetroot juice consumption has been found to acutely 
improve cerebral blood flow (CBF) in older adults (Presley et al., 2011) and increase 
prefrontal cortex blood flow and improve cognitive function in young participants 
(Wightman et al., 2015). Although these studies highlight the potential for cognitive 
function improvements following beetroot consumption, there is a significant gap in 
the research on more prolonged intervention with dietary nitrate, particularly with an 
older population who may already be showing signs of cognitive ageing. 
 
Consequently, the present study explores the effects of prolonged beetroot 
consumption on cognitive function in older adults. This study investigated baseline, 
mid way and end of study cognitive test scores to assess the effects of repeated 
consumption of whole beetroot on domain specific cognitive functioning. The effects 
of an eight-week supplementation with whole beetroot have not been investigated 
before, so this pilot study aimed to assess not only the cognitive effects but also the 
compliance of the participants to a longer-term intervention with a whole vegetable. It 
was hypothesised that supplementing the diet with repeat beetroot consumption 
would have a positive impact on cognitive function in an older age group. This 
hypothesis was tested using an online cognitive-testing platform performed at 
baseline, after four weeks and after eight weeks of the consumption of 150g whole 
beetroot every second day compared to a control food. 
5.2 Methods 
The participants, exclusion criteria, interventions, and study design and protocol were 
the same as those used in Chapter 4. This study was approved by the Newcastle 
University ethical committee (Appendix G). Participants consumed 150g whole 
cooked beetroot every second day and/or a medium-sized banana for eight weeks. 
Participants were cognitively healthy with no diagnosis of clinical cognitive decline. 
They were also not taking psychoactive medication and fasted for at least two hours 
prior to attending the research facility; caffeine intake was also restricted.  
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5.2.1 Cognitive function 
Participants were briefed on the cognitive tasks and given two full practice runs to 
reduce learning effects during the study. An online cognitive battery was provided by 
CogTrack™ and consisted of nine cognitive tasks: immediate word recall, pattern 
separation, simple reaction time, digit vigilance, choice reaction time, spatial working 
memory, numeric working memory, delayed word recall, and word recognition. The 
tasks took a total of approximately 20 minutes to complete. Scores from each test 
were combined to produce the following cognitive indices: Attentional Intensity Index, 
Sustained Attention Index, Working Memory Capacity Index, Cognitive Reaction 
Time, Attentional Fluctuation Index, and Memory Retrieval Speed Index. Each of 
these six factors combines the same task measures as used in the Cognitive Drug 
Research (CDR) system to form the factor scores named power of attention, 
continuity of attention, quality of memory and speed of memory. Participants 
performed the CogTrack™ system on two consecutive occasions at the screening 
visit to ensure that any effects of practice, familiarity or test anxiety were overcome 
prior to the first testing day. This method is known as pre-baseline massed practice 
and has been described by Goldberg et al. (2015) and Bell et al. (2018) as a solution 
to the issue of practice effects in cognitive testing. Participants then completed the 
nine tasks at baseline, midway and end of study testing visits, in a fasted state and in 
an individual booth in the research facility. They also completed the tasks on two 
occasions at home, during weeks three and seven, if they had access to a computer.  
5.2.2 Cognitive indices 
The cognitive indices described above were derived from variables such as number 
of false alarms, average speed and accuracy. Examples of these are shown in Figure 
5.1.  
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Figure 5.1: Example of the variables used to calculate indices of cognitive 
function. Column 1 represents the acronym used, column 2 represents the name 
and source of the variable and column 3 represents the units used for 
measurement.  
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The indices were then calculated using the equations in Figure 5.2 below. 
 
 
Figure 5.2: Indices of cognitive function, calculated using the variables shown in 
Figure 5.1.   
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5.2.3 Statistical analysis 
Statistical analyses were completed using IBM SPSS (version 24.0). Summary data 
are presented as means ± SD with 95% confidence intervals (CI). Two-tailed 
independent t-tests were used to assess differences in baseline measures between 
the two intervention groups. Changes over time were analysed using a mixed model 
repeated measures ANOVA with time as the within-subjects factor and intervention 
as the between-subjects factor. Models were tested for sphericity using Mauchly’s 
test and multivariate models were applied if these assumptions were violated. Where 
significances were found, post hoc tests with Bonferroni adjustment to control for 
multiple comparisons were run. Statistical significance was set at P<0.05.  
5.3 Results 
5.3.1 Baseline characteristics 
A total of 36 participants were randomised to the interventions and completed the 
trial, with an average age of 67.4±5.6 years (Table 4.3). 19 participants were 
randomised to the intervention group and 17 to the control group. Participants in both 
groups were matched for height, weight, BMI, waist circumference and body fat 
(P>0.05) but the control group’s average age was 70 years compared to the 
intervention group’s average of 65 years, which were statistically different (P=0.009). 
Interim cognitive test scores were not included in analysis due to the inability to 
control for the effects of dietary intake before testing at these time points. There were 
no significant differences between the cognitive scores in the beetroot and the control 
group at baseline (all P>0.05). Number of years in education were similar across 
groups with a mean of 16.4±3.3 (P=0.12). 
5.3.2 Dropout and body composition 
The interventions were well tolerated and no adverse events were reported. One 
participant was withdrawn before the midway point due to starting a course of 
medication. Weight, BMI, waist circumference and body fat did not change over the 
course of the intervention period (P>0.05). 
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Table 5.1: Mean cognitive indices over the eight-week intervention period 
following beetroot consumption and control; n=36.  
 Beetroot Control 
 Baseline Mid way End Baseline Mid way End 
AI (ms) 1372.7 1370.7 1391.4 1375.9 1366.3 1368.6 
SA (%) 95.7 94.9 95.6 93.4 95.0 95.6 
WMC (%) 93.2 91.9 91.4 86.2 93.5* 90.8 
CRT (ms) 186.1 175.0 152.1*a 171.4 188.4 186.8a 
AF 62.3 55.2 50.8* 56.8 58.5 56.4 
MRS (ms) 4202.1 3908.8 3872.6* 4157.9 3922.1 3856.2 
 
AI= attentional intensity, SA= sustained attention, WMC= working memory 
capacity, CRT= cognitive reaction time, AF= attentional fluctuation, MRS= 
memory retrieval speed. * denotes significant difference to baseline. a denotes 
significant difference between beetroot and control groups at end of study. 
 
Attentional Intensity Index (AI) 
There was no effect of time (P=0.63) or intervention (P=0.86) on AI, or an interaction 
between time and intervention (P=0.53).  
Sustained Attention Index (SA) 
There was no effect of time (P=0.31) or intervention (P=0.45) on SA. There was no 
interaction between time and intervention (P=0.14).  
Working Memory Capacity Index (WMC) 
There was no effect of time (P=0.28) or intervention (P=0.53) on WMC following 
beetroot or the control. There was a notable trend towards an interaction between 
time and intervention (P=0.07). Post hoc analyses show indicate that there was no 
difference over time in the beetroot group but WMC was higher at midway than 
baseline in the control group (+7.2%; P=0.01; 95%CI: 1.3, 13.1). 
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Figure 5.3: Mean (±SEM) working memory capacity over the course of eight-week 
supplementation with beetroot or a banana control; n=36. Statistical analysis 
using mixed model repeated measures ANOVA (time as within-subjects factor, 
intervention as between-subjects factor). * denotes significant difference to 
baseline in control group.  
Cognitive Reaction Time Index (CRT) 
There was no effect of time (P=0.41) or intervention (P=0.46) on CRT but there was 
an interaction between time and intervention (P=0.04), as shown in Figure 5.4. 
Analyses show that CRT at the end of study was significantly faster in the beetroot 
group than the control group (-34.7ms; P=0.02; 95%CI: -63.4, -6.1). CRT at the end 
of study was also significantly faster than at baseline (-34ms; P=0.04; 95%CI: -67.1, -
0.9) in the beetroot group but not in the control group (P=0.83). There was no 
difference between CRT at baseline and mid way in either group (P>0.05). 
* 
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Figure 5.4: Mean (±SEM) cognitive reaction time over the course of eight-week 
supplementation with beetroot or a banana control; n=36. Statistical analysis 
using mixed model repeated measures ANOVA (time as within-subjects factor, 
intervention as between-subjects factor). * denotes significant difference to 
baseline. 
 
Attentional Fluctuation Index (AF) 
There was no effect of time (P=0.14) or intervention (P=0.76), or an interaction 
between time and intervention (P=0.14), on AF following eight weeks 
supplementation with beetroot or a control.  
Memory Retrieval Speed Index (MRS) 
There was a significant effect of time (P=0.001) on MRS but no effect of intervention 
(P=0.93) (Figure 5.5). There was no interaction between time and intervention 
(P=0.93). Pairwise comparisons show that MRS was significantly faster than baseline 
at mid way (-265.6ms; P=0.009; 95%CI: -476.0, -55.1) and at end of study (-
316.7ms; P=0.003; 95%CI: -540.9, -92.4) across both groups.  
  * 
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Figure 5.5: Mean (±SEM) memory retrieval speed over the eight-week intervention 
period following beetroot consumption or banana control; n=36. Statistical 
analysis using mixed model repeated measures ANOVA with time as within-
subjects factor and intervention as between-subjects factor. * denotes significant 
difference to baseline across both groups. 
 
5.4 Discussion 
5.4.1 Summary of findings 
This study is the first investigation into the effects of prolonged beetroot ingestion on 
cognitive function. Results show that eight weeks of supplementation with whole 
beetroot had positive effects on cognitive reaction time and memory retrieval speed 
in older adults. Other areas of cognition, such as attention and working memory were 
unaffected by the intervention, which suggests a specific benefit of beetroot on time-
related indices or on certain sub-sets of cognitive tests. The beetroot intervention 
was well tolerated and results on reaction time mirror those demonstrated by other 
authors, showing that whole beetroot is an effective source of dietary nitrate that can 
be introduced in larger amounts to the diet to infer benefits to cognitive performance.  
* 
 * 
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5.4.2 Prolonged beetroot consumption and cognitive function indices 
Whole beetroot provides a source of nitrate, which is sequentially reduced to nitric 
oxide (NO) following ingestion. NO has a role in the regulation of cerebral blood flow 
(CBF), neurotransmission and blood flow-metabolism coupling (Szabo, 1996). The 
ageing process is associated with endothelial dysfunction, which can impair cerebral 
haemodynamics by reducing the availability of NO and increasing ROS production 
(Toda et al., 2009). The ageing brain is therefore subject to diminished levels of NO 
and a consequent reduction in blood flow. These modulations can contribute to a 
decline in cognitive performance evident into older age. This is the first trial showing 
that the inclusion of whole beetroot in the diet may have positive effects on cognition 
in an older population. Improvements were seen specifically in cognitive reaction time 
and memory retrieval speed, although other indices, such as sustained attention and 
working memory capacity, were unaffected by the intervention. This suggests specific 
task-related improvements following beetroot consumption. These results reiterate 
those described by Gilchrist et al. (2014), who were the first to demonstrate a benefit 
of beetroot juice consumption on cognitive performance in older adults with Type 2 
diabetes. These authors found improvements in simple reaction time but no effect on 
memory or rapid visual information processing (RVIP) following a 14-day 
intervention. Patients with Type 2 diabetes have been found to have deficits in 
cognitive function compared to healthy participants (Gilchrist et al., 2014), which may 
heighten their sensitivity to cognitive testing. Indeed, Kelly et al. (2013) found no 
improvement in serial subtractions, RVIP and number recall following 2.5 days of 
supplementation with beetroot juice in older adults. The healthy cohort used by Kelly 
et al. (2013) may have had a reduced sensitivity to the effects of dietary nitrate. The 
positive results shown in the present study on healthy volunteers, however, suggest 
that this cohort was sensitive to the cognitive testing and intervention used and 
therefore other factors may be involved. For example, the more prolonged 
intervention period used in the present study and by Gilchrist et al. (2014) may have 
led to improvements in cognitive function not evident after an acute intervention 
period, such as the 2.5 days used by Kelly et al. (2013). Furthermore, Justice et al. 
(2015) supplemented with sodium nitrite for 10-weeks and demonstrated a 14% and 
18% improvement in the trail making task (TMT) B following 80mg/d and 160mg/d, 
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respectively, in older adults. This again highlights that longer-term supplementation 
may be more beneficial to cognitive performance. 
 
There was no improvement in TMT-A in the study by Justice et al. (2015), which 
further suggests task-specific improvements following nitrate supplementation. The 
more complicated TMT-B is used as an index of executive function. Task switching, 
working memory and executive function are all regulated by the frontal cortex in the 
brain, which has been found to be preferentially influenced by dietary nitrate 
supplementation (Presley et al., 2011). Presley et al. (2011) demonstrated increased 
perfusion in the frontal cortex following high doses of beetroot juice incorporated into 
a nitrate-rich diet over two days in adults aged 75 years on average. Together these 
data suggest that heightened blood perfusion to specific regions of the brain following 
dietary nitrate supplementation may dictate alterations in cognitive performance. 
 
Wightman et al. (2015) demonstrated that dietary nitrate in the form of beetroot juice 
modulated the CBF response to task performance in young volunteers. These 
authors found concomitant improvements in serial 3s subtractions, a task that relies 
on working memory and psychomotor speed, but not in serial 7s subtractions or 
RVIP 90-150 minutes after the ingestion of beetroot juice. Interestingly, the RVIP task 
gave rise to a lower CBF than the serial 3s subtractions task, which may explain the 
difference in performance. Wightman et al. (2015) timed outcome measures to 
coincide with the peak in plasma nitrite that occurs post-ingestion of nitrate, as 
described in Chapter 2, which suggest a peak in NO production and thus vasodilatory 
action. In the present study, cognitive testing took place out with the peak in plasma 
nitrite that would have occurred following the consumption of beetroot and the 
breakdown of dietary nitrate. The effects, therefore, may be underestimated if CBF is 
a key mediator in cognitive enhancements. This is mirrored by the study by Gilchrist 
et al. (2014), in which cognitive testing occurred more than 12 hours post-ingestion of 
dietary nitrate. The improvements in reaction time evident in this and the present 
study may be due to an additive effect of a longer-term supplementation period. 
Investigation into CBF and cognitive performance following prolonged ingestion of 
dietary nitrate is therefore warranted. 
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Beetroot is also rich in a number of potentially active phytochemicals such as 
betalains, which may work synergistically to scavenge ROS in the brain and reduce 
the negative effects of oxidative stress, and enhance the availability of NO as 
described in Chapter 1. A more prolonged intervention with foods containing these 
phytochemicals may afford more time in which to enhance vascular structure and 
function in the brain through an increase in NO. Due to the low bioavailability of 
betalains and the lack of available standards for analysis, it was beyond the scope of 
this thesis to investigate the effects of betalains in this study. However, this remains a 
promising avenue of research for future long-term interventions with beetroot.  
 
A high vegetable intake is proposed to be associated with a slower rate of cognitive 
decline into older age (Kang et al., 2005; Loef & Walach, 2012; Morris et al., 2006). 
Increasing vegetable consumption from 0.9 servings/day to 2.8 servings/day has 
been found to reduce the rate of decline by 40% (Morris et al., 2006). Specifically, 
green leafy vegetables are identified as the most beneficial in maintaining normal 
cognitive functioning (Kang et al., 2005; Loef & Walach, 2012). Although the 
mechanism behind this is unclear and may be due to other lifestyle choices 
associated with an increased intake of vegetables, the preferential benefit of green 
leafy vegetables in the DASH may be involved. As mentioned in Chapter 1, Larsen et 
al. (2006) proposed that nitrate is responsible for the blood pressure-lowering effect 
of the DASH through the vasodilatory properties of NO. The role of NO in the 
regulation of CBF therefore puts this compound, and dietary nitrate from which it can 
be produced, in an important position regarding cognitive decline. An increase in 
nitrate-rich vegetables such as beetroot, therefore, may be particularly beneficial in 
slowing cognitive decline in older adults. 
5.4.3 Strengths and weaknesses 
This study investigated, for the first time, the effects of prolonged intake of dietary 
nitrate through whole beetroot on cognitive function. Using a cohort of adults over the 
age of 60 increases the applicability of the research, as older adults are more at risk 
of cognitive impairment than younger populations. Furthermore, the free-living design 
of the trial with minimal dietary restriction strengthens the external validity of the 
results. 
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Although the CogTrack™ cognition programme provided a comprehensive battery of 
tests for use in healthy adults, tasks more specifically directed at assessing executive 
function, task switching and working memory may have aided the interpretation of 
results in relation to CBF and dietary nitrate. This study did not assess CBF, which 
again would have allowed for further investigation into the effects of dietary nitrate. 
Whilst the results show promise, further investigation into longer-term 
supplementation with beetroot is warranted. 
5.5 Conclusions 
The addition of small amounts of whole beetroot to the habitual diet of older adults 
shows promise in improving aspects of cognitive performance over a prolonged 
period of time. It is likely that there is an additive effect of dietary nitrate following 
repeated consumption of beetroot, which works towards increasing NO in the 
vascular system in a population whose NO levels are diminished. The acceptability of 
whole beetroot as an intervention food over an extended time period allows for future 
research to investigate the beneficial effects of this vegetable more fully. 
 
 
 
  
 180 
Chapter 6. General discussion and conclusions 
6.1 Overview 
With a growing concern over the lack of fruit and vegetables consumed in the UK on 
a daily basis and the negative effects that this can have on the health of the 
population, it is imperative that research continues to investigate the positive effects 
of whole vegetables. Although vegetable juices, gels and powders are a 
concentrated and practical source of nutrients, the applicability of these products 
long-term remains uncertain. Beetroot is one such vegetable that has undergone 
processing into numerous forms, primarily due to attention on its nitrate content, 
which is a bioactive compound that can be broken down into the vasodilator NO. 
Older adults have a lower endogenous production of NO, which puts them at risk of 
vascular dysfunction in both the cardiovascular and cerebrovascular systems. 
Therefore, an older population should benefit most from the potential effects of whole 
beetroot consumption. Consequently, the purpose of this thesis was, firstly to assess 
the availability of nitrate from whole beetroot in older adults and the dose required to 
elicit physiological effects while maintaining compliance, and secondly to investigate 
the effects of more prolonged and repeated consumption of whole beetroot in this 
population, principally on cognitive function and gut health. 
 
The initial investigation into the acute effects of beetroot (Chapters 2 and 3) 
demonstrated the bioavailability of nitrate from the whole vegetable but a lack of 
physiological effects in older adults compared to younger participants. Despite this, 
whole beetroot, in amounts up to 200g, was found to be an acceptable supplement 
for an older population and one that could be applied to a longer-term study. 
Subsequently, whole beetroot was used as a supplement for an eight-week 
intervention in older adults (Chapters 4 and 5) and showed promise as a beneficial 
dietary component for gut health and cognitive function. Collectively, the results 
presented in this thesis suggest a benefit of whole beetroot beyond the widely 
studied effects on blood pressure, particularly when consumed over a prolonged 
period of time. 
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6.2 Acute effects of whole beetroot consumption 
The acute effects of dietary nitrate are due to an increase in NO, which has 
vasodilatory properties in the vascular system (Ignarro, 2002). Whilst the 
pharmacokinetics and bioavailability of dietary nitrate from beetroot juice and in 
young adults are well known, age-related and source differences are still unclear. 
Furthermore, studies on dietary nitrate have involved large variation in doses, making 
direct comparison between age groups difficult. The present study showed that whole 
beetroot was bioavailable in both young and old adults following a direct comparison 
in two age groups. The pharmacokinetic profile of the nitrate was also similar across 
age groups, showing that the timing of physiological responses is comparable. 
Plasma nitrate and nitrite levels were found to rise significantly following the 
consumption of whole beetroot in a dose-dependent manner. It appears, however, 
that a tightly regulated excretory system comes into play to maintain nitrate levels 
within a certain range. Indeed, urinary nitrate retention was found to be lower with 
larger doses of nitrate in both age groups. It may be that beyond a certain threshold 
of dietary intake the body excretes unnecessary nitrate through urine and, although 
not tested in this study, excretion may occur through faeces also. A dose response 
was also evident in NO levels in exhaled breath (FeNO). Both age groups responded 
similarly to whole beetroot with FeNO increasing by up to 77% from baseline. FeNO 
was modestly correlated with plasma nitrate levels, which explains the dose 
response and demonstrates the increase in NO levels from dietary nitrate in whole 
beetroot. 
 
There were a number of age-related differences to the beetroot doses and the 
physiological effects of the dietary nitrate. Firstly, older adults showed lower levels of 
plasma nitrite despite receiving the same doses of beetroot and with comparable 
plasma nitrate levels to the young group. This suggests inefficiency in the breakdown 
of plasma nitrate to nitrite. This breakdown occurs in the oral cavity by commensal 
nitrate-reducing bacteria and some aspects of ageing such as changes to the 
microbiome may hinder this pathway (Miller et al., 2012). These lower levels of 
plasma nitrite may be responsible for the lack of physiological effects following 
beetroot consumption in the older group. Acute ingestion of beetroot did not lower 
blood pressure in the old but had a significant hypotensive effect on the young. Even 
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the smallest dose of beetroot, 100g, reduced both SBP and DBP in the young group 
in a matter of hours. This disparity, despite the age groups receiving equal doses 
again suggests age-related differences in the processing of dietary nitrate. It is 
pertinent that these mechanistic discrepancies are elucidated, in order for older 
adults to be able to yield the potent beneficial effects of dietary nitrate from natural 
sources such as whole beetroot. One promising aspect of the dose response is that 
larger amounts of nitrate, albeit from a potassium nitrate solution, stimulated a 
decrease in blood pressure in the old group and larger doses appeared to reduce the 
disparity in blood pressure response between the age groups. It may be the case, 
therefore, that larger doses of dietary nitrate are required by older populations in 
order to receive the same benefits of those experienced by younger age group. 
Advantageously, qualitative results from this study show that older adults are more 
tolerant of larger doses of beetroot than younger adults, which may allow for more 
age-specific supplementation of beetroot in longer-term trials. 
6.3 Longer-term effects of whole beetroot consumption 
A limited number of studies have investigated the effects of prolonged ingestion of 
nitrate, leaving a significant gap in the research. Chapters 4 and 5 describe the 
effects of eight-weeks of supplementation with beetroot on functional capacity, blood 
pressure, gut health and cognitive function, the latter of which have not previously 
been investigated in a longer-term setting.  
 
There are equivocal results on dietary nitrate and functional capacity in a longer-term 
setting. Siervo et al. (2016) found no effects of a seven-day intervention with beetroot 
juice on multiple measures of functional capacity, while Justice et al. (2015) found 
modest improvements in grip strength and balance over 10 weeks but not in TUG. It 
was hypothesised that longer-term supplementation with beetroot would improve 
measures of functional capacity in the present study but there was no effect on grip 
strength, TUG or lung function. It is speculated that, despite a potential chronic 
increase in circulating nitrate, the time of testing fell out with the peak in plasma 
nitrite and therefore NO and consequently had no effect on functional capacity in a 
healthy cohort. 
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A chronic increase in circulating nitrate or nitrite would be of great benefit to the 
vascular system in older adults, who have lower levels of endogenously produced 
NO due to deficits in the precursor L-arginine and the NO synthase cofactor 
tetrahydrobiopterin. Lower availability of NO leads to vascular dysfunction and can 
cause hypertension. In the present study, SBP was found to be lower following the 
eight-week intervention period, which may be a reflection of the increase in 
circulating nitrate. Natural foods that can chronically increase nitrate and have a 
consequent blood pressure-lowering effect would be a substantial development in 
treatments to reduce hypertension. Furthermore, there was good compliance with the 
beetroot supplement provided, which is important for the application of this food to 
longer-term intervention studies. 
 
Longer-term supplementation with beetroot also shows promise as a beneficial 
dietary component for gut and cognitive health, which recent evidence suggests may 
be linked (Leung & Thuret, 2015). Beetroot consumption was found to increase total 
SCFA production, which is a marker for overall gut health due to the effect of SCFAs 
such as butyrate and acetate on inflammation, gut wall integrity and cancer cell 
apoptosis. Butyrate specifically has anti-inflammatory actions on both the gut and the 
brain (Noble et al., 2017) and concentrations were found to rise by 99% following the 
eight-week intervention period. This is particularly important in older adults, as this 
populations has lower levels of butyrate due to a reduction in the bacteria that 
produce it (Biagi et al., 2013). Beetroot consumption had an additional effect on gut 
bacterial with analysis displaying an increase in diversity compared with the control 
food. More diversity in gut bacteria may increase numbers of SCFA-producing 
bacteria and therefore improve gut health. Overall, these benefits to gut health are 
likely to due to the prolonged intervention period and would not be evident in an 
acute setting. Similarly, any improvements to cognitive function that are linked to the 
gut microbiome would manifest after long-term supplementation. However, 
improvements in cognition function with dietary nitrate have been linked to increased 
CBF due to a rise in NO production (Presley et al., 2011; Wightman et al., 2015). In 
this thesis, cognitive function was not assessed acutely, so it is unclear as to the 
effects of whole beetroot in this setting. However, the eight-week intervention with 
beetroot was found to improve indices of cognitive function related to speed i.e. 
cognitive reaction time and memory retrieval speed. This may be related to the 
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chronic rise in plasma nitrate seen in Chapter 4 or the increase in SCFA production 
and bacterial diversity in the gut. Whilst cognitive decline into old age cannot be 
prevented, it may be possible to slow the rate of decline and improvements in 
cognitive reaction time could prove beneficial to ADLs and independence in later life.  
6.4 Public health perspectives 
One major benefit of the research conducted during this thesis is the applicability of 
results in a real-world setting. Although beetroot has been reformulated into a 
number of products such as gels and juices, the acceptability and benefit of these 
supplements long-term is debatable. These products are a more concentrated form 
of dietary nitrate and other potentially active compounds but they lack fibre, are 
higher in sugar and are costlier than the whole vegetable. This study found that 
whole beetroot was well tolerated both acutely and over a more prolonged period, 
with high compliance with the interventions in both studies. The consistent 
consumption of whole beetroot for longer than eight weeks may then be tolerable 
both for future research interventions and in the everyday diet of the population.  
 
In young participants, the consumption of whole beetroot acutely lowered SBP by up 
to 7.3mmHg and DBP by up to 5.1mmHg, which, if maintained, would significantly 
lower the risk of stroke and CHD (Collins et al., 1990). The longer-term study in 
Chapter 4 demonstrated a reduction in SBP by 7.8mmHg in an older population. As 
between 45% and 66.5% of adults over the age of 55 are class as hypertensive, a 
reduction in SBP to the extent demonstrated here could reduce some of the burden 
and risk of hypertension in the UK. More long-term studies are required to fully 
elucidate the chronic blood pressure-lowering effects of dietary nitrate. 
 
Another public health concern is the lack of fibre intake in the general population and 
the negative effects of this on the GI system (Kendall et al., 2010; Marlett et al., 
2002). As mentioned, processing of beetroot, and many other vegetables and fruit, 
into juices and other concentrated forms removes fibre and limits the scope of the 
benefits of consuming these products. Vegetables in their whole form offer benefits 
beyond the activity of an isolated compound, combining fibre with synergistic effects 
of antioxidants, phenolic compounds and vitamins and minerals. The study in 
Chapter 4 was the first to examine the effects of whole beetroot on the gut 
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microbiome but the promising results suggest an improvement in markers of gut 
health. With research on the importance of the gut to overall health in its early 
stages, the preliminary results shown here may lead to significant developments in 
the research surrounding population health. 
6.5 Future research 
While a number of interesting findings emerged from the studies in this thesis, there 
are also areas that warrant further investigation and replication. As mentioned, the 
lack of effect on blood pressure in the old group compared to the young merits 
exploration into the mechanisms behind age-related differences in the nitrate-nitrite-
NO pathway. One such mechanism is the uptake of nitrate into the salivary system, 
which is regulated by the nitrate-transporter sialin. While it was outside the scope of 
this thesis to investigate this transporter specifically, future research on the saliva 
samples taken may begin to elucidate the mechanisms behind the lower plasma 
nitrite levels evident in an ageing population. 
 
Despite in vitro and rodent studies illustrating the potent effects of betalains from 
beetroot and other foods such as the protection of red blood cells and LDLs from 
oxidation (Esatbeyoglu et al., 2015; Sawicki et al., 2016), their low bioavailability and 
the lack of standards for analysis have limited the scope of research in human 
intervention studies. The antioxidant capacity of betalains may be important in the 
cerebrovascular system, which is particularly vulnerable to oxidative stress, and in 
older populations in which oxidative stress is concomitant with the ageing process. 
Therefore, specific analysis into plasma levels of betalains or the accumulation of this 
compound in areas susceptible to oxidative stress may benefit the body of research 
on beetroot. Furthermore, on a similar note, research into the low-grade inflammation 
associated with ageing and therapeutic approaches to reducing it may affect markers 
of functional capacity. Justice et al. (2015) suggest that improvements seen in motor 
function in old mice may be related to a reduction in low-grade inflammation in the 
muscles; this analysis could be replicated in human volunteers. 
 
The investigation into cognition in this study could have benefitted from the 
assessment of cerebral blood flow (CBF) and further investigation into the correlation 
between CBF and cognitive function following beetroot supplementation. Wightman 
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et al. (2015) for example, found heightened CBF acutely following beetroot juice 
consumption and subsequent improvements in cognitive function. It is unclear as to 
whether chronic improvements in cognition, potentially related to a persistent 
increase in circulating nitrate, would be correlated with CBF but it is worthy of further 
examination. 
 
A limit to the application of this series of investigations in public health, and one that 
was mentioned in relation to functional capacity, is the use of healthy participants 
throughout. A healthy cohort allowed for an accurate representation of the age-
related differences in pharmacokinetics and bioavailability in this thesis but limits the 
application in diseased populations. Continuing the investigations from this thesis into 
populations with hypertension or cognitive impairment may demonstrate additional 
benefits of beetroot consumption or highlight further deficits in the nitrate-nitrite-NO 
pathway with age-related disease. Either way, studies including more at-risk 
populations would increase the applicability of the work on beetroot and physiological 
outcomes. 
6.6 Conclusion 
In conclusion, the series of investigations in this thesis have provided evidence that 
whole beetroot is a well-accepted intervention food that can effectively raise nitrite 
and NO levels in both young and old populations. Furthermore, prolonged 
consumption of this vegetable can have a positive effect on blood pressure, gut 
bacterial diversity and cognitive function, making it a beneficial and under-used whole 
food and dietary staple. The mechanisms behind the nitrate-nitrite-NO pathway that 
lead to physiological benefits following beetroot consumption need to be further 
explored in an ageing population and in those more at risk of the deleterious effects 
of low NO availability such as cognitively impaired and hypertensive patients. 
 
  
 187 
Reference list 
Anhê, F. F., Pilon, G., Roy, D., Desjardins, Y., Levy, E. & Marette, A. (2016) 
Triggering Akkermansia with Dietary Polyphenols: A New Weapon to Combat 
the Metabolic Syndrome? Gut microbes [Online], 7 (2), pp. 146–153.  
Appel, L. J., Brands, M. W., Daniels, S. R., Karanja, N., Elmer, P. J. & Sacks, F. M. 
(2006) Dietary Approaches to Prevent and Treat Hypertension: A Scientific 
Statement from the American Heart Association. Hypertension, 47 (2), pp. 296–
308. 
Asgary, S., Afshani, M. R., Sahebkar, A., Keshvari, M., Taheri, M., Jahanian, E., 
Rafieian-Kopaei, M., Malekian, F. & Sarrafzadegan, N. (2016) Improvement of 
Hypertension, Endothelial Function and Systemic Inflammation Following Short-
Term Supplementation with Red Beet (Beta Vulgaris L.) Juice: A Randomized 
Crossover Pilot Study. Journal of Human Hypertension, 30 (10), pp. 627–632. 
Asgary, S., Rastqar, A. & Keshvari, M. (2018) Functional Food and Cardiovascular 
Disease Prevention and Treatment: A Review. Journal of the American College 
of Nutrition [Online], 37 (5), pp. 429–455. 
Ashor, A. W., Chowdhury, S., Oggioni, C., Qadir, O., Brandt, K., Ishaq, A., Mathers, 
J. C., Saretzki, G. & Siervo, M. (2016) Inorganic Nitrate Supplementation in 
Young and Old Obese Adults Does Not Affect Acute Glucose and Insulin 
Responses but Lowers Oxidative Stress. Journal of Nutrition [Online], 146 (11), 
pp. 2224–2232.  
Ashworth, A., Mitchell, K., Blackwell, J. R., Vanhatalo, A. & Jones, A. M. (2015) High-
Nitrate Vegetable Diet Increases Plasma Nitrate and Nitrite Concentrations and 
Reduces Blood Pressure in Healthy Women. Public Health Nutrition, 18 (14), pp. 
2669–2678. 
Avogaro, A., Toffolo, G., Kiwanuka, E., Kreutzenberg, S. V. De, Tessari, P. & Cobelli, 
C. (2003) L-Arginine-Nitric Oxide Kinetics in Normal and Type 2 Diabetic 
Subjects: A Stable-Labelled 15N Arginine Approach. Diabetes, 52 (3), pp. 795–
802. 
Avoort, C. M. T. van der, Loon, L. J. C. van, Hopman, M. T. E. & Verdijk, L. B. (2018) 
Increasing Vegetable Intake to Obtain the Health Promoting and Ergogenic 
Effects of Dietary Nitrate. European Journal of Clinical Nutrition [Online], pp. 1–
5.  
  
 188 
Babateen, A. M., Fornelli, G., Donini, L. M., Mathers, J. C. & Siervo, M. (2018) 
Assessment of Dietary Nitrate Intake in Humans: A Systematic Review. The 
American Journal of Clinical Nutrition [Online], 108 (4), pp. 878–888.  
Bailey, S. J., Fulford, J., Vanhatalo, A., Winyard, P. G., Blackwell, J. R., Dimenna, F. 
J., Wilkerson, D. P., Benjamin, N. & Jones, A. M. (2010) Dietary Nitrate 
Supplementation Enhances Muscle Contractile Efficiency during Knee-Extensor 
Exercise in Humans. J Appl Physiol, 109, pp. 135–148. 
Bar-Shai, M., Carmeli, E., Ljubuncic, P. & Reznick, A. Z. (2008) Exercise and 
Immobilization in Aging Animals: The Involvement of Oxidative Stress and NF-
ΚB Activation. 
Barry, E., Galvin, R., Keogh, C., Horgan, F. & Fahey, T. (2014) Is the Timed Up and 
Go Test a Useful Predictor of Risk of Falls in Community Dwelling Older Adults: 
A Systematic Review and Meta- Analysis. BMC Geriatrics, 14 (1). 
Bartsch, H., Ohshima, H. & Pignatelli, B. (1988) Inhibitors of Endogenous Nitrosation 
Mechanisms and Implications in Human Cancer Prevention. Mutation Research 
- Fundamental and Molecular Mechanisms of Mutagenesis, 202 (2), pp. 307–
324. 
Basu, A., Rhone, M. & Lyons, T. J. (2010) Berries: Emerging Impact on 
Cardiovascular Health Arpita. Nutrition Reviews [Online], 68 (3), pp. 168–177.  
Bazzano, L. A., He, J., Ogden, L. G., Loria, C. M., Vupputuri, S., Myers, L. & 
Whelton, P. K. (2002) Fruit and Vegetable Intake and Risk of Cardiovascular 
Disease in US Adults : The First National Health and Nutrition Examination 
Survey Epidemiologic Follow-up Study 1 – 3. 
Beek, C. M. van der, Dejong, C. H. C., Troost, F. J., Masclee, A. A. M. & Lenaerts, K. 
(2017) Role of Short-Chain Fatty Acids in Colonic Inflammation, Carcinogenesis, 
and Mucosal Protection and Healing. Nutrition Reviews, 75 (4), pp. 286–305. 
Beghetti, M., Puigdefabregas, J. W. B. & Merali, S. (2014) Sildenafil for the 
Treatment of Pulmonary Hypertension in Children. Expert Review of 
Cardiovascular Therapy, 12 (10), pp. 1157–1184. 
Belkaid, Y. & Hand, T. (2014) Role of Microbiota in Immunity and Inflammation. Cell, 
157 (1), pp. 121–141. 
Bell, L., Lamport, D. J., Field, D. T., Butler, L. T. & Williams, C. M. (2018) Practice 
Effects in Nutrition Intervention Studies with Repeated Cognitive Testing. 
Nutrition and Healthy Aging, 4 (4), pp. 309–322. 
  
 189 
Benetou, V., Orfanos, P., Lagiou, P., Trichopoulos, D., Boffetta, P. & Trichopoulou, A. 
(2008) Vegetables and Fruits in Relation to Cancer Risk: Evidence from the 
Greek EPIC Cohort Study. Cancer Epidemiology Biomarkers and Prevention, 17 
(2), pp. 387–392. 
Benjamin, N., O’Driscoll, F., Dougall, H., Duncan, C., Smith, L., Golden, M. & 
McKenzie, H. (1994) Stomach NO Synthesis. Nature, 368, p. 502. 
Bescús, R., Rodríguez, F. A., Iglesias, X., Ferrer, M. D., Iborra, E. & Pons, A. (2011) 
Acute Administration of Inorganic Nitrate Reduces V̇O2peak in Endurance 
Athletes. Medicine and Science in Sports and Exercise, 43 (10), pp. 1979–1986. 
Biagi, E., Candela, M., Turroni, S., Garagnani, P., Franceschi, C. & Brigidi, P. (2013) 
Ageing and Gut Microbes: Perspectives for Health Maintenance and Longevity. 
Pharmacological Research [Online], 69 (1), pp. 11–20.  
Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J., Monti, D., 
Satokari, R., Franceschi, C., Brigidi, P. & Vos, W. de (2010) Through Ageing, 
and beyond: Gut Microbiota and Inflammatory Status in Seniors and 
Centenarians. PLoS ONE, 5 (5). 
Biagi, E., Rampelli, S., Turroni, S., Quercia, S., Candela, M. & Brigidi, P. (2017) The 
Gut Microbiota of Centenarians: Signatures of Longevity in the Gut Microbiota 
Profile. Mechanisms of Ageing and Development [Online], 165, pp. 180–184.  
Björne, H., Petersson, J., Phillipson, M., Weitzberg, E., Holm, L. & Lundberg, J. O. 
(2004) Nitrite in Saliva Increases Gastric Mucosal Blood Flow. Journal of Clinical 
Investigation, 113 (1), pp. 106–114. 
Blacher, J., Asmar, R., Djane, S., London, G. M. & Safar, M. E. (1999) Aortic Pulse 
Wave Velocity as a Marker of Cardiovascular Risk in Hypertensive Patients. 
Hypertension [Online], 33 (5), pp. 1111–1117.  
Blekkenhorst, L. C., Lewis, J. R., Prince, R. L., Devine, A., Bondonno, N. P., 
Bondonno, C. P., Wood, L. G., Puddey, I. B., Ward, N. C., Croft, K. D., 
Woodman, R. J., Beilin, L. J. & Hodgson, J. M. (2018) Nitrate-Rich Vegetables 
Do Not Lower Blood Pressure in Individuals with Mildly Elevated Blood Pressure: 
A 4-Wk Randomized Controlled Crossover Trial. [Online], 9 (June), pp. 894–908.  
Bloomfield, D. A. & Park, A. (2017) Decoding White Coat Hypertension. World 
Journal of Clinical Cases [Online], 5 (3), p. 82. 
Bogdan, C. (2001) Nitric Oxide and the Immune Response. Nature Immunology, 2 
(10), pp. 907–916. 
  
 190 
Bohannon, R. W. (2006) Reference Values for the Timed Up and Go Test. Journal of 
Geriatric Physical Therapy [Online], 29 (2), pp. 64–68.  
Bondonno, C. P., Croft, K. D., Ward, N., Considine, M. J. & Hodgson, J. M. (2015) 
Dietary Flavonoids and Nitrate: Effects on Nitric Oxide and Vascular Function. 
Nutrition Reviews, 73 (4), pp. 216–235. 
Bondonno, C.P., Croft, K.D., Hodgson, J.M. (2015). Dietary nitrate, nitric oxide, and 
cardiovascular health. Critical Reviews in Food Science and Nutrition, 56 (12), 
pp. 2036-2052. 
Bondonno, C. P., Liu, A. H., Croft, K. D., Ward, N. C., Shinde, S., Moodley, Y., 
Lundberg, J. O., Puddey, I. B., Woodman, R. J. & Hodgson, J. M. (2015) 
Absence of an Effect of High Nitrate Intake from Beetroot Juice on Blood 
Pressure in Treated Hypertensive Individuals: A Randomized Controlled Trial. 
American Journal of Clinical Nutrition, 102 (2), pp. 368–375. 
Britton, E. & McLaughlin, J. T. (2013) Ageing and the Gut. Proceedings of the 
Nutrition Society, 72 (1), pp. 173–177. 
Brown, G., Rumsey, J., Worth, I., Lee, D. & Scaife, A. (2016) Food Statistics 
Pocketbook 2016. National Statistics, pp. 1–62. 
Bryan, N. S. (2015) The Potential Use of Salivary Nitrite as a Marker of NO Status in 
Humans. Nitric Oxide - Biology and Chemistry, 45, pp. 4–6. 
Bryan, N. S. & Ivy, J. L. (2015) Inorganic Nitrite and Nitrate: Evidence to Support 
Consideration as Dietary Nutrients. Nutrition Research [Online], 35 (8), pp. 643–
654.  
Buckner, R. L. (2004) Memory and Executive Function in Aging and AD: Multiple 
Factors That Cause Decline and Reserve Factors That Compensate. Neuron, 44 
(1), pp. 195–208. 
Bult, H., Boechxstaens, G., Pelckmans, P., Jordaens, F., Maercke, Y. Van & 
Herman, A. (1990) Nitric Oxide as an Inhibitory Non-Adrenergic Non-Cholinergic 
Neurotransmitter. Nature, 345 (6273), pp. 346–347. 
Butler, A. R. & Feelisch, M. (2008) Therapeutic Uses of Inorganic Nitrite and Nitrate: 
From the Past to the Future. Circulation, 117 (16), pp. 2151–2159. 
Cai, Y. Z., Sun, M. & Corke, H. (2003) Antioxidant Activity of Betalains from Plants of 
the Amaranthaceae. J Agric Food Chem, 51 (8), pp. 2288–2294. 
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., 
Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., Marcos, A., Margioris, A., 
  
 191 
Matusheski, N., Nordmann, H., O’Brien, J., Pugliese, G., Rizkalla, S., Schalkwijk, 
C., Tuomilehto, J., Wärnberg, J., Watzl, B. & Winklhofer-Roob, B. M. (2011) 
Dietary Factors and Low-Grade Inflammation in Relation to Overweight and 
Obesity. British Journal of Nutrition [Online], 106 (S3), pp. S5–S78.  
Caldwell, K., Charlton, K. E., Roodenrys, S. & Jenner, A. (2016) Anthocyanin-Rich 
Cherry Juice Does Not Improve Acute Cognitive Performance on RAVLT. 
Nutritional Neuroscience [Online], 19 (9), pp. 423–424.  
Campanella, B., Onor, M., Pagliano, E. (2017). Rapid determination of nitrate in 
vegetables by gas chromatography mass spectometry. Analytica Chimica, Acta, 
980, pp 33-40. 
Cani, P. D. (2018) Human Gut Microbiome: Hopes, Threats and Promises. Gut, 67 
(9), pp. 1716–1725. 
Canizzo, E., Clement, C., Sahu, R., Follo, C. & Santambrogio, L. (2011) Oxidative 
Stress, Inflammaging, and Immunosenescence. Journal of Proteonomics 
[Online], 74, pp. 2313–2323.  
Cao, G., Russell, R., Lischner, N. & Prior, R. (1998) Serum Antioxidant Capacity Is 
Increased by Consumption of Strawberries, Spinach, Red Wine or Vitamin C in 
Elderly Women. The Journal of nutrition, 128 (12), pp. 2383–2390. 
Carasca, C., Magdas, A., Tilea, I. & Incze, A. (2017) Assessment of Post-Occlusive 
Reactive Hyperaemia in the Evaluation of Endothelial Function in Patients with 
Lower Extremity Artery Disease. Acta Medica Marisiensis [Online], 63 (3), pp. 
129–132.  
Carberry, P. a, Shepherd, A. M. M. & Johnson, J. M. (1992) Resting and Maximal 
Forearm Skin Blood Flows Are Reduced in Hypertension. Hypertension, 20 (3), 
pp. 349–355. 
Carosio, S., Berardinelli, M. G., Aucello, M. & Musarò, A. (2011) Impact of Ageing on 
Muscle Cell Regeneration. Ageing Research Reviews, 10 (1), pp. 35–42. 
Casey, D. P., Treichler, D. P., Ganger, C. T., Schneider, A. C. & Ueda, K. (2015) 
Acute Dietary Nitrate Supplementation Enhances Compensatory Vasodilation 
during Hypoxic Exercise in Older Adults. Journal of Applied Physiology [Online], 
118 (2), pp. 178–186.  
Celidoni, M., Dal Bianco, C. & Weber, G. (2017) Retirement and Cognitive Decline. A 
Longitudinal Analysis Using SHARE Data. Journal of Health Economics [Online], 
56 December, pp. 113–125.  
  
 192 
Chapman, T. H., Wilde, M., Sheth, A. & Madden, B. P. (2009) Sildenafil Therapy in 
Secondary Pulmonary Hypertension: Is There Benefit in Prolonged Use? 
Vascular Pharmacology, 51 (2–3), pp. 90–95. 
Cheng, H. M., Cheng, H. K. & George, T. W. (2015) The Effect of Red and Yellow 
Beetroot Juices on Blood Pressure in Free-Living Normotensive Males: A Pilot 
Study. Proceedings of the Nutrition Society [Online], 74 (OCE5), p. E333.  
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. 
L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T. & Roccella, E. J. 
(2003) Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42 
(6), pp. 1206–1252. 
Claesson, M. J., Jeffery, I. B. & O’Toole, P. W. (2012) Gut Microbiota Composition 
Correlates with Dit and Health in the Elderly. Nature, 488, pp. 178–184. 
Clifford, T., Babateen, A., Shannon, O. M., Capper, T., Ashor, A., Stephan, B., 
Robinson, L., O’Hara, J. P., Mathers, J. C., Stevenson, E. & Siervo, M. (2018) 
Effects Of Inorganic Nitrate And Nitrite Consumption On Cognitive Function And 
Cerebral Blood Flow: A Systematic Review And Meta-Analysis Of Randomised 
Clinical Trials. Critical Reviews in Food Science and Nutrition [Online], 4 (0), pp. 
1–11.  
Clifford, T., Constantinou, C. M., Keane, K. M., West, D. J., Howatson, G. & 
Stevenson, E. J. (2017) The Plasma Bioavailability of Nitrate and Betanin from 
Beta Vulgaris Rubra in Humans. European Journal of Nutrition, 56 (3), pp. 1245–
1254. 
Close, G. L., Kayani, A., Vasilaki, A. & McArdle, A. (2005) Skeletal Muscle Damage 
with Exercise and Aging. Sports Medicine, 35 (5), pp. 413–427. 
Coldham, F., Lewis, J. & Lee, H. (2006) The Reliability of One vs. Three Grip Trials in 
Symptomatic and Asymptomatic Subjects. Journal of Hand Therapy, 19 (3), pp. 
318–327. 
Coles, L. T. & Clifton, P. M. (2012) Effect of Beetroot Juice on Lowering Blood 
Pressure in Free-Living, Disease-Free Adults: A Randomized, Placebo-
Controlled Trial. Nutrition Journal [Online], 11 (1), p. 1.  
Collerton, J., Collerton, D., Arai, Y., Barrass, K., Eccles, M., Jagger, C., McKeith, I., 
Saxby, B. K., Kirkwood, T., Bond, J., James, O., Robinson, L. & Zglinicki, T. Von 
(2007) A Comparison of Computerized and Pencil-and-Paper Tasks in 
  
 193 
Assessing Cognitive Function in Community-Dwelling Older People in the 
Newcastle 85+ Pilot Study. Journal of the American Geriatrics Society, 55 (10), 
pp. 1630–1635. 
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., 
MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., Hennekens, C. H., 
Fiebach, N. H., Qizilbash, N. & Hennekens, C. H. (1990) Blood Pressure, Stroke, 
and Coronary Heart Disease. The Lancet, 335 (8693), pp. 827–838. 
Corner, L. & Bond, J. (2004) Being at Risk of Dementia: Fears and Anxieties of Older 
Adults. Journal of Aging Studies, 18 (2), pp. 143–155. 
Cosby, K., Partovi, K., Crawford, J., Patel, R., Reiter, C., Martyr, S., Yang, B., 
Waclawiw, M., Zalos, G., Xu, X., Huang, K., Shields, H., Kim-Shapiro, D. B., 
Schechter, A. N., Cannon, R. O. & Gladwin, M. T. (2003) Nitrite Reduction to 
Nitric Oxide by Deoxyhemoglobin Vasodilates the Human Circulation. Nature 
medicine, 9 (12), pp. 1498–1505. 
Cracowski, J. L., Minson, C. T., Salvat-Melis, M. & Halliwill, J. R. (2006) 
Methodological Issues in the Assessment of Skin Microvascular Endothelial 
Function in Humans. Trends in Pharmacological Sciences, 27 (9), pp. 503–508. 
Craig, C., Marshall, A., Sjostrom, A., Bauman, A., Booth, M., Ainsworth, B., Pratt, M., 
Ekelund, U., Yngve, A., Sallis, J. & Oja, P. (2003) International Physical Activity 
Questionnaire: 12-Country Reliability and Validity. Medicine and Science in 
Sports and Exercise, 35 (8), pp. 1381–1395. 
Dahl, W., Agro, N., Eliasson, A., Mialki, K., Olivera, J., Rusch, C. & Young, C. (2017) 
Health Benefits of Fiber Fermentation. J Am Coll Nutr, 36 (2), pp. 127–136. 
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, 
B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., Biddinger, S. B., 
Dutton, R. J. & Turnbaugh, P. J. (2014) Diet Rapidly and Reproducibly Alters the 
Human Gut Microbiome. Nature [Online], 505 (7484), pp. 559–563.  
Deary, I. J., Corley, J., Gow, A. J., Harris, S. E., Houlihan, L. M., Marioni, R. E., 
Penke, L., Rafnsson, S. B. & Starr, J. M. (2009) Age-Associated Cognitive 
Decline. British Medical Bulletin, 92 (1), pp. 135–152. 
Dede, D. S., Yavuz, B., Yavuz, B. B., Cankurtaran, M., Halil, M., Ulger, Z., 
Cankurtaran, E. S., Aytemir, K., Kabakci, G. & Ariogul, S. (2007) Assessment of 
Endothelial Function in Alzheimer’s Disease: Is Alzheimer’s Disease a Vascular 
Disease? Journal of the American Geriatrics Society, 55 (10), pp. 1613–1617. 
  
 194 
Dejam, A., Hunter, C. J., Tremonti, C., Pluta, R. M., Hon, Y. Y., Grimes, G., Partovi, 
K., Pelletier, M. M., Oldfield, E. H., Cannon, R. O., Schechter, A. N. & Gladwin, 
M. T. (2007) Nitrite Infusion in Humans and Nonhuman Primates: Endocrine 
Effects, Pharmacokinetics, and Tolerance Formation. Circulation, 116 (16), pp. 
1821–1831. 
Delp, M. D., Behnke, B. J., Spier, S. A., Wu, G. & Muller-Delp, J. M. (2008) Ageing 
Diminishes Endothelium-Dependent Vasodilatation and Tetrahydrobiopterin 
Content in Rat Skeletal Muscle Arterioles. Journal of Physiology, 586 (4), pp. 
1161–1168. 
DeVan, A. E., Johnson, L. C., Brooks, F. A., Evans, T. D., Justice, J. N., 
Cruickshank-Quinn, C., Reisdorph, N., Bryan, N. S., McQueen, M. B., Santos-
Parker, J. R., Chonchol, M. B., Bassett, C. J., Sindler, A. L., Giordano, T. & 
Seals, D. R. (2016) Effects of Sodium Nitrite Supplementation on Vascular 
Function and Related Small Metabolite Signatures in Middle-Aged and Older 
Adults. Journal of Applied Physiology [Online], 120 (4), pp. 416–425. 
Dressel, H., la Motte, D. de, Reichert, J., Ochmann, U., Petru, R., Angerer, P., Holz, 
O., Nowak, D. & Jörres, R. A. (2008) Exhaled Nitric Oxide: Independent Effects 
of Atopy, Smoking, Respiratory Tract Infection, Gender and Height. Respiratory 
Medicine, 102 (7), pp. 962–969. 
Duncan, C., Dougall, H., Johnston, P., Green, S., Brogan, R., Leifert, C., Smith, L., 
Golden, M. & Benjamin, N. (1995) Chemical Generation of Nitric Oxide in the 
Mouth from the Enterosalivary Circulation of Dietary Nitrate. Nature medicine, 1 
(6), pp. 546–551. 
Duncan, C., Li, H., Dykhuizen, R., Frazer, R., Johnston, P., MacKnight, G., Smith, L., 
Lamza, K., McKenzie, H., Batt, L., Kelly, D., Golden, M., Benjamin, N. & Leifert, 
C. (1997) Protection against Oral and Gastrointestinal Diseases: Importance of 
Dietary Nitrate Intake, Oral Nitrate Reduction and Enterosalivary Nitrate 
Circulation. Comparative Biochemistry and Physiology - A Physiology, 118 (4), 
pp. 939–948. 
Duncan, S. H. & Flint, H. J. (2013) Probiotics and Prebiotics and Health in Ageing 
Populations. Maturitas [Online], 75 (1), pp. 44–50.  
Duncan, S. H., Lobley, G. E., Holtrop, G., Ince, J., Johnstone, A. M., Louis, P. & Flint, 
H. J. (2008) Human Colonic Microbiota Associated with Diet, Obesity and 
Weight Loss. International Journal of Obesity, 32 (11), pp. 1720–1724. 
  
 195 
Dweik, R. A., Boggs, P. B., Erzurum, S. C., Irvin, C. G., Leigh, M. W., Lundberg, J. 
O., Olin, A., Plummer, A. L., Taylor, D. R., Thoracic, A. & Committee, S. (2011) 
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide 
Levels (FENO) for Clinical Applications. Am J Respir Crit Care Med, 184, pp. 
602–615. 
Ecobici, M. & Stoicescu, C. (2017) Arterial Stiffness and Hypertension - Which 
Comes First? Maedica [Online], 12 (3), pp. 184–190.  
Egashira, K., Inou, T., Hirooka, Y., Kai, H., Sugimachi, M., Suzuki, S., Kuga, T., 
Urabe, Y. & Takeshita, A. (1993) Effects of Age on Endothelium-Dependent 
Vasodilation of Resistance Coronary Artery by Acetylcholine in Humans. 
Circulation, 88 (1), pp. 77–81. 
Eggebeen, J., Kim-Shapiro, D. B., Haykowsky, M., Morgan, T. M., Basu, S., 
Brubaker, P., Rejeski, J. & Kitzman, D. W. (2016) One Week of Daily Dosing 
With Beetroot Juice Improves Submaximal Endurance and Blood Pressure in 
Older Patients With Heart Failure and Preserved Ejection Fraction. JACC: Heart 
Failure, 4 (6), pp. 428–437. 
Esatbeyoglu, T., Wagner, A. E., Schini-Kerth, V. B. & Rimbach, G. (2015) Betanin-A 
Food Colorant with Biological Activity. Molecular Nutrition and Food Research, 
59, pp. 36–47. 
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., 
Chalmers, J., Rodgers, A. & Rahimi, K. (2016) Blood Pressure Lowering for 
Prevention of Cardiovascular Disease and Death: A Systematic Review and 
Meta-Analysis. The Lancet [Online], 387 (10022), pp. 957–967.  
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, 
Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., Vos, W. M. de & Cani, P. D. 
(2013) Cross-Talk between Akkermansia Muciniphila and Intestinal Epithelium 
Controls Diet-Induced Obesity. Proceedings of the National Academy of 
Sciences [Online], 110 (22), pp. 9066–9071. 
Everard, K. M., Lach, H. W., Fisher, E. B. & Baum, M. C. (2000) Relationship of 
Activity and Social Support to the Functional Health of Older Adults. The 
Journals of Gerontology Series B: Psychological Sciences and Social Sciences 
[Online], 55 (4), pp. S208–S212.  
Fang, J. (2014) Bioavailability of Anthocyanins. Drug Metabolism Reviews, 46 (4), 
pp. 508–520. 
  
 196 
Faria, A., Fernandes, I., Norberto, S., Mateus, N. & Calhau, C. (2014) Interplay 
between Anthocyanins and Gut Microbiota. Journal of Agricultural and Food 
Chemistry, 62 (29), pp. 6898–6902. 
Fava, F., Rizzetto, L. & Tuohy, K. M. (2018) Gut Microbiota and Health: Connecting 
Actors across the Metabolic System. Proceedings of the Nutrition Society 
[Online], (June), pp. 1–12.  
Ferrari, A. U., Radaelli, A. & Centola, M. (2003) Aging and the Cardiovascular 
System. Journal of Applied Physiology [Online], 95 (6), pp. 2591–2597. Available 
from: <http://jap.physiology.org/lookup/doi/10.1152/japplphysiol.00601.2003>. 
Ferrucci, L., Harris, T., Guralnik, J., Tracy, R., Corti, M., Cohen, H., Penninx, B., 
Pahor, M., Wallace, R. & Havlik, R. (1999) Serum IL-6 Level and the 
Development of Disability in Older Persons. Journal of the American Geriatrics 
Society, 47 (6), pp. 639–646. 
Finley, J. W., Burrell, J. B. & Reeves, P. G. (2007) Pinto Bean Consumption Changes 
SCFA Profiles in Fecal Fermentations, Bacterial Populations of the Lower Bowel, 
and Lipid Profiles in Blood of Humans. The Journal of nutrition [Online], 137 (11), 
pp. 2391–2398.  
Forman, J.P., Rimm, E.B., Stampfer, M.J., Curham, G.C. (2005). Folate intake and 
the risk of incident hypertension among US women. JAMA, 293 (3), pp. 320-329. 
Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. 
P., Invidia, L., Celani, L., Scurti, M., Cevenini, E., Castellani, G. C. & Salvioli, S. 
(2007) Inflammaging and Anti-Inflammaging: A Systemic Perspective on Aging 
and Longevity Emerged from Studies in Humans. Mechanisms of Ageing and 
Development, 128 (1), pp. 92–105. 
Frank, D. N., Amand, A. L. S., Feldman, R. A., Boedeker, E. C., Harpaz, N. & Pace, 
N. R. (2007) Molecular-Phylogenetic Character- Isation of Microbial Community 
Imbalances in Human Inflammatory Bowel Diseases. Proc Natl Acad Sci U S A, 
104 (34), pp. 13780–13785. 
Frank, T., Stintzing, F. C., Carle, R., Bitsch, I., Quaas, D., Straß, G., Bitsch, R. & 
Netzel, M. (2005) Urinary Pharmacokinetics of Betalains Following Consumption 
of Red Beet Juice in Healthy Humans. Pharmacological Research, 52 (4), pp. 
290–297. 
Garaschuk, O., Semchyshyn, H. M. & Lushchak, V. I. (2018) Healthy Brain Aging: 
Interplay between Reactive Species, Inflammation and Energy Supply. Ageing 
  
 197 
Research Reviews, 43, pp. 26–45. 
Gates, P. E., Boucher, M. L., Silver, A. E., Monahan, K. D. & Seals, D. R. (2007) 
Impaired Flow-Mediated Dilation with Age Is Not Explained by L-Arginine 
Bioavailability or Endothelial Asymmetric Dimethylarginine Protein Expression. 
Journal of Applied Physiology [Online], 102 (1), pp. 63–71.  
Gault, M. L. & Willems, M. E. T. (2013) Aging, Functional Capacity and Eccentric 
Exercise Training. Aging and Disease [Online], 4 (6), pp. 351–363. 
Gee, L. C. & Ahluwalia, A. (2016) Dietary Nitrate Lowers Blood Pressure: 
Epidemiological, Pre-Clinical Experimental and Clinical Trial Evidence. vol. 18. 
Georgiev, V. G., Weber, J., Kneschke, E. M., Denev, P. N., Bley, T. & Pavlov, A. I. 
(2010) Antioxidant Activity and Phenolic Content of Betalain Extracts from Intact 
Plants and Hairy Root Cultures of the Red Beetroot Beta Vulgaris Cv. Detroit 
Dark Red. Plant Foods for Human Nutrition, 65 (2), pp. 105–111. 
Gibson, G. R. (1999) Dietary Modulation of the Human Gut Microflora Using the 
Prebiotics Oligofructose and Inulin. The Journal of Nutrition [Online], 129 (7), p. 
1438S–1441S.  
Gilchrist, M., Winyard, P. G., Aizawa, K., Anning, C., Shore, A. & Benjamin, N. (2013) 
Effect of Dietary Nitrate on Blood Pressure, Endothelial Function, and Insulin 
Sensitivity in Type 2 Diabetes. Free Radical Biology and Medicine [Online], 60, 
pp. 89–97.  
Gilchrist, M., Winyard, P. G., Fulford, J., Anning, C., Shore, A. C. & Benjamin, N. 
(2014) Dietary Nitrate Supplementation Improves Reaction Time in Type 2 
Diabetes: Development and Application of a Novel Nitrate-Depleted Beetroot 
Juice Placebo. Nitric Oxide - Biology and Chemistry [Online], 40, pp. 67–74.  
Girouard, H. & Iadecola, C. (2006) Neurovascular Coupling in the Normal Brain and 
in Hypertension, Stroke, and Alzheimer Disease. J Appl Physiol, 100, pp. 328–
335. 
Goldberg, T. E., Harvey, P. D., Wesnes, K. A., Snyder, P. J. & Schneider, L. S. 
(2015) Practice Effects Due to Serial Cognitive Assessment: Implications for 
Preclinical Alzheimer’s Disease Randomized Controlled Trials. Alzheimer’s and 
Dementia: Diagnosis, Assessment and Disease Monitoring [Online], 1, pp. 103–
111.  
González, C. A., Pera, G., Agudo, A., Bueno-De-Mesquita, H. B., Ceroti, M., Boeing, 
H., Schulz, M., Giudice, G. Del, Plebani, M., Carneiro, F., Berrino, F., Sacerdote, 
  
 198 
C., Tumino, R., Panico, S., Berglund, G., Simán, H., Hallmans, G., Stenling, R., 
Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J. R., Allen, N., 
Key, T. J., Bingham, S., Day, N. E., Linseisen, J., Nagel, G., Overvad, K., 
Jensen, M. K., Olsen, A., Tjønneland, A., Büchner, F. L., Peeters, P. H. M., 
Numans, M. E., Clavel-Chapelon, F., Boutron-Ruault, M. C., Roukos, D., 
Trichopoulou, A., Psaltopoulou, T., Lund, E., Casagrande, C., Slimani, N., 
Jenab, M. & Riboli, E. (2006) Fruit and Vegetable Intake and the Risk of 
Stomach and Oesophagus Adenocarcinoma in the European Prospective 
Investigation into Cancer and Nutrition (EPIC-EURGAST). International Journal 
of Cancer, 118 (10), pp. 2559–2566. 
Goodrich, J. K., Rienzi, S. C. Di, Poole, A. C., Koren, O., Walters, W. A., Caporaso, 
J. G., Knight, R. & Ley, R. E. (2014) Conducting a Microbiome Study. Cell 
[Online], 158 (2), pp. 250–262.  
Govoni, M., Jansson, E. A., Weitzberg, E. & Lundberg, J. O. (2008) The Increase in 
Plasma Nitrite after a Dietary Nitrate Load Is Markedly Attenuated by an 
Antibacterial Mouthwash. Nitric Oxide - Biology and Chemistry [Online], 19 (4), 
pp. 333–337.  
Guo, F. H., Comhair, S. A. A., Zheng, S., Dweik, R. A., Eissa, N. T., Thomassen, M. 
J., Calhoun, W. & Erzurum, S. C. (2000) Molecular Mechanisms of Increased 
Nitric Oxide (NO) in Asthma: Evidence for Transcriptional and Post-Translational 
Regulation of NO Synthesis. The Journal of Immunology [Online], 164 (11), pp. 
5970–5980. 
Gupta, A., Butts, B., Kwei, K., Dvorakova, K., Stratton, S., Briehl, M. & Bowden, G. 
(2001) Attenuation of Catalase Activity in the Malignant Phenotype Plays a 
Functional Role in an in Vitro Model for Tumor Progression. Cancer Letters, 173 
(2), pp. 115–125. 
Gutterman, D. D., Chabowski, D. S., Kadlec, A. O., Durand, M. J., Freed, J. K., Ait-
Aissa, K. & Beyer, A. M. (2016) The Human Microcirculation: Regulation of Flow 
and Beyond. Circulation Research, 118 (1), pp. 157–172. 
Haber, G., Heaton, K., Murphy, D. & Burroughs, L. (1977) Depletion and Disruption 
of Dietary Fibre: Effects on Satiety, Plasma-Glucose, and Serum-Insulin. Lancet, 
2 (8040), pp. 679–682. 
Hairi, N., Cumming, R., Naganathan, V., Handelsman, D., Couteur, D. Le, Creasey, 
H., Waite, L., Seibel, M. & Sambrook, P. (2010) Loss of Muscle Strength, Mass 
  
 199 
(Sarcopenia), and Quality (Specific Force) and Its Relationship with Functional 
Limitation and Physical Disability: The Concord Health and Ageing in Men 
Project. The American Geriatrics Society, 58, pp. 2055–2062. 
Hall, M. W., Singh, N., Ng, K. F., Lam, D. K., Goldberg, M. B., Tenenbaum, H. C., 
Neufeld, J. D., Beiko, R. G. & Senadheera, D. B. (2017) Inter-Personal Diversity 
and Temporal Dynamics of Dental, Tongue, and Salivary Microbiota in the 
Healthy Oral Cavity. npj Biofilms and Microbiomes [Online], 3 (1), pp. 0–1.  
Hallberg, L., Brune, M. & Rossander-Hulthen, L. (1989) Is There a Physiological Role 
of Vitamin C in Iron Absorption? Annals of the New York Academy of Sciences, 
498 (1), pp. 324–332. 
Harman, D. (1956) Aging: A Theory Based on Free Radical and Radiation Chemistry. 
Journals of Gerontology, 11, pp. 298–300. 
Hasler, C. M. (2002) Functional Foods: Benefits, Concerns and Challenges-a 
Position Paper from the American Council on Science and Health. The Journal 
of nutrition [Online], 132 (12), pp. 3772–3781.  
Heerdt, B. G., Houston, H. & Augenlicht, L. H. (1997) Fatty Acid-Initiated Apoptosis 
Cell Cycle Arrest and Cells Is Linked to Mitochondrial Function. Cell growth & 
differentiation, 8 (May), pp. 523–532. 
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A., Hibberd, 
M. L., Forssberg, H. & Pettersson, S. (2011) Normal Gut Microbiota Modulates 
Brain Development and Behavior. Proceedings of the National Academy of 
Sciences [Online], 108 (7), pp. 3047–3052.  
Heiss, C., Dejam, A. & Kleinbongard, P. (2003) Vascular Effects of Cocoa Rich in 
Flavan-3-Ols. Jama, 290 (8), pp. 1030–1031. 
Hinojosa, E., Boyd, A. R. & Orihuela, C. J. (2009) Age‐Associated Inflammation and 
Toll‐Like Receptor Dysfunction Prime the Lungs for Pneumococcal Pneumonia. 
The Journal of Infectious Diseases, 200 (4), pp. 546–554. 
Hobbs, D. A., Kaffa, N., George, T. W., Methven, L. & Lovegrove, J. A. (2012) Blood 
Pressure-Lowering Effects of Beetroot Juice and Novel Beetroot-Enriched Bread 
Products in Normotensive Male Subjects. British Journal of Nutrition, 108 (11), 
pp. 2066–2074. 
Holland, C., Smith, E., Csapo, I., Gurol, M., Brylka, D., Killiany, R., Blacker, D., 
Albert, M., Guttmann, C. & Greenberg, S. (2008) Spatial Distribution of White-
Matter Hyperintensities in Alzheimer Disease, Cerebral Amyloid Angiopathy, and 
  
 200 
Healthy Aging. Stroke, 39 (4), pp. 1127–1133. 
Hord, N. G., Tang, Y. & Bryan, N. S. (2009) Food Sources of Nitrates and Nitrites: 
The Physiologic Context for Potential Health Benefits. American Journal of 
Clinical Nutrition, 90, pp. 1–10. 
Houghton, D., Stewart, C. J., Stamp, C., Nelson, A., Aj Ami, N. J., Petrosino, J. F., 
Wipat, A., Trenell, M. I., Turnbull, D. M. & Greaves, L. C. (2018) Impact of Age-
Related Mitochondrial Dysfunction and Exercise on Intestinal Microbiota 
Composition. Journals of Gerontology - Series A Biological Sciences and 
Medical Sciences, 73 (5), pp. 571–578. 
Howdon, D. & Rice, N. (2018) Health Care Expenditures, Age, Proximity to Death 
and Morbidity: Implications for an Ageing Population. Journal of Health 
Economics, 57, pp. 60–74. 
Hughes, W. E., Ueda, K., Treichler, D. P. & Casey, D. P. (2016) Effects of Acute 
Dietary Nitrate Supplementation on Aortic Blood Pressure and Aortic 
Augmentation Index in Young and Older Adults. Nitric Oxide - Biology and 
Chemistry [Online], 59, pp. 21–27.  
Ignarro, L. J. (2002) Nitric Oxide as a Unique Signaling Molecule in the Vascular 
System: A Historical Overview. Journal of Physiology and Pharmacology, 53 (4 
I), pp. 503–514. 
Imms, F. J., Lee, W. Sen & Ludlow, P. G. (1988) Reactive Hyperaemia in the Human 
Forearm. Quarterly Journal of Experimental Physiology, 73 (2), pp. 203–215. 
Inaba, Y., Chen, J. A. & Bergmann, S. R. (2010) Prediction of Future Cardiovascular 
Outcomes by Flow-Mediated Vasodilatation of Brachial Artery: A Meta-Analysis. 
International Journal of Cardiovascular Imaging, 26 (6), pp. 631–640. 
Jackson, J. K., Patterson, A. J., MacDonald-Wicks, L. K., Oldmeadow, C. & McEvoy, 
M. A. (2018) The Role of Inorganic Nitrate and Nitrite in Cardiovascular Disease 
Risk Factors: A Systematic Review and Meta-Analysis of Human Evidence. 
Nutrition Reviews, 76 (5), pp. 348–371. 
Jajja, A., Sutyarjoko, A., Lara, J., Rennie, K., Brandt, K., Qadir, O. & Siervo, M. 
(2014) Beetroot Supplementation Lowers Daily Systolic Blood Pressure in Older, 
Overweight Subjects. Nutrition Research [Online], 34 (10), pp. 868–875.  
James, P. E., Willis, G. R., Allen, J. D., Winyard, P. G. & Jones, A. M. (2015) Nitrate 
Pharmacokinetics: Taking Note of the Difference. Nitric Oxide - Biology and 
Chemistry [Online], 48 (3), pp. 44–50.  
  
 201 
Jeffery, I. B., O’Toole, P. W., Ohman, L., Claesson, M. J., Deane, J., Quigley, E. & 
Simren, M. (2012) An Irritable Bowel Syndrome Subtype Defined by Species-
Specific Alterations in Faecal Microbiota. Gut, 61 (7), pp. 997–1006. 
Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y., Li, J. & Liu, Y. (2015) 
Dysbiosis Gut Microbiota Associated with Inflammation and Impaired Mucosal 
Immune Function in Intestine of Humans with Non-Alcoholic Fatty Liver Disease. 
Scientific Reports, 5, pp. 1–7. 
Jin, K. (2010) Modern Biological Theories of Aging. Aging and Disease, 1 (2), pp. 72–
74. 
Jobgen, W.S., Jobgen, S.C., Li, H., Meininger, C.J., Wu, G. (2007). Analysis of nitrite 
and nitrate in biological samples using high-performance liquid chromatography. 
J Chromatogr B Analyt Technol Biomed Life Sci, 851 (1), pp. 71-82. 
Jonvik, K. L., Nyakayiru, J., Pinckaers, P. J., Senden, J. M., Loon, L. J. van & Verdijk, 
L. B. (2016) Nitrate-Rich Vegetables Increase Plasma Nitrate and Nitrite 
Concentrations and Lower Blood Pressure in Healthy Adults. The Journal of 
nutrition, 146 (5), pp. 986–993. 
Joseph, J. A., Denisova, N., Fisher, D., Bickford, P., Prior, R. & Cao, G. (1998) Age-
Related Neurodegeneration and Oxidative Stress: Putative Nutritional in 
Tervention. Neurol Clin, 16 (3), pp. 747–755. 
Joshipura, K. J., Ascherio, A., Manson, J., Stampfer, M., Rimm, E., Speizer, F., 
Hennekens, C., Spiegelman, D. & Willett, W. (1999) Fruit and Vegetable Intake 
in Relation to Risk of Ischemic Stroke. Jama [Online], 282 (13), pp. 1233–1239.  
Justice, J. N., Gioscia-Ryan, R. A., Johnson, L. C., Battson, M. L., Picciotto, N. E. de, 
Beck, H. J., Jiang, H., Sindler, A. L., Bryan, N. S., Enoka, R. M. & Seals, D. R. 
(2015) Sodium Nitrite Supplementation Improves Motor Function and Skeletal 
Muscle Inflammatory Profile in Old Male Mice. Journal of Applied Physiology 
[Online], 118 (2), pp. 163–169.  
Justice, J. N., Johnson, L. C., DeVan, A. E., Cruickshank-Quinn, C., Reisdorph, N., 
Bassett, C. J., Evans, T. D., Brooks, F. A., Bryan, N. S., Chonchol, M. B., 
Giordano, T., McQueen, M. B. & Seals, D. R. (2015) Improved Motor and 
Cognitive Performance with Sodium Nitrite Supplementation Is Related to Small 
Metabolite Signatures: A Pilot Trial in Middle-Aged and Older Adults. Aging, 7 
(11), pp. 1004–1021. 
Kaminsky, L. A. & Montoye, A. H. K. (2014) Physical Activity and Health: What Is the 
  
 202 
Best Dose? Journal of the American Heart Association, 3 (5), pp. 5–8. 
Kang, J. H., Ascherio, A. & Grodstein, F. (2005) Fruit and Vegetable Consumption 
and Cognitive Decline in Aging Women. Ann Neurol, 57, pp. 713–720. 
Kannel, W. B. (1996) Blood Pressure as a Cardiovascular Risk Factor. JAMA, 275 
(20), pp. 1571–1576. 
Kanner, J., Harel, S. & Granit, R. (2001) Betalains - A New Class of Dietary 
Cationized Antioxidants. Journal of Agricultural and Food Chemistry, 49 (11), pp. 
5178–5185. 
Kapil, V., Khambata, R. S., Robertson, A., Caulfield, M. J. & Ahluwalia, A. (2015) 
Dietary Nitrate Provides Sustained Blood Pressure Lowering in Hypertensive 
Patients: A Randomized, Phase 2, Double-Blind, Placebo-Controlled Study. 
Hypertension, 65 (2), pp. 320–327. 
Kapil, V., Milsom, A. B., Okorie, M., Maleki-Toyserkani, S., Akram, F., Rehman, F., 
Arghandawi, S., Pearl, V., Benjamin, N., Loukogeorgakis, S., MacAllister, R., 
Hobbs, A. J., Webb, A. J. & Ahluwalia, A. (2010) Inorganic Nitrate 
Supplementation Lowers Blood Pressure in Humans: Role for Nitrite-Derived No. 
Hypertension, 56 (2), pp. 274–281. 
Kapil, V., Rathod, K. S., Khambata, R. S., Bahra, M., Velmurugan, S., Purba, A., S. 
Watson, D., Barnes, M. R., Wade, W. G. & Ahluwalia, A. (2018) Sex Differences 
in the Nitrate-Nitrite-NO•pathway: Role of Oral Nitrate-Reducing Bacteria. Free 
Radical Biology and Medicine, 126 (April), pp. 113–121. 
Karlsson, F., Tremaroli, V., Nielsen, J. & Bäckhed, F. (2013) Assessing the Human 
Gut Microbiota in Metabolic Diseases. Diabetes, 62 (10), pp. 3341–3349. 
Kazimierczak, R., Hallmann, E., Lipowski, J., Drela, N., Kowalik, A., Püssa, T., Matt, 
D., Luik, A., Gozdowskif, D. & Rembiałkowska, E. (2014) Beetroot (Beta Vulgaris 
L.) and Naturally Fermented Beetroot Juices from Organic and Conventional 
Production: Metabolomics, Antioxidant Levels and Anticancer Activity. Journal of 
the Science of Food and Agriculture, 94 (13), pp. 2618–2629. 
Keane, K. M., George, T. W., Constantinou, C. L., Brown, M. A., Clifford, T. & 
Howatson, G. (2016) Effects of Montmorency Tart Cherry (Prunus Cerasus L.) 
Consumption on Vascular Function in Men with Early Hypertension. American 
Journal of Clinical Nutrition, 103, pp. 1531–1539. 
Kelly, J., Fulford, J., Vanhatalo, A., Blackwell, J. R., French, O., Bailey, S. J., 
Gilchrist, M., Winyard, P. G. & Jones, A. M. (2013) Effects of Short-Term Dietary 
  
 203 
Nitrate Supplementation on Blood Pressure, O2 Uptake Kinetics, and Muscle 
and Cognitive Function in Older Adults. AJP: Regulatory, Integrative and 
Comparative Physiology [Online], 304 (2), pp. R73–R83. 
Kelm, M. & Schrader, J. (1990) Control of Coronary Vascular Tone by Nitric Oxide. 
Circulation Research, 66 (6), pp. 1561–1575. 
Kendall, C. W. ., Esfahani, A. & Jenkins, D. J. (2010) The Link between Dietary Fibre 
and Human Health. Food Hydrocolloids [Online], 24, pp. 42–48.  
Kenjale, A. A., Ham, K. L., Stabler, T., Robbins, J. L., Johnson, J. L., VanBruggen, 
M., Privette, G., Yim, E., Kraus, W. E. & Allen, J. D. (2011) Dietary Nitrate 
Supplementation Enhances Exercise Performance in Peripheral Arterial 
Disease. Journal of Applied Physiology [Online], 110 (6), pp. 1582–1591.  
Kent, K., Charlton, K., Roodenrys, S., Batterham, M., Potter, J., Traynor, V., Gilbert, 
H., Morgan, O. & Richards, R. (2017) Consumption of Anthocyanin-Rich Cherry 
Juice for 12 Weeks Improves Memory and Cognition in Older Adults with Mild-to-
Moderate Dementia. European Journal of Nutrition, 56 (1), pp. 333–341. 
Kharitonov, S., Chung, K., Evans, D., O’Connor, B. & Barnes, P. (1996) Increased 
Exhaled Nitric Oxide in Asthma Is Mainly Derived Fom the Lower Respiratory 
Tract. American Journal of Respiratory and Critical Care Medicine, 153 (6), pp. 
1773–1780. 
Kingston, A., Collerton, J., Davies, K., Bond, J., Robinson, L., Jagger, C. (2012) 
Losing the ability in activities of daily living in the oldest old: a hierarchic disability 
scale from the Newcastle 85+ Study. PLoS One, 7 (2). 
Kodukula, K., Faller, D. V., Harpp, D. N., Kanara, I., Pernokas, J., Pernokas, M., 
Powers, W. R., Soukos, N. S., Steliou, K. & Moos, W. H. (2017) Gut Microbiota 
and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something. 
BioResearch Open Access [Online], 6 (1), pp. 123–132.  
Korpela, K., Flint, H. J., Johnstone, A. M., Lappi, J., Poutanen, K., Dewulf, E., 
Delzenne, N., Vos, W. M. De & Salonen, A. (2014) Gut Microbiota Signatures 
Predict Host and Microbiota Responses to Dietary Interventions in Obese 
Individuals. PLoS ONE, 9 (3). 
Krikorian, R., Shidler, M. D., Nash, T. A., Kalt, W., Vinqvist-Tymchuk, M. R., Shukitt-
Hale, B. & Joseph, J. A. (2010) Blueberry Supplementation Improves Memory in 
Older Adults. Journal of Agricultural and Food Chemistry, 58 (7), pp. 3996–4000. 
Kujala, T. S., Vienola, M. S., Klika, K. D., Loponen, J. M. & Pihlaja, K. (2002) Betalain 
  
 204 
and Phenolic Compositions of Four Beetroot (Beta Vulgaris) Cultivars. European 
Food Research and Technology, 214 (6), pp. 505–510. 
Kung, C. & Luscher, T. (1995) Different Mechanisms of Endothelial Dysfunction with 
Aging and Hypertension in Rat Aorta. Hypertension, 25 (2), pp. 194–200. 
Kunz, J. (2000) Initial Lesions of Vascular Aging Disease (Arteriosclerosis). 
Gerontology, 46 (6), pp. 295–299. 
la Fuente, M. De, Hernanz, A., Guayerbas, N., Alvarez, P. & Alvarado, C. (2004) 
Changes with Age in Peritoneal Macrophage Functions. Implication 
Ofleukocytes in the Oxidative Stress of Senescence. Cellular and Molecular 
Biology, 50, pp. 83–90. 
Lansley, K. E., Winyard, P. G., Fulford, J., Vanhatalo, A., Bailey, S. J., Blackwell, J. 
R., DiMenna, F. J., Gilchrist, M., Benjamin, N. & Jones, A. M. (2011) Dietary 
Nitrate Supplementation Reduces the O2 Cost of Walking and Running: A 
Placebo-Controlled Study. Journal of Applied Physiology [Online], 110 (3), pp. 
591–600.  
Lanza, G. & Crea, F. (2010) Primary Coronary Microvascular Dysfunction: Clinical 
Presentation, Pathophysiology, and Management. Circulation, 121 (21), pp. 
2317–2325. 
Lara, J., Ashor, A. W., Oggioni, C., Ahluwalia, A., Mathers, J. C. & Siervo, M. (2016) 
Effects of Inorganic Nitrate and Beetroot Supplementation on Endothelial 
Function: A Systematic Review and Meta-Analysis. European Journal of 
Nutrition, 55 (2), pp. 451–459. 
LaRoche, D. P., Greenleaf, B. L., Croce, R. V. & McGaughy, J. A. (2014) Interaction 
of Age, Cognitive Function, and Gait Performance in 50-80-Year-Olds. Age, 36 
(4). 
Larsen, F. J., Ekblom, B., Sahlin, K., Lundberg, J. O. & Weitzberg, E. (2006) Effects 
of Dietary Nitrate on Blood Pressure in Healthy Volunteers. The New England 
journal of medicine [Online], 355 (26), pp. 2792–2793.  
Lauer, T., Preik, M., Rassaf, T., Strauer, B. E., Deussen, A., Feelisch, M. & Kelm, M. 
(2001) Plasma Nitrite Rather than Nitrate Reflects Regional Endothelial Nitric 
Oxide Synthase Activity but Lacks Intrinsic Vasodilator Action. Proc Natl Acad 
Sci U S A, 23 (98), pp. 12814–12819. 
Lee, E. J., An, D., Nguyen, C. T. T., Patil, B. S., Kim, J. & Yoo, K. S. (2014) Betalain 
and Betaine Composition of Greenhouse- or Field-Produced Beetroot (Beta 
  
 205 
Vulgaris L.) and Inhibition of HepG2 Cell Proliferation. Journal of Agricultural and 
Food Chemistry, 62 (6), pp. 1324–1331. 
Legrand, D., Adriaensen, W., Vaes, B., Matheï, C., Wallemacq, P. & Degryse, J. 
(2013) The Relationship between Grip Strength and Muscle Mass (MM), 
Inflammatory Biomarkers and Physical Performance in Community-Dwelling 
Very Old Persons. Archives of Gerontology and Geriatrics, 57 (3), pp. 345–351. 
Leung, K. & Thuret, S. (2015) Gut Microbiota: A Modulator of Brain Plasticity and 
Cognitive Function in Ageing. Healthcare [Online], 3 (4), pp. 898–916.  
Li, J., O, W., Li, W., Jiang, Z.-G. & Ghanbari, H. (2013) Oxidative Stress and 
Neurodegenerative Disorders. International Journal of Molecular Sciences 
[Online], 14 (12), pp. 24438–24475.  
Lidder, S. & Webb, A. J. (2013) Vascular Effects of Dietary Nitrate (as Found in 
Green Leafy Vegetables and Beetroot) via the Nitrate-Nitrite-Nitric Oxide 
Pathway. British Journal of Clinical Pharmacology, 75 (3), pp. 677–696. 
Loef, M. & Walach, H. (2012) Fruit, Vegetables and Prevention of Cognitive Decline 
or Dementia: A Systematic Review of Cohort Studies. Journal of Nutrition, 
Health and Aging, 16 (7), pp. 626–630. 
Luciana, M. (2003) Practitioner Review: Computerized Assessment of 
Neuropsychological Function in Children: Clinical and Research Applications of 
the Cambridge Neuropsychological Testing Automated Battery (CANTAB). 
Journal of Child Psychology and Psychiatry and Allied Disciplines, 44 (5), pp. 
649–663. 
Lundberg, J. O., Feelisch, M., Björne, H., Jansson, E. Å. & Weitzberg, E. (2006) 
Cardioprotective Effects of Vegetables: Is Nitrate the Answer? Nitric Oxide - 
Biology and Chemistry, 15 (4), pp. 359–362. 
Lundberg, J. O. & Govoni, M. (2004) Inorganic Nitrate Is a Possible Source for 
Systemic Generation of Nitric Oxide. Free Radical Biology and Medicine, 37 (3), 
pp. 395–400. 
Lundberg, J. O. N., Weitzberg, E., Lundberg, J. M. & Alving, K. (1994) Intragastric 
Nitric Oxide Production in Humans: Measurements in Expelled Air. Gut, 35 (11), 
pp. 1543–1546. 
Lundberg, J. O., Weitzberg, E., Cole, J. A. & Benjamin, N. (2004) Nitrate, Bacteria 
and Human Health. Nature reviews. Microbiology, 2 (7), pp. 593–602. 
Lyons, D., Roy, S., Patel, M., Benjamin, N. & Swift, C. G. (1997) Impaired Nitric 
  
 206 
Oxide-Mediated Vasodilatation and Total Body Nitric Oxide Production in 
Healthy Old Age. Clinical Science [Online], 93 (6), pp. 519–525.  
Manassaram, D. M., Backer, L. C., Messing, R., Fleming, L. E., Luke, B. & Monteilh, 
C. P. (2010) Nitrates in Drinking Water and Methemoglobin Levels in Pregnancy: 
A Longitudinal Study. Environmental Health: A Global Access Science Source, 9 
(1), pp. 1–12. 
Marcell, T. J. (2003) Sarcopenia : Causes , Consequences , and Preventions. 
Journal of Gerontology, 58 (10), pp. 911–916. 
Marlett, J. A., McBurney, M. I. & Slavin, J. L. (2002) Health Implications of Dietary 
Fiber [Online]. vol. 102. pp. 993–1000.  
Marshall, R.S., Lazar, R.M., Pile-Spellman, J., Young, W.L., Duong, D.H., Joshi, S.,     
Ostapkovich, N. (2001) Recovery of brain function during induced cerebral 
hypoperfusion. Brain, 124 (6), pp. 1208-1217. 
Mathiowetz, V. (1984) Grip and Pinch Strength: Normative Data for Adults. 
McIlvenna, L. C., Monaghan, C., Liddle, L., Fernandez, B. O., Feelisch, M., 
Muggeridge, D. J. & Easton, C. (2017) Beetroot Juice versus Chard Gel: A 
Pharmacokinetic and Pharmacodynamic Comparison of Nitrate Bioavailability. 
Nitric Oxide - Biology and Chemistry, 64, pp. 61–67. 
McKnight, G. M., Smith, L. M., Drummond, R. S., Duncan, C. W., Golden, M. & 
Benjamin, N. (1997) Chemical Synthesis of Nitric Oxide in the Stomach from 
Dietary Nitrate in Humans. Gut, 40 (2), pp. 211–214. 
McRae, M. P. (2013) Betaine Supplementation Decreases Plasma Homocysteine in 
Healthy Adult Participants: A Meta-Analysis. Journal of Chiropractic Medicine 
[Online], 12 (1), pp. 20–25.  
Mellion, T. B., Ignarro, L. J., Ohlstein, E. H., Pontecorvo, E. G., Hyman, A. L. & 
Kadowitz, P. J. (1981) Evidence for the Inhibitory Role of Guanosine 3’,5’-
Monophosphate in ADP-Induced Human Platelet Aggregation in the Presence of 
Nitric Oxide and Related Vasodilators. Blood, 57 (3), pp. 946–955. 
Miller, G. D., Marsh, A. P., Dove, R. W., Beavers, D., Presley, T., Helms, C., 
Bechtold, E., King, S. B. & Kim-Shapiro, D. (2012) Plasma Nitrate and Nitrite Are 
Increased by a High-Nitrate Supplement but Not by High-Nitrate Foods in Older 
Adults. Nutrition Research, 32 (3), pp. 160–168. 
Minson, C.T., Woong, B.J. (2004). Reactive hyperemia as a test of endothelial or 
microvascular function. Journal of the American College of Cardiology, 43 (11). 
  
 207 
Mitek, M., Anyzewska, A. & Wawrzyniak, A. (2013) Estimated Dietary Intakes of 
Nitrates in Vegetarians Compared to a Traditional Diet in Poland and Acceptable 
Daily Intakes: Is There a Risk? Roczniki Panstwowego Zakladu Higieny [Online], 
64 (2), pp. 105–109.  
Modin, A., Björne, H., Herulf, M., Alving, K., Weitzberg, E. & Lundberg, J. O. N. 
(2001) Nitrite-Derived Nitric Oxide: A Possible Mediator of ‘acidic-Metabolic’ 
Vasodilation. Acta Physiologica Scandinavica, 171 (1), pp. 9–16. 
Moncada, S. & Higgs, A. (1993) The L-Arginine-Nitric Oxide Pathway. N Engl J Med, 
329 (27), pp. 2002–2012. 
Moorcroft, M.J., Davis, J., Compton, R.G. (2001). Detection and determination of 
nitrate and nitrite: a review. Talanta, 54 (5), pp 785-803. 
Moore, V. C. (2012) Spirometry: Step by Step. Breathe, 8 (3), pp. 233–240. 
Morgado, M., Oliveira, G. V. De, Vasconcellos, J., Monteiro, M. L., Conte-Junior, C., 
Pierucci, A. P. T. R. & Alvares, T. S. (2016) Development of a Beetroot-Based 
Nutritional Gel Containing High Content of Bioaccessible Dietary Nitrate and 
Antioxidants. International Journal of Food Sciences and Nutrition, 67 (2), pp. 
153–160. 
Morgan, X. C. & Huttenhower, C. (2012) Human Microbiome Analysis. PLoS 
Computational Biology, 8 (12). 
Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L. & Wilson, R. S. (2006) 
Associations of Vegetable and Fruit Consumption with Age-Related Cognitive 
Change. Neurology, 67 (8), pp. 1370–1376. 
Mosconi, L. (2013) Glucose Metabolism in Normal Aging and Alzheimer’s Disease: 
Methodological and Physiological Considerations for PET Studies. Clinical and 
Translational Imaging, 1 (4). 
Nagababu, E. & Rifkind, J. M. (2007) Measurement of Plasma Nitrite by 
Chemiluminescence without Interference of S-, N-Nitroso and Nitrated Species. 
Free Radical Biology and Medicine. 
Natarajan, N. & Pluznick, J. L. (2014) From Microbe to Man: The Role of Microbial 
Short Chain Fatty Acid Metabolites in Host Cell Biology. AJP: Cell Physiology 
[Online], 307 (11), pp. C979–C985.  
Nathan, C. & Xie, Q. wen (1994) Nitric Oxide Synthases: Roles, Tolls, and Controls. 
Cell, 78 (6), pp. 915–918. 
Navaratnarajah, A. & Jackson, S. (2017) The Physiology of Ageing. Medicine in 
  
 208 
Older Adults, 45 (1), pp. 6–10. 
Netzel, M., Stintzing, F. C., Quaas, D., Straß, G., Carle, R., Bitsch, R., Bitsch, I. & 
Frank, T. (2005) Renal Excretion of Antioxidative Constituents from Red Beet in 
Humans. In: Food Research International, 2005. 
Newman, A. B., Arnold, A. M., Naydeck, B. L., Fried, L. P., Burke, G. L., Enright, P., 
Gottdiener, J., Hirsch, C. & Leary, D. O. (2003) “Successful Aging”. Archives of 
Internal Medicine, 163, pp. 2315–2322. 
NICE (2011) Hypertension in Adults: Diagnosis and Management [Online]. 
Ninfali, P. & Angelino, D. (2013) Nutritional and Functional Potential of Beta Vulgaris 
Cicla and Rubra. Fitoterapia [Online], 89 (1), pp. 188–199.  
Noble, E. E., Hsu, T. M. & Kanoski, S. E. (2017) Gut to Brain Dysbiosis: Mechanisms 
Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment. 
Frontiers in Behavioral Neuroscience [Online], 11.  
Norman, K., Stobäus, N., Gonzalez, M. C., Schulzke, J. D. & Pirlich, M. (2011) Hand 
Grip Strength: Outcome Predictor and Marker of Nutritional Status. Clinical 
Nutrition [Online], 30 (2), pp. 135–142.  
O’Sullivan, M., Jones, D., Summers, P., Morris, R., Williams, S. & Markus, H. (2001) 
Evidence for Cortical ‘“Disconnection”’ as a Mechanism of Age-Related 
Cognitive Decline. Neurology, 57 (4), pp. 632–638. 
O’Toole, P. W. & Claesson, M. J. (2010) Gut Microbiota: Changes throughout the 
Lifespan from Infancy to Elderly. International Dairy Journal [Online], 20 (4), pp. 
281–291. 
Oggioni, C., Jakovljevic, D. G., Klonizakis, M., Ashor, A. W., Ruddock, A., 
Ranchordas, M., Williams, E. & Siervo, M. (2018) Dietary Nitrate Does Not 
Modify Blood Pressure and Cardiac Output at Rest and during Exercise in Older 
Adults: A Randomised Cross-over Study. International Journal of Food Sciences 
and Nutrition [Online], 69 (1), pp. 74–83.  
Ogra, P. L. (2010) Ageing and Its Possible Impact on Mucosal Immune Responses. 
Ageing Research Reviews [Online], 9 (2), pp. 101–106.  
Olin, A. C., Aldenbratt, A., Ekman, A., Ljungkvist, G., Jungersten, L., Alving, K. & 
Torén, K. (2001) Increased Nitric Oxide in Exhaled Air after Intake of a Nitrate-
Rich Meal. Respiratory Medicine, 95 (2), pp. 153–158. 
Oliveira, G. V. de, Morgado, M., Pierucci, A. P. & Alvares, T. S. (2016) A Single Dose 
of a Beetroot-Based Nutritional Gel Improves Endothelial Function in the Elderly 
  
 209 
with Cardiovascular Risk Factors. Journal of Functional Foods [Online], 26, pp. 
301–308.  
Omar, S. A., Artime, E. & Webb, A. J. (2012) A Comparison of Organic and Inorganic 
Nitrates/Nitrites. Nitric Oxide - Biology and Chemistry [Online], 26 (4), pp. 229–
240.  
ONS (2017) National Population Projections: 2016-Based Statistical Bulletin - Office 
for National Statistics. [Online], pp. 1–10.  
Oosterman, J., Harten, B. Van, Weinstein, H., Scheltens, P., Sergeant, J. & 
Scherder, E. (2008) White Matter Hyperintensities and Working Memory: An 
Explorative Study. Neuropsycol Dev Cogn, 15 (3), pp. 384–399. 
Pacher, P., Beckman, J. S. & Liaudet, L. (2007) Nitric Oxide and Peroxynitrite in 
Health and Disease. Physiological Reviews, 87 (1), pp. 315–424. 
Padayatty, S., Katz, A., Wang, Y., Eck, P. & Kwon, O. (2003) Vitamin C as an 
Antioxidant: Evaluation of Its Role in Disease Prevention. Journal of the 
American College of Cardiology, 22 (1), pp. 18–35. 
Palmer, R. M. J., Rees, D. D., Ashton, D. S. & Moncada, S. (1988) L-Arginine Is the 
Physiological Precursor for the Formation of Nitric Oxide in Endothelium-
Dependent Relaxation. Biochemical and Biophysical Research Communications, 
153 (3), pp. 1251–1256. 
Pandey, K. B. & Rizvi, S. I. (2009) Plant Polyphenols as Dietary Antioxidants in 
Human Health and Disease. Oxidative Medicine and Cellular Longevity, 2 (5), 
pp. 270–278. 
Pannala, A. S., Mani, A. R., Spencer, J. P. E., Skinner, V., Bruckdorfer, K. R., Moore, 
K. P. & Rice-Evans, C. A. (2003) The Effect of Dietary Nitrate on Salivary, 
Plasma, and Urinary Nitrate Metabolism in Humans. Free Radical Biology and 
Medicine, 34 (5), pp. 576–584. 
Parkar, S. G., Trower, T. M. & Stevenson, D. E. (2013) Fecal Microbial Metabolism of 
Polyphenols and Its Effects on Human Gut Microbiota. Anaerobe [Online], 23, 
pp. 12–19.  
Patel, R. S., Mheid, I. Al, Morris, A. A., Ahmed, Y., Kavtaradze, N., Ali, S., 
Dabhadkar, K., Brigham, K., Hooper, W. C., Alexander, R. W., Jones, D. P. & 
Quyyumi, A. A. (2011) Oxidative Stress Is Associated with Impaired Arterial 
Elasticity. Atherosclerosis [Online], 218 (1), pp. 90–95.  
Penninx, B., Ferrucci, L., Leveille, S., Rantanen, T., Pahor, M. & Guralnik, J. (2000) 
  
 210 
Lower Extremity Performance in Nondisabled Older Persons as a Predictor of 
Subsequent Hospitalization. J Gerontol A Biol Sci Med Sci, 55 (11), pp. M691-7. 
Percival, R. S., Challacombe, S. J. & Marsh, P. D. (1991) Age-Related 
Microbiological Changes in the Salivary and Plaque Microflora of Healthy Adults. 
Journal of Medical Microbiology, 35 (1), pp. 5–11. 
Peters, R. (2006) Ageing and the Brain. Postgraduate Medical Journal, 82, pp. 84–
88. 
PHE (2017) Salt Reduction Targets for 2017 About Public Health England. 
Pinder, A. G., Rogers, S. C., Khalatbari, A., Ingram, T. E. & James, P. E. (2008) The 
Measurement of Nitric Oxide and Its Metabolites in Biological Samples by 
Ozone-Based Chemiluminescence [Online]. In: Methods in Molecular Biology. 
vol. 476.  
Powlson, D. S., Addiscott, T. M., Benjamin, N., Cassman, K. G., Kok, T. M. de, 
Grinsven, H. van, L’hirondel, J.-L., Avery, A. A. & Kessel, C. van (2008) When 
Does Nitrate Become a Risk for Humans? Journal of Environment Quality 
[Online], 37 (2), p. 291.  
Presley, T. D., Morgan, A. R., Bechtold, E., Clodfelter, W., Dove, R. W., Jennings, J. 
M., Kraft, R. A., Bruce King, S., Laurienti, P. J., Jack Rejeski, W., Burdette, J. H., 
Kim-Shapiro, D. B. & Miller, G. D. (2011) Acute Effect of a High Nitrate Diet on 
Brain Perfusion in Older Adults. Nitric Oxide - Biology and Chemistry [Online], 24 
(1), pp. 34–42. 
Pribis, P. & Shukitt-Hale, B. (2014) Cognition: The New Frontier for Nuts and Berries. 
American Journal of Clinical Nutrition, 100 (SUPPL. 1). 
Public Health England (2015) McCance and Widdowson’s Composition of Foods 
Integrated Dataset. [Online].  
Public Health England (2018) National Diet and Nutrition Survey: Results from Years 
7 and 8 (Combined) of the Rolling Programme (2014/2015 to 2015/2016). PHE 
Publications [Online], 8.  
Qu, X. M., Wu, Z. F., Pang, B. X., Jin, L. Y., Qin, L. Z. & Wang, S. L. (2016) From 
Nitrate to Nitric Oxide: The Role of Salivary Glands and Oral Bacteria. Journal of 
Dental Research, 95 (13), pp. 1452–1456. 
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J. & 
Glockner, F. (2013) The SILVA Ribosomal RNA Gene Database Project: 
Improved Data Processing and Web-Based Tools. Nucleic Acids Research, 41, 
  
 211 
pp. D5990–D596. 
Rabbitt, P., Scott, M., Thacker, N., Lowe, C., Jackson, A., Horan, M. & Pendleton, N. 
(2006) Losses in Gross Brain Volume and Cerebral Blood Flow Account for Age-
Related Differences in Speed but Not in Fluid Intelligence. Neuropsychology, 20 
(5), pp. 549–557. 
Raitakari, O. T. & Celermajer, D. S. (2000) Flow-Mediated Dilatation. Br J Clin 
Pharmacol, 50, pp. 397–404. 
Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, 
G. & Nishigaki, I. (2013) The Vascular Endothelium and Human Diseases. 
International Journal of Biological Sciences, 9 (10), pp. 1057–1069. 
Rammos, C., Hendgen-Cotta, U. B., Sobierajski, J., Bernard, A., Kelm, M. & Rassaf, 
T. (2014) Dietary Nitrate Reverses Vascular Dysfunction in Older Adults with 
Moderately Increased Cardiovascular Risk. Journal of the American College of 
Cardiology [Online], 63 (15), pp. 1584–1585.  
Ranu, H., Wilde, M. & Madden, B. (2011) Pulmonary Function Tests. The Ulster 
medical journal [Online], 80 (2), pp. 84–90.  
Raubenheimer, K., Hickey, D., Leveritt, M., Fassett, R., Munoz, J. O. D. Z., Allen, J. 
D., Briskey, D., Parker, T. J., Kerr, G., Peake, J. M., Pecheniuk, N. M. & 
Neubauer, O. (2017) Acute Effects of Nitrate-Rich Beetroot Juice on Blood 
Pressure, Hemostasis and Vascular Inflammation Markers in Healthy Older 
Adults: A Randomized, Placebo-Controlled Crossover Study. Nutrients, 9 (11). 
Rein, M. J., Renouf, M., Cruz-Hernandez, C., Actis-Goretta, L., Thakkar, S. K. & Silva 
Pinto, M. da (2013) Bioavailability of Bioactive Food Compounds: A Challenging 
Journey to Bioefficacy. British Journal of Clinical Pharmacology, 75 (3), pp. 588–
602. 
Ricciardolo, F. L. M. (2004) Nitric Oxide in Health and Disease of the Respiratory 
System. Physiological Reviews [Online], 84 (3), pp. 731–765.  
Rink, S. M., Mendola, P., Mumford, S. L., Poudrier, J. K., Browne, R. W., Wactawski-
Wende, J., Perkins, N. J. & Schisterman, E. F. (2013) Self-Report of Fruit and 
Vegetable Intake That Meets the 5 a Day Recommendation Is Associated with 
Reduced Levels of Oxidative Stress Biomarkers and Increased Levels of 
Antioxidant Defense in Premenopausal Women. Journal of the Academy of 
Nutrition and Dietetics [Online], 113 (6), pp. 776–785.  
Robinson, K., Arheart, K., Refsum, H., Brattström, L., Ueland, P., Rubba, P., Palma-
  
 212 
reis, R., Meleady, R., Witteman, J., Graham, I., Robinson, K., Arheart, K., 
Refsum, H. & Brattstro, L. (1998) Low Circulating Folate and Vitamin B 6 
Concentrations Risk Factors for Stroke , Peripheral Vascular Disease , and 
Coronary. 
Ruitenberg, A., Heijer, T. den, Bakker, S., Swieten, J. van, Koudstaal, P., Hofman, A. 
& Breteler, M. (2005) Cerebral Hypoperfusion and Clinical Onset of Dementia: 
The Rotterdam Study. Ann Neurol, 57 (6), pp. 789–794. 
Rutherford, T. (2012) Population Ageing: Statistics. House of Commons library 
[Online], (February), pp. 1–8.  
Saffrey, M. J. (2014) Aging of the Mammalian Gastrointestinal Tract: A Complex 
Organ System. Age, 36 (3), pp. 1019–1032. 
Salles, N. (2007) Basic Mechanisms of the Aging Gastrointestinal Tract. Dig Dis 
[Online], 25, pp. 112–117.  
Salminen, A., Huuskonen, J., Ojala, J., Kauppinen, A., Kaarniranta, K. & Suuronen, 
T. (2008) Activation of Innate Immunity System during Aging: NF-KB Signaling Is 
the Molecular Culprit of Inflamm-Aging. Ageing Research Reviews, 7 (2), pp. 
83–105. 
Saul, R. L., Kabir, S. H., Bruce, W. R., Archer, M. C. & Cohen, Z. (1981) 
Reevaluation of Nitrate and Nitrite Levels in the Human Intestine. Cancer 
Research, 41 (6), pp. 2280–2283. 
Sawicki, T., Bączek, N. & Wiczkowski, W. (2016) Betalain Profile, Content and 
Antioxidant Capacity of Red Beetroot Dependent on the Genotype and Root 
Part. Journal of Functional Foods, 27, pp. 249–261. 
Scahill, R., Frost, C., Jenkins, R., Whitwell, J., Rossor, M. & Fox, N. (2003) A 
Longitudinal Study of Brain Volume Changes in Normal Aging Using Serial 
Registered Magnetic Resonance Imaging. Archives of Neurology, 60 (7), pp. 
989–994. 
Scalbert, A., Manach, C., Morand, C., Rémésy, C. & Jiménez, L. (2005) Dietary 
Polyphenols and the Prevention of Diseases. Critical Reviews in Food Science 
and Nutrition, 45 (4), pp. 287–306. 
Schini-Kerth, V. B., Auger, C., Kim, J. H., Etienne-Selloum, N. & Chataigneau, T. 
(2010) Nutritional Improvement of the Endothelial Control of Vascular Tone by 
Polyphenols: Role of NO and EDHF. European Journal of Physiology, 459 (6), 
pp. 853–862. 
  
 213 
Schini-Kerth, V. B., Auger, C., Kim, J. H., Étienne-Selloum, N. & Chataigneau, T. 
(2010) Nutritional Improvement of the Endothelial Control of Vascular Tone by 
Polyphenols: Role of NO and EDHF. Pflugers Archiv European Journal of 
Physiology, 459 (6), pp. 853–862. 
Schoental, R. (1963) Induction of Tumours of Stomach in Rats and Mice by N-
Nitroso- N-Alkylurethanes. Nature, 13 (199), p. 190. 
Scholey, A. (2018) Nutrients for Neurocognition in Health and Disease: Measures, 
Methodologies and Mechanisms. Proceedings of the Nutrition Society, 77 (1), 
pp. 73–83. 
Schulz, E., Anter, E. & Keaney, J. F. (2004) Oxidative Stress, Antioxidants, and 
Endothelial Function. Current Medicinal Chemistry, 11 (9), pp. 1093–1104. 
Schwiertz, A., Lehmann, U., Jacobasch, G. & Blaut, M. (2002) Influence of Resistant 
Starch on the SCFA Production and Cell Counts of Butyrate-Producing 
Eubacterium Spp. in the Human Intestine. Journal of Applied Microbiology, 93 
(1), pp. 157–162. 
Scott-Warren, V. & Maguire, S. (2017) Physiology of Ageing. Anaesthesia and 
Intensive Care Medicine [Online], 18 (1), pp. 52–54.  
Scott, K. P., Duncan, S. H. & Flint, H. J. (2008) Dietary Fibre and Gut Microbiota. 
Nutrition Bulletin, 33 (3), pp. 201–211. 
Sepúlveda, C., Palomo, I. & Fuentes, E. (2015) Primary and Secondary Haemostasis 
Changes Related to Aging. Mechanisms of Ageing and Development [Online], 
150, pp. 46–54.  
Sergis, N., Jackman, C. M., Masters, A., Krimigis, S. M., Thomsen, M. F., Hamilton, 
D. C., Mitchell, D. G., Dougherty, M. K. & Coates, A. J. (2013) Particle and 
Magnetic Field Properties of the Saturnian Magnetosheath: Presence and 
Upstream Escape of Hot Magnetospheric Plasma. Journal of Geophysical 
Research: Space Physics [Online], 118 (4), pp. 1620–1634.  
Sessa, W. C. (2004) ENOS at a Glance. Journal of Cell Science, 117 (12), pp. 2427–
2429. 
Shannon, O. M., Duckworth, L., Barlow, M. J., Woods, D., Lara, J., Siervo, M. & 
O’Hara, J. P. (2016) Dietary Nitrate Supplementation Enhances High-Intensity 
Running Performance in Moderate Normobaric Hypoxia, Independent of Aerobic 
Fitness. Nitric Oxide - Biology and Chemistry [Online], 59, pp. 63–70. 
Shannon, O.M., McGawley, K., Nyback, L., Duckworth, L., Barlow, M.J., Woods, D., 
  
 214 
Siervo, M., O'Hara, J.P. (2017). "Beet-ing" the mountain: a review of the 
physiological and performance effects of dietary nitrate supplementation at 
simulated and terrestrial altitude. Sports Medicine, 47 (11), pp. 2155-2169.  
Shepherd, A. I., Wilkerson, D. P., Dobson, L., Kelly, J., Winyard, P. G., Jones, A. M., 
Benjamin, N., Shore, A. C. & Gilchrist, M. (2015) The Effect of Dietary Nitrate 
Supplementation on the Oxygen Cost of Cycling, Walking Performance and 
Resting Blood Pressure in Individuals with Chronic Obstructive Pulmonary 
Disease: A Double Blind Placebo Controlled, Randomised Control Trial. Nitric 
Oxide - Biology and Chemistry [Online], 48, pp. 31–37.  
Shiva, S. (2013) Nitrite: A Physiological Store of Nitric Oxide and Modulator of 
Mitochondrial Function. Redox Biology [Online], 1 (1), pp. 40–44.  
Shukitt-Hale, B. (1999) The Effects of Aging and Oxidative Stress on Psychomotor 
and Cognitive Behavior. Age (Omaha), 22 (1), pp. 9–17. 
Shukitt-Hale, B., Bielinski, D. F., Lau, F. C., Willis, L. M., Carey, A. N. & Joseph, J. A. 
(2015) The Beneficial Effects of Berries on Cognition, Motor Behaviour and 
Neuronal Function in Ageing. British Journal of Nutrition, 114 (10), pp. 1542–
1549. 
Siervo, M., Lara, J., Ogbonmwan, I. & Mathers, J. C. (2013) Inorganic Nitrate and 
Beetroot Juice Supplementation Reduces Blood Pressure in Adults: A 
Systematic Review and Meta-Analysis. The Journal of nutrition [Online], 143 (6), 
pp. 818–826.  
Siervo, M., Oggioni, C., Jakovljevic, D. G., Trenell, M., Mathers, J. C., Houghton, D., 
Celis-morales, C., Ashor, A. W., Ruddock, A., Ranchordas, M., Klonizakis, M. & 
Williams, E. A. (2016) ScienceDirect Dietary Nitrate Does Not Affect Physical 
Activity Outcomes in Health Older Adults in a Randomized , Crossover Trial. 
Nutrition Research [Online].  
Siervo, M., Oggioni, C., Jakovljevic, D. G., Trenell, M., Mathers, J. C., Houghton, D., 
Celis-Morales, C., Ashor, A. W., Ruddock, A., Ranchordas, M., Klonizakis, M. & 
Williams, E. A. (2016) Dietary Nitrate Does Not Affect Physical Activity 
Outcomes in Health Older Adults in a Randomized, Crossover Trial. Nutrition 
Research [Online], 36 (12), pp. 1361–1369.  
Siervo, M., Oggioni, C., Lara, J., Celis-Morales, C., Mathers, J. C., Battezzati, A., 
Leone, A., Tagliabue, A., Spadafranca, A. & Bertoli, S. (2015) Age-Related 
Changes in Resting Energy Expenditure in Normal Weight, Overweight and 
  
 215 
Obese Men and Women. Maturitas [Online], 80 (4), pp. 406–413.  
Snyder, S. H. (1992) Nitric Oxide: First in a New Class of Neurotransmitters? 
Science, 257 (5069), pp. 494–496. 
Sobko, T., Marcus, C., Govoni, M. & Kamiya, S. (2010) Dietary Nitrate in Japanese 
Traditional Foods Lowers Diastolic Blood Pressure in Healthy Volunteers. Nitric 
Oxide - Biology and Chemistry [Online], 22 (2), pp. 136–140.  
Som, S., Raha, C. & Chatterjee, I. . (1983) Ascorbic Acid: A Scavenger of 
Superoxide Radical. Acta Vitaminol Enzymol, 5 (4), pp. 243–250. 
Spiegelhalder, B., Eisenbrand, G. & Preussmann, R. (1976) Influence of Dietary 
Nitrate on Nitrite Content of Human Saliva: Possible Relevance to in Vivo 
Formation of N-Nitroso Compounds. Food Cosmet Toxicol., 14 (6), pp. 545–548. 
Stamler, J. S. & Meissner, G. (2001) Physiology of Nitric Oxide in Skeletal Muscle. 
Physiological Reviews, 81 (1), pp. 209–237. 
Steffen, T., Hacker, T. & Mollinger, L. (2002) Age- and Gender-Related Test 
Performance in Community-Dwelling Elderly People: Six-Minute Walk Test, Berg 
Balance Scale, Timed up and Go Test, and Gait Speeds. Physical Therapy, 82 
(2), pp. 128–137. 
Storey, A. (2018) Living Longer: How Our Population Is Changing and Why It 
Matters. 
Sutton-Tyrrell, K., Najjar, S. S., Boudreau, R. M., Venkitachalam, L., Kupelian, V., 
Simonsick, E. M., Havlik, R., Lakatta, E. G., Spurgeon, H., Kritchevsky, S., 
Pahor, M., Bauer, D. & Newman, A. (2005) Elevated Aortic Pulse Wave Velocity, 
a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-
Functioning Older Adults. Circulation, 111 (25), pp. 3384–3390. 
Syddall, H., Cooper, C., Martin, F., Briggs, R. & Sayer, A. A. (2003) Is Grip Strength 
a Useful Single Marker of Frailty? Age and Ageing, 32 (6), pp. 650–656. 
Szabo, C. (1996) Physiological and Pathophysiological Roles of Nitric Oxide in the 
Central Nervous System. Brain Research Bulletin, 41 (3), pp. 131–141. 
Szelenyl, J. (2001) Cytokines and the Central Nervous System. Brain Research 
Bulletin, 54 (4), pp. 329–338. 
Taddei, S., Virdis, A., Ghiadoni, L., Salvetti, G., Magagna, A., Salvetti, A. & Bernini, 
G. (2001) Age-Related Reduction of NO Availability And. Circulation, pp. 274–
279. 
Tagawa, T., Imaizumi, T., Endo, T. & et al (1994) Tole of Nitric Oxide in Reactive 
  
 216 
Hyperemia Inhuman Forearm Vessels. Circulation, 90, pp. 2285–2290. 
Tannenbaum, R., Wishnok, S. & Leaf, C. (1991) Inhibition of Nitrosamine by Ascorbic 
Acid. The American Journal of Clinical Nutrition, 53, p. 247S–250S. 
Taylor, D. R., Mandhane, P., Greene, J. M., Hancox, R. J., Filsell, S., McLachlan, C. 
R., Williamson, A. J., Cowan, J. O., Smith, A. D. & Sears, M. R. (2007) Factors 
Affecting Exhaled Nitric Oxide Measurements: The Effect of Sex. Respiratory 
Research, 8, pp. 1–9. 
Tesoriere, L., Gentile, C., Angileri, F., Attanzio, A., Tutone, M., Allegra, M. & Livrea, 
M. A. (2013) Trans-Epithelial Transport of the Betalain Pigments Indicaxanthin 
and Betanin across Caco-2 Cell Monolayers and Influence of Food Matrix. 
European Journal of Nutrition, 52 (3), pp. 1077–1087. 
Tesoriere, L., Tesoriere, L., Allegra, M., Butera, D. & Livrea, M. A. (2004) Absorption 
, Excretion , and Distribution of Dietary Antioxidant Betalains in LDLs : Potential 
Health Effects of Betalains in Humans Betalains in LDLs : Potential Health 
Effects of Betalains in Humans 1 – 3. (February 2016), pp. 941–945. 
Thijssen, D. H. J., Black, M. A., Pyke, K. E., Padilla, J., Atkinson, G., Harris, R. A., 
Parker, B., Widlansky, M. E., Tschakovsky, M. E. & Green, D. J. (2011) Reply to 
“Letter to the Editor: ‘Assessment of Flow-Mediated Dilation in Humans: A 
Methodological and Physiological Guideline’’’”’”. American Journal of Physiology-
Heart and Circulatory Physiology [Online], 300 (2), pp. H713–H713.  
Thomas, F., Hehemann, J. H., Rebuffet, E., Czjzek, M. & Michel, G. (2011) 
Environmental and Gut Bacteroidetes: The Food Connection. Frontiers in 
Microbiology, 2 (MAY), pp. 1–16. 
Tiihonen, K., Ouwehand, A. C. & Rautonen, N. (2010) Human Intestinal Microbiota 
and Healthy Ageing. Ageing Research Reviews [Online], 9 (2), pp. 107–116.  
Tilg, H. & Moschen, A. (2014) Microbiota and Diabetes: An Evolving Relationship. 
Gut, 63 (9), pp. 1513–1521. 
Ting, Y., Jiang, Y., Ho, C. T. & Huang, Q. (2014) Common Delivery Systems for 
Enhancing in Vivo Bioavailability and Biological Efficacy of Nutraceuticals. 
Journal of Functional Foods [Online], 7 (1), pp. 112–128.  
Toda, N., Ayajiki, K. & Okamura, T. (2009) Cerebral Blood Flow Regulation by Nitric 
Oxide: Recent Advances. Pharmacological Research, 61 (1), pp. 62–97. 
Torel, J., Cillard, J. & Cillard, P. (1986) Antioxidant Activity of Flavonoids and 
Reactivity with Peroxy Radical. Phytochemistry, 25 (2), pp. 383–385. 
  
 217 
Travers, J., Marsh, S., Aldington, S., Williams, M., Shirtcliffe, P., Pritchard, A., 
Weatherall, M. & Beasley, R. (2007) Reference Ranges for Exhaled Nitric Oxide 
Derived from a Random Community Survey of Adults. Am J Respir Crit Care 
Med, 176, pp. 238–242. 
Tuohy, K., Fava, F. & Viola, R. (2014) ‘The Way to a Man’s Heart Is through His Gut 
Microbiota’ - Dietary pro- and Prebiotics for the Management of Cardiovascular 
Risk. Proc Nutr Soc, 73 (2), pp. 172–185. 
Umar, A. & Iqbal, M. (2007) Nitrate Accumulation in Plants, Factors Affecting the 
Process, and Human Health Implications. A Review. Agronomy for Sustainable 
Development, 27, pp. 45–57. 
Vandeputte, D., Falony, G., Vieira-Silva, S., Tito, R. Y., Joossens, M. & Raes, J. 
(2016) Stool Consistency Is Strongly Associated with Gut Microbiota Richness 
and Composition, Enterotypes and Bacterial Growth Rates. Gut, 65 (1), pp. 57–
62. 
Vanhatalo, A., Bailey, S. J., Blackwell, J. R., DiMenna, F. J., Pavey, T., Wilkerson, D. 
P., Benjamin, N., Winyard, P. G. & Jones, A. M. (2010) Acute and Chronic 
Effects of Dietary Nitrate Supplementation on Blood Pressure and the 
Physiological Responses to Moderate-Intensity and Incremental Exercise . Am J 
Physiol Regul Integr Comp Physiol. [Online], 299 (4), pp. R1121-31.  
Vanin, A., Bevers, L., Slama-Schwok, A. & Faassen, E. van (2007) Nitric Oxide 
Synthase Reduces Nitrite to NO under Anoxia. Cell Mol Life Sci, 64 (1), pp. 96–
103. 
Velmurugan, S., Gan, J. M., Rathod, K. S., Khambata, R. S., Ghosh, S. M., Hartley, 
A., Eijl, S. Van, Sagi-kiss, V., Chowdhury, T. A., Curtis, M., Kuhnle, G. G. C. & 
Wade, W. G. (2016) Dietary Nitrate Improves Vascular Function in Patients with 
Hypercholesterolemia : A Randomized , Double-Blind , Placebo-Controlled 
Study. Am J Clin Nutr, 103 (July), pp. 25–38. 
Velzen, A. G. van, Sips, A. J. A. M., Schothorst, R. C., Lambers, A. C. & Meulenbelt, 
J. (2008) The Oral Bioavailability of Nitrate from Nitrate-Rich Vegetables in 
Humans. Toxicology Letters, 181 (3), pp. 177–181. 
Vints, A. M., Oostveen, E., Eeckhaut, G., Smolders, M. & Backer, W. A. De (2005) 
Time-Dependent Effect of Nitrate-Rich Meals on Exhaled Nitric Oxide in Healthy 
Subjects. Chest [Online], 128 (4), pp. 2465–2470. 
Vuilleumier, P., Decosterd, D., Maillard, M., Burnier, M. & Hayoz, D. (2002) 
  
 218 
Postischemic Forearm Skin Reactive Hyperemia Is Related to Cardiovascular 
Risk Factors in a Healthy Female Population. Journal of Hypertension, 20 (9), 
pp. 1753–1757. 
Wang, J., Brown, M. A., Tam, S. H., Chan, M. C. & Whitworth, J. A. (1997) Effects of 
Diet on Measurement of Nitric Oxide Metabolites. Clinical and Experimental 
Pharmacology and Physiology, 24 (6), pp. 418–420. 
Wang, Y., Branicky, R., Noë, A. & Hekimi, S. (2018) Superoxide Dismutases: Dual 
Roles in Controlling ROS Damage and Regulating ROS Signaling. Journal of 
Cell Biology, 217 (6), pp. 1915–1928. 
Webb, A. J., Patel, N., Loukogeorgakis, S., Okorie, M., Aboud, Z., Misra, S., Rashid, 
R., Miall, P., Deanfield, J., Benjamin, N., MacAllister, R., Hobbs, A. J. & 
Ahluwalia, A. (2008) Acute Blood Pressure Lowering, Vasoprotective, and 
Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite. 
Hypertension, 51 (3), pp. 784–790. 
Weitzberg, E. & Lundberg, J. O. (2013) Novel Aspects of Dietary Nitrate and Human 
Health. Annual Review of Nutrition [Online], 33 (1), pp. 129–159.  
Weller, R., Pattullo, S., Smith, L., Golden, M., Ormerod, A. & Benjamin, N. (1996) 
Nitric Oxide Is Generated on the Skin Surface by Reduction of Sweat Nitrate. 
Journal of Investigative Dermatology, 107 (3), pp. 327–331. 
Werner, P. & Korczyn, A. D. (2008) Mild Cognitive Impairment: Conceptual, 
Assessment, Ethical, and Social Issues. Clinical Interventions in Aging, 3 (3), pp. 
413–420. 
Wightman, E. L., Haskell-Ramsay, C. F., Thompson, K. G., Blackwell, J. R., Winyard, 
P. G., Forster, J., Jones, A. M. & Kennedy, D. O. (2015) Dietary Nitrate 
Modulates Cerebral Blood Flow Parameters and Cognitive Performance in 
Humans: A Double-Blind, Placebo-Controlled, Crossover Investigation. 
Physiology and Behavior [Online], 149, pp. 149–158.  
Wild, K., Howieson, D., Webbe, F., Seelye, A. & Kaye, J. (2008) The Status of 
Computerized Cognitive Testing in Aging: A Systematic Review. Alzheimer’s and 
Dementia: Diagnosis, Assessment and Disease Monitoring, 4 (6), pp. 428–437. 
Winquist, R., Bunting, P., Baskin, E. & Wallace, A. (1984) Decreased Endothelium-
Dependent Relaxation in New Zealand Genetic Hypertensive Rats. Journal of 
Hypertension, 2 (5), pp. 541–545. 
Woodmansey, E. J. (2007) Intestinal Bacteria and Ageing. Journal of Applied 
  
 219 
Microbiology, 102, pp. 1178–1186. 
Wootton-Beard, P. C., Brandt, K., Fell, D., Warner, S. & Ryan, L. (2014) Effects of a 
Beetroot Juice with High Neobetanin Content on the Early-Phase Insulin 
Response in Healthy Volunteers. Journal of Nutritional Science [Online], 3, p. e9.  
Wootton-Beard, P. C. & Ryan, L. (2011) A Beetroot Juice Shot Is a Significant and 
Convenient Source of Bioaccessible Antioxidants. Journal of Functional Foods 
[Online], 3 (4), pp. 329–334.  
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y., Keilbaugh, S. A., Bewtra, 
M., Knights, D., Walters, W. A., Knight, R., Sinha, R., Gilroy, E., Gupta, K., 
Baldassano, R., Nessel, L., Li, H., Bushman, F. & Lewis, J. (2011) Linking Long-
Term Dietary Patterns with Gut Microbial Enterotypes. 334 (October), pp. 105–
109. 
Yamamoto-Suganuma, R. & Aso, Y. (2009) Relationship between Post-Occlusive 
Forearm Skin Reactive Hyperaemia and Vascular Disease in Patients with Type 
2 Diabetes - A Novel Index for Detecting Micro- and Macrovascular Dysfunction 
Using Laser Doppler Flowmetry. Diabetic Medicine, 26, pp. 83–88. 
Yeboah, J., Crouse, J. R., Hsu, F. C., Burke, G. L. & Herrington, D. M. (2007) 
Brachial Flow-Mediated Dilation Predicts Incident Cardiovascular Events in 
Older Adults: The Cardiovascular Health Study. Circulation, 115 (18), pp. 2390–
2397. 
Yusuf, S., Reddy, S., Ôunpuu, S. & Anand, S. (2001) Clinical Cardiology : New 
Frontiers Global Burden of Cardiovascular Diseases. Clinical Cardiology, 104, 
pp. 2746–2753. 
Zhang, Z., Naughton, D., Winyard, P. G., Benjamin, N., Blake, D. R. & Symons, M. C. 
R. (1998) Generation of Nitric Oxide by a Nitrite Reductase Activity of Xanthine 
Oxidase: A Potential Pathway for Nitric Oxide Formation in the Absence of Nitric 
Oxide Synthase Activity. Biochemical and Biophysical Research 
Communications, 249 (3), pp. 767–772. 
Zhou, K. (2017) Strategies to Promote Abundance of Akkermansia Muciniphila, an 
Emerging Probiotics in the Gut, Evidence from Dietary Intervention Studies. 
Journal of Functional Foods [Online], 33, pp. 194–201.  
Zielińska-Przyjemska, M., Olejnik, A., Kostrzewa, A., Łuczak, M., Jagodziński, P. P. 
& Baer-Dubowska, W. (2012) The Beetroot Component Betanin Modulates ROS 
Production, DNA Damage and Apoptosis in Human Polymorphonuclear 
  
 220 
Neutrophils. Phytotherapy research : PTR [Online], 26 (6), pp. 845–852.   
  
 221 
Appendix A: Confirmation of NHS ethical approval 
 
  
 222 
Appendix B: Participant information sheet 
 
Participant Information Sheet 
 
Title of project: Bioavailability of phenolic compounds, betalain and inorganic 
nitrate following incremental portions of whole beetroot in older and younger 
adults. 
 
You are invited to participate in this dietary intervention study. Please take 
time to read the following information carefully. It explains why the research is 
being done and what it involves. If you have any questions about the 
information, please just ask for further explanation. Thank you for reading this. 
Discuss with others if you wish and please take time to decide whether you 
would like to take part. 
 
PART 1 
 
What is the purpose of the research project? 
 
Ageing has an effect on many systems in the body, including the ability to 
breakdown and utilise compounds within food. Beetroot is rich in nitrate and 
polyphenols, and these can have beneficial effects on the body. Younger and 
older adults however, may process these compounds differently and therefore 
their beneficial effects can be attenuated. The aim of this study is: 1) to 
assess the availability of compounds following consumption of beetroot or a 
dose of inorganic nitrate 2) to assess the effect of these compounds on 
vascular function 
 
Why have I been chosen? 
 
You have been chosen because you are healthy and of a suitable age to take 
part in this study. The project will involve 30 participants in total.  
 
Do I have to take part? 
 
Your participation is entirely voluntary and all results will be strictly 
anonymous. If you decide to take part you are still free to withdraw at any time 
without reason and without your medical care being affected. If you do decide 
to take part, you will be given this information sheet to keep and be asked to 
sign a consent form. 
 
What will the research project involve? 
 
We will contact you by phone to answer any questions you may have about 
the study. We will then ask you some questions about your medical history to 
check whether you can participate. You will not be included in the study if you 
have any medical conditions or are taking medications that will affect the 
measurements in the study. If you are a suitable participant, you will be invited 
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to attend the Clinical Research Facility (CRF) at the Royal Victoria Infirmary 
where the study will take place.  
 
Initial screening: You will arrive at the CRF for an initial screening visit, which 
should take no longer than 45 minutes. We will go through the participant 
information sheet and answer any questions. After having had time to make a 
decision, you will be asked to sign a consent form stating that you would like 
to take part in this research study. We will go through a short medical history 
questionnaire, measure your height and weight to calculate your BMI, and will 
take a resting blood pressure measurement. These results will be needed to 
decide whether you can be included in the study or not. If your BMI and blood 
pressure readings are outside a specific range, you will not be able to take 
part in the study. The visit will then conclude by taking a blood sample, which 
will amount to about two teaspoons in volume. We will provide you with all the 
information and materials necessary to continue the study. You will be asked 
to attend the CRF on a further four occasions, separated by around seven 
days, for further testing. Before each of the four visits, you will be provided 
with an evening meal to consume the day before. You will be asked to follow 
a restricted diet in the two days leading up to each visit and on the day before 
the first visit we will ask you to collect urine samples. You will also be asked to 
refrain from using anti-bacterial gum and mouthwash for the duration of the 
study. 
 
Study visits: You will attend the CRF in the morning and your blood pressure, 
blood flow and anthropometric measurements will be taken, along with a 
blood, urine and saliva sample. You will be given breakfast and will then be 
asked to consume a set amount of beetroot (100g, 200g or 300g) or will be 
given a dose of potassium nitrate in a solution. Over the next 5 hours, blood 
pressure, blood flow, and blood, urine and saliva samples will be taken at 
regular intervals. You will be fitted with a cannula for blood samples, which 
may cause slight discomfort when initially inserted but should be painless 
once in place. After the last sample has been taken, you will receive lunch 
and will then be free to leave. You will be provided with your evening meal to 
consume for that day and some sample pots to measure your urine and saliva 
over the following 12 hours. This protocol will be repeated on the following 
three visits. During the study you will be asked to complete a food diary, 
physical activity questionnaire and complete a survey to assess your 
enjoyment of the beetroot provided.  
 
Measurements and samples taken 
 
10ml of blood (about two teaspoons) will be taken at seven time points during 
the visit, to analyse the compounds in the blood following beetroot or 
potassium nitrate consumption. 70ml of blood will be taken in total for each 
visit. Blood samples will be taken using a cannula that will be inserted into 
your arm for the entirety of the visit. You will also be asked to provide urine 
and saliva samples at similar time points, which will involve simply depositing 
a sample into a designated container. Your blood pressure will be measured 
using an inflatable cuff similar to the one used in GP surgeries. We will 
measure your blood flow at the start, middle and end of the testing period, 
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using a non-invasive technique called post-occlusive reactive hyperaemia. 
This will assess whether the beetroot or potassium nitrate that you consume 
has any impact on the width of your blood vessels and how much blood flows 
through them. The final measurement will be the amount of nitric oxide that 
you exhale in your breath, called fractional exhaled nitric oxide (FeNO). 
Everyone exhales nitric oxide normally but we know that the amount you 
exhale can be influenced by diet and the amount of nitrate consumed. We will 
measure your FeNO at seven time points throughout the visit by asking you to 
breath into a handheld sensor.  
 
Expenses and payments 
 
You will receive a one-off voucher worth £100 on completion of the study, as 
long as you have completed all four visits, as compensation for your time. In 
addition, some meals will be provided the day before and day of each visit. 
Reasonable travel costs to and from the CRF will also be covered.  
 
What do I have to do? 
 
You will be asked to follow a low-nitrate and low-polyphenol diet for the two 
days leading up to each study visit and your evening meal will be provided on 
the day before each visit. A list of foods and beverages to avoid will be 
provided. You will also be given breakfast and lunch when attending the CRF 
on each day and will be provided with a meal to consume at the end of the 
visit day.  
 
What data do I need to supply? 
 
We will require your name and address or email for correspondence and for 
transport. Your details will not be linked to that data collected during the study. 
We will require your age to determine your eligibility for the study and will ask 
you for details of your medical history during a telephone screening call.  
 
What are the side effects of the treatment when taking part? 
 
Consumption of beetroot can cause beeturia, turning your urine and/or stool a 
red or pink colour. This is harmless and completely normal.  
 
Are there any other possible disadvantages of taking part? 
 
Giving up time to participate must be considered. We will be taking blood from 
a vein in your arm by inserting a cannula and it is possible that you might 
experience slight discomfort when it is being placed in the arm and/or bruising 
when it is taken out. You will be asked to follow a restricted diet in the run up 
to testing, which may be very different to your normal diet. 
 
What are the possible benefits of taking part? 
 
Beetroot counts towards your 5-a-day, so you will be giving your day a small 
health boost. Beetroot has also been found to acutely reduce blood pressure, 
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which has many benefits to health. You will have your height, weight, waist 
circumference and body fat percentage measured, which are useful to know. 
 
What happens at the end of the research project? 
 
At the end of the project, we will be able to inform you of the results of the 
study. Results will be presented with the intention to publish in scientific 
journals. All results will be presented as grouped data and your individual 
results will not be identifiable. 
 
What if there is a problem? 
 
If you have a concern or complaint about any aspect of the study, Prof Emma 
Stevenson will deal this with immediately. You can contact her on 0191 208 
7865 or write to her at the address detailed below. Medical staff are always on 
hand in the Clinical Research Facility.  
 
If you prefer to raise your concerns with someone not involved in your care, 
you can contact the Patient Advice and Liaison Service (PALS). This service 
is confidential and can be contacted on Freephone: 0800 032 0202 
 
Alternatively, if you wish to make a formal complaint you can contact the 
Patient Relations Department through any of the details below: 
 
Telephone: 0191 223 1382 or 0191 223 1454 
Email: patient.relations@nuth.nhs.uk 
Address: Patient Relations Department, The Newcastle upon Tyne Hospitals 
NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, NE7 7DN. 
 
Will my taking part in the project be kept confidential? 
 
Yes, we value your input to this project and all data gathered from you will be 
treated in the strictest of confidence. Only members of the research team will 
have access to the data, which will be stored for 5 years, and the results will 
be anonymous so you cannot be directly identified. Also, although the results 
may be published, your data will be compiled with others and available as an 
average, so again you cannot be identified. 
 
What will happen to the results of the research study? 
 
You will not be identified in any report or publication. You will be given a copy 
of the results once they are published if you wish.  
 
Who has reviewed the study? 
 
This study has been internally reviewed by the research team at Newcastle 
University and ethical review of the study has been conducted by East of 
England – Cambridge Central Research Ethics Committee.  
 
Who are the contacts for further information? 
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Tess Capper 
MoveLab, 4th Floor William Leech Building 
Newcastle University 
NE2 4HH 
0191 208 8264 
 
Prof Emma Stevenson 
Room 4.078, 4th Floor William Leech Building 
Newcastle University 
NE2 4HH 
0191 208 7865 
 
PART 2 
 
What if relevant new information becomes available? 
 
If new information is published during the course of a study, this can 
sometimes change how the research should go forward. If this happens, you 
will be notified immediately and the study will be altered accordingly.  
 
Will anyone else know that I’m doing this? 
 
We will inform your GP that you will be taking part in this study. Only 
members of the research team will have access to the data. All information 
that is collected during this research study will be kept strictly confidential and 
your name and address will be removed so that you cannot be recognised 
from it. Any information you give or data collected will be retained for a 
maximum duration of 5 years.  
 
What will happen if I don’t want to carry on with the study? 
 
You will be able to withdraw from the study at any time. Measurements 
already made would still be used if you were to agree to this.  
 
What will happen to samples taken in the study? 
 
We will take samples of blood, urine and saliva during this study. Because we 
cannot analyse all of the samples straightaway, we will need to place some of 
the samples in storage. Samples will be taken, processed and then frozen 
and stored in a controlled-access freezer in the Clinical Research Facility. 
Each sample will be anonymised using a unique participant code and cannot 
be traced back to the individual. After samples have been fully analysed they 
will be destroyed.  
 
What will happen to data from this study? 
 
Personal data will be stored in medical notes created at the Clinical Research 
Study for use during the study. Only members of the research team will have 
access to this information and hard files will be stored in a secured filing 
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cabinet behind controlled-access doors. Personal data will be anonymised by 
the Chief Investigator and thereafter only codes will be used to identify 
participant data. Clinical data will not be released to anyone other than the 
research team. All study data will be analysed at Newcastle University by 
members of the research team using statistical software. Dr Daniel West 
(Chief Investigator) will act as custodian for the data generated by the study. 
After the study has ended, files will be stored under password protection and 
in locked cabinets and archived appropriately.  
 
Who is organising and funding the research? 
 
This project is funded by Newcastle University as a PhD studentship. The 
design and organisation of the study is the responsibility of Tess Capper, Prof 
Emma Stevenson and Dr Mario Siervo, the latter of whom is recognised as an 
expert in this field.  
 
Design of this information sheet 
 
This document is written in accordance with the requirements of the European 
Clinical Trials Directive 2001/20/EC, the ICH Good Clinical Practice guidelines 
and the UK Medicines for Human Use (Clinical Trials) Regulation 2004.     
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Appendix C: Power calculation, Chapters 2 and 3 
The study found overall greater concentrations of plasma nitrate in younger 
compared to older individuals over a 3-hour sampling period and the 
estimated effect size f (partial η2) for a within-between repeated-measure 
ANOVA was 0.03 (0.175). Using these parameters in the same ANOVA 
model, we calculated that 12 participants per group (90/8=11.25) would be 
needed to detect a significant difference between doses and age groups with 
a power of 80% and P<0.05.  Sample size calculations were performed using 
G Power 3.1 for Windows. 
 
F tests - ANOVA: Repeated measures, within-between interaction 
Analysis: A priori: Compute required sample size  
Input: Effect size f = 0.1758631 
 α err prob = 0.05 
 Power (1-β err prob) = 0.80 
 Number of groups = 8 
 Number of measurements = 8 
 Corr among rep measures = 0.5 
 Nonsphericity correction ε = 0.5 
Output: Noncentrality parameter λ = 22.2680376 
 Critical F = 1.6481176 
 Numerator df = 17.5000000 
 Denominator df = 294 
 Total sample size = 90 
 Actual power = 0.8319245  
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Appendix D: Nitrate intake questionnaire, chapters 2 and 3 
NITRATE INTAKE QUESTIONAIRE 
We are interested in finding out about the amount of nitrate containing food that 
people consume as part of their everyday lives.  The questions will ask you about the 
types and frequency of food you consume in the last 7 days.  Think about all the 
foods you ate in the last 7 days. Please answer each question or ask the 
investigators in this study if there are any questions that you are still unsure of.   
 
Please tick on every line. 
 
During the last 7 days how many times did you eat the following foods ?  
 
Food Type      Frequency   
         Portion Size 
a. Green leafy vegetables            Everyday        
Small 
(Broccoli, cabbage, spinach, lettuce, etc.)                 4 – 6 days  
      Medium 
             2 – 3 days        
Large 
             0 – 1 day 
 
       Frequency  
 Portion Size 
b. Aubergine, courgette, turnip, pumpkin         Everyday        
Small 
        4 – 6 days        
Medium 
            2 – 3 days        
Large 
            0 – 1 day 
 
Frequency   
   Portion Size 
c. Canned Products           Everyday        
Small 
(Canned corn, canned peas, canned tomatoes,                4 – 6 days  
      Medium 
etc.)                                        2 – 3 days 
      Large 
            0 – 1 day 
 
Frequency   
   Portion Size 
d. Cured Meat and/or bacons          Everyday        
Small 
                 4 – 6 days        
Medium 
             2 – 3 days        
Large 
             0 – 1 day 
 
Frequency  
 Portion Size 
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e. Mature cheese              Everyday        
Small 
                 4 – 6 days        
Medium 
             2 – 3 days        
Large 
             0 – 1 day 
 
Frequency  
 Portion Size 
f. Beet and beetroot             Everyday        
Small 
                 4 – 6 days        
Medium 
             2 – 3 days        
Large 
             0 – 1 day 
 
 
Please tick every line 
During the last 7 days how many times did you eat the following foods?  
FOOD TYPE FREQUENCY 
 Everyday 4 – 6 days 2 – 3 days 0 – 1 day 
1. Fresh Cheese 
• Brie 
• Ricotta 
• Cream Cheese 
• Mozzarella 
• Others 
 
 
 
 
 
   
2. Cereals 
• Potatoes 
• Pasta 
• Rice 
• Breakfast Cereals 
• Bread 
• Savoury Biscuits 
 
 
 
 
 
 
  
   
3. Meat & Fish 
• Turkey 
• Chicken 
• Beef 
• Pork 
• Fish  
• Other 
 
 
 
 
 
 
   
4. Legumes 
• Bean 
• Peas 
• Chickpeas 
• Lentils 
    
5. Vegetables 
• Carrot 
• Cucumber 
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• Pepper 
• Tomato 
• Mushroom 
• Cauliflower 
 
 
FOOD TYPE FREQUENCY 
 Everyday 4 – 6 days 2 – 3 days 0 – 1 day 
6. Fruits 
• Apples 
• Banana 
• Strawberries 
• Peach 
• Berries 
• Others 
    
7. Sweets 
• Chocolate 
• Cakes 
• Sweets 
• Biscuits 
• Ice Cream 
    
8. Sauces 
• Ketchup 
• Mayonnaise 
• Others 
 
 
 
 
 
 
 
 
9. Dairy Product 
• Milk 
• Yogurt 
    
10. Drink 
• Caffeinated 
• Non – caffeinated  
• Soft Drinks 
• Fruit Juice 
    
 
 
THANK YOU FOR TAKING YOUR TIME TO COMPLETE THIS QUESTIONAIRE 
 
  
     
     
    
      
      
      
           
     
     
     
            
    
    
    
            
  
 232 
Appendix E: Visual analogue scale, chapters 2 and 3   
  
The palatability of the dietary intervention – beetroot 
 
This questionnaire is designed to assess how much you enjoyed the beetroot 
given to you in this visit. Please make a mark on the lines under each title 
according to how you felt about each aspect of the intervention. 
 
 
Visual appeal 
 
 
0 1 2 3 4 5 6 7 8 9 10 
Dislike very much           Like very much
           
 
Smell 
 
 
0 1 2 3 4 5 6 7 8 9 10 
Dislike very much           Like very much
     
Taste 
 
 
0 1 2 3 4 5 6 7 8 9 10 
Dislike very much           Like very much
            
 
Texture 
 
 
0 1 2 3 4 5 6 7 8 9 10 
Dislike very much           Like very much
          
 
Aftertaste 
 
 
0 1 2 3 4 5 6 7 8 9 10 
   None              Much 
 
Volume of food 
 
 
0 1 2 3 4 5 6 7 8 9 10 
Too much   
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Appendix F: Section of food diary and restricted food list 
 
DAY 1 (48 hours pre-trial 1) 
Date:        /              /  
 
Please use a separate line for each item eaten; write in weight of plate; leave a line between different ‘plate’ entries. 
A B C D E F 
 
Time Food eaten Brand name of 
each item 
(except fresh 
food) 
Full description of each item including: 
- fresh, frozen, dried, canned 
- boiled, grilled, fried, roasted 
- type of fat used for cooking 
Weight 
Served 
Weight of 
Leftovers 
Actual 
Weight 
am/pm home away  
(gms) 
 
(gms) 
 
(gms) 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
 
 
 
Dietary restrictions 
 
The foods below are high in specific polyphenols (antioxidants) and 
nitrate/nitrite so we would like you to avoid them in order to ensure that any 
changes that we see in your samples are directly a result of the beetroot or 
nitrate intervention. If you come across any other foods that you know are 
high in nitrate or antioxidants, then please avoid these too. 
 
Foods that should be AVOIDED: 
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• Tea, coffee, hot chocolate and alcohol (especially red wine, beer and 
apple cider) 
 
• Fruit juice (especially Ribena) and soft drinks (coca cola etc.) 
 
• Fruits (especially apples, pears, apricots, prunes, plums, cherries, 
peaches, blueberries and grapes) 
 
• Vegetables (especially tomatoes, asparagus, cabbage, turnips, leek, 
garlic, carrots, peppers, onions, broccoli, cauliflower and beetroot) 
 
• Salad leaves and vegetables – spinach, rocket, lettuce, chard, 
radishes, cucumber, spring onion, celery and Chinese cabbage 
 
• Chocolate and chocolate products 
 
• Wholemeal, granary and brown bread, pasta and rice 
 
• Wholegrain cereals – Weetabix, Bran Flakes, Corn Flakes, oats, muesli 
 
• Beans (baked beans and green beans), lentils and peas 
 
• Curry dishes and spices (paprika, turmeric etc.) 
 
• Herbs – parsley, dill, basil, coriander, chives etc. 
 
• Tomato sauce (ketchup, pasta sauce) 
 
• Cured meats (bacon, sausages, salami, ham, chorizo and hot dogs) 
 
 
Foods that you may eat: 
 
• White bread 
• Butter, vegetable oil (avoid olive oil) 
• White pasta, rice and noodles 
• Unprocessed meat, fish and seafood 
• Eggs 
• Peeled white potatoes (mashed, chips, roasted) 
• Mushrooms 
• Digestive biscuits, rich teas, shortbread and other plain biscuits 
• Milk and milk products (plain yoghurt, mild cheese) 
• Pastry 
• Custard and rice pudding 
• Ready salted crisps 
• Vanilla ice-cream 
• Vanilla milkshake 
• Plain scones with butter/cream (no jam) 
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You can drink water at all times 
 
 
We are aware that it may be difficult for you to follow such a diet, as it 
may differ substantially from your normal diet. The reason we ask you to 
change your normal diet is that the foods listed above contain similar 
components to what we would like to test during the intervention. 
Therefore, if you do eat the foods above, it may interfere with the study. 
 
 
Example diet 
 
Breakfast: 
• White toast with butter 
• Yoghurt or milk 
• Eggs on toast 
• Pastries (no jam or chocolate coated) 
• Waffles, pancakes 
• Rice Crispies with milk 
 
Lunch: 
• Sandwich (white bread/bagel/pitta bread/wrap/roll) with any of the 
following fillings (no salad) 
- Chicken 
- Cheese 
- Tuna 
- Egg  
- Prawns 
- Butter 
- Mayonnaise 
• Packet of crisps (plain) 
• Burger and chips 
 
Dinner: 
• Anything from breakfast or lunch options 
• Fish and chips (no ketchup) 
• Chicken pie 
• Chicken and mushrooms with rice/potato/chips/noodles 
• Macaroni cheese 
• Tuna/salmon/cod with rice or pasta (no vegetable-based sauce) 
• Steak/pork/lamb with potatoes 
• Spaghetti with mushrooms and cream sauce 
 
Snacks:  
• Digestive/rich tea/shortbread biscuits 
• Ready salted crisps 
• Natural yoghurt 
• Toast and butter 
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Appendix G: Confirmation of university ethical approval  
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Appendix H: Chapter 2 supplementary figures 
Cumulative Excretion - young 
There was a significant effect of time (P<0.001) and intervention (P<0.001) on 
urinary nitrate excretion in the young, and an interaction between the two 
factors (P=0.001). Pairwise comparisons show that excretion was significantly 
higher following PN than 100g beetroot (+144.1mg; P<0.001; 95%CI: 80.2, 
208.0) and 200g beetroot (+122.5mg; P=0.004; 95%CI: 39.5, 205.4). Post hoc 
analyses show that all doses increased excretion over the time period (all 
P<0.05) but cumulative excretion at 12-24hours was significantly higher 
following PN than 100g beetroot (+245.6mg; P<0.001; 95%CI: 126.1, 364.9) 
and 200g beetroot (+203.6mg; P=0.01; 95%CI: 40.5, 366.7). 
 
 
Cumulative urinary nitrate excretion over 24 hours following incremental 
doses of nitrate in the young group. Data presented as mean ± SEM; n=12. 
Statistical analysis using two-factor repeated measures ANOVA 
(intervention x time). BR = beetroot, PN = potassium nitrate positive 
control. 
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Cumulative Excretion – old  
There was a significant effect of time (P<0.001) and intervention (P<0.001) on 
nitrate excretion in the old group, and an interaction between the two factors 
(P=0.001). Pairwise comparisons show that excretion was significantly higher 
following PN than following 100g beetroot (+209.1mg; P=0.001; 95%CI: 99.8, 
318.4) and following 200g beetroot (+180.9mg; P=0.003; 95%CI: 68.3, 293.4), 
and there was a notable trend following 300g beetroot (+139.0mg; P=0.08; 
95%CI: -13.9, 292.1). Excretion was significantly higher than baseline at each 
time point measured (all P≤0.001). Post hoc analyses show that cumulative 
excretion at 12-24hours was significantly greater following PN than 100g 
beetroot (+359.1mg; P=0.001; 95%CI: 161.3, 556.9) and 200g beetroot 
(309.6mg; P=0.003; 95%CI: 116.6, 502.7), demonstrating a dose response.  
 
Cumulative urinary nitrate excretion over 24 hours following incremental 
doses of nitrate in the old group. Data presented as mean ± SEM; n=12. 
Statistical analysis using two-factor repeated measures ANOVA 
(intervention x time). BR = beetroot, PN = potassium nitrate positive 
control. 
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Excretion – young 
There was a significant effect of time (P=0.001) and intervention (P<0.001) on 
urinary excretion, but no interaction between the two factors (P=0.47). 
Pairwise comparisons show that excretion following PN was significantly 
higher than following 100g beetroot (+61.4mg; P<0.001; 95%CI: 31.5, 91.2) 
and following 200g beetroot (+50.9mg; P=0.01; 95%CI: 10.1, 91.7). Excretion 
was significantly higher at 6-12hours than at 0-3hours (+51.6mg; P=0.002; 
95%CI: 19.6, 83.1).  
 
Urinary nitrate excretion over 24 hours in the young group. Data presented 
as mean ± SEM; n=12. Statistical analysis using two-factor repeated 
measures ANOVA (intervention x time). BR = beetroot, PN = potassium 
nitrate positive control.  
 
Excretion – old 
There was a significant effect of time (P=0.006) and intervention (P<0.001) on 
urinary excretion in the old, but no interaction between the two factors 
(P=0.16). Pairwise comparisons show that excretion following PN was 
significantly higher than following 100g beetroot (+89.8mg; P=0.001; 95%CI: 
40.3, 139.2) and following 200g beetroot (+77.4mg; P=0.003; 95%CI: 29.1, 
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125.7). Excretion was significantly higher at 6-12hours than at 0-3hours 
(+36.7mg; P=0.02; 95%CI: 5.5, 67.8).  
 
Urinary nitrate excretion over 24 hours in the old group. Data presented as 
mean ± SEM; n=12. Statistical analysis using two-factor repeated 
measures ANOVA (intervention x time). BR = beetroot, PN = potassium 
nitrate positive control. 
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Appendix I: Short chain fatty acid analysis, Chapter 4 
 
 
Standard retention times for master mix internal control. Including: acetate 
(A), propionate (B), isobutyrate (C), butyrate (D), isovalerate (E), valerate 
(F) and 3MV (G). 
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Gas chromatography readout for a sample to determine concentration of 
acetate (A), propionate (B), isobutyrate (C), butyrate (D), isovalerate (E), 
valerate (F) and 3MV (G). 
 
  A 
 B 
  C 
D 
E F 
G 
